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ABSTRACT 
Modeling Microcephaly Caused by Inactivation of the Minor Spliceosome Using a U11 
Conditional Knockout Mouse 
Mary Baumgartner, Ph.D 
University of Connecticut, 2019 
 
The minor spliceosome is one of two pre-mRNA splicing machineries required for protein-coding 
gene expression. In multiple eukaryotic lineages, the minor spliceosome is required to remove 
<1% of introns (minor introns) from the pre-mRNA transcripts of minor intron-containing genes 
(MIGs). Despite the few minor introns in the genome, disruption of minor splicing impairs 
development in numerous species. In humans, minor spliceosome mutations are linked numerous 
developmental diseases that impact central nervous system (CNS) development. However, the role 
of minor splicing and MIG expression in mammalian CNS development and function remains 
unexplored. To address this, I characterized the expression of the minor spliceosome-specific small 
nuclear RNA (snRNA) components and MIGs in the developing mouse embryo and retina. This 
approach revealed enriched expression of the minor spliceosome-specific snRNAs in the 
developing mouse CNS and limb buds, and in differentiating retinal neurons. I next sought to 
inactivate the minor spliceosome in the developing mouse cortex (pallium) by ablating Rnu11, 
which encodes the minor spliceosome-specific U11 snRNA. In the Rnu11 conditional knockout 
(cKO) pallium, U11-null radial glial cells (RGCs) displayed DNA damage, p53 accumulation, and 
cell cycle defects, culminating in self-amplifying RGC death and microcephaly. Conversely, 
neurons appeared to survive postnatally. These results suggested that MIG expression is essential 
for cycling cell survival, but is not immediately necessary for neuron survival. To investigate this, 
I leveraged publications identifying genes essential for cycling cell survival. MIGs were 
significantly enriched in the essential gene lists, underscoring their importance for cycling cell 
survival. In parallel, I explored how the developmental defects in the Rnu11 cKO mice affected 
their behavior in adulthood. The Rnu11 mutant mice displayed heightened anxiety and significant 
social and motor behavior impairments. Unexpectedly, Rnu11 heterozygous mice showed reduced 
sociability and enhanced whole-body motor performance. These findings suggest that U11 
haploinsufficiency differentially impacts brain development/function, and identify the first 
phenotype associated with U11 haploinsufficiency. In all, these findings reveal the roles minor 
splicing plays in mammalian CNS development/function, laying the foundation for studies of 
disease pathogenesis and for research linking minor splicing to progenitor cell behavior, cell type-
specific survival, and mouse behavior.   
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Chapter 1: Minor intron splicing 
 This chapter covers the process of RNA splicing—in particular, a specific type of RNA 
splicing called minor intron splicing. Briefly, the chapter begins with an overview of RNA splicing 
research, leading up to the discovery of minor intron splicing in the 1990s. The second half of the 
chapter will focus on minor intron splicing itself, including the identification of minor introns, the 
machinery that removes them, conservation of minor intron splicing, and connections between 
minor intron splicing, development, and disease. Specifically, the relationship between disruption 
of minor intron splicing and diseases of the central nervous system will be detailed. While the 
majority of my dissertation research addresses how minor intron splicing inactivation causes 
microcephaly, I began my dissertation research by asking a broader question: how does minor 
spliceosome inactivation impact central nervous system development? Therefore, in the following 
chapters, I will expand upon the role of minor intron splicing in both systems I employed in my 
dissertation research: the developing mouse retina and the developing mouse cortex.  
 
1.1 RNA splicing 
Until the 1960s, scientists thought that eukaryotic protein-coding genes were organized 
similarly to prokaryotic genes—i.e., they were continuous, protein-coding sequences of DNA [1]. 
That theory was complicated by the results of pulse-chase experiments, in which newly transcribed 
RNA in HeLa cells was radiolabeled with tritiated uridine, often followed by application of the 
transcription inhibitor actinomycin. In these experiments, accumulation of radiolabeled RNA was 
first observed in the nucleus, followed by accumulation of radiolabeled RNA in the cytoplasm [2]. 
Notably, the nuclear radiolabeled RNA species varied in size, some of which were much larger 
than the cytoplasmic radiolabeled RNA species observed [3-5]. Further analysis of this 
heterogeneous nuclear RNA (hnRNA) in HeLa cells revealed that some hnRNA species were 
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similar in nucleotide composition to rRNA (>60% GC content), while other, larger hnRNA species 
were similar in nucleotide composition to HeLa cell DNA (~45% GC content) [6]. Moreover, 
investigation into the DNA-like hnRNA revealed that these RNA were polyadenylated and had a 
5’ cap structure similar to mRNA [7-13]. In light of these findings, a popular hypothesis was that 
the DNA-like hnRNA were mRNA precursors, which were cleaved into shorter, mature mRNAs, 
much like the process of rRNA production from larger rRNA precursors [1, 14].  
The precise relationship between the DNA-like hnRNA and cytoplasmic mRNA was 
finally elucidated in 1977. Two independent groups, led by Dr. Phillip Sharp and Dr. Richard 
Roberts, employed DNA-RNA hybridization of fragmented adenovirus 2 (Ad2) DNA and viral 
mRNA produced by Ad2-infected HeLa cells [15, 16]. The R-loop structures formed by DNA-
RNA hybridization were then visualized by electron microscopy. Unexpectedly, they found that 
the viral mRNAs were not hybridizing to a continuous Ad2 DNA sequence. Instead, some viral 
mRNA species partially hybridized to the Ad2 DNA fragments, with unbound 5’ or 3’ mRNA 
tails. More strikingly, other viral mRNAs hybridized fully to the Ad2 DNA fragment—but this 
hybridization was not to a continuous DNA sequence. Instead, sequences in these mRNAs mapped 
to different DNA regions, creating loops of unhybridized, intervening DNA along the RNA-DNA 
hybrid. These publications concluded that precursor mRNAs undergo post-transcriptional 
processing, in which these intervening sequences are removed and the coding regions are linked 
together; this process became known as RNA splicing [15, 16].  
Based on these findings, in 1978 Dr. Walter Gilbert described eukaryotic genes as mosaics 
of intervening, intragenic “introns” and expressed “exons,” which are retained in the mature 
mRNA [17]. However, this newly discovered gene organization raised a new question: how does 
the cell distinguish between introns and exons in the pre-mRNA transcript? 
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1.1.1 Intron definition: the concept of consensus sequences 
 In the years following the seminal 1977 RNA splicing papers, work from multiple groups 
revealed that specific, conserved sequences mark the 5’ exon-intron boundary and the 3’ intron-
exon boundary. Based on analysis of available intronic sequences, the sequence at the 5’ end of 
the intron, called the 5’ splice site (5’SS), was defined as 5’-AG/GTRAGT (R=purine, /=exon-
intron boundary) [18-20]. Similarly, a 3’ splice site (3’SS) at the 3’ end of intron was defined as 
5’-NYAG/G-3’ (N=any nucleotide, Y=pyrimidine), and this sequence was always preceded by a 
stretch of at least 10 pyrimidines, known as the polypyrimidine tract (PPT) [18-21] (Figure 1.1). 
While some variation in these splice site sequences was observed, virtually all of the introns 
studied contained a 5’ terminal nucleotide pair of GT and a 3’ terminal nucleotide pair of AG, 
leading to the GT-AG intron boundary rule [22]. However, these exon/intron boundary consensus 
sequences are not sufficient for successful splicing, which also requires an intronic consensus 
sequence of 5’-CTRACT-3’, called the branch point sequence (BPS), found upstream of the PPT 
[20, 21, 23, 24]. 
 
1.1.2 The spliceosome and the splicing reaction 
 With these consensus sequences identified, the search for the cellular process allowing for 
the identification and removal of introns began. In 1980, the Wall and Steitz groups both proposed 
a mechanism by which small nuclear RNAs (snRNAs) that were complementary to these 
consensus sequences would base-pair to these sites on the pre-mRNA transcript, allowing them to 
identify intronic sequences and drive the splicing reaction [25, 26]. Over the next few years, 
sequence alignments and biochemical experiments led to the identification of five splicing 
snRNAs: U1, U2, U4, U5, and U6 [27-33]. Moreover, autoimmune antibodies from patients with 
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systemic lupus erythematosus were used to identify a large array of proteins that associate with 
these snRNAs to form small nuclear ribonucleoprotein particles (snRNPs) [27]. It has now been 
shown that these five snRNPs comprise the U2-type spliceosome, named for the U2 snRNA that 
is crucial for the splicing process [34, 35].  
The process of RNA splicing can be divided into three basic steps: intron recognition; the 
first trans-esterification reaction, forming the intron lariat and releasing the 5’ exon; and the second 
trans-esterification reaction, which releases the intron lariat and ligates the 5’ and 3’ exons together 
[36, 37]. Briefly, the process of intron recognition is mediated by U1 base-pairing to the 5’SS and 
U2 snRNA base-pairing to the BPS (Figure 1.1) [28-30]. Base-pairing between the U2 snRNA and 
the BPS is stabilized by the U2AF protein, which binds to the downstream PPT and 3’SS (Figure 
1.1) [38-40]. The base-pairing between the U2 snRNA and the BPS is imperfect, causing 
protrusion of an adenosine in the BPS (Figure 1.1) [41]. The three remaining snRNAs exist as a 
tri-snRNP, U4/U6.U5, in which U4 and U6 are base-paired and the U5 snRNP associates via 
protein interactions (Figure 1.1) [42]. The U4/U6.U5 tri-snRNP manipulates the orientation of the 
pre-mRNA transcript so that the splicing reaction can occur. Specifically, U6 dissociates from U4 
in order to base-pair to the 5’SS, displacing U1, and to base-pair to the U2 snRNA (Figure 1.1) 
[43-47]. While U4 leaves the active spliceosome at this step and does not directly base-pair to the 
pre-mRNA transcript, it is essential for stabilizing the tri-snRNP up until this point [33, 48, 49]. 
Meanwhile, U5 binds to the 3’SS and regions in the 5’ exon [50]. Ultimately, these events re-orient 
the pre-mRNA transcript, looping the intron such that the BPS is adjacent to the 5’SS and the 3’ 
exon is next to the 5’ exon (Figure 1.1). The close proximity of the 5’SS and the protruding BPS 
adenosine triggers the first trans-esterification reaction, in which the 2’ hydroxyl group of the BPS 
adenosine performs a nucleophilic attack on the 5’ phosphate group at the end of the 5’ exon. This 
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reaction links the 5’ end of the intron to the BPS adenosine, creating an intron lariat and releasing 
the 5’ exon (Figure 1.1) [36, 37]. The U5 snRNP remains bound to the 5’ and 3’ exons, maintaining 
them in close proximity (Figure 1.1) [51, 52]. This prompts the second trans-esterification 
reaction, in which the 3’ hydroxyl group at the end of the 5’ exon performs a nucleophilic attack 
on the 5’ phosphate group at the start of the 3’ exon. This second reaction excises the intron lariat, 
which is degraded in the nucleus, and links the end of the 5’ exon to the beginning of the 3’ exon  
(Figure 1.1) [36, 37].  
 
1.2 Minor introns and the minor spliceosome 
 In every step of RNA splicing, base-pairing between the spliceosomal snRNAs and the 
pre-mRNA transcript is both extensive and essential, as described above. Therefore, it was widely 
believed that all spliceosomal introns contained the aforementioned consensus sequences. 
However, as more sequencing data became available, scientists began to identify spliceosomal 
introns without these consensus sequences—and yet, these introns were being successfully spliced 
from pre-mRNA transcripts. 
 
1.2.1 Divergent, minor-class introns 
 In 1991, Jackson re-evaluated the intronic sequences previously described and analyzed by 
Senapathy and Shapiro [53, 54] and identified two introns, found in the cartilage matrix protein 
(CMP) and human nucleolar protein P120 (P120) genes, with divergent splice site sequences that 
did not follow the accepted GT-AG rule [55]. Instead, these introns contained AT-AC terminal 
dinucleotides, which led to the name “AT-AC introns” [56]. Further examples of these AT-AC 
introns were identified in 1994, when Hall and Padgett identified two additional AT-AC introns, 
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one in the mouse Rep-3 gene and the other in the Drosophila gene prospero. Their analysis 
revealed that all four of these AT-AC introns contained unique 5’SS and 3’SS consensus sequences 
of 5’-/ATATCCTT-3’ and 5’-YCCAC/-3’, the latter of which was not preceded by the PPT seen 
in canonical GT-AG introns [57]. They also identified the presence of a highly conserved branch 
point sequence of 5’-TCCTTAAC-3’ [57]. Later alignment and mutational studies further clarified 
these sequences to be 5’-/RTATCCTTT-3’ for the 5’SS, 5’-TTCCTTRAY-3’ for the BPS, and 5’-
YAGC/-3’ for the 3’SS [19, 20, 58]. Due to the divergence in these three consensus sequences, Hall 
and Padgett noted that the complementarity required for spliceosomal snRNA base-pairing was 
lost. Then, based on the known splicing mechanism, it should not be possible for these introns to 
be removed—except, they were being spliced successfully. Therefore, Hall and Padgett proposed 
that a specialized, parallel set of spliceosomal snRNAs must exist to splice this minor class of 
divergent introns [57]. 
 
1.2.2 The distinct, minor-class spliceosome and its action 
The successful splicing of these minor-class introns, which could not be mediated by the 
U2-type spliceosome, led to the hunt for snRNAs that could recognize and splice these introns. In 
their 1994 paper, Hall and Padgett curated sequences of all known snRNAs to identify candidate 
snRNAs that could recognize the divergent consensus sequences of these introns [57]. This 
revealed two potential candidates. The first, the U12 snRNA, contained a stretch of nucleotides 
(3’-AGGAATC-5’) that was complementary to the divergent BPS they identified, 5’-
TCCTTAAC-3’ [57]. Importantly, if this region of U12 were to base-pair to the AT-AC intron 
BPS, one of the BPS adenosines would bulge outward, due to imperfect complementarity (Figure 
1.1). In the U2-type spliceosome, this BPS adenosine bulge is required for the splicing reaction to 
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occur [41]. If this minor class of AT-AC introns were removed by a parallel set of splicing snRNAs 
in steps analogous to those of U2-type splicing, then U12 likely functioned as the analogue of U2. 
The second candidate, the U11 snRNA, was proposed as a potential analogue to U1, since it 
contained a 3’-GGAAA-5’ sequence that could base-pair to the divergent 5’SS (5’-ATATCCTTT-
3’) (Figure 1.1) [57]. However, this hypothesized base-pairing would only span the last 5 
nucleotides of the divergent 5’SS, which Hall and Padgett cautioned might be insufficient for 5’SS 
recognition [57]. Both U11 and U12 were sequenced by Montzka and Steitz in 1988, who noted 
that both were low abundance, nuclear snRNAs [59]. To distinguish these low abundance snRNA 
candidates from the abundant splicing snRNAs of the U2-type spliceosome, Hall and Padgett 
described U11 and U12 as “minor snRNAs,” sowing the seeds for future terminology: the 
divergent introns became known as “minor introns,” due to their small number in the genome, 
which are spliced by the “minor spliceosome” [20, 57, 60]. To parallel this terminology, U2-type 
introns were named “major introns,” and the U2-type spliceosome was termed the “major 
spliceosome.” Hall and Padgett also highlighted Montzka and Steitz’s finding that the majority of 
U12 snRNA existed in a di-snRNP with U11 [57, 59]. This led Hall and Padgett to suggest that 
the strong base-pairing of U12 to the BPS might stabilize U11 base-pairing to the 5’SS, despite 
the incomplete complementarity [57].  
In 1996, two separate groups, led by Steitz and Padgett, independently confirmed that U12 
does base-pair to the BPS, and that U12 is crucial for minor intron splicing. Using 2’-O-methyl 
oligonucleotides, Tarn and Steitz showed that disrupting the U12-BPS interaction prevented the 
removal of a minor intron [56]. Similarly, Hall and Padgett showed that mutating the BPS within 
a minor intron also ablated its splicing, and compensatory mutations in U12 rescued minor splicing 
[60]. Notably, while the primary sequence of U12 differed greatly from that of U2, its predicted 
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secondary structure was very similar to that of U2 [59, 61]. Given the essential role of U12 in the 
removal of these introns, minor introns are also known as U12-type introns, which are spliced by 
the U12-type spliceosome [34, 35]. Interestingly, the requirement for BPS conservation is not 
observed for major introns, as BPS mutations in these introns have no significant effect on U2 
snRNP binding [62]. Instead, U2 snRNP binding requires the presence of a downstream 
polypyrimidine tract, to which the protein U2 auxiliary factor (U2AF) binds [38-40].  
In their 1996 paper, Tarn and Steitz also identified U11 and the U5 snRNA in the minor 
spliceosome, by in vitro splicing assays followed by Northern blot and chromatography analyses 
[56]. When they applied a 2’-O-methyl oligonucleotide that targeted a region of U5 involved in 
exon interactions during major splicing, they observed inhibition of both major and minor splicing 
in their in vitro splicing assay, suggesting that U5 plays the same role in the major and minor 
splicing pathways [56]. However, it was unclear whether U11 directly participated in splicing, 
because they could not target U11 by 2’-O-methyl oligonucleotides [56]. This echoed earlier 
attempts to target U11 for study: Christofori and Keller were unable to target U11 snRNA for 
RNase degradation using an array of complementary oligonucleotides [63], and Montzka and 
Steitz found that deoxyoligonucleotide-targeted nuclease digestion failed to degrade U11, despite 
the use of 11 different oligonucleotides staggered along the entirety of the U11 sequence [59]. 
Together, these results suggested that the U11 snRNP is too compact to be targeted by 
complementary oligonucleotides; therefore, Tarn and Steitz could not discount the possibility that 
U11 was only present in the minor spliceosome because the majority of U12 exists as a U11/U12 
di-snRNP [56, 59]. However, they did note that the predicted secondary structure of U11 was very 
similar to that of U1 [56]. In 1997, the Steitz and Padgett groups finally showed that U11 interacts 
with the 5’SS and that disruption of this base-pairing negatively affected minor splicing, through 
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experiments using 4-thiouridine (4SU) crosslinking and mutation analysis, respectively [34, 64]. 
The importance of U11 in minor splicing was further underscored in 1999, when Frilander and 
Steitz used peptide nucleic acid (PNA) oligomers targeting the 5’SS interacting site of U11 to 
prevent minor splicing [65]. They also reported that the recognition of the 5’SS by U11 depended 
on the presence of the U12-BPS interaction, and vice versa [65]. From these studies, a splicing 
model was proposed in which U11 and U12 simultaneously recognize their respective consensus 
sequences during minor intron splicing, essentially condensing the first two steps observed in 
major intron splicing into one (Figure 1.1) [20, 65]. 
In a second 1996 paper, Tarn and Steitz identified the minor splicing counterparts of the 
U6 and U4 snRNAs, using a pull-down strategy targeting the cap structure of U6, which they 
reasoned was shared with the minor-class U6 analogue [66]. This strategy pulled down two 
unknown snRNAs, which Tarn and Steitz named U6atac and U4atac for the AT-AC introns they 
remove [66]. Although the primary sequences of these snRNAs differed from that of U6 and U4, 
the predicted secondary structures of U6atac and U4atach were similar to that of U6 and U4, 
respectively [66, 67]. Sequence analysis of U6atac revealed that it contained a 5’-AAGGA-3’ 
sequence, which could base-pair to the 5’SS of minor introns (5’-ATATCCTTT-3’) (Figure 1.1) 
[66]. To test whether this sequence was necessary for minor splicing, Tarn and Steitz added an 
oligonucleotide targeting this region of U6atac to their in vitro splicing reaction, which specifically 
ablated minor splicing [66]. In addition to testing this 5’SS-U6atac interaction, Tarn and Steitz 
also investigated whether U6atac base-paired with U12, since base-pairing is observed between 
U2 and U6 in major splicing. Indeed, they found that a 2’-O-methyl oligonucleotide against the 5’ 
end of U12 prevented minor splicing, but did not affect major splicing. The association of U6atac 
with U12 in the active minor spliceosome was further verified by psoralen crosslinking, which 
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showed that the presence of a minor intron-containing substrate was necessary to generate 
significant U12/U6atac crosslinking [66]. In 1997, Yu and Steitz confirmed the base-pairing 
between U6atac and the 5’SS by a 4-thiouridine (4SU) crosslinking analysis [64]. Subsequently, 
Incorvaia and Padgett showed that, when minor splicing was prevented by 5’SS mutations, 
compensatory mutations in the proposed 5’SS-interacting region of U6atac could rescue minor 
splicing [68]. For U4atac, Tarn and Steitz did not identify any potential base-pairing between 
U4atac and the minor-class consensus sequences, indicating that it might have a chaperone 
function similar to U4 [66]. To test whether U4atac was necessary for minor splicing, Tarn and 
Steitz used oligonucleotide-directed RNase H degradation to remove U4atac from their in vitro 
splicing reaction. They found that degradation of U4atac resulted in a loss of minor splicing, but 
no change in major splicing, indicating its importance in the minor splicing process [66].  
With the snRNA components of the minor spliceosome identified, the question of the 
protein components of the minor spliceosome emerged. In the first study of minor spliceosomal 
proteins in 1999, Will et al. found that, of the 20 U11/U12 di-snRNP-related proteins they 
identified, the majority were also found in the major spliceosome; only 6 proteins were unique to 
the minor spliceosomal snRNP [69]. Similar analysis of the U4atac/U6atac.U5 tri-snRNP revealed 
that its protein composition was highly similar to that of the U4/U6.U5 tri-snRNP [70]. Further 
work by the Luhrmann group in 2004 identified 7 proteins specific to the U11/U12 di-snRNP: 
U11/U12-65K, U11/U12-59K, U11/U12-48K, U11/U12-35K, U11/U12-31K, U11/U12-25K, and 
U11/U12-20K [71]. While all seven proteins were associated with the U11/U12 di-snRNP, four of 
them—U11/U12-59K, U11/U12-48K, U11/U12-35K, and U11/U12-25K—could be found in the 
mono-U11 snRNP, indicating that they interact with the U11 snRNA [71]. The specific functions 
of many of the minor spliceosome-specific proteins remain unknown. In 2004, the Luhrmann 
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group interrogated the role of the U11-associated U11/U12-59K protein in HeLa cells by RNAi-
mediated knockdown, which resulted in cell death. While this result underscored the importance 
of this protein’s function, its specific role in minor splicing could not be assessed [71]. In 2005, 
Benecke et al. found that the U11/U12-65K protein binds to both U11/U12-59K protein and the 
3’ stem loop of the U12 snRNA, suggesting that it may play a role in stabilizing the U11/U12 di-
snRNP [72]. Turunen et al. similarly described the U11/U12-59K protein as an anchor protein in 
2008, when they found that the U11-associated U11/U12-48K protein binds to the U11/U12-59K 
protein and the 5’ end of the 5’SS of the pre-mRNA transcript [73]. They also reported that RNAi-
mediated knockdown of this 48K protein reduced the amount of U11/U12 di-snRNP in HeLa cells, 
indicating that this protein may also play a role in U11/U12 di-snRNP stabilization [73]. Based on 
its domains and experiments performed in Arabidopsis thaliana, the U11/U12-31K protein likely 
functions as an RNA chaperone [74]. Although knockdown of the 31K protein negatively affects 
minor splicing, its exact role in the process is unclear [74]. For the remaining 35K, 25K, and 20K 
U11/U12 proteins, no reports describing their functions have been published since their initial 
discovery. However, binding assays using plant minor spliceosome-specific proteins suggest that 
the 35K protein binds to 25K, 31K, and 35K, and that the 25K protein binds to the 65K, 59K, 48K, 
35K, 31K, and 25K proteins [75]. 
Since the components of the minor spliceosome act analogously to those of the major 
spliceosome, the process of minor splicing is extremely similar to that of major splicing. The 
primary difference lies in the first step of minor splicing, a.k.a. intron recognition. Unlike U1 and 
U2 in the major spliceosome, U11 and U12 exist as a di-snRNP [59]. Therefore, the first step of 
minor splicing involves simultaneous recognition of the 5’SS and BPS by U11 and U12, 
respectively (Figure 1.1) [20, 65]. U11 base-pairing to the last 5 nucleotides of the 5’SS is 
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stabilized by the U11/U12-48K protein, which binds to the 5’ end of the 5’SS and to the anchor 
protein U11/U12-59K [73]. After this intron recognition step, the U4atac/U6atac.U5 tri-snRNP is 
recruited to the intron, at which point U6atac base-pairs to the 5’SS and to U12, displacing both 
U11 and U4atac in the process (Figure 1.1) [20, 64, 66]. Meanwhile, U5 binds to both the 5’ exon 
and the 3’SS (Figure 1.1) [56, 76]. The close proximity of the bulging adenosine in the BPS to the 
5’ exon triggers the first trans-esterification event, in which the 2’ hydroxyl of the BPS adenosine 
performs a nucleophilic attack on the 5’ phosphate group at the end of the 5’ exon. Like in major 
splicing, this first trans-esterification reaction forms an intron lariat, while freeing the 5’ exon, 
which remains in close proximity with the 3’ exon due to U5 snRNP binding (Figure 1.1). This 
elicits the second trans-esterification reaction, in which the 3’ phosphate group at the end of the 
5’ exon performs a nucleophilic attack on the 5’ phosphate group at the beginning of the 3’ exon, 
ligating these exons together and freeing the intron lariat (Figure 1.1) [20, 56]. Notably, the vast 
majority of minor intron-containing genes (MIGs) primarily contain major introns, with only 1-2 
minor introns [58]. Therefore, MIG expression requires the coordinated activity of both the major 
and the minor spliceosomes to generate a fully spliced mRNA transcript. 
Ultimately, minor intron splicing is a parallel splicing pathway for a small minority of 
introns (<0.5% of introns in the human genome), which shares its biochemical pathway, the U5 
snRNA, and most of its proteins with the major spliceosome [20, 56, 58, 69, 70]. Since its 
discovery, scientists have sought to understand when minor splicing emerged during evolution, 
and why such a complex machinery has been maintained, in spite of the existence of another 
spliceosome.  
 
1.2.3 Conservation and utility of minor intron splicing 
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 Throughout the 1990s and early 2000s, multiple groups reported that minor introns were 
found throughout metazoans and land plants, pinning the age of the minor spliceosome to at least 
1 billion years [77-79]. Unexpectedly, they could not identify any minor introns or minor snRNAs 
in the nematode Caenorhabditis elegans, indicating that minor splicing had been lost altogether in 
this metazoan lineage [77]. It was only in 2006, when Russell et al. analyzed partially sequenced 
protist and fungal genomes, that the first minor introns and minor spliceosome components were 
identified in the amoeboid protist A. castellanii, the fungus R. oryzae, and two water molds, P. 
ramorum and P. sojae [80]. Based on the presence of minor introns and components of the minor 
spliceosome in all five eukaryotic supergroups, they suggested that minor splicing was likely 
present in the last eukaryotic common ancestor (LECA) [80]. In 2008, Davila Lopez et al. 
performed the most comprehensive search for minor snRNAs yet described, scanning a total of 
149 eukaryotic genomes [81]. Their analysis identified minor snRNA genes in the nematode T 
spiralis, the slime mold P. polypephalum, and the fungal lineages Zygomycota and 
Chytridiomycota [81]. More strikingly, they did not identify substantial numbers of minor snRNA 
genes in the fungal lineages of Microsporidia, Ascomytoca, or Basidiomycota, and no minor 
snRNA genes were identified in red or green algae, indicating multiple losses of the minor 
spliceosome in eukaryotic evolution [81]. In 2010, the same group performed a similar analysis of 
minor introns, in which they extracted all minor introns from a subset of these eukaryotic genomes 
[82]. From their findings in both of these papers, Davila Lopez et al. calculated that minor splicing 
had been independently lost at least nine times across eukaryotic evolution [82]. Even in lineages 
that have retained minor introns and the minor spliceosome, there are indications of minor intron 
loss across evolution. For example, the Makałowski group found higher rates of minor intron loss 
in dipteran insects than in other Insecta lineages, which was unrelated to total genome size (average 
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of 18.1 minor introns vs average of 42.8) [83]. Oddly, however, the dipteral lineage also contains 
the only known example of minor intron gain in a species. Notably this gene, Zrsr2, has been 
shown to be essential for minor splicing, and the addition of a minor intron in this gene may 
represent a drive toward auto-regulation within the minor splicing pathway [83]. Overall, these 
findings exemplify the dynamic flux in the maintenance of the minor spliceosome and minor 
introns across eukaryotic evolution, tracing back to early eukaryotes. 
 Despite the preponderance of evidence indicating a drive to lose minor splicing throughout 
evolution, minor introns and the minor spliceosome are highly conserved in most metazoans and 
plants. In fact, compared to major introns, the positions of minor introns are more highly conserved 
between plants and animals [84]. This contradiction is unexpected—why is this pathway so highly 
conserved among metazoans and plants, when it has been lost multiple times in other eukaryotic 
lineages? One possibility, as Mount proposed in 1996, is that minor splicing is a molecular fossil 
[85]. In this model, the maintenance of the minor introns and the minor spliceosome is dependent 
primarily on chance. For example, if an ancestral minor intron sits in an essential gene, it is likely 
it will be retained and conserved; if an ancestral minor intron is found in a gene that is rarely 
expressed, it is likely to be lost. Similarly, if a minor intron-containing gene (MIG) is less essential 
in species A than it is in species B, it is more likely to be lost in species A [85].  
Another possibility is that the conservation of minor introns in early evolution may have 
been ensured by their presence in crucial genes, but they have now evolved additional regulatory 
roles separate from that requirement. For example, it has been shown that minor intron splicing is 
less efficient than major intron splicing in HeLa and S2 Drosophila melanogaster cell lines, due 
to the low levels of the minor snRNAs [86]. These unspliced transcripts would either be trapped 
in the nucleus or be degraded by nonsense-mediated decay in the cytoplasm [86, 87]. In this model, 
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minor intron splicing is a regulatory switch that allows the cell to regulate all minor intron-
containing gene (MIG) expression en masse, by altering the levels of the minor spliceosome 
components and thereby controlling the rate of minor intron splicing. This model is supported by 
work from the Dreyfuss group, who found that U6atac was the rate-limiting component of the 
minor spliceosome [88]. When they stabilized U6atac snRNA in HeLa cells, resulting in increased 
U6atac levels, they observed increased rates of minor intron splicing both in a transfected splicing 
construct and across multiple endogenous genes [88]. Additionally, the minor spliceosome may 
play a role in alternative splicing regulation. In Drosophila, the MIG prospero, which encodes a 
neuronal transcription factor, contains an intron with a twintron structure, in which a major intron 
is nested within a minor intron. Minor intron splicing of this twintron would remove 29 amino 
acids, 5 of which encode the N-terminal homeodomain [89]. In 2004, Scamborova et al. showed 
that the nested major intron is preferentially spliced during early embryogenesis, while the outer 
minor intron is preferentially spliced in later development [90]. Genes with similar twintron 
architectures have been identified in insects and vertebrates, indicating that this type of isoform 
regulation may be relatively common [91]. 
 In all, the conservation of minor introns, regardless of the evolutionary pressures that 
sustained them, suggests an important biological role for minor splicing, particularly in lineages 
that have maintained high numbers of minor introns [58]. In order to understand this role, it is 
necessary to determine the functions of MIGs.   
 
1.2.4 Minor intron-containing genes (MIGs) 
Most efforts to identify MIGs rely on scans of high-quality genomes for introns with these 
minor-class consensus sequences. As of now, three multi-species minor intron databases have been 
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published: SpliceRack, the U12 Database (U12DB), and ERISdb, a plant-specific database [19, 
58, 92]. Of these databases, only the U12DB both contains entries for a large range (20) of species 
and is still accessible, although it has not been updated since 2007 [58]. Even before the publication 
of these databases, multiple groups suspected that minor splicing might control specific functions, 
based on observations that minor introns were enriched in specific gene families. For example, in 
1997, Wu and Krainer noted the presence of multiple MIGs within the voltage-gated sodium 
channel (VGSC) and voltage-gated calcium channel (VGCC) alpha subunit gene families, which 
encode the pore region of these voltage-gated ion channels [93-95]. Since these gene families share 
a common ancestral gene, Wu and Krainer predicted that minor introns would be identified in 
other genes within the voltage-gated ion channel superfamily [93]. Indeed, based on the human 
minor introns listed in the U12DB, 90% of both VGSC and VGCC alpha subunit genes contain at 
least one minor intron [58, 94, 95]. Moreover, all 4 VGCC auxiliary alpha2delta subunit genes, 
which function in VGCC trafficking and gating modulation, are MIGs [58, 96]. Together, these 
observations strongly suggest that cell excitability, particularly action potential propagation and 
muscle contraction, and vesicle fusion are regulated by minor splicing [94-96].  
 Since 2000, multiple other MIG-rich gene families have been identified, spanning a wide 
variety of functions. While sequencing the human matrilin genes, Muratoglu et al. (2000) 
identified minor introns in all 4 matrilin genes, implicating minor splicing in the regulation of 
extracellular matrix assembly, particularly in cartilage [97, 98]. In 2001, Levine and Durbin 
identified 404 minor introns in the human genome, and they noted enrichment of MIGs in the E2F 
transcription factor, phospholipase C, diaphanous-related formin, and a subset of guanine 
nucleotide exchange factor (GEF) gene families [99]. Based on the human minor introns listed in 
the U12DB, 75% of E2F genes, 47% of phospholipase C genes, 100% of diaphanous-related 
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formin genes, 75% of Ras guanyl-releasing (RASGRP) genes, and 71% of Rap-GEF genes contain 
minor introns [58]. The U12DB also identified numerous other gene families with minor intron 
enrichment, such as the mitogen activated-protein kinase (MAPK) family, of which 62% contain 
minor introns, and the phosphatase 2 (PP2A) regulatory B55 subunit genes, which are all MIGs 
[58]. Notably, the RASGRP and MAPK gene families converge on the Ras signaling pathway, 
which modulates cell survival, growth, and differentiation [100]. Moreover, the E2F transcription 
factors are well-known regulators of cell proliferation and differentiation, while the B55 subunit 
of PP2A conveys substrate specificity, allowing for the dephosphorylation of retinoblastoma 
family and Smad proteins, in turn inhibiting E2F activity [101, 102]. Given the high percentage of 
MIGs found in all of these gene families, it is plausible that minor splicing also plays a role in 
regulating cell proliferation and differentiation. Indeed, disruptions in minor splicing have been 
associated with abnormal cell cycle regulation and differentiation [103, 104]. 
With the advent of bioinformatics-based approaches to identify MIGs throughout genomes, 
it became possible to investigate the functional classifications of MIGs on a wider scale. For 
example, in 1998, Burge et al. reported that many (25%) of the 56 MIGs they identified in their 
multi-genome scan were involved in “information processing” functions, such as DNA replication, 
DNA repair, transcription, RNA processing, and translation [77]. Similarly, when Chang et al. 
extracted ~500 minor introns from the human genome, they observed enrichment of MIGs in RNA 
metabolism pathways, spanning both mRNA and non-coding RNA processing, and transcription 
regulation [105]. More recently, Merico et al. leveraged mouse phenotypes from the Mammalian 
Phenotype Ontology dataset and functional gene-set resources, such as Gene Ontology, KEGG, 
and BioCarta, to identify common functions performed by the 744 MIGs they identified in the 
human genome [106]. Using Fisher’s exact tests to determine statistical significance, they 
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observed enrichment for numerous “information processing”-related functions, including DNA 
replication/repair, transcription regulation, and RNA processing, along with enrichment for ion 
channels [106]. However, they also identified functional enrichments for cell cycle, 
neurodevelopment, skeletal development, and embryonic survival [106]. In plants, MIG functions 
were similarly investigated by Gault et al. in 2017, who used Pfam domain analysis to study MIGs 
conserved between maize (Zea mays) and human. Their initial analysis of all 408 maize MIGs 
identified in the ERISdb revealed functional enrichments in cell cycle, RNA processing, 
transcription, translation, protein folding/degradation, and metabolism, similar to the functions 
identified in previous reports of human MIGs [104]. When they analyzed the 233 maize MIGs 
with human homologs, they found that 22% (50) of these conserved MIGs regulated cell cycle, 
while an additional 14% (33) were involved in protein glycosylation [104].  
 In the past decade, most efforts to investigate the functions regulated by minor splicing 
have sought to study the effects of minor spliceosome inactivation in a given model system; by 
studying the biological processes that are affected, researchers can extract the functions that 
require normal MIG expression. There are two common methods for this type of research: (1) to 
study naturally occurring diseases that are caused by minor spliceosome inactivation; and (2) to 
study an experimental model of minor spliceosome inactivation. The results generated from these 
two approaches are discussed in the following section. 
  
1.3 Minor splicing, development, and disease  
From the discovery of minor splicing until the mid- to late-2000s, most publications in the 
field sought to investigate the components, biochemistry, and evolution of minor splicing. Barring 
reports describing two models of minor spliceosome disruption [74, 89], most research was 
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performed in vitro or in cell culture. In 2011, however, the field underwent a major shift. That 
year, two back-to-back Science papers reported that inactivation of the minor spliceosome caused 
a severe developmental disorder, called microcephalic osteodysplastic primordial dwarfism type 
1 (MOPD1) [107, 108]. Since 2011, research into the connection between minor splicing, 
development, and disease has exploded; currently, disruption of minor intron splicing has been 
linked to nine diseases, seven of which affect the central nervous system.  
 
1.3.1 Minor splicing and early/embryonic development 
The first study indicating the importance of the minor spliceosome in early development 
was forward genetics work in Drosophila melanogaster, published in 2002. Otake et al. 
determined that the embryonic lethality and third instar death observed in two fly lines (EP(3)3147 
and l(2)k01105) were caused by P element-mediated disruption of the U12 and U6atac snRNA 
genes, respectively [89]. Introducing wild-type U12 or U6atac transgenes into these lines rescued 
these phenotypes, and RT-PCR confirmed that minor splicing was disrupted in the U6atac mutant 
larvae [89]. Surprisingly, they also detected the presence wild-type U6atac snRNA in the U6atac 
mutant larvae; the levels of this wild-type U6atac snRNA were inversely correlated with the 
amounts of mutant U6atac, suggesting that wild-type U6atac is maternally contributed in flies [89]. 
They proposed that this might explain why these U6atac mutant flies escaped embryonic lethality, 
unlike the U12 mutants [89]. In 2010, the Frilander group further characterized the U6atac mutant 
line by microarray and RT-PCR analysis [109]. The microarray they employed was designed to 
detect the expression of most exons in the Drosophila genome, by designing one probe for each 
exon. For hybridization, total RNA samples from first, second, and third instar larvae from 
heterozygote controls and homozygous mutants were used. Unexpectedly, this microarray analysis 
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did not reveal dramatic changes in the expression of MIGs in the mutant line, and the results did 
not indicate global aberrant splicing near minor introns in these MIGs [109]. While RT-PCR 
analysis of minor splicing did indicate increased minor intron retention in the U6atac mutants, it 
also revealed substantial amounts of properly spliced transcripts, suggesting that minor 
spliceosome function is not completely disrupted in this fly line [109]. Although the microarray 
did not reveal dramatic shifts in MIG expression, it did show significant downregulation of general 
metabolism genes in the mutant larvae [109]. The most downregulated MIG in the mutant larvae 
was CG15081/l(2)03709, a gene that encodes the mitochondrial protein prohibitin, which is 
necessary for mitochondrial stability and function [109]. Importantly, mutation in this gene has 
previously been shown to cause larval lethality in Drosophila [110]. Based on these findings, they 
concluded that disruption of this MIG likely caused the downregulation of metabolism genes and, 
eventually, larval death, even though the minor splicing defect in this line appeared to be relatively 
mild [109].  
In the same year, the Kang group published the first study describing the effects of minor 
spliceosome dysfunction on Arabidopsis thaliana development, by targeting the gene that encodes 
the U11/U12-31K protein [74]. Initially, this group employed a mutant Arabidopsis thaliana line, 
which contained a T-DNA insertion in the coding region of U11/U12-31K. However, they were 
unable to generate homozygous mutants, suggesting that complete loss of U11/U12-31K function 
is embryonically lethal [74]. To further study the role of this gene in Arabidopsis, they instead 
employed artificial microRNA (amiRNA) to knock down U11/U12-31K levels by ~70-85% in 
developing plants. These transgenic plants exhibited various developmental abnormalities, 
including leaf serration, arrested meristem growth, and post-bolting rosette leaf production [74]. 
Additionally, the Kang group found that subsequent generations of transgenic amiRNA lines with 
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the strongest U11/U12-31K knockdown displayed more dramatic phenotypes, ranging from an 
inability to grow beyond the vegetative stage, death, and embryonic lethality, further underscoring 
the importance of U11/U12-31K function in Arabidopsis thaliana development [74]. RT-PCR 
analysis of minor splicing in these transgenic lines revealed minor intron retention correlating with 
the strength of amiRNA-mediated U11/U12-31K knockdown; however, for some MIGs, minor 
intron retention was not observed in these amiRNA transgenic lines [74]. They also reported that 
these phenotypes and the observed minor intron retention could be rescued with amiRNA-resistant 
U11/U12-31K and, as described in the Kang group’s 2012 paper, with O. sativa U11/U12-31K 
[74, 111]. In addition, external application of the hormone gibberellic acid, which induces cell 
division and expansion, could rescue the inflorescence stem growth in the transgenic lines; qRT-
PCR analysis of the meristem regions of the untreated amiRNA plants revealed that expression of 
the genes involved in gibberellic acid metabolism was downregulated compared to wild-type 
levels [111]. To further clarify the role of the minor spliceosome in A. thaliana development, the 
Kang group used a similar strategy to target the gene encoding a different minor spliceosome-
specific protein, U11/U12-65K [112]. As with U11/U12-31K, they found that T-DNA disruption 
of the U11/U12-65K gene was embryonically lethal, since they could not generate homozygous 
mutants. Similarly, amiRNA-mediated knockdown of U11/U12-65K resulted in a familiar 
complement of phenotypes, including stunted primary inflorescence stems, leaf serration, post-
bolting rosette leaf formation, and small size; RT-PCR analysis also revealed higher levels minor 
intron retention in the amiRNA plants than in wild-type plants [112]. All of the phenotypes and 
the minor intron retention were rescued with amiRNA-resistant U11/U12-65K [112]. Together, 
these studies underscore the importance and necessity of minor spliceosome function in 
Arabidopsis thaliana development. 
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Currently, there are four reports describing the role of minor splicing in vertebrate 
development. In 2014, the Heath group leveraged the clbn zebrafish mutant, which they found was 
caused by mutation in an intron of rnpc3, the gene encoding the U11/U12-65K protein [113]. The 
clbn mutants were characterized by microcephaly, micropthalmia, swim bladder defects, delayed 
yolk absorption, hypoplasia of the pancreas and liver, and intestinal epithelium abnormalities 
[113]. These phenotypes began to emerge 4.5 days postfertilization; the mutants died 2.5 to 5.5 
days later [113]. To determine the global effect of this rnpc3 mutation on gene expression and 
splicing, Markmiller et al. performed RNAseq using RNA from 108 hour-postfertilization wild-
type and mutant larvae [113]. In parallel, to prevent ambiguous read mapping to short, repetitive 
sequences in introns, they generated a zebrafish uniqueome, which contained only regions to which 
reads would uniquely map. They then mapped the RNAseq reads to this zebrafish uniqueome. 
They also acquired an updated dataset of zebrafish minor intron candidates, extracted by Alioto 
using the U12DB pipeline, and discarded minor intron candidates that did not have conserved 
terminal dinucleotides of either AT-AC or GT-AG, conservation at the 5’SS and BPS, or sufficient 
evidence from mRNA, EST, published RNAseq, or published protein-coding gene data [58, 113]. 
This RNAseq analysis revealed that minor intron retention was more common than major intron 
retention in the wild-type larvae (65.5% vs. 49.6%), and that retention of ~25% of minor introns 
was unique to the clbn mutant [113]. Interestingly, as was reported in Drosophila and Arabidopsis, 
the majority of MIGs (~90%) were not differentially expressed between the wild-type and mutant 
samples [113]. Of the differentially expressed MIGs, 40 were downregulated in the mutant larvae, 
compared with the 10 that were upregulated [113]. Overall, Markmiller et al. found that MIGs 
involved in mRNA quality control and cell cycle repression were differentially expressed or 
displayed some degree of minor intron retention in the mutant larvae [113]. This finding led them 
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to propose a model in which disruption of these mRNA control pathway MIGs leads to the 
destabilization of overall gene expression, minor and major intron-containing alike, by affecting 
multiple levels of mRNA processing, including transcription, splicing, mRNA transport, and 
mRNA degradation [113].  
In December of 2018, the Heath group extended their investigation into the role of 
U11/U12-65K in development to a mammalian system, by employing a novel transgenic mouse 
line targeting the U11/U12-65K gene Rnpc3 for deletion [114]. Specifically, exons 4 and 5 of the 
Rnpc3 gene were flanked by loxP sites to conditionally deplete Rnpc3 levels [114]. In the germline 
Rnpc3-/- mice, they observed embryonic lethality prior to blastocyst implantation; they did not 
observe any phenotype in the germline Rnpc3+/- mice [114]. Using a tamoxifen-inducible, systemic 
Cre recombinase, Doggett et al. depleted Rnpc3 throughout adult transgenic mice. Within a week 
of tamoxifen induction, the mutant mice displayed significantly lower levels of lymphocytes, 
monocytes, erythrocytes, and thrombocytes; decreased thymus size; and substantial degeneration 
of the lining of the gastrointestinal tract [114]. The degeneration of the gastrointestinal mucosa 
occurred alongside significant cell death and reductions in cell proliferation [114]. Both semi-
quantitative and quantitative RT-PCR revealed increased minor intron retention in numerous 
MIGs, without a corresponding increase in major intron retention, in purified epithelial cells from 
the small and large intestines of the mutant mice [114]. Within the gastrointestinal mucosa, 
Doggett et al. also reported higher Rnpc3 mRNA levels in the proliferating compartments relative 
to the differentiated cell populations; similar trends of expression were observed in the skin and 
the lung epithelia [114]. While Doggett et al. did not investigate the effects of Rnpc3 depletion on 
the hematopoietic stem cells of the red bone marrow, their findings also indicated that Rnpc3 is 
required for normal hematopoiesis [114, 115]. From their findings, Doggett et al. concluded that 
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Rnpc3 expression is likely essential for the survival of stem cell populations, while differentiated 
cells appear to survive with very low levels of U11/U12-65K [114].  
The other two papers investigating the role of minor spliceosome in vertebrate 
development, Baumgartner et al. 2015 and Baumgartner et al. 2018, are described in chapters 3 
and 4, respectively [116, 117]. 
 
1.3.2 Minor splicing and the central nervous system 
 Until 2014, there were no experimental models for studying minor spliceosome 
inactivation in mammalian development. To my knowledge, the papers published as part of my 
dissertation research (Baumgartner et al. 2015 and Baumgartner et al. 2018) were the first two 
publications investigating minor splicing disruption in a mammalian model system. Thus, the 
primary resource available for studying the role of minor splicing in a mammalian system are 
clinical reports of diseases linked to minor spliceosome disruption. Of the nine diseases that have 
been linked to disruption in minor splicing, seven are disorders of the central nervous system [103, 
106-108, 118-123]. Specifically, five of these disorders are characterized by either microcephaly 
or hypoplasia of specific brain regions [106-108, 119, 121, 122]. The remaining two disorders, 
along with one disease marked by cerebellar hypoplasia, involve degeneration of motor system 
neurons [118, 120, 121].  
  
1.3.2.1 Microcephaly 
Minor spliceosome dysfunction was first linked to a human disease in 2011, when two 
independent groups showed that mutation in the U4atac gene, RNU4ATAC, causes the severe 
developmental disorder microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1), also 
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known as Taybi-Linder syndrome (TALS) [107, 108]. This disorder is characterized by restricted 
intrauterine growth, microcephaly, brain abnormalities, malformed bones and joints, dry skin, and 
sparse hair. Common brain abnormalities include agenesis of the corpus callosum, gyrification 
defects, hypoplasia of the cortical lobes, and agenesis of the cerebellar vermis. Individuals with 
the disorder rarely survive past early childhood [124-127]. Using a combined approach of genome-
wide mapping and high throughput, second generation sequencing, He et al. found that all MOPD1 
patients from a consanguineous Ohio Amish population shared the same genomic G to A mutation 
at nucleotide 51 (g.51G>A) of the RNU4ATAC gene [107]. He et al. also identified RNU4ATAC 
g.30G>A, g.55G>A, and g.111G>A mutations in German MOPD1 patients [107]. To determine 
the effects of these mutations on minor splicing efficiency, He et al. employed an in vivo splicing 
assay in CHO cells, using a splicing reporter that could only be targeted by exogenous U11, 
U6atac, and U4atac snRNAs. This assay revealed that each MOPD1-linked U4atac mutant 
construct reduced minor splicing efficiency by over 90% [107]. Further analysis of the effects of 
the g.51G>A mutation, using fibroblasts derived from MOPD1 patients with this mutation, showed 
that minor intron splicing was less efficient in the MOPD1 fibroblasts compared to wild-type cells, 
and this minor splicing defect could be rescued by wild-type U4atac snRNA [107]. Interestingly, 
they found that not all minor introns were equally retained in the MOPD1 fibroblasts [107]. In the 
second 2011 paper, Edery et al. used high-throughput targeted sequencing to identify RNU4ATAC 
mutations in MOPD1 families and patients from the Mediterranean basin, Morocco, India, North 
America, and Norway [108]. In addition to finding the same g.51G>A mutation described by He 
et al., Edery et al. identified three additional RNU4ATAC mutations of g.50G>A, g.50G>C, and 
g.53C>G [108]. Unexpectedly, most MIGs they interrogated showed either normal expression or 
significant upregulation in the MOPD1 cell lines [108]. Despite this, Edery et al. detected increased 
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minor intron retention in all of the MIGs interrogated by qRT-PCR and semi-quantitative PCR 
analysis [108]. As observed by He et al., the degree of minor intron retention varied across the 
tested MIGs, indicating a differential effect on minor splicing across these minor introns [108].  
Subsequent reports have identified six additional RNU4ATAC mutations in MOPD1 
patients: g.29T>C, g.40C>T, g.46G>A, g.66G>C, g.124G>A, and an 85-bp insertion in position 
g.101, caused by an 85 bp tandem duplication of nucleotides 16-100 [127-130]. Most of the 
mutations associated with MOPD1 are located in the 5’ stem-loop (nt 26-57) of the U4atac snRNA, 
which could disrupt binding of the U4atac/U6atac di-snRNP proteins 15.5K and PRPF31 [131-
134]. In particular, the Padgett group found that mutations in positions 50 and 51 significantly 
reduced binding of 15.5K to U4atac [134]. Since the binding of 15.5K protein allows additional 
di-snRNP proteins to bind to U4atac, these mutations also prevented PRPF31 binding [132]. They 
also found that the g.30G>A mutation blocked PRPF31 binding [134]. For the remaining MOPD1-
linked mutations, g.66G>C is located in linear RNA at the base of stem I, which would extend this 
stem; g.111>A sits in the stem of the 3’ stem loop (nt 83-115); and g.124>A is found in the Sm 
binding region (nt 116-124), which is important for snRNP assembly and maintenance of U4atac 
levels [67, 134, 135]. The 85 bp insertion into position 100 of RNU4ATAC is predicted to disrupt 
the 3’ stem loop [127]. Notably, these different mutations appear to correlate with different 
survival outcomes in patients. For instance, Nagy et al. reported a 9-year-old MOPD1 patient with 
homozygous 55G>A mutations [125]. Similarly, Abdel-Salam et al. described three MOPD1 
patients with mild phenotypes, associated with homozygous g.55G>A and heterozygous g.66G>C 
and g.124G>A mutations [128]. Another MOPD1 patient, who lived to 12.75 years, had one 
g.30G>A allele and one g.111G>A allele [125]; an 18-year-old MOPD1 patient was identified 
who was homozygous for the g.55G>A mutation [136]. Kroigard et al. reported a pair of siblings, 
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aged 17 and 24, who were heterozygous for the g.40C>T and 85-bp duplication mutations [127]. 
The latter of these patients is the oldest known MOPD1 patient [127]. Together, these results 
suggest that mutations located outside of the 5’ stem-loop are less detrimental to minor splicing 
than 5’ stem-loop mutations, especially the g.51G>A mutation, which has been linked to a shorter 
lifespan compared to other mutations [125].  
In 2015, mutation of U4atac was linked to another developmental disorder, called Roifman 
syndrome [106]. Roifman syndrome is characterized by restricted intrauterine growth, 
microcephaly, malformation of the bone and joints, retinal dystrophy, and antibody deficiency 
[106, 137]. Unlike MOPD1, premature death has not been reported in Roifman syndrome; the 
oldest reported patient was 20 years old at the time of publication [106, 138]. Using whole-genome 
sequencing, Merico et al. found that Roifman syndrome patients had compound heterozygous 
mutations in RNU4ATAC. Specifically, of the 6 patients, two were heterozygous for g.13C>T and 
g.37G>A mutations; one had heterozygous g.13C>T and g.48G>A mutations; two patients had 
one g.16G>A and one g.51G>A allele; and one patient had g.8C>T and g.118T>C alleles [106]. 
As expected, RNAseq of Roifman syndrome patient mononuclear blood cells revealed 
significantly elevated minor intron retention than observed in carrier controls, while major splicing 
was not affected [106]. Merico et al. also observed a general trend of MIG upregulation in patients, 
which they suggested might be a compensatory response to increased minor intron retention [106]. 
Between 2016 and 2017, RNU4ATAC mutations were identified in two additional Roifman 
syndrome patients [139, 140]. One of these patients had compound heterozygous mutations of 
g.17G>A and g.116A>G [139, 140]. The other had a homozygous g.16G>A RNU4ATAC mutation 
[140].  
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Of the mutations identified in Roifman syndrome patients, only the g.51G>A has been 
observed in MOPD1; the Roifman syndrome patients with this mutation also had a g16G>A 
mutation, which is located in stem II (nt 1-19), a structure formed by base-pairing between U4atac 
and U6atac [67, 106]. Notably, in 5 of these 8 Roifman syndrome patients, the compound 
heterozygous mutations included one mutation located in the 5’ stem-loop of U4atac, and one 
mutation in stem II. In two of the remaining 3 patients, the compound heterozygous mutations 
were located in stem II and the Sm binding region, respectively [106, 139, 140]. The final Roifman 
syndrome patient is the only one with a homozygous RNU4ATAC mutation, located in stem II 
[140]. Notably, stem II mutations have not been reported in MOPD1 patients, suggesting that they 
are unique to Roifman syndrome [107, 108, 127-130]. Disruption of stem II in these patients could 
underlie the presence of Roifman syndrome-specific phenotypes, such as retinal dystrophy and 
antibody deficiency [106, 140]. Based on the phenotype of Roifman syndrome patients, relative to 
that of MOPD1, the Roifman group hypothesized that stem II mutations in U4atac are less 
detrimental to minor spliceosome function than the 5’ stem-loop mutations observed in MOPD1 
[106].  
In 2018, Farach et al. connected RNU4ATAC mutation to yet another developmental 
disorder: Lowry Wood syndrome. Symptoms of Lowry Wood syndrome include restricted 
intrauterine growth, microcephaly, and skeletal dysplasia; retinitis pigmentosa is also common 
[122, 141, 142]. Sequencing of RNU4ATAC in three patients revealed compound heterozygous 
mutations. One patient had heterozygous g.5A>C and g.51G>A mutations; the other two had one 
g.111G>A allele and an allele with both g.46G>A and 123G>A mutations [122]. A subsequent 
report, in 2018, identified two additional Lowry Wood syndrome patients with compound 
heterozygous RNU4ATAC mutations: one patient had heterozygous g.53C>T and g.8C>A 
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mutations, while the second patient had one g.120T>G allele and one g.114G>C allele and more 
severe symptoms [143]. Three of these mutations, g.46G>A, g.51G>A, and g.111G>A, have been 
observed in MOPD1 patients; while the nucleotide substitutions vary, the positions of the g.8C>A 
and g.53C>T mutations match those reported in Roifman syndrome and MOPD1, respectively 
[106-108, 127-130]. These were the first reports of the g.5A>C, g.114G>C, g.120T>G, and 
g.123G>A mutations. The g.5A>C mutation is located within stem II. However, based on 
mutational studies of the complementary position of U6atac, this mutation probably has a mild 
impact on minor spliceosome activity [144]. The g.114G>C mutation is located at the base of the 
3’ stem-loop, where it would disrupt complementarity; mutational analyses suggest that such a 
disruption would have a minor effect on minor spliceosome activity [144]. The g.120T>G and 
g.123G>A mutations would affect the Sm binding site, potentially impacting snRNP assembly and 
U4atac stability [134, 135]. Like Roifman syndrome, Lowry Wood syndrome patients with 
mutations in the 5’ stem-loop have compound heterozygous mutations, with the other mutation 
located elsewhere in RNU4ATAC, either in stem II, the 3’ stem-loop, or the Sm binding region. 
Both Roifman syndrome and Lowry Wood syndrome are also mild disorders, relative to MOPD1. 
Even within MOPD1, there is a wide range of symptom severity, dependent on the specific 
RNU4ATAC mutations [107, 127]. It is likely that these disorders exist on a continuum of minor 
spliceosome disruption, such that severe MOPD1 lies at the end corresponding to the most severe 
minor spliceosome disruption, while Lowry Wood syndrome and Roifman syndrome sit at the 
opposite end, and mild cases of MOPD1 are spread throughout the middle [143].  
Alongside U4atac, mutations in other minor spliceosome-specific components are also 
associated with microcephaly. In 2014, Argente et al. linked mutations in RNPC3, which encodes 
the U11/U12-65K protein, to a family with isolated growth hormone deficiency (IGHD) [119]. 
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IGHD patients grow at slower than normal rates, resulting in a small stature. In addition to their 
short stature, all three patients examined displayed mild microcephaly and hypoplasia of the 
anterior pituitary [119]. Argente et al. determined that the RNPC3 mutations in the IGHD patients 
would lead to a P474T missense or R502X nonsense mutation in the C-terminal RNA binding 
motif (RRM) in the U11/U12-65K protein [119]. Given that U11/U12-65K bridges the U11-
associated 59K protein and the U12 snRNA, and that the 65K protein binds U12 via its C-terminal 
RRM, this mutation could affect U11/U12 di-snRNP integrity [72]. Indeed, subsequent 
biochemical work revealed that these mutations significantly reduced U11/U12 di-snRNP 
stability, due to either impaired RRM folding or NMD-mediated reduction in U11/U12-65K 
protein levels [119, 145]. As expected, RNAseq of patient and family control mononuclear blood 
cell samples revealed increased minor intron retention and aberrant splicing around minor introns; 
however, relative to the entire MIG pool, relatively few MIGs displayed altered splicing of the 
minor intron in the patient samples [119].  
In 2017, Elsaid et al. identified the first disease linked to mutation in the U12 snRNA: 
familial, early-onset cerebellar ataxia [121]. The affected individuals in this Qatari family had 
significantly delayed motor milestones from early infancy onward. While none of the patients were 
microcephalic, all of them had cerebellar hypoplasia, indicative of abnormal cerebellar 
development [121]. Unlike the other disorders described in this subsection, however, this is not a 
purely developmental disease: Elsaid et al. report indications of cerebellar degeneration, as well 
[121]. Whole genome sequencing of these patients revealed a homozygous g.84C>T mutation, 
positioned at the base of stem loop III [121]. This mutation would disrupt base-pairing at the base 
of the stem region of stem loop III, shortening the overall structure. Based on mutational work 
from the Shukla group, the length of stem loop III has a mild effect on minor spliceosome activity 
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[146]. However, RNAseq of mononuclear blood cell samples revealed elevated minor intron 
retention of 144 minor introns in patient samples relative to carrier controls [121]. 
 As implied by the phenotype of these cerebellar ataxia patients, minor spliceosome 
disruption is not implicated only in disorders affecting central nervous system development. A 
growing body of literature is linking minor spliceosome disruption to specific motor disorders that 
are characterized by degeneration of motor system neurons.  
 
1.3.2.2 Motor disorders 
The association between motor disorders and minor spliceosome function was first 
suggested in 2007, when Gabanella et al. published work on a mouse model of severe spinal 
muscular atrophy (SMA) [147]. SMA, a motor neuron disorder characterized by motor neuron 
degeneration and muscle atrophy, is caused by mutation in the gene SMN1 [148]; its protein, SMN, 
is required for the formation of all spliceosomal snRNPs, except for U6 and U6atac [149, 150]. 
Using immunoprecipitation, Gabanella et al. found that U11 and U12 were the only snRNPs with 
significantly lower levels in the SMA mouse spinal cord and brain extracts analyzed [147]. These 
findings were supported by Zhang et al. in 2008 and Boulisfane et al. in 2011, who observed 
downregulation of minor snRNAs/snRNPs in an SMA mouse model and SMA patient-derived 
cells, respectively [151, 152]. Despite observing a 25-fold reduction in the U4atac/U6atac.U5 tri-
snRNP, Boulisfane et al. only identified aberrant minor intron splicing in 4 of the 30 MIGs they 
interrogated by qRT-PCR [152]. From these results, they concluded that the inefficient splicing of 
one or two MIGs specifically involved in motor neuron function might result in SMA. The idea 
that the missplicing of specific MIGs may lead to the symptoms of SMA was further supported in 
2012, when Lotti et al. employed a Drosophila model of SMA to study minor snRNA levels and 
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minor intron splicing, which revealed significant downregulation of all snRNAs, minor intron 
retention in two MIGs, and downregulation of 7 other MIGs [118]. Using Drosophila larvae, they 
found that cholinergic neuron-specific knockdown of one of these MIGs, which they named 
stasimon, resulted in a neurotransmitter release defect very similar to that observed in smn mutant 
flies [118]. Analysis of stasimon, also known as Tmem41b, in a mouse model of SMA revealed a 
significant downregulation of stasimon mRNA in motor and proprioceptive neurons in the early 
symptomatic stage of the disease [118]. Moreover, antisense morpholino-mediated knockdown of 
stasimon in zebrafish also resulted in phenotypes similar to those seen after smn knockdown [118]. 
Notably, misexpression of stasimon could rescue specific smn phenotypes in both Drosophila and 
zebrafish [118]. Based on these findings, they concluded that while the minor snRNA 
downregulation in SMA does not cause universal minor intron missplicing, misexpression of 
specific MIGs, such as stasimon, could potentially cause SMA [118].  
However, not all evidence supports the model that SMA is primarily caused by aberrant 
minor intron splicing or MIG misexpression. In 2009, Baumer et al. reported that minor intron 
splicing was largely unaffected in an SMA mouse model, based on exon microarray analysis [153]. 
Huo et al. performed a similar analysis in 2014, using exon junction microarrays with SMA mouse 
motor neuron samples; they found that all significant changes in alternative splicing occurred at 
major, not minor, introns [154]. Furthermore, when the Dreyfuss group interrogated splicing and 
gene expression in motor neurons and white matter glia from pre-symptomatic SMA mice by 
RNAseq, they found that only 9 MIGs were alternatively spliced in the SMA samples [155]. 
Notably, none of these splice events occurred adjacent to the minor introns within these genes, and 
they did not detect altered splicing or expression of stasimon, suggesting that minor splicing 
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defects are not the primary cause of SMA [155]. In all, it is currently unclear where minor splicing 
dysfunction fits in the timeline SMA progression.  
More recently, minor spliceosome function has also been implicated in the motor disorder 
amyotrophic lateral sclerosis (ALS), which is characterized by progressive degeneration of motor 
neurons culminating in muscle atrophy [156]. Mutations in multiple proteins have been associated 
with ALS, including the proteins fused in sarcoma (FUS) and TAR-DNA-binding protein 43 kDa 
(TDP-43) [156]. Both FUS and TDP-43 are heterogeneous nuclear ribonucleoproteins (hnRNPs) 
that are involved in RNA transcription and splicing [157]. TDP-43 also associates with gemins, 
which are involved in snRNP biogenesis [135, 158]. In ALS patients, cytoplasmic protein 
aggregates form in the motor neurons [159]. In most patients, these aggregates contain TDP-43; 
in a subset of ALS patients, the cytoplasmic protein aggregates contain FUS [160]. Cytoplasmic 
aggregation of either protein can reduce their levels in the nucleus, which is proposed to disrupt 
their function [159]. In 2013, Ishihara et al. reported significant downregulation of gemin and, 
unexpectedly, SMN protein levels both in TDP-43 knockdown cells and in samples from ALS 
patients [161]. They also observed downregulation of both the U12 snRNA and the U11/U12 di-
snRNP in these cells and in spinal neuron samples from ALS patients [161]. Investigation into the 
splicing of minor and major introns in three specific MIGs (IPO4, IFT80, and GARS) by qRT-
PCR revealed that only IPO4 showed significantly elevated minor intron retention, while the other 
two MIGs were spliced normally [161]. Overall, these results suggested that downregulation of 
the U11/U12 di-snRNP might cause MIG-specific misexpression and minor intron retention in 
ALS patients. This was further supported in 2014, when Highley et al. used exon microarrays to 
identify gene expression and splicing changes in lower motor neurons from ALS patients. This 
analysis showed downregulation of U11/U12-25K (SNRNP25) and U11/U12-48K (SNRNP48) in 
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the ALS samples, as would be expected from the downregulation of the U11/U12 di-snRNP 
observed by Ishihara et al. [161, 162]. However, Highley et al. did not report whether they 
identified changes in MIG expression or splicing from their microarray analysis, so it remained 
unclear whether widespread MIG misexpression occurred in ALS.  
In 2016, Reber et al. linked minor spliceosome disruption with an ALS-causative FUS 
mutation, the first report of its kind [120]. They were also the first to establish that FUS binds to 
the U11/U12 snRNP, based on pulldown experiments with anti-FUS antibodies and biotinylated 
antisense oligonucleotides targeting U11 [120]. Subsequent experiments with in vivo splicing 
constructs indicated that the FUS protein recruits the U11/U12 di-snRNP to minor introns [120]. 
To directly assess the effects of ALS-associated cytoplasmic FUS accumulation on minor intron 
splicing, they studied the ALS-causative mutation P525L, which is located in the FUS nuclear 
localization signal [120]. This mutation causes early-onset, aggressive ALS, in which symptoms 
appear before 25 years of age [163]. Strikingly, this mutation not only disrupted minor intron 
splicing, but it also sequestered U11 and U12 snRNA to cytoplasmic FUS aggregates [120]. Based 
on their findings, Reber et al. proposed a model in which ALS associated with FUS mutation is 
caused by sequestration of the U11/U12 di-snRNP in the cytoplasmic FUS protein aggregates, 
resulting in depletion of U11/U12 di-snRNP in the nucleus and global inhibition of minor intron 
splicing [120]. This model predicts that ALS is not caused by a loss of FUS function, but rather 
by a toxic gain of function. Indeed, a report from the Shneider group, published the same year as 
the Reber et al. paper, showed that FUS conditional knockout mice did not develop ALS-like 
symptoms [164]. Using a FUS-P525L mouse model of ALS, they also determined that motor 
neuron death was not caused by interaction between the mutant and wild-type FUS, or by increased 
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FUS activity [164]. Instead, the P525L mutation itself caused a toxic gain of function—just as the 
model proposed by Reber et al. would predict [120, 164].  
These motor disorders suggest that mature motor neurons are particularly sensitive to levels 
of minor splicing activity, such that impaired minor splicing leads to their death. Moreover, the 
developmental disorders linked to disrupted minor splicing indicate that dividing, progenitor cell 
populations are differentially sensitive to levels of minor splicing activity. Specifically, the 
progenitor cells of the central nervous system and the limbs appear to be the most sensitive to 
minor spliceosome disruption. In my dissertation research, I am interested in understanding the 
effects of minor spliceosome disruption on the progenitor cells of the central nervous system.  
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Chapter 1: Figures 
 
Figure 1.1. Comparison of the components and action of the major, U2-type and minor, 
U12-type splicing pathways.  
At top is a schematic of a pre-mRNA, in which boxes are exons and lines are introns, with the 
locations of the three consensus sequences: the 5’ splice site (5’SS), branch point sequence (BPS), 
and 3’ splice site (3’SS). The steps of the U2-type, major and U12-type, minor splicing pathways 
are shown at the left and right, respectively. The analogous snRNAs and snRNPs are color-coded 
(U1/U11=blue; U2/U12=green; U4/U4atac=orange; U6/U6atac=red; U5=purple). The center 
panels show snRNA base-pairing to either the intron or to other snRNAs during each of these 
steps. The red “A” in the BPS panels marks the branchpoint adenosine. 
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Chapter 2: Central nervous system development 
This chapter will cover the model systems used in my dissertation research: the mouse 
retina and the mouse cortex. Both of these tissues are affected in diseases caused by minor 
spliceosome inactivation. For example, as discussed in Chapter 1, many of the developmental 
disorders linked to disruption in minor intron splicing are characterized by microcephaly [119, 
124, 140, 143]. In the most severe of these, MOPD1, microcephaly often presents alongside 
numerous brain defects, many of which are cortical abnormalities [124-127]. In both Lowry Wood 
and Roifman syndromes, many patients display retinal dystrophy [140, 143]. Details about the 
structure and development of these tissues are discussed in the following subsections. 
 
2.1 Retinal development 
Thanks to its stereotyped structure, easy accessibility, and comparatively simple neuronal 
composition, the retina was one of the first characterized models of central nervous system 
organization and development [165, 166]. These advantages of the retina made it a powerful initial 
system in which to study the role of minor intron splicing in central nervous system development. 
Moreover, some of the diseases associated with minor spliceosome disruption are characterized 
by retinal defects, further strengthening the rationale for employing the developing mouse retina 
for my dissertation research [140, 143].  
 
2.1.1 Structure of the mouse retina 
 The mammalian eye is comprised of three distinct layers of tissue: the outermost sclera, a 
tough layer of fibrous connective tissue; the choroid, the vascular, middle layer of connective 
tissue; and the retina, the innermost layer of thin neural tissue [167]. A single-cell layer of retinal 
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pigment epithelium (RPE) is located between the choroid and the outermost neurons of the retina, 
the photoreceptors. The pigment in the RPE cells allow them to absorb scattered light, protecting 
the retina and improving its function [168]. The cells also act as an interface between the blood 
vessels of the choroid and the cells of the retina, by transporting nutrients from the blood to the 
retina while shuttling retinal waste products into the blood [169]. On the other side of the retina, 
the inner limiting membrane separates the retina from the vitreous humor of the eye. This structure 
is formed by astrocytes and the end feed of Müller glia, the major glial cell of the retina [167]. The 
retina is comprised of three nuclear layers of neurons and two synaptic layers. The outer nuclear 
layer (ONL) contains the nuclei of the rod and cone photoreceptors; the cytoplasmic outer 
segments of these photoreceptors lie between the ONL and the RPE [167, 170]. These outer 
segments contain stacks of membranes, in which the rod- and cone-specific visual pigments are 
embedded [171]. Nuclei of the interneurons and glia of the retina are found in the middle nuclear 
layer, called the inner nuclear layer (INL). Amacrine cells, bipolar cells, and horizonal cells 
comprise the interneurons of the INL; the INL also houses the Müller glia. The outermost nuclear 
layer is the ganglion cell layer (GCL), which contains the output cell of the retina, the ganglion 
cells. The two synaptic layers are sandwiched between the nuclear layers of the retina: the outer 
plexiform layer (OPL) is comprised of synapses between the ONL photoreceptors and the 
horizonal and bipolar cells of the INL, while the inner plexiform layer (IPL) consists of synapses 
between amacrine and bipolar cells of the INL and the ganglion cells of the GCL [167, 170]. Axons 
from the ganglion cells throughout the retina coalesce into the optic nerve, ultimately synapsing in 
target brain regions, such as the geniculate nucleus and superior colliculus [167, 172].  
 During the process of phototransduction, light has to pass through the GCL, IPL, INL, 
OPL, and ONL, to reach the outer segments of the photoreceptors. These photons interact with the 
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visual pigments found in the rod and cone outer segments, changing the conformations of these 
proteins [171]. Activation of these visual pigments results in hyperpolarization of the 
photoreceptors, which in turn reduces the amount of neurotransmitter released into the OPL [171]. 
The response of the bipolar cells of the INL depends on the specific bipolar cell type and their 
post-synaptic glutamate receptors; ultimately, the signal is transmitted through the bipolar cells in 
the INL to the ganglion cells of the GCL [173]. The horizontal cells of the INL, which synapse 
with multiple photoreceptors, mediate lateral inhibition of these photoreceptors, thereby 
modulating and coordinating photoreceptor output to the bipolar cells [174]. The final interneuron 
of the INL, the amacrine cells, modulate activity between the bipolar cells and the ganglion cells 
in the IPL [175]. The signal received by the ganglion cells of the GCL is then transmitted through 
the optic nerve and to the brain [167]. While Müller glia are not directly involved with this process, 
evidence suggests that they act as photo-optic tubes, allowing light to pass more easily through the 
retina to the photoreceptors. Since Müller glia stretch from the inner limiting membrane to the far 
edge of the ONL and contain few organelles, light can pass through this structure with minimal 
scattering [167, 176]. They also function in the maintenance of neuronal health, through uptake of 
neuronal waste products and excess neurotransmitters [177]. 
 
2.1.2 Development of the mouse retina 
 In the mouse, eye development around embryonic day (E) 8.5. At this time-point, the lateral 
regions of the diencephalon evaginate to form the optic vesicles, which continue to expand laterally 
[178]. When the distal side of the optic vesicle comes in close contact with the surface ectoderm 
at around E9.5, it triggers thickening of the surface ectoderm into the lens placode [178, 179]. The 
lens placode then signals back to the optic vesicle, inducing optic vesicle invagination [178, 179]. 
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By E10.5, this optic vesicle invagination forms a thin, cup-like structure, fittingly termed the optic 
cup. The inner wall of the optic cup, which used to be the lateral wall of the optic vesicle, becomes 
the neural retina. In contrast, the outer wall receives signals from the surrounding mesenchyme 
and gives rise to the RPE [178, 179].  
 As retinal development progresses, the retinal neuroepithelial cells (a.k.a. retinal progenitor 
cells) begin to divide at the apical edge of the retina, adjacent to the RPE, to produce retinal neurons 
[180]. As neurons are born, they migrate out of the proliferative, neuroblastic zone to their 
respective neuronal layer [181, 182]. Neurogenesis in the developing mouse retina begins around 
embryonic day (E) 11; both neurogenesis and gliogenesis end by approximately postnatal day (P) 
14 [178]. Thanks to extensive pulse-chase experiments performed by Drs. Richard L Sidman and 
Richard W. Young, the birth windows of the different retinal neurons are known [183, 184]. The 
first neurons born are ganglion cells, amacrine cells, horizonal cells, and cone photoreceptors, 
starting at E11. While the birth of these neurons begins around the same time in retinal 
development, their birth windows terminate at different time-points. Horizonal cell birth only 
continues until E15, while cone photoreceptors are born until E18. Birth of ganglion cells and 
amacrine cells continues until P3, although very few ganglion cells are born postnatally. Bipolar 
cells are the next cell type generated, with their production starting at E14 and ending at P11. The 
first Müller glia are born at E16, and their production continues until P9. Finally, rod 
photoreceptors are born both embryonically and postnatally, with production starting around E12 
and ending around P14. In summary, most ganglion cells, horizontal cells, amacrine cells, and 
cone photoreceptors are born during embryonic retinal development. In contrast, most bipolar 
cells, Müller glia, and rod photoreceptors are born postnatally [183, 184].  
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 While the adult retina contains three distinct nuclear layers, the E11 retina is initially 
comprised of a single layer of retinal progenitor cells. As neurogenesis begins, newborn ganglion 
cells begin to migrate to the basal edge of the retina [178]. By E14, the retina has two separate 
layers: the GCL and the outer neuroblastic layer (ONBL), which contains the retinal progenitor 
cells and newly born neurons [185]. Although the INL and ONL are not distinguishable at this 
point in development, newborn amacrine cells line the inner edge of the ONBL [186]. At 
approximately P5, the ONBL separates into the ONL and INL; active separation of these two 
nuclear layers continues until P10 [187].  
 
2.2 Cortical development  
As mentioned in Chapter 1, microcephaly is one of the most common symptoms of the 
CNS disorders linked to minor spliceosome disruption [124, 140, 143]. Given the size of the 
cerebral cortex in the human brain, microcephaly is often caused by impaired development of the 
cerebral cortex [188]. Indeed, hypoplasia of the cortical lobes has been reported in MOPD1 
patients. Moreover, the microcephaly observed in MOPD1 commonly presents alongside cortical 
abnormalities, including hypoplasia of the cortical lobes, aberrant gyrification, and agenesis of the 
corpus callosum [124-127]. Therefore, I sought to study the effects of minor spliceosome 
inactivation in the developing mammalian cortex, using the developing mouse cortex as a model 
system. The following subsections expound upon the structure, development, and progenitor cells 
of the mammalian cortex. 
 
2.2.1 Structure of the mammalian cortex 
 The mammalian cerebral cortex is, as its name suggests, the outer layer of the cerebrum. 
This gray matter structure is comprised of six distinct neuronal layers, numbered from the 
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outermost I to innermost VI layers, along with a host of glial cells. Layer VI is located above a 
layer of white matter, comprised of axons from layers II-VI. Neurons of the cortex are divided into 
two general types: excitatory pyramidal cells, which project to different regions of the brain and 
make up ~80% of cortical neurons; and inhibitory interneurons, which modulate the activity of 
these excitatory neurons and comprise the remaining ~20% of cortical neurons [189]. Inhibitory 
interneurons are found throughout the cortical layers, although they are concentrated in layers I, 
II, and V [190]. 
The outermost neuronal layer, layer I, is also known as the molecular layer. In the adult 
brain, layer I contains sparsely distributed inhibitory neurons, which receive input from the 
thalamus and other cortical regions [191, 192]. However, in the developing cortex, this layer is 
tightly packed with inhibitory Cajal-Retzius cells [191]; their source and function are described in 
the next subsection. Layers II and III contain commissural projection neurons, due to their 
projections to the contralateral cerebral cortex through the corpus callosum or, less commonly, the 
anterior commissure. The commissural projection neurons that cross through the corpus callosum 
are also known as callosal projection neurons [193]. In rodents, layers II and III are difficult to 
distinguish based on their cytoarchitecture alone; therefore, these layers are often studied together 
and referred to as layer II/III [189]. Layer IV is characterized by excitatory granular neurons, which 
receive input from thalamocortical projections and project up into layer II/III [193]. Layers V and 
VI primarily consist of output projection neurons that transmit signals to subcortical regions of the 
brain, called corticofugal projection neurons [193]. Specifically, most projection neurons of layer 
V are subcerebral projection neurons, which synapse with targets in the midbrain, brainstem, or 
spinal cord, depending on the cortical location of the neuron’s cell body [193]. For example, 
subcerebral projection neurons of the motor cortex send axons to the spinal cord and motor nuclei 
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of the brainstem [193]. Layer VI consists of corticothalamic projection neurons, which alter 
thalamic neuron activity and therefore modulate the signals sent from the thalamus to layer IV 
[193, 194]. While most commissural projection neurons are found in layer II/III, commissural 
neurons are found throughout layers IV-VI. Some of these are associative projection neurons that 
project ipsilaterally, to different regions within the same hemisphere, while some are callosal 
neurons that project contralaterally. Some commissural neurons in layer V project ventrally, to the 
striatum [193, 195]. In addition to excitatory neurons that project to a single target, some cortical 
projection neurons have multiple projections that target different brain regions [193]. 
In addition to neurons, multiple subtypes of glial cells are present in the mammalian 
cerebral cortex. Astrocytes, the most common and most commonly studied glial subtype, are found 
throughout the cortical layers, where they associate with neurons and the vasculature [196, 197]. 
Astrocytic processes wrap around the blood vessels in the cortex; as a result, astrocytes contribute 
to the blood brain barrier, regulate vascular tone in the brain, and transport water, nutrients, and 
wastes between the blood and nearby neurons [198]. The many and varied functions of astrocytes 
also include the regulation of extracellular ion homeostasis; uptake and metabolism of extracellular 
neurotransmitters; synaptogenesis; promotion of synaptic pruning; and, more controversially, 
modulation of neuronal activity via the release of “gliotransmitters” [198-201]. The next glial 
subtype, the oligodendrocytes, are found in all cortical layers, although they are the densest in the 
deep layers (V-IV) [202]. Oligodendrocytes are the myelinating cells of the central nervous 
system, allowing for faster action potential conduction [203]. Oligodendrocytes are produced from 
NG2-expressing oligodendrocyte precursor cells (OPCs), the third glial cell type in the cortex [202, 
203]. OPCs also produce a subset of astrocytes in the mouse brain [202]. In the mature cortex, 
OPCs are scattered throughout the cortical layers [202]. Evidence indicates that they serve as a 
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pool of quiescent progenitor cells that, in the presence of a demyelinating insult, migrate to the site 
of injury, proliferate, and differentiate into oligodendrocytes, thereby driving remyelination [204]. 
The final type of glia in the cortex is microglia. Microglia are a type of macrophage that function 
in the brain’s inflammatory immune response, and, like astrocytes and OPCs, microglia are 
uniformly distributed across the cortical layers [205]. Microglia have also been implicated in 
synaptic pruning, the promotion of neuron survival during development, and the regulation of 
neural progenitor cell number in the prenatal cortex [205]. 
  
2.2.2 Timeline of cortical development 
 In the mouse, the developing forebrain is first distinguishable in the closing neural tube 
around E8. At this point, specific regions along the rostral end of the closing neural tube begin to 
grow outward, bulging into defined vesicles [206]. The most rostral of these is the prosencephalon, 
or the primordial forebrain. By E9, the prosencephalon has segmented further, into the rostral-
most telencephalon and the diencephalon. Specifically, the rostral end of the prosencephalon 
bulges laterally into two symmetrical vesicles, laying the foundation for the two cerebral 
hemispheres [207]. The dorsal region of the telencephalon will develop into the cerebral cortex 
and hippocampus, while the ventral telencephalon will produce the striatum. These regions of the 
telencephalon are alternatively called the pallium (dorsal telencephalon) and the subpallium 
(ventral telencephalon) [208]. 
 When the dorsal telencephalon is formed, it is comprised of a monolayer of 
pseudostratified neuroepithelial cells, whose processes anchor them to the apical (ventricular) and 
basal (pial) edges of the dorsal telencephalon. As these cells progress through the cell cycle, their 
nuclei move along the apical-basal plane such that mitosis occurs at the apical/ventricular edge, 
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while S-phase occurs at the basal edge [209]. Until E10, these neuroepithelial cells undergo 
symmetric, proliferative divisions to produce two neuroepithelial daughter cells, in order to 
amplify the progenitor pool [210, 211]. At E10, the neuroepithelial cells transition into radial glial 
cells (RGCs), also known as apical progenitors (APs) [211, 212]. Like the neuroepithelial cells, 
RGCs undergo INM as they progress through the cell cycle [209, 211]. Most of these RGCs 
undergo symmetric proliferative divisions, producing two RGCs. However, starting between E10 
and E11, some RGCs undergo asymmetric, differentiative divisions, which make one RGC and 
one differentiating cell [213-216]. Some of these differentiative divisions are neurogenic, in which 
this second daughter cell is a newborn excitatory neuron [215-217]. These newborn cortical 
neurons use the basal process of their mother RGC to migrate from the ventricular edge to the 
basal edge of the dorsal telencephalon. As more neurons reach their final destinations, the dorsal 
telencephalon becomes laminar, with the RGC-comprised ventricular zone (VZ) and the neuronal 
cortical plate (CP). Other differentiative divisions generate one RGC and another progenitor cell 
of the cortex, called intermediate progenitor cells (IPCs), also known as basal progenitors (BPs) 
[216, 218, 219]. These IPCs migrate away from the ventricular edge to sit between the VZ and the 
CP. These IPCs eventually form a third layer in the pallium, called the subventricular zone (SVZ), 
which becomes distinguishable from the VZ by E13 [220]. Unlike RGCs, IPCs have multipolar, 
short processes that do not span the dorsal telencephalon, and they do not undergo INM [218, 219, 
221]. Most IPCs undergo symmetric neurogenic divisions to produce two neurons, which use 
nearby RGC basal processes to migrate to the CP [211, 216, 222]. A small fraction of IPCs divide 
symmetrically to expand the IPC pool, producing two IPCs, prior to terminal symmetric 
neurogenic division [216]. As a result, most excitatory neurons of the mouse cortex originate from 
IPCs [220]. RGCs can also divide to produce one RGC, which remains in the VZ, and a monopolar 
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RGC lacking an apical process, which will reside in the SVZ. These basal RGCs, also known as 
outer RGCs, primarily undergo asymmetric neurogenic divisions [223, 224].   
 Neurogenesis in the developing mouse cortex occurs from E11 to E18, just prior to birth. 
Cortical excitatory neurons are born in an “inside-out” manner, in which the deep layer neurons 
are born first and the upper layer neurons late in cortical neurogenesis. The first neurons born in 
the dorsal telencephalon are subplate neurons, which are produced from E10 until E12 [193]. 
These subplate neurons form a transitory neuronal layer below layer VI that persists until 
approximately P10. These neurons are important for cortical development, playing roles in synapse 
maturation and in the guidance of both incoming thalamocortical axons to layer IV and outgoing 
corticothalamic axons [225]. In this window of time, the neurons that will form layer I are also 
invading the basal dorsal telencephalon, forming the transient marginal zone of the developing 
cortex. These inhibitory neurons, which include Cajal-Retzius cells, are produced from other 
regions of the developing forebrain and migrate tangentially into the cortex. Specifically, the Cajal-
Retzius cells originate from the cortical hem, the pallial/subpallial border, and the retrobulbar 
area/pallial septum. These cells produce the extracellular matrix protein reelin, which serves as a 
signal to stop basally directed migration of newborn excitatory neurons [226]. Given their 
developmental function, most Cajal-Retzius cells undergo apoptosis, starting from approximately 
P8 [227, 228]. Layer VI corticothalamic projection neurons are the next born in the dorsal 
telencephalon, between E11.5 and E13.5. From E13.5 until E14.5, the subcerebral projection 
neurons of layer V are born. Layer IV granular neurons are the next type generated, between E13.5 
and E14.5. While the majority of the commissural projection neurons of layer II/III are born last 
in cortical development, between E14.5 and E18, production of these neurons actually begins by 
E12.5 [193]. Throughout the production of excitatory neurons from the neural progenitor cells 
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(NPCs) of the dorsal telencephalon, inhibitory neuron production is occurring in the ganglionic 
eminences of the ventral telencephalon. These inhibitory neurons migrate both tangentially and 
radially into the developing cortex, starting at E12 and ending by birth [229]. 
 Production of glia from the progenitor cells of the dorsal telencephalon starts in late 
embryonic development, with most glia being born postnatally. At the end of neurogenesis, the 
RGCs of the VZ begin to transform into astrocytes, while other astrocytes are born from SVZ 
progenitor cells [230]. These newborn astrocytes can divide to amplify the astrocyte pool in the 
first two weeks of postnatal development [231]. Astrocytes are also produced from OPCs, another 
glial subtype and primary source of oligodendrocytes in the cerebral cortex [202]. Most OPCs are 
produced in the ventral telencephalon, from the ganglionic eminences and the anterior 
entopeduncular region. The first wave of these ventrally produced OPCs migrate tangentially to 
the dorsal telencephalon by E16, in a migratory stream concentrated in the deep layers of the 
pallium [202, 232]. Postnatally, OPCs are produced from progenitor cells of the developing cortex, 
which migrate radially up into the neuronal layers [202, 232]. The final cortical glial subtype, the 
microglia, originate from the yolk sac in early embryonic development. These microglia invade 
the developing brain by E9.5, prior to the onset of neurogenesis; in the dorsal telencephalon, these 
microglia cluster in the proliferative VZ and SVZ [233, 234].   
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Chapter 3: The role of minor intron splicing in mouse retinal development 
This chapter marks the beginning of my research into the role of minor intron splicing in 
central nervous system development, by focusing on the retina. First, the expression of the minor 
spliceosomal snRNAs in the whole mouse embryo and in the developing mouse retina is discussed, 
followed by a microarray-based analysis of MIG expression across retinal development and 
investigation into the outcome of minor spliceosome inactivation in the neonatal mouse retina. 
 
 
3.1 Rationale 
As discussed in Chapter 1, diseases associated with minor spliceosome dysfunction 
indicate that minor intron splicing is essential for mammalian CNS development [103, 106-108, 
118-123]. However, prior to 2015, there were no publications investigating how minor intron 
splicing regulates CNS development in a mammalian model system. Given the paucity of research 
on minor splicing in mammalian CNS development, I sought to characterize the expression of the 
minor spliceosome-specific snRNAs in the developing mouse CNS. To study how minor splicing 
affects CNS development, I employed two separate approaches, which I ran in parallel. First, I 
began breeding a U11 conditional knockout mouse the Kanadia laboratory had generated to a 
transgenic mouse line that expresses cre recombinase in the developing cortex; these mouse lines 
are explained in more detail in Chapter 4 [117, 235]. Second, I sought to study minor splicing in 
an easily accessible model of CNS development: the developing mouse retina. Notably, retinal 
dystrophy is observed in Roifman syndrome and Lowry Wood syndrome, further emphasizing the 
importance of minor splicing in the mammalian retina [140, 143]. To study minor splicing in 
mouse retinal development, I employed a custom microarray for MIG expression, using cDNA 
samples spanning embryonic and postnatal retinal development, and investigated the effects of 
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minor spliceosome inactivation in the neonatal retina, by P0 retinal electroporations of a published 
antisense morpholino that blocks association of the U12 snRNA with the BPS of minor introns 
[236, 237]. The following sections include the contents of one of my publications, entitled “Minor 
splicing snRNAs are enriched in the developing mouse CNS and are crucial for the survival of 
differentiating retinal neurons” [116].  
 
3.2 Results 
 
3.2.1 Identification of potential murine gene copies of the minor spliceosome-specific snRNAs 
First, we wanted to explore the expression kinetics of the minor snRNAs across mouse 
development. For this, we sought to design probes specific to the U4atac, U6atac, U11, and U12 
snRNAs. However, current databases do not reflect possible isotypes (i.e., gene copies) of these 
snRNAs in the mammalian genome. While two isotypes for U6atac and U12 have already been 
reported [238], we undertook a bioinformatics analysis to identify other potential isotypes for all 
the minor-class snRNAs. For a given snRNA, we first extracted the known human minor-class 
snRNA sequence from the NCBI database. We then employed BLAT to align this known human 
sequence with the mouse genome in order to identify potential isotypes [239]. This yielded 
multiple loci; only those with >87% identity were considered potential isotypes. Next, we 
identified the locus that was syntenic to the human locus of each snRNA.  
 Only one U4atac gene copy (Gm22710) was identified in the mouse genome, which was 
considered syntenic to the human RNU4ATAC, since both are located within the same intron of 
the gene Clasp1 (Figure 3.1A). The U6atac isotype (Gm26473) found on chromosome 2 was 
considered syntenic to the human RNU6ATAC, since both are flanked by Wdr5 and Rxra (Figure 
3.1B). The U11 isotype (Rnu11) found on chromosome 4 was considered syntenic to the human 
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RNU11, as both are flanked by the genes Gmeb1 and Taf12 (Figure 3.2A). The U12 isotype 
(Rnu12) found on chromosome 15 was considered syntenic to the human RNU12, as both are 
flanked by the same genes, Poldip3 and Cyb5r3 (Figure 3.2B). To further characterize whether or 
not the remaining potential gene copies would produce functional snRNAs, we investigated 
conservation at their respective functional sites. For U6atac, there are four functional sites: the 5’ 
interaction site, the U12-U6atac helix I site, the stem I site, and the stem II site [66-68]. 
Interestingly, for all the potential U6atac gene copies (Gm25541, Gm26573, Gm26044, Gm23879, 
Gm23494, and Gm24831), none were 100% conserved within these four functional domains 
(Figure 3.1B). For U11, there are two functional sites: the 5’ interaction site and the Sm-binding 
site [34, [240]. Four U11 isotypes (Gm25097, Gm22472, Gm25785, and Gm24890) from the 
Ensembl database showed near 100% identity for these functional sites (Figure 3.2A). For U12, 
there are three crucial functional sites: the U12-U6atac helix I site, the branch site interaction 
region, and the Sm-binding site [56, 61, [240]. There were two other U12 isotypes (Gm25703 and 
Gm24525) from the Ensembl database that showed near 100% identity for all three functional sites 
(Figure 3.2B).   
The bioinformatics strategy used to identify possible gene copies does not a priori predict 
the transcription of the genes. To determine this, we mined RNAseq data obtained from 
cytoplasmic extracts of embryonic day (E) 16 and postnatal day (P) 0 mouse retinae [241]. First, 
we sought to verify whether the RNAseq data reflected previous findings in regards to snRNA 
expression levels, where the major snRNAs are expressed 100-fold higher than the minor snRNAs 
[56, 59]. Indeed, we found that the minor-class snRNA levels were at least 100-fold lower than 
their major-class snRNA counterparts, except for U11, whose levels were only 30-fold lower than 
U1 (Figure 3.3A). This confirmation of the dataset provided us the confidence to interrogate the 
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expression levels of the identified gene copies in the RNAseq data. For U6atac, two of the six 
identified U6atac gene copies, Gm25541 and Gm23879, were expressed at these two time points 
(Figure 3.3B). For U11, Rnu11 was the highest expressed gene copy, and, of the remaining 
candidates, only Gm24890 showed expression above threshold (Figure 3.3B; methodology: [241]). 
Notably, although the functional sites of U11 are conserved in this potential gene copy, Gm24890 
is 32 nucleotides shorter than the known U11 sequence. The levels of the known U12 gene, Rnu12, 
were the highest, with Gm25703 expressed at much lower levels (Figure 3.3B). The other 
identified U12 gene copies were not expressed (Figure 3.3B). These results suggest that U6atac, 
U11, and U12 have at least two potential gene copies that are expressed at some point during 
development. However, whether these products of these potential gene copies are functional in 
minor intron splicing remains is unclear. 
 
3.2.2 The minor spliceosomal snRNAs are enriched in the developing murine CNS and limbs 
Next, we employed whole mount in situ hybridization (WISH) on embryos at E9.5, E10.5, 
and E12.5 with probes for U4atac, U6atac, U11, and U12. Here, we utilized full length snRNA 
sequence for probe preparation, which could hybridize with all snRNAs transcribed from potential 
gene copies (Figures 3.1&3.2). Expression of U4atac was observed in the entire embryo at E9.5, 
with enrichment in the developing CNS, branchial arches, fore- and hind-limb buds, and the 
somites (Figure 3.4). At E10.5 and E12.5, U4atac expression persisted in the same structures, 
except expression in the developing heart was visibly lower than the surrounding tissues at E12.5 
(Figure 3.4A’&A’’ arrowhead). Similarly, expression of U6atac was observed in the developing 
CNS, branchial arches, and fore- and hind-limb buds at E9.5, with persistent expression in the 
same structures at E10.5 and E12.5 (Figure 3.4B-B’’). As with U4atac, there was little U6atac 
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expression in the developing heart at E12.5 (Figure 3.4B’’ arrowhead). Both U11 and U12 showed 
robust expression in the CNS, branchial arches, fore- and hind-limb buds, and somites at E9.5 
(Figure 3.4C&D). While the expression pattern continued in the same structures at E10.5 and 
E12.5 for both U11 and U12, there was a distinctly low signal in the developing hindbrain (Figure 
3.4C’’&D’’ arrowheads). WISH was performed using either an antisense and a control sense probe 
for each snRNA. No signal was observed using the U11, U12, or U6atac sense probes, but sense 
U4atac probe showed faint signal in the developing ventricles in the E10 embryo (Figure 3.5). 
Overall, WISH analysis showed near ubiquitous expression of all minor-class snRNAs, with 
specific enrichment in the developing head and limb buds. 
 
3.2.3 The minor spliceosomal snRNAs are expressed across embryonic mouse retinal 
development 
Our WISH analysis revealed that all minor-class snRNAs were enriched in the developing 
head compared to the rest of the embryo, in agreement with the phenotypes observed in 
developmental diseases characterized by minor spliceosome disruption [124, 140, 143]. To further 
investigate the expression of the minor splicing components in the developing mouse CNS, we 
used the mouse retina as a model system and performed section in situ hybridization (SISH) across 
embryonic retinal development (E12, E14, E16, and E18). During embryonic development, all 
four minor-class snRNAs were observed in both the ONBL, which consists of newly born neurons 
and cycling progenitor cells, and the newly forming ganglion cell layer (GCL) (Figure 3.6) [178, 
185]. It should be noted that expression of U12 appeared to be highly enriched in the ganglion 
cells, such that its relative expression was reduced in the ONBL by E18, barring scattered cells in 
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the ONBL with high U12 expression (Figure 3.6M-P). In contrast, robust expression of U11 was 
maintained in the ONBL at E18 (Figure 3.6I-L). 
 
3.2.4 The minor spliceosomal snRNAs are enriched in differentiating retinal neurons 
 Next, we extended our SISH analysis across postnatal retinal development (P0, P4, P6, 
P14, and adult). At P0, expression of all minor-class snRNAs except U6atac was observed at a 
higher level in the differentiating neurons in the GCL and the newly differentiating amacrine cells 
lining the basal edge of the ONBL (Figure 3.7A, K, & P arrowheads) [186]. Specifically, U12 and 
U11 showed increased levels of expression in the GCL (Figure 3.7K&P). To confirm this 
enrichment, we dissociated P0 retinae and performed double fluorescent in situ hybridization for 
U11 or U12, along with NF68, a marker for retinal ganglion cells [242]. Indeed, expression of U11 
and U12 was higher in cells that were also positive for NF68 when compared to the other DAPI+ 
cells (Figure 3.8). At P4, P6, and P14, expression of all minor-class snRNAs appeared to be 
enriched in differentiating neurons (Figure 3.7B-S). Specifically, horizontal cells were observed 
with enriched expression of all four snRNAs at P4 (Figure 3.7B, G, L, Q arrowheads). At P6, 
expression of all four snRNAs was also observed in photoreceptors at the basal edge of the ONBL 
(Figure 3.7C, H, M, & R arrowheads). Finally, expression of all four snRNAs was observed in all 
retinal neurons at P14, and this expression was maintained in the adult retina (Figure 3.7D, I, N, 
S, E, J, O, & T).  
 
3.2.5 Expression of MIG isoforms that require minor intron splicing shifts between 
embryonic and postnatal retinal development  
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Another way to understand the role of the minor spliceosome is by understanding its 
targets. In this case, those targets are minor intron-containing genes (MIGs). To study the MIGs 
in the mouse genome, we extracted 461 MIGs from the U12 Intron Database [58]. To glean the 
molecular pathways in which MIGs might participate, we performed DAVID analysis on these 
genes [243, 244]. This analysis yielded 45 GOTERM terms with Bonferroni corrections ≤0.005. 
Shown in Table S1 are select functions enriched by these MIGs, such as intracellular transport, 
transmembrane transport, voltage-gated ion transport, MAP kinase activity, and ATP binding. 
While this analysis revealed the potential functions that MIGs could execute, only by 
understanding which MIGs are expressed and when these MIGs are expressed in the developing 
retina can one determine the molecular pathways in which they participate. To this end, we 
designed a custom microarray, which allowed us to interrogate the expression of exon-exon 
junctions that require minor splicing (Figure 3.9A). We employed this custom microarray on 
cDNA made from RNA prepared from cytoplasmic extracts from E12, E16, E18, P0, P4, P10, and 
P25 retinae. Here, we chose to specifically employ cytoplasmic extracts because the cytoplasmic 
mRNA pool represents mRNAs that have been successfully spliced and exported, thus proxying 
for the protein produced.  
 The raw microarray data was processed through Genesis (v1.7.6) and subjected to k-means 
clustering to find MIGs that had exon junctions with similar expression kinetics [245]. This 
analysis generated 10 clusters, which were further subdivided into “embryonic,” “postnatal,” or 
both embryonic+postnatal (“E+P”) categories (Figure 3.10A-C). The production of these three 
categories is described in detail in Section 3.4, the materials and methods subsection corresponding 
to this chapter. There were three clusters that showed enrichment of interrogated exon junctions 
during embryonic development. The first, cluster 1, showed enrichment at E12 to P0, followed by 
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a precipitous decline from P4 to P25. The second cluster showed enrichment at E12, followed by 
a drop to threshold at E16, after which it remained at threshold, except for a drop at P4 below 
threshold (Figure 3.10A). The final embryonic cluster, cluster 3, showed a spike in expression at 
E16 and a spike just above threshold at P4, with expression remaining at or below threshold for 
all other time points (Figure 3.10A). There were also three clusters with exon junctions enriched 
postnatally. The first cluster, cluster 4, showed a steady increase in expression from E12 until P25, 
with expression above threshold from P4 onward (Figure 3.10B). In cluster 5, expression of exon 
junctions was just above threshold at E12, below threshold from E14 to P4, and showed a steady 
increase in expression from P4 to P25 (Figure 3.10B). The final postnatal cluster, cluster 6, 
contained exon junctions with a sharp rise in expression at P4 (Figure 3.10B). The remaining four 
clusters were grouped in the “embryonic+postnatal” (E+P) category. The first, cluster 7, showed 
bimodal expression, with the first peak at E16 and the second at P10 (Figure 3.10C). The second 
E+P cluster, cluster 8, also showed bimodal exon junction expression, with the largest peak at P0 
and a second peak just about threshold at P10 (Figure 3.10C). The third cluster, cluster 9, showed 
a steady expression just above threshold at all time points, except for the subthreshold troughs at 
E12 and P10 (Figure 3.10C). The final E+P cluster, cluster 10, showed bimodal expression, with 
peaks at E12 and P4 (Figure 3.10C). 
 While the identification of MIGs that have exon junctions with overlapping expression 
patterns suggests dynamic regulation of MIGs, it does not inform their biological role in the 
developing retina. To extract this information, we curated genes belonging to either the embryonic 
clusters, the postnatal clusters, or the E+P clusters, followed by DAVID analysis. Interestingly, 
MIGs in the embryonic category enriched for functions involved in RNA metabolism, including 
RNA processing and ribosome biogenesis, along with cell cycle, nuclear transport, and mRNA 
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transport (Figure 3.10A’). In contrast, MIGs in the postnatal category enriched for transport-related 
functions, including intracellular protein transport, vesicle-mediated transport, MAP kinase 
activity, and voltage-gated calcium channel activity (Figure 3.10B’). Interestingly, the genes 
underlying vesicle-mediated transport are genes mostly involved in synapse formation, such as 
Huntingtin, which is shown to be required for synaptic development [246], and syntaxin binding 
protein 5, which is known to be involved in the docking and fusion of synaptic vesicle [247]. 
Finally, in the E+P clusters, MIGs enriched for protein transport, sodium ion transport, voltage-
gated calcium channel activity, and phospholipase C activity (Figure 3.10C’).   
 
3.2.6 The minor spliceosome is required for the survival of differentiating retinal neurons 
Our custom microarray analysis revealed that MIGs are dynamically expressed across 
retinal development. Moreover, DAVID analysis showed distinct function enrichments for MIGs 
enriched embryonically versus postnatally (Figure 5). Specifically, MIGs enriched postnatally 
showed enrichment for functions such as ion transport, protein transport, and vesicle-mediated 
transport. All of these functions suggest that these genes are involved in the terminal differentiation 
of retinal neurons, such as synapse formation. This result, together with the minor-class snRNA 
enrichment in differentiating neurons observed in SISH analysis, led us to hypothesize that the 
minor spliceosome is required for proper neuronal differentiation. To test this hypothesis, we 
employed in vivo P0 retinal co-electroporations of antisense morpholino (MO) against the U12 
snRNA and a pCAG-GFP expression plasmid to drive GFP expression in electroporated cells (ref); 
a scrambled morpholino (Scr-MO) was co-electroporated with pCAG-GFP in littermate controls. 
Specifically, the antisense MO targeting U12 was complementary to nucleotides 9-33, which 
would disrupt base-pairing both between U12 and the BPS and between U12 and U6atac [236]. 
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The electroporated pups were harvested at P14 to analysis. In the U12 MO-electroporated P14 
retina, we observed very few GFP+ neurons relative to the control, suggesting that the 
electroporated neurons might be undergoing apoptosis in the absence of minor spliceosome 
activity (Figure 3.11). To confirm this, we performed deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) to identify cell death in U12 MO- and scrambled MO-electroporated neurons 
(Figure 3.11D&D’). Indeed, we observed TUNEL+ cells in the outer nuclear layer (ONL) of the 
U12 MO-electroporated retina (Figure 3.11D’), including GFP+/TUNEL+ neurons undergoing 
apoptosis (Figure 3.11D’’). In all, this suggested that loss of minor spliceosome function most 
likely resulted in neuronal death. However, it did not rule out progenitor cell death. To distinguish 
between these two possibilities, we harvested retinae of P0-electroporated mice at P3, P7, and P10. 
At P3, we observed U12 MO-electroporated retinae with GFP+ progenitor cells and newly 
differentiating amacrine cells at the basal edge of the ONBL, similar to those in retinae 
electroporated with the scrambed control MO. We also performed TUNEL on these sections, and 
we observed no difference in number of TUNEL+ cells between control and U12 MO-
electroporated retinae. A similar analysis was performed at P7, where we observed GFP+ cells in 
both control and U12 MO-electroporated retinae. However, we observed more TUNEL+ cells in 
the U12 MO-electroporated retinae. A similar increase in TUNEL+ cells was observed at P10 
(Figure 3.10F). In all, the majority of the TUNEL+ cells were observed between P7 and P10, so 
we quantified the number of TUNEL+ cells as a percentage of the total number of GFP+ 
electroporated cells. This analysis showed that there was a significant increase in TUNEL+ cells, 
relative to the number of GFP+ electroporated cells, in the U12 MO-electroporated retinae when 
compared to the scrambled MO-electroporated retinae at P7 and P10 (Figure 3.10E&F).  
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3.3 Discussion 
Here, we have bioinformatically shown the presence of multiple potential isotypes for each 
minor-class snRNA, except for U4atac, along with the expression of these isotypes in the E16 and 
P0 retina. While their transcription across the entirety of development remains unexplored, their 
presence raises the possibility that a mutation in one could be compensated by the other isotypes. 
It is also possible that each isotype might have a tissue-specific expression pattern, and therefore 
a tissue-specific function, necessitating further exploration into the expression of these potential 
isotypes. Interestingly, U4atac, which lacks even potential gene copies, is the snRNA linked to the 
most diseases, including MOPD1 [124, 140, 143]. Some of the symptoms of MOPD1 include 
microcephaly, micrognathia, and skeletal dysplasia [126]. Indeed, WISH expression analysis for 
U4atac across embryonic mouse development revealed that it was enriched in the developing head, 
branchial arches, and limb buds, thus suggesting an important role for this snRNA and, by 
extension, the minor spliceosome, in mammalian CNS and skeletal development. Given that the 
minor spliceosome requires the presence of all minor snRNAs to function, it is not surprising that 
the other snRNAs show similar expression patterns. The efficiency of minor splicing has been 
associated with limiting amounts of these snRNAs. Specifically, in HeLa cells, the levels of U6atac 
are maintained very low and are upregulated under stress to increase the efficiency of minor 
splicing [88]. Our RNA sequencing analysis also supports the premise of U6atac as a limiting 
factor, as its levels were much lower than any of the other minor-class snRNAs (Figure 3.3A). 
Thus, it can be imagined that a similar mechanism, whereby U6atac levels inform the efficiency 
of minor intron splicing, might play a role in overall embryonic development. WISH analysis 
showed that all four minor-class snRNAs are enriched in the developing CNS and limb buds, which 
suggests that minor splicing is most effective in the developing CNS and limb buds (Figure 3.4). 
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Unexpectedly, WISH analysis using the sense probe for U4atac also revealed enrichment in the 
developing head (Figure 3.5). Since the mouse U4atac gene, Gm22710, lies within a Clasp1 intron 
on the opposite strand, it is possible that the U4atac sense probe is hybridizing with unspliced 
Clasp1 transcripts, resulting in the observed signal (Figure 3.1A).  
 The enrichment of the minor-class snRNAs in the developing head suggests that the 
functions executed by the minor spliceosome and its targets play a major role in the developing 
mouse CNS. Specifically, in the retina, the minor-class snRNAs were further enriched in newly 
differentiating retinal neurons during postnatal development (Figures 3.6&3.7). Interestingly, this 
enrichment was also observed in differentiating retinal neurons in embryonic development, but 
only for U12 (Figure 3.6N-P); the other minor-class snRNAs were enriched ubiquitously in the 
embryonic retina (Figure 3.6). Given that all minor-class snRNAs are required to form a functional 
minor spliceosome, this divergence in expression was unexpected. One possibility is that the U12 
antisense probe is detecting the expression of both U12 and the piwi-interacting RNA (piRNA) 
that is embedded in the Rnu12 gene [248, 249]. Another possibility is that the U12 snRNA 
performs another function, separate from its role in minor splicing, that is needed in these 
differentiating neurons. In either case, further investigation is required to understand this 
divergence in U12 expression. The expression kinetics of another minor snRNA, U6atac, also 
differs from those of the other minor snRNAs (Figure 3.7). Instead of the differentiating neuron-
specific enrichment at P0 seen for the other snRNAs, U6atac signal was ubiquitous in the P0 retina 
(Figure 3.7A,F,K,P). Since U6atac has been linked to stress response, it is possible that stress 
caused by the birthing process could result in the ubiquitous expression observed [88]. As with 
U12, this divergent expression warrants further investigation.  
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The shift from ubiquitous minor-class snRNA signal in the embryonic retina to more 
specific enrichment in newly differentiating retinal neurons in postnatal development suggests that 
the demand for minor splicing shifts across retinal development. In turn, this shift suggests that 
the targets of minor splicing, the MIGs, play shifting roles in mouse retinal development. Indeed, 
our microarray analysis showed that MIGs enriched in embryonic development were involved in 
a specific set of functions, while those enriched in postnatal development were involved in a 
separate set of functions. These shifts in MIG-regulated functions across retinal development are 
schematized in Figure 3.12, with each function denoted by a certain color. Here, RNA processing 
and cell cycle were enriched only in embryonic retinal development, while vesicle-mediated 
transport was only enriched in postnatal development (Figure 3.12, orange, green, and purple). 
Intracellular protein transport was maintained across all of retinal development (Figure 3.12, red). 
Additionally, calcium homeostasis-related functions, including voltage-gated calcium channel 
activity and phospholipase C activity, were present across retinal development, with enrichment 
in postnatal development (Figure 3.12, yellow). Notably, the embryonic functions identified here 
mirror those affected in developing zebrafish with deficient minor splicing, which die 7-10 days 
post fertilization [113]. In these larval zebrafish, the expression of genes involved in exosome 
formation, mRNA transport, and cell cycle was disrupted [113].  
Intriguingly, some of the postnatally enriched MIGs involved in vesicle-mediated transport 
have been linked to neuronal differentiation, such as syntaxin binding protein 5 and huntingtin 
[246, 247]. Taken together with the retinal SISH data, this suggests that minor splicing is vital for 
the terminal differentiation of retinal neurons. This idea is further captured by our observation that 
U12 morpholino-mediated disruption of minor spliceosome function resulted in apoptosis between 
P7 and P10, when the majority of neurons born postnatally undergo differentiation. In all, our 
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analysis is one of the first attempts to decipher the role of the minor spliceosome in mouse 
development. Moreover, it creates a framework within which we can begin to further delineate the 
role of this unique machinery in mammalian development. 
 
3.4 Materials and methods 
Gene Copy Analysis 
Known human minor spliceosome-specific snRNA gene sequences for RNU4ATAC, 
RNU6ATAC, RNU11, and RNU12 were obtained from the National Center for Biotechnology 
Information (NCBI) database. These were then compared to the mouse genome utilizing the UCSC 
BLAT function [239]. All sequences were compared against the Dec. 2011 (GRCm38/mm10) 
assembly, using default settings for the BLAT function [248]. Sequence similarity was rated by 
BLAT based on percent sequence conservation (% identity) and a score of nucleotide matches vs. 
mismatches between the query and return sequences (score). Any BLAT return with overall 
identity of less than 87% or a score of less than 87 was ignored. The gene loci of BLAT returns 
were verified using the Ensembl Genome Browser [250]. Minor spliceosomal snRNA secondary 
structures were also obtained from Ensembl.  
 
Animal Protocol 
     CD1 mice from Charles River Laboratory, MA, were used for all experiments. All mice 
procedures were compliant with the protocols approved by the University of Connecticut’s 
Institutional Animal Care and Use Committee (IACUC). 
 
RNA Sequencing 
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 CD1 mouse retinae were collected at embryonic day (E) 16 and postnatal day (P) 0. RNA 
was isolated using the Thermo Scientific NE-PER Nuclear and Cytoplasmic Extraction Kit 
(Thermo Fisher Scientific), as described previously [251]. The cytoplasmic samples were then 
used for RNAseq on the Illumina HighSeq 2000 platform. The details of data processing and 
analysis are available in [241]. 
 
Whole Mount in Situ Hybridization (WISH)  
Amplified PCR products of full-length mouse U11, U12, U4atac, and U6atac snRNAs were 
generated using the primers in Table S2. These products were then cloned into pGEMT, followed 
by PCR with T7 and SP6 primers. The resulting PCR products were then used for in vitro 
transcription for production of DIG-labeled antisense RNA probes. Whole-mount in situ 
hybridization on E9.5, E10.5, and E12.5 mouse embryos was performed as described previously 
[252]. 
 
Section in Situ Hybridization (SISH) 
 Sixteen μm cryosections of CD1 mouse heads (for embryonic time points) and retinae (for 
postnatal time points) were used for in situ hybridization, as described previously [242]. The same 
probes used for whole mount in situ hybridization were also used for section in situ hybridization. 
 
Double Fluorescent in Situ Hybridization 
 Retinae from P0 CD1 mice were dissociated and processed for double fluorescent in situ 
hybridization, as described previously [242, 253]. Antisense RNA probes against U11 and U12 
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were labeled with FITC. The DIG-labeled antisense probe against NF68 was the same as that 
described previously [242]. 
 
Custom Microarray Design 
The custom microarray was designed by leveraging the U12DB [58]. From the U12DB, a 
list of 461 MIGs was extracted, and the exon-exon junctions requiring minor splicing were curated. 
Of the 461 MIGs, 329 MIGs had 1 minor intron, 116 had 2 minor introns, 11 had 3 minor introns, 
and 5 had 4 minor introns (Figure 3.9B). As shown in Figure 3.9A, we designed probe sets at the 
exon-exon junctions formed by minor splicing, which allowed us to detect both the successful 
splicing of each minor intron and the expression of all MIG isoforms generated by minor intron 
splicing. Internal control probe sets were designed by Affymetrix to validate successful 
hybridization, and only those arrays that met these requirements were used for our analysis. 
Retinae from CD1 mice at different stages of development (E12, E14, E16, E18, P0, P4, 
and P25) were harvested and subjected to the RNA fractionation as previously described [251]. 
One µg of the cytoplasmic RNA was then employed for microarray analysis, which was performed 
at the Yale Center for Genome Analysis.  
 
Microarray Data Analysis 
Expression levels of probe targets were computed from the raw intensity values using the 
Robust Multichip Average (RMA), which was performed with the affy R package [254-256]. Here, 
data normalization was performed for a probe-set over time, and not among the probe-sets. This 
analysis allowed us to capture expression kinetics of a given exon-exon junction over time without 
the influence of expression levels of different probe-sets at the same time point. Subsequently, the 
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data were processed through Genesis (v1.7.6) for k-means clustering [245]. Here, we ran 50 
iterations to generate a total of 10 clusters that fell into three categories based on expression 
kinetics. These trends were defined as embryonic, postnatal, and both (“embryonic+postnatal”). 
However, we encountered an issue with probe distribution within clusters. In our analysis, a given 
MIG can have multiple probe-sets, each of which detects the splicing of a specific minor intron. 
Additionally, different combinations of these minor introns may be spliced in different isoforms. 
As a result, a single probe set for a MIG could hybridize with a single isoform, or all isoforms, or 
select isoforms of that MIG, depending on how many isoforms contain that exon-exon junction. 
Since each isoform may have a different expression profile across time, the probe-sets for the same 
MIG could show up in different clusters. Indeed, this is what we observed. Thus, to find MIGs 
with the highest degree of overlap in expression kinetics, we analyzed how each MIG’s probe-sets 
were distributed across the aforementioned clusters. If all (100%) of a gene’s probe-sets were 
found in clusters that belonged to the same category (e.g., embryonic), the gene was considered to 
belong to that category (e.g., embryonic). In contrast, if all of a MIG’s probe-sets were not present 
in the same category, that gene was moved to the embryonic+postnatal category. After this binning 
process, the final three gene lists were separately analyzed using DAVID [243, 244].  
 
U12 Morpholino P0 in vivo Electroporation 
     Previously published U12 morpholino (5’-TCGTTATTTTCCTTACTCATAAGTT-3’) or 
scrambled control morpholino (5’-CCTCTTACCTCAGTTACAATTTATA-3’) were co-
electroporated with pCAG-GFP in P0 mouse retinae [221] (Gene Tools). Electroporation was 
performed as previously described, with one modification [213, 222]. Instead of using a Hamilton 
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needle, we employed a glass needle attached to a femtojet (Eppendorf) to deliver plasmids. 
Electroporated retinae were harvested at P3, P7, P10, and P14. 
 
TUNEL 
     TUNEL assay was performed on 16 μm cryosections of P0 electroporated retinae using the in 
situ cell death detection kit, TMR red (Roche Diagnostics), in accordance with the manufacturer’s 
instructions.  
 
Image Acquisition and TUNEL Quantification 
Processed sections were imaged by confocal fluorescence microscopy, which was 
performed with a Leica SP2 confocal microscope. Collected images were further processed using 
IMARIS (Bitplane Inc.) and Adobe Photoshop CS4 (Adobe Systems Inc.). GFP+ and TUNEL+ 
cells were manually counted using the spot tool in the IMARIS software. The mean 
TUNEL+/GFP+ ratios for U12 morpholino- and scrambled morpholino-electroporated retinal 
images were calculated. Statistical significance was determined using two-tailed student’s t-tests. 
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Chapter 3: Figures 
 
Figure 3.1. Gene isotypes of U4atac and U6atac in the mouse genome.  
Human snRNA gene sequences for (A) RNU4ATAC and (B) RNU6ATAC were compared to the 
mouse genome utilizing the UCSC BLAT tool and returns were rated based on percent sequence 
conservation (% Identity) and a match vs. mismatch score (Score). At the top of each table is the 
human snRNA gene. All genes listed under the dark dividing line are BLAT returns organized by 
score. Gene loci were determined using Ensembl Genome browser to visualize genes flanking all 
BLAT returns. The secondary structure for each snRNA was also given by Ensembl. Colored 
boxes indicate sequences within the snRNA which are important for either RNA or protein 
interactions. Deviations in these binding sequences are denoted by either blue letters (nucleotide 
mismatches), red dashes (nucleotide deletions), or green letters (nucleotide additions). 
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Figure 3.2. Gene isotypes of U11 and U12 in the mouse genome. 
Human minor spliceosome snRNA gene sequences for (A) RNU11 and (B) RNU12 were compared 
to the mouse genome utilizing the UCSC BLAT tool and returns were rated based on percent 
sequence conservation (% Identity) and a match vs. mismatch score (Score). At the top of each 
table is the human snRNA gene. All genes listed under the dark dividing line are BLAT returns 
organized by score. Gene loci were determined using Ensembl Genome browser to visualize genes 
flanking all BLAT returns. The secondary structure for each snRNA was also given by Ensembl. 
Colored boxes indicate sequences within the snRNA which are important for either RNA or protein 
interactions. Deviations in these binding sequences are denoted by either blue letters (nucleotide 
mismatches), green letters (nucleotide additions), or red dashes (nucleotide deletions). 
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Figure 3.3. Multiple minor snRNA gene copies are expressed in the deep sequencing data 
from E16 and P0 mouse retinae. 
(A) Expression levels of the major and minor snRNAs in the cytoplasm of the E16 and P0 mouse 
retinae, by deep sequencing.  Samples are listed on the x-axis, with FPKM values on the y-axis, 
on a log scale.  Solid lines represent the levels of the minor snRNAs (purple=U4atac, 
green=U6atac, blue=U11, red=U12), while dashed lines represent the levels of their major snRNA 
counterparts (purple=U4, green=U6, blue=U1, red=U2). (B) Expression of the potential minor 
snRNA gene copies in the E16 and P0 cytoplasmic extracts by deep sequencing. Heading colors 
correspond to the colors from (A). A threshold of 1 FPKM was used for deeming whether a gene 
was expressed. FPKM = fragments per kilobase per million reads. FPKM = fragments per kilobase 
of transcript per million mapped reads 
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Figure 3.4. The minor snRNAs are enriched in the embryonic mouse head.  
Whole mount in situ hybridization with DIG-labeled anti-sense RNA probe for U4atac (A-A”), 
U6atac (B-B’’), U11 (C-C”), and U12 (D-D”) in E9.5 (A, B, C, D), E10.5 (A’, B’, C’, D’), and 
E12.5 (A’’, B’’, C’’, D’’) mouse embryos. Lateral and dorsal views of embryos are shown here. 
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Figure 3.5. Control analysis for WISH with sense and antisense probes for the minor 
snRNAs.  
In situ hybridization using DIG-labeled RNA sense (right column) and antisense (left column) 
probes for all minor snRNAs in the E10 mouse embryo. Lateral and dorsal views of the embryos 
are shown here. 
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Figure 3.6. The minor snRNAs are expressed in embryonic progenitor cells and 
differentiating neurons in the developing mouse retina.  
Section in situ hybridization with DIG-labeled anti-sense RNA probe for U4atac (A-D), U6atac 
(E-H), U11 (I-L), and U12 (M-P) across embryonic retinal development. Minor snRNA names 
are listed on the left, with the developmental time points listed at top. The entire collage was 
modified in Adobe Photoshop CS4 with the following values: 50 for shadow input, 0.85 for 
midtone input, and 239 for highlight input. Scale bars are all 100 µm. ONBL = outer neuroblastic 
layer; GCL = ganglion cell layer. 
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Figure 3.7. The minor snRNAs are enriched in differentiating neurons in the postnatal mouse retina.  
Section in situ hybridization with DIG-labeled anti-sense RNA probe for U4atac (A-E), U6atac (F-J), U11 (K-O), and U12 (P-T) across 
postnatal retinal development from P0 to adult. Minor snRNA names are listed on the left, with the developmental time points listed at 
top. The entire collage was modified in Adobe Photoshop CS4 with the following values: 61 for shadow input, 0.87 for midtone input, 
and 240 for highlight input. Scale bars are all 100 µm. ONL = outer nuclear layer; INL = inner nuclear layer; GCL = ganglion cell layer. 
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Figure 3.8. U11 and U12 snRNA expression is enriched in retinal ganglion cells at P0.  
(A-D) Double fluorescent in situ hybridization on P0 retinal cells with FITC-labeled U11 probe 
(green) along with DIG-labeled Nf68 (red). (E-H) FITC-labeled U12 probe (green) along with 
DIG-labeled NF68 (red). Nuclei were stained with DAPI (blue). Each color layer of the collage 
was modified with Adobe Photoshop CS4 with the following values. Blue layer: 0 for shadow 
input, 0.73 for midtone input, and 113 for highlight input. Green layer: 0 for shadow input, 0.61 
for midtone input, and 72 for highlight input. Red layer: 0 for shadow input, 0.65 for midtone 
input, and 110 for highlight input. 
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Figure 3.9. Custom microarray design and probe set statistics.  
(A) Probe set design. Major introns are shown in black and minor introns in orange. Probe sets 
were designed to span minor splicing-dependent exon-exon junctions, shown here as orange lines 
above these exon-exon junctions. (B) Minor intron exon-exon junction probe set statistics for all 
MIGs identified by the microarray. Numbers within each slice represent the number of MIGs with 
the specified number of minor splicing-dependent exon-exon junction probe sets. 
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Figure 3.10. MIGs play different roles in embryonic versus postnatal retinal development.  
Cluster images on the left show normalized exon-exon junction expression across cytoplasmic 
retinal samples at E12, E16, E18, P0, P4, P10, P25 (x-axis). Normalized expression values are 
listed on the y-axis. Clusters are represented in centroid view obtained from Genesis, where each 
bar at a given time point represents the variation in expression kinetics of each exon-exon junction 
at that time point. The background for embryonic clusters is colored blue (A), the background for 
postnatal clusters is yellow (B), and the background for clusters in the embryonic+postnatal 
category is colored gray (C). Shown on right are the results of DAVID analysis. Headings for the 
three bins correspond to their cluster color and contain total gene lists for that bin: blue for 
embryonic (A’), yellow for postnatal (B’), and gray for embryonic+postnatal (C’). Only terms 
from the GOTERM category with a Benjamini value of ≤0.05 were included. Domain-specific 
DAVID results were discarded. Synonymous terms were also discarded in favor of a representative 
term with the highest number of genes. Indented terms indicate that the indented function was 
enriched by a subset of genes in the preceding functional term. 
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Figure 3.11. U12 snRNA function is essential for the survival of differentiating postnatal 
retinal neurons.  
Shown here are sections of retinae that were electroporated with either control (scrambled) 
morpholino (left column) or morpholino against U12 (right column), followed by harvests at P3 
(A, A’), P7 (B, B’), P10 (C, C’), and P14 (D-D’’’). Cell death was detected by TUNEL assay, 
shown in red, and nuclei are marked by DAPI (blue). Higher magnification of a GFP+ neuron 
undergoing apoptosis (red) is shown in the inset (D’’). Quantification of TUNEL+ and GFP+ cells 
in images collected from electroporated retinae (n=4 for control morpholino, n=4 for U12 
morpholino) harvested at P7 (E) and P14 (E’). The y-axis shows the ratio of TUNEL+ cells to 
GFP+ cells. The x-axis denotes the electroporated morpholino (scrambled = Scr-MO; U12 = U12-
MO). The bars represent the mean ratio calculated for a single image from a given condition. The 
p value calculated using a two-tailed t-test is shown over the black line connecting the two bars.   
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Figure 3.12. Functions executed by MIGs are dynamic across retinal development.  
Schematized representation of the kinetics of MIG expression and the functions they execute 
across retinal development (from E12 to P25), as determined by microarray analysis. Colors and 
shapes correspond to the temporal shifts in functions across retinal development. The Ca2+ 
homeostasis category can be broken down further into “voltage-gated calcium channel activity” 
and “phospholipase C activity.” Time on the x-axis is not to scale. 
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Chapter 4: The role of minor intron splicing in mouse cortical development 
 This chapter addresses the requirement for minor intron splicing for mouse cortical 
development, using a novel Rnu11 conditional knockout (cKO) mouse generated by the Kanadia 
lab in association with the University of Connecticut Health Center. First, this chapter covers the 
effects of constitutive ablation of Rnu11, the gene encoding the minor spliceosome-specific U11 
snRNA. The majority of this chapter describes the impact of U11 ablation on the developing mouse 
cortex—i.e., the microcephaly we observe in these mice. 
 
4.1 Rationale 
As discussed in Chapters 1 and 2, the symptoms of the disorders linked to minor 
spliceosome disruption indicate that this process is essential for normal brain development and 
function [124, 140, 143]. In particular, the numerous and consistent cortical defects observed in 
MOPD1 patients further underscore the importance of minor intron splicing for cortical 
development [124-127]. To my knowledge, there are no publications describing mammalian 
models of minor spliceosome inactivation, barring my own papers. Moreover, I could not find any 
reports of any model systems of development, mammalian or otherwise, in which the minor 
spliceosome could be conditionally ablated. Given this gap of knowledge in the field, I sought to 
study both the effects of constitutive minor spliceosome inactivation in the developing mouse, and 
the effects of conditional minor spliceosome inactivation in the developing mouse cortex, using 
our Rnu11 conditional knockout mouse. The following sections contain the contents of one of my 
publications, entitled “Minor spliceosome inactivation causes microcephaly, owing to cell cycle 
defects and death of self-amplifying radial glial cells” [117]; prior to its publication in 
Development, a version of this paper was published as a bioRxiv pre-print, entitled “Minor 
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spliceosome inactivation in the developing mouse cortex causes self-amplifying radial glial cell 
death and microcephaly” [257]. 
 
4.2 Pathogenesis of microcephaly 
  The microcephaly observed in diseases linked to minor spliceosome disruption is a type 
of primary microcephaly, or microcephaly caused by defects in brain development that result in 
microcephaly at birth. Given the expansion of cortical volume in humans, relative to total brain 
size, microcephaly is often caused by impaired cortical development [188]. Proper cortical 
development requires a balance between amplification of the neural progenitor cells (NPCs) and 
neurogenesis. Overproduction of neurons at the expense of self-amplifying NPC divisions can 
deplete the NPC pool early in cortical development, resulting in microcephaly [258]. This is 
particularly relevant for the RGCs, which function to maintain the NPC population of the 
developing cortex [222]. Shifts in the proportions of RGCs and IPCs can also impact cortical 
growth, because IPCs primarily function in neuron production [220]. If RGCs produce fewer IPCs 
in favor of neurogenic divisions, then the total number of neurons that can be produced in the finite 
window of cortical neurogenesis drops substantially, resulting in microcephaly [259]. In short, 
primary microcephaly can be caused by (1) death of the NPC or neuronal populations; (2) 
increased neuron production, resulting in depletion of the NPC pool; and/or (3) decreased IPC 
production in favor of neurogenic divisions, resulting in fewer neurons [260]. The following 
subsections explain some of the known mechanisms underlying microcephaly that is linked to 
these developmental defects, including cell cycle defects and the DNA damage-p53-apoptosis axis. 
 
4.2.1 The process of cell division  
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The cell cycle is divided into three basic phases, which can themselves be further 
subdivided. In interphase, the progenitor cell grows in size and duplicates its DNA, to ensure there 
is enough material to split between two daughter cells. In mitosis, the cell’s doubled contents are 
physically moved to separate poles of the mother cell. Finally, in cytokinesis, contracture of a 
cytoskeletal ring pinches the cytoplasmic membrane and frees the two daughter cells. Interphase 
is subdivided into three stages. First is a “gap”/growth phase called G1, in which the cell decides 
whether it will continue through interphase or exit the cell cycle [261]. Following G1 phase is the 
DNA synthesis phase called S phase, during which both the cell’s DNA and its centrosome are 
replicated [262]. The centrosome is a microtubule-organizing organelle comprised of two 
centrioles, cylindrical structures consisting of nine microtubule triplets that recruit a matrix of 
pericentriolar proteins to the centrosome [263]. These centrosomes function in bipolar spindle 
assembly during mitosis [263]. During S phase, the newly formed sister chromatids are linked 
together by cohesin, a complex of four protein subunits; these sister chromatids will remain linked 
by cohesin until mid-mitosis [264]. The third phase of interphase is a second gap/growth phase 
called G2 phase [261].  
In interphase, there are multiple cell cycle checkpoints to ensure proper cell division. The 
intra-S-phase checkpoint monitors DNA replication during S phase, when the cell risks 
accumulating DNA damage. This checkpoint is mediated by the ATR and Chk2 proteins, which 
recognize DNA polymerase-protein complexes (replisomes) that encounter a blockade to their 
progression and stall on the template DNA [265]. These proteins function to stabilize the stalled 
replisome on the template DNA until the blockade is removed, often via the DNA damage repair 
pathway [265]. The second checkpoint is the G2/M checkpoint, which involves surveillance of 
cell size and of the DNA, to identify any sites of DNA damage. If the cell determines it is of 
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insufficient size or detects sites of DNA damage, the cell will arrest in G2 phase until the problem 
is addressed [265, 266]. 
Mitosis is subdivided into five phases: prophase, prometaphase, metaphase, anaphase, and 
telophase. During prophase, the DNA condenses into chromosomes, while the two centrosomes 
translocate to opposite poles of the cell. The centrosomes also begin driving the nucleation of 
microtubules, which dynamically grow and retract as they search for their targets. Some of these 
microtubules will bind to the mitotic chromosomes; others will associate with the proteins lining 
the cell cortex or with microtubules extending from the opposite pole of the cell [267, 268]. 
Simultaneously, kinetochores begin to assemble at the centromeric DNA of the chromosomes. 
Kinetochores are large protein complexes that mediate the connection between the mitotic 
chromosomes and the mitotic spindle microtubules [267, 269]. While a subset of inner kinetochore 
proteins is bound to the centromere throughout cell cycle, recruitment of the outer kinetochore 
proteins only occurs in prophase [269]. In prometaphase, the nuclear envelope separating the 
mitotic chromosomes from the probing microtubules breaks down. These microtubules then bind 
to the kinetochores, such that each paired sister chromatid is anchored by two microtubules, one 
originating from each centrosome [267, 268]. Next, anaphase is triggered by the degradation of 
cohesin from the paired sister chromatids, which is mediated by a specific ubiquitin ligase called 
the anaphase-promoting complex (APC/C). The APC/C ubiquitinates multiple target proteins, 
including the protein securin, the inhibitory subunit of the separase protease. Degradation of 
securin triggers activation of separase, which cleaves cohesin [270]. This allows the sister 
chromatids to separate and for each microtubule to pull a sister chromatid to its respective 
centrosome. As these sister chromatids are drawn to the two poles of the cell, unbound 
microtubules of the mitotic spindle elongate to overlap in the center of the cell. When the 
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chromosomes arrive at their respective pole, telophase is triggered, at which point the nuclear 
envelopes begin to reform around these bipolar assemblies of decondensing chromosomes [267, 
268]. Like in interphase, there are multiple checkpoints during mitosis, including the spindle 
assembly checkpoint. As its name suggests, the purpose of this checkpoint is to ensure that 
microtubules are bound to all paired sister chromatids prior to the metaphase-to-anaphase 
transition. Activation of this checkpoint is triggered by signaling between the unbound kinetochore 
and the mitotic checkpoint complex (MCC). Activation of the MCC triggers inhibition of the 
Cdc20 protein, a co-factor of the APC/C. As a result, APC/C activity is inhibited, the cohesin 
linking the sister chromatids remains intact, and mitosis is halted in metaphase [271, 272]. 
While cytokinesis is completed after telophase, the cell begins preparing for this process 
in anaphase. In anaphase, an actomyosin ring starts forming around the central spindle, the region 
of overlapping microtubules located in the middle of the dividing cell [273]. Phosphorylation of 
the myosin in the contractile ring triggers closure of the ring, pinching the membrane down over 
the central spindle as the cell continues through telophase. Simultaneously, the central spindle is 
remodeled into a tightly packed intracellular bridge called the cytokinetic midbody [273]. This 
structure is essential for the final stage of cytokinesis, abscission, in which the pinched plasma 
membrane fully separates, releasing two daughter cells [273].  
 
4.2.2 Microcephaly and cell division defects 
Most of the known mutations underlying primary microcephaly affect cell division, 
resulting in the death of NPCs, an increased drive to differentiation in RGCs, or a combination of 
the two [274]. In a recent review of primary microcephaly published by the Walsh group, they 
highlight that over half of the known primary microcephaly genes are localized to the centrosome 
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and are involved in centrosome biogenesis/duplication [275]. Other genes associated with primary 
microcephaly are involved in kinetochore assembly and cytokinesis [275].  
Notably, many of the centriole biogenesis genes linked to primary microcephaly interact 
with each other during centrosome duplication. For example, the protein products of two of the 
most commonly mutated primary microcephaly genes, ASPM and WDR62, interact at the centriole, 
where they are both function in centriole biogenesis [275, 276]. Specifically, the WDR62 protein 
is required for proper localization of both ASPM and the primary microcephaly protein CEP63 to 
the centriole. Localization of WDR62 itself to the centriole is also dependent on another primary 
microcephaly protein, CEP152. Ultimately, the presence of these four proteins at the centriole 
recruits yet another primary microcephaly protein, SAS-4, to the centriole [276]. Work using Aspm 
and Wdr62 knockout mice indicate that disruption of this pathway causes centriole duplication 
defects; delocalizes RGCs from the VZ; and drives RGCs to undergo differentiative, IPC-
producing divisions at the expense of proliferative divisions, resulting in depletion of the NPC 
pool and therefore microcephaly [276]. Sas-4 knockout mice displayed a similar phenotype, with 
centriole depletion and delocalization of RGCs from the VZ. Instead of an increased drive to 
differentiate, Sas4-null progenitor cells displayed defective mitotic spindle assembly, resulting in  
mitotic delays characterized by prolongation of prophase/pro-metaphase [277, 278].  
 Another subset of primary microcephaly-linked genes is involved in attachment between 
the spindle assembly microtubules and the kinetochores of the mitotic chromosomes. CENPE 
encodes a kinetochore motor protein that functions in spindle microtubule-kinetochore attachment; 
mutation of this gene causes a microcephalic primordial dwarfism (MPD) syndrome. Cells derived 
from patients with CENPE mutations displayed spindle assembly defects, chromosome 
missegregation, and mitotic delays [275, 279]. Similarly, mutations in the gene CASC5, a 
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kinetochore protein required for both proper kinetochore-microtubule attachment and the spindle 
assembly checkpoint, are linked to primary microcephaly [275, 280].  
 Mutations in genes that regulate cytokinesis are also associated with primary microcephaly. 
For example, mutation of the cytokinetic midbody protein citron kinase (Citk) causes abnormal 
cytokinesis in NPCs, resulting in multinucleated cells, apoptosis, and microcephaly [281, 282]. 
Subsequent work has revealed that citron kinase functions in midbody organization, both by 
linking the proteins of the contractile ring and the central spindle and by maintaining the protein 
architecture of the midbody during late cytokinesis [283]. Loss of citron kinase function results in 
disorganization of the cytokinetic midbody, loss of cell cortex-central spindle linkages, and 
ultimately failure of abscission [283]. Recently, mutations in the gene KIF14 were also linked to 
primary microcephaly [284]. KIF14 is another protein of the cytokinetic midbody, and depletion 
of KIF14 revealed its importance for the localization of citron kinase to the midbody [285]. As 
anticipated, patient fibroblasts displayed aberrant cytokinesis, with many binucleated and 
apoptotic cells [284].  
 The majority of the cell division-associated primary microcephaly genes are involved in 
mitosis or cytokinesis. However, a host of genes involved in DNA replication are also linked to 
primary microcephaly. Specifically, causative mutations of primary microcephaly were identified 
in ORC1, ORC4, and ORC6, genes that encode different subunits of the origin of replication 
complex, which is necessary for the initiation of DNA replication in S-phase [286-289]. Mutations 
of other genes that function in the pre-replication complex, including CDT1 and CDC6, also cause 
primary microcephaly [286]. Primary microcephaly is also linked to stabilizing mutations in 
GMNN (geminin), which interacts with CDT1 to inhibit DNA replication [290]. More recently, 
primary microcephaly has been linked to loss-of-function mutations in the MIG CDC45, which 
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functions in the pre-initiation complex and in DNA unwinding during DNA replication [291]. It is 
notable that mutations in these genes all cause the same MPD disorder, called Meier-Gorlin 
syndrome. In contrast, the primary microcephaly mutations in the aforementioned centrosomal, 
kinetochore, and cytokinetic genes result in different severities of microcephaly and in different 
sets of symptoms [275]. 
 Experimental work investigating the connection between cell cycle and NPC behavior has 
complemented the identification of cell cycle-regulating genes linked to primary microcephaly. In 
2003, the Huttner group investigated the effects of G1 length on NPC behavior by culturing mouse 
embryos in the cell cycle inhibitor olomoucine, which inhibits both the G1/S and G2/M transitions 
[292]. In the embryos cultured with olomoucine, they observed premature neuron production in 
the E9.5 dorsal telencephalon, leading them to propose that G1 length informs NPC division type, 
such that longer G1 length drives NPCs to differentiative divisions [292]. In 2009, Pilaz et al. 
employed the opposite approach to study the effect of G1 length on NPC behavior: they sought to 
overexpress the cyclins D1 and E1, which function in G1/S progression, to shorten G1 phase in 
ventricular NPCs [293]. As expected, this in utero electroporation strategy significantly shortened 
G1 in the electroporated NPCs and resulted in larger clone sizes, indicative of a shift from 
differentiative to proliferative division [293]. Analysis of the RGCs and IPCs in the electroporated 
pallium revealed that G1 shortening drove both RGCs and IPCs to proliferative divisions at the 
expense of differentiative, neurogenic divisions [293]. In 2016, an effort to characterize 
microcephaly in mice heterozygous for the exon-junction complex Magoh gene (MagohWT/KO) 
revealed that length of mitosis can also inform NPC behavior [294]. Pilaz et al. identified mitotic 
delay, characterized by shortening of prophase and lengthening of prometaphase, in the Magoh 
heterozygous RGCs. The mitotically delayed RGCs from the Magoh heterozygous pallium also 
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preferentially divided to produce neurons, at the expense of proliferative divisions; Pilaz et al. also 
observed significantly more apoptotic progeny from these RGCs [294]. Strikingly, culturing brain 
slices with drugs that inhibit the progression of prometaphase recapitulated the phenotype of the 
Magoh heterozygous RGCs: RGCs that had been delayed in prometaphase preferentially divided 
to produce neurons, and longer lengths of mitosis increased the likelihood of producing apoptotic 
progeny [294]. Given that most of the genes linked to primary microcephaly are involved in mitosis 
progression, it is possible that a similar mechanism may underlie microcephaly in these patients.  
 
4.2.3 Microcephaly, p53 activation, and DNA damage 
In many mouse models, primary microcephaly is caused by activation of the transcription 
factor p53 and p53-mediated apoptosis. For example, in a mouse model of microcephaly caused 
by inactivation of the primary microcephaly gene Cep63, cortical NPCs showed upregulation of 
p53 alongside mitotic delay and DNA damage—and genetic ablation of p53 rescued microcephaly 
in the Cep63-deficient mice [295]. In mice, deletion of the primary microcephaly gene Sas-4 
caused mitotic delay, prophase/prometaphase prolongation, p53 upregulation, and apoptosis in 
cortical NPCs. Moreover, genetic ablation of p53 rescued microcephaly in the Sas-4 knockout 
mice [277, 278]. Similarly, haploinsufficiency of Magoh resulted in mitotic delay, elongation of 
prometaphase/metaphase, p53 upregulation, and apoptosis; genetic deletion of p53 rescued 
microcephaly in these mice [294, 296]. Loss-of-function mutation in Kif20b, a kinesin microtubule 
motor protein, caused abnormal abscission and apoptosis in cortical NPCs [297]; a recent preprint 
showed that genetic ablation of p53 partially rescued microcephaly in these mice [298]. In 
microcephalic mice heterozygous (WT/KO) for the gene Tubb5, which is linked to primary 
microcephaly [299], cortical NPCs displayed mitotic delay, elongation of metaphase, upregulation 
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of p53, and apoptosis [300]. Genetic deletion of Citk caused aberrant cytokinesis, DNA damage, 
p53 upregulation, and apoptosis, resulting in microcephaly [301, 302]. Overall, these mouse 
models of primary microcephaly reveal a trend in their cellular defects: p53 upregulation and 
apoptosis are often associated with mitotic delay, specifically mitotic delay caused by prolongation 
of prophase, prometaphase, or metaphase.  
Activation of the p53 transcription factor is triggered by a variety of cellular stress signals, 
which increase levels of p53 protein. Specifically, under normal physiological conditions, p53 is 
targeted for degradation by the E3 ubiquitin ligase MDM2 [303]. Cellular stress signals trigger 
phosphorylation, acetylation, and other post-translational modification of p53, which disrupts the 
association between p53 and MDM2 [304]. As a result, protein levels of p53 increase, without 
requiring changes in transcription from the TP53 gene [303, 304]. Increased levels of p53 
correspond to nuclear translocation of p53 and increased transcriptional activity of the protein, 
resulting in upregulation of its targets [305]. Generally, the target genes of p53 can be categorized 
into two functions: cell cycle arrest or apoptosis. The specific target genes that p53 upregulates—
cell cycle arrest genes versus pro-apoptotic genes—depend upon multiple factors in the cell, 
including p53 levels, such that higher levels inform the specific post-transcriptional modifications 
made to p53, determine the expression levels of different p53 co-factors, and drive p53-mediated 
apoptosis [306, 307]. Evidence indicates that cytoplasmic and mitochondrial p53 can also drive 
apoptosis, independently of p53 transcriptional activity in the nucleus [308]. Notably, embryo 
culture work from Bazzi and Anderson (2014) showed that drug-induced mitotic delay triggered 
rapid accumulation of p53 in the subsequent G1 phase, resulting in apoptosis shortly after [277]. 
Currently, the specific protein interactions underlying this pathway are unclear. Instead, most 
research into p53-mediated apoptosis has investigated the link between DNA damage and p53 
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upregulation. Briefly, DNA damage triggers activation of the protein kinases ATM, ATR, and 
DNA-PK and proteins of the PARP family, which function as key mediators of the DNA damage 
response [309]. The aforementioned kinases induce p53 activation by either directly 
phosphorylating p53 or by activating the effector kinases CHK1 and CHK2, which themselves 
phosphorylate p53. This results in p53 upregulation, increased expression of pro-apoptotic target 
genes, and p53-mediated apoptosis [309, 310]. The PARP proteins PARP1/2 function to recruit 
ATM to sites of DNA damage, thereby indirectly mediating p53 activation and p53-mediated 
apoptosis in response to DNA damage [309].  
In fact, many microcephaly-linked genes regulate the DNA damage response. For example, 
the first gene linked to microcephaly, Microcephalin, functions in the DNA damage response 
pathway [311, 312]. Many of the causative mutations of Seckel syndrome, an MPD disorder, are 
found in genes that regulate the DNA damage response, such as ATR, which functions in the G2/M 
DNA damage checkpoint and in the intra-S-phase checkpoint to stabilize stalled replication forks 
[265, 313]; RBBP8, which regulates double-strand break resection and ATR recruitment to sites 
of DNA damage [314, 315]; DNA2, a MIG that functions in multiple types of DNA damage repair 
[58, 316, 317]; and TRAIP, whose function is required for phosphorylation of DNA damage 
markers during S-phase [318]. Other DNA damage response genes that have been linked to 
primary microcephaly include DONSON [319, 320]; LIG4 [321]; NBS1 [322, 323]; NSMCE2 
[324]; PNKP [325]; and XLF [275, 326]. It is thought that mutations in these genes result in the 
accumulation of DNA damage, causing NPC death and microcephaly [275]. Indeed, in Nbs1 
conditional knockout mice, genetic ablation of Nbs1 in the developing CNS caused significant 
DNA damage, upregulation of p53, reduced NPC proliferation, and apoptosis; complete genetic 
ablation of p53 partially rescued microcephaly in these mice [327]. The DNA damage-p53-
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apoptosis axis is also implicated in microcephaly caused by Zika virus infection, based on work in 
Zika virus-infected human NPCs [328].  
Comparison of the cellular phenotypes of these mouse models of primary microcephaly 
suggest that two different pathways can induce p53 activation and p53-mediated apoptosis. In the 
first of these, disruption of primary microcephaly genes that regulate cell cycle causes mitotic 
delays, which then induce p53 upregulation and p53-mediated apoptosis. In the second, DNA 
damage accumulation induces activation of key DNA damage response mediator proteins, and 
signaling between these DNA damage response proteins and p53 results in p53 upregulation and 
p53-mediated apoptosis.   
 
4.3 Results 
4.3.1 Constitutive loss of the minor spliceosome-specific U11 snRNA results in embryonic 
lethality 
We generated the Rnu11 cKO mouse by engineering loxP sites 1090 bp upstream and 1159 
bp downstream of the Rnu11 gene (Figures 4.1 and 4.2A). Successful targeting of the loxP sites 
was confirmed by long-range nested PCR in targeted embryonic stem cells (Figure 4.1B-C) and 
further validated by the loss of the wild-type (WT) allele in Rnu11Flx/Flx mice (Figure 4.2A). EIIa-
Cre-mediated germline recombination generated Rnu11WT/KO mice, which showed the presence of 
the knockout (KO) allele that was absent in Rnu11WT/WT genomic DNA (Figure 4.2A). Quantitative 
PCR (qPCR) for the WT allele showed 50% reduction in Rnu11WT/KO mice compared to 
Rnu11WT/WT mice (Figure 4.2B). Intercrossing Rnu11WT/KO mice did not yield Rnu11KO/KO mice 
(Figure 4.2C), indicating embryonic lethality. 
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4.3.2 Ablation of U11 in the developing mouse cortex results in microcephaly 
 We employed Emx1-Cre mice to specifically ablate Rnu11 in the pallium [235]. Emx1-Cre 
expression begins at E9.5 in the neuroepithelium of the pallium, prior to the production of RGCs, 
IPCs, or neurons at E10-E11 [235, 329]. Therefore, Emx1 promoter-driven Cre activity drives 
recombination of the Rnu11 floxed allele in these neuroepithelial cells, and all cells originating 
from these neuroepithelial cells—i.e., the RGCs, IPCs, and excitatory neurons—would then inherit 
the recombined knockout allele. Ablation of U11 in the pallium resulted in profound microcephaly 
at birth in Rnu11Flx/Flx::Emx1-Cre+/- mutant mice, due to collapse of the cortex and absence of the 
hippocampus (Figure 4.2D). To understand how this microcephaly precipitated, we sought to 
determine the kinetics of U11 snRNA loss after Emx1-Cre-mediated Rnu11 ablation. Section in 
situ hybridization (SISH) for U11 snRNA revealed a reduction in U11 signal (purple) in the E10 
mutant pallium, relative to the control (Rnu11WT/Flx::Emx1-Cre+/-) (Figure 4.2E). This U11-null 
domain was expanded in the E11 mutant pallium, and by E12, the majority of cells in the Emx1-
Cre domain lacked U11 expression (Figure 4.2F&G). We observed scattered U11+ cells at this 
point (Figure 4.2G), which may represent either inefficient Emx1-Cre recombination or migrating 
interneurons produced in the ventral telencephalon, where Emx1-Cre is not active [235, 330]. 
There was no observable morphological difference between mutant and littermate control pallia at 
E10, E11, and E12 (Figure 4.2E-G). At E13, we observed persistence of the U11-null domain 
alongside collapse of the lateral ventricle in the mutant telencephalon, without a significant change 
in pallial thickness (Figure 4.2H&J). At E14, the thickness of the mutant pallium was significantly 
reduced relative to the control (Figure 4.2I-J).   
 
4.3.3 Ablation of U11 in the developing mouse cortex causes cell death 
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We first performed fluorescent ISH (FISH) for U11 to identify the U11-null domain, 
followed by terminal dUTP nick-end labeling (TUNEL) to detect apoptotic cells. Results showed 
sporadic loss of U11 snRNA in the E11 mutant pallium without a significant increase in TUNEL+ 
cells (Figure 4.3A). Onset of cell death was observed at E12, with a statistically significant increase 
in TUNEL+ cells in the mutant compared to littermate controls (Figure 4.3B), which continued at 
E13 and E14 (Figure 4.3C-D). Since TUNEL marks cells in late stages of apoptosis, we sought to 
verify the timing of cell death in the mutant pallium using a marker of early apoptosis [331]. For 
this, we employed immunofluorescence (IF) for cleaved caspase 3 (CC3) [332] at E11 and E12, 
which confirmed that the onset of cell death was occurring at E12 (Figure 4.3E-F).  
 
4.3.4 Ablation of U11 predominantly affects survival of neural progenitor cells 
 To identify the cell type being lost in the mutant pallium, we investigated the numbers of 
proliferating NPCs (Ki67+) versus neurons (NeuN+) by IF [333, 334]. We found no change in the 
number of proliferating NPCs in the E12 mutant pallium compared to the control (Figure 
4.4A&D). However, at E13 and E14, the number of Ki67+ NPCs was significantly reduced in the 
mutant pallium compared to the control (Figure 4.4B-D). Unlike NPCs, we did not observe a 
significant difference in the number of neurons between the control and mutant at E12 or E13 
(Figure 4.4A-B&D). To confirm that the neurons present in the E12 and E13 mutant pallium were 
in fact U11-null, we performed U11 FISH in conjunction with IF for Ki67 and NeuN, which 
showed the presence of both U11-null NPCs and U11-null neurons (Figure 4.5A). Finally, at E14, 
there were significantly fewer neurons in the mutant compared to the control, which was consistent 
with the depletion of the NPC population at E13 (Figure 4.4B-D). To further investigate whether 
neurons were dying in the U11-null pallium, we employed IF for Tuj1, which marks both immature 
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and mature neurons [335], and CC3, and quantified the percentage of CC3+ dying cells that were 
Tuj1+ neurons. In the E12 mutant pallium, the vast majority (93.4±2.1%) of the CC3+ cells were 
pyknotic, indicative of late-stage apoptotic cells (Figure 4.5C). By E13, virtually all CC3+ cells 
were pyknotic (data not shown). Since pyknotic cells in the late stages of apoptosis are unlikely to 
retain Tuj1 expression, we only considered non-pyknotic CC3+ cells for the analysis. This 
quantification revealed that 4.44±2.42% of non-pyknotic CC3+ cells in the E12 mutant pallium 
were Tuj1+ neurons, which was not significantly higher than that observed in the control (0%; 
Figure 4.5C). Together, these data suggested that most of the dying cells were likely the U11-null 
NPCs, not the U11-null neurons.   
 
4.3.5 Cell types of the developing mouse cortex display differential sensitivity to U11 loss 
 We next sought to identify the type of NPC being lost in the U11-null pallium. Using the 
nuclear RGC marker Pax6, we did not observe a significant difference in the number of RGCs 
between the control and mutant at E12 (Figure 4.4E&H) [336]. At E13, there was a significant 
reduction in the number of RGCs with nuclear Pax6 signal in the mutant compared to the control 
(Figure 4.4F&H). However, widespread cytoplasmic Pax6 expression, which was rarely seen in 
control sections, was observed in the mutant (Figure 4.4F). This cytoplasmic staining was 
primarily observed around condensed nuclei, suggesting that the cytoplasmic Pax6 expression was 
occurring in dying cells. This was confirmed by colocalization of the cytoplasmic Pax6 expression 
with CC3 (Figure 4.5B-B’’’). Therefore, only cells with nuclear Pax6 expression were quantified. 
At E14, there were few RGCs in the mutant, which was consistent with the small number of Ki67+ 
cells at this time-point (Figure 4.4D&G-H). Next, we investigated the number of IPCs in the U11-
null pallium using the marker Tbr2 [337], which revealed no significant difference in the E12 
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mutant compared to the control (Figure 4.4I&L). At E13, we observed a significant reduction in 
the IPC population in the mutant relative to the control (Figure 4.4J&L), which continued at E14 
(Figure 4.4K-L).  
Both the RGC and IPC populations were significantly reduced in the mutant pallium at 
E13, but not at E12, relative to the control (Figure 4.4D&H). However, the trends of RGC and IPC 
loss across mutant pallium development were not similar: While there was a significant decline in 
the number of RGCs in the E13 mutant pallium compared to the E12 mutant pallium, there was 
no significant change in the number of IPCs between these time-points in the mutant (Figure 4.5D-
E). A significant decline in IPC number was only observed between E13 and E14 mutant pallium 
(Figure 4.5E). Therefore, the decline in RGC number occurred earlier in the mutant pallium than 
the decline in IPCs, suggesting that IPCs were being produced in the U11-null pallium.  
The observation that the E13 control and mutant pallia both contained similar numbers of 
neurons suggested that neuron production was also occurring in the E12 mutant pallium (Figure 
4.4B&D). To study neuron production in the mutant pallium, we pulsed pregnant dames carrying 
E12 embryos with the thymidine analog 5-bromo-2’-deoxyruidine (BrdU), to mark S-phase NPCs, 
followed by harvest at E13 [338]. After removing pyknotic BrdU+ cells, quantification showed a 
significant decrease in NeuN+/BrdU+ cells as a percentage of all NeuN+ cells in the E13 mutant 
pallium compared to the control. In contrast, there was no significant difference in the percentage 
of non-pyknotic BrdU+ cells that were NeuN+ between the E13 control (15.7±2.17%) and mutant 
(15.5±3.5%; Figure 4.5F) pallium. The presence of BrdU+ neurons in the mutant indicated that 
U11-null NPCs produced neurons between E12 and E13. Together, these findings suggested that 
the majority of cells dying between E12 and E13 were self-amplifying RGCs. 
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4.3.6 Few genes are differentially expressed in the embryonic day 12 U11-null pallium 
 To understand the molecular defects underlying the loss of self-amplifying RGCs, we 
performed RNAseq on control (N=5) and mutant (N=5) pallia from E12 embryos (Figure 4.6A 
inset). At this time-point, U11 loss occurs throughout the entire Emx1-Cre domain without major 
histological changes, such as shifts in NPC number (Figure 4.2G and 4.4D). Confirmation of the 
pallial dissection was reflected by the expression of Emx1 in the control (19.1 fragments per 
kilobase per million mapped reads [FPKM]) and mutant (20.3 FPKM) (Table S3). Expression of 
Dbx1, which marks the pallial-subpallial boundary, and Lhx6, which is expressed in the medial 
ganglionic eminence [339], were expressed below 1 FPKM in both the control and mutant samples 
(Table S3). Together, these results confirm the integrity of our dissection. Expression of Rnu11 
was reduced by 2.95-fold in the mutant compared to the control, which was further confirmed by 
quantitative reverse transcriptase-PCR (qRT-PCR) (Figure 4.6B, Table S3). The incomplete loss 
of U11 expression in the mutant likely reflects (1) contamination of non-Emx1-lineage cells of the 
meninges and blood vessels (Figure 4.2G) [340]; (2) contamination from non-Emx1-lineage cells 
migrating into the pallium (Figure 4.2G) [330]; and/or (3) incomplete recombination by Emx1-
Cre. Regardless, the mutant samples showed a clear reduction in U11 expression compared to the 
control, which was in agreement with the ISH analysis (Figure 4.2G). Next, we interrogated the 
expression of all protein-coding genes with ≥1 FPKM in the control or mutant. Overall, there was 
an increase in the number of genes upregulated (74; ≥2-fold change [FC], P≤0.01) relative to those 
downregulated (11; ≥2-FC, P≤0.01) in the mutant (Figure 4.6A). 
 
4.3.7 U11-null neural progenitor cells display DNA damage and p53 upregulation 
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 DAVID analysis [243, 244] performed on the downregulated protein-coding genes 
revealed no significant enrichments for GO-terms by Benjamini score. However, the upregulated 
protein-coding genes significantly enriched for the GO-term “intrinsic apoptotic signaling pathway 
in response to DNA damage by p53 class mediator” (Table S4), implicating this pathway in the 
cell death observed at this time-point (Figure 4.3). To test whether DNA damage and p53 
activation were occurring in the E12 mutant, we employed IF with the DNA damage marker 
ɣH2AX [341], along with antibody against p53. We observed that the majority of ɣH2AX+ cells 
were pyknotic (54.1±3.5%), suggesting that they were dying cells (Figure 4.6D). To verify this, 
we employed the early-apoptotic marker CC3, which revealed that 93.2±3.5% of ɣH2AX+ cells 
were CC3+ (Figure 4.6D). Because most cells undergoing the final stages of apoptosis do not 
express nuclear markers, we removed all pyknotic ɣH2AX+ cells from our quantification strategy. 
Using this approach, we observed significantly more non-pyknotic ɣH2AX+ cells scattered 
throughout the E12 U11-null pallium relative to the control (Figure 4.6E). Similarly, we observed 
significantly more cells upregulating p53 throughout the E12 U11-null pallium compared to the 
control (Figure 4.6E). Given the GO-term enriched for by the upregulated protein-coding genes, 
and reports that p53 stabilization occurs in response to DNA damage [342], we expected that most 
ɣH2AX+ cells would also upregulate p53. Indeed, 74.7±11.9% of ɣH2AX+ cells were also 
upregulating p53 (Figure 4.6E, left inset). In contrast, only 6.7±2.0% of p53-upregulating cells 
were also ɣH2AX+ (Figure 4.6E, right inset). At E11, we observed significantly more ɣH2AX+ 
cells in the mutant pallium (2.67±0.76) compared to the control (0; Figure 4.6E). However, we did 
not observe a significant difference in the number of p53-upregulating cells in the control and 
mutant, suggesting that the precipitation of DNA damage begins at E11, while cell death occurs at 
E12 (Figure 4.6E). 
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4.3.8 Most DNA damage and p53 upregulation occur in U11-null radial glial cells 
Since the majority of the cells dying between E12 and E13 were self-amplifying RGCs, we 
next investigated whether RGCs were the cell type accumulating DNA damage and upregulating 
p53. We found that 46.3±3.2% of ɣH2AX+ cells were Pax6+ RGCs, while virtually none were 
NeuN+ neurons (5.1±5.1%) or Tbr2+ IPCs (0%, Figure 4.6F). To test whether RGCs were the 
primary cell type upregulating p53, we also performed IF for p53 and Pax6. This revealed that the 
vast majority of p53-upregulating cells were Pax6+ RGCs (98.1±0.85%), a significant enrichment 
compared to the percentage of Pax6+ RGCs found in the mutant pallium (93.61±0.56%; Figure 
4.6G). In all, we found that U11-null RGCs are the primary cell type both accumulating DNA 
damage and upregulating p53, which likely contribute to their widespread death between E12 and 
E13.  
 
4.3.9 Ablation of U11 results in significant minor intron retention in the E12 U11-null 
pallium 
 Since U11 is an essential component of the minor spliceosome [64, 65], the expected result 
of U11 loss is disruption of minor intron splicing. However, none of the genes upregulated in the 
E12 mutant pallium that enriched for p53-mediated apoptosis contained minor introns, indicating 
that their upregulation is a secondary effect of U11 loss. Therefore, we next investigated the 
expression of the minor spliceosome targets, i.e., the MIGs, and the splicing of their minor introns. 
Overall, the vast majority of MIGs were not differentially expressed (Figure 4.6A). Only one MIG, 
Spc24, showed >2-fold downregulation in the mutant (Figure 4.6A arrow, Table S3), which was 
independently confirmed by qRT-PCR (Figure 4.6C). To assess minor intron splicing, we 
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employed the strategy previously described by Madan et al. in 2015 [103], which utilizes a mis-
splicing index (MSI) to reflect intron retention. Using this strategy, we identified 299 (out of 545) 
minor introns and 11,187 (out of 54,500 randomized major introns) that passed the filtering 
criteria, indicating that they show some level of intron retention (Section 4.5 Materials and 
methods). We then calculated the difference in MSI for each intron between the mutant and the 
control (mutant MSI – control MSI; ∆MSI) and generated frequency plots (Figure 4.7A). These 
revealed a rightward ∆MSI shift for the 299 minor introns, while the 11,187 randomized major 
introns followed a normal distribution (Figure 4.7A). This indicated that loss of U11 inactivates 
the minor spliceosome, resulting in elevated retention of minor, but not of major, introns. 
To identify the specific minor introns with elevated retention in the mutant, we employed student’s 
t-tests to compare the MSI of each minor intron between the control and mutant samples. Of the 
299 minor introns, we identified 186 minor introns, found in 178 MIGs, with significantly elevated 
minor intron retention in the mutant. For three of these MIGs (Coa3, Parp1, and Pten), this was 
confirmed by qRT-PCR (Figure 4.8A). Minor intron retention has been predicted to result in the 
introduction of premature stop codons, subsequently targeting MIG transcripts for degradation by 
the nonsense mediated decay (NMD) pathway [86]. To test whether retention of these 186 minor 
introns would indeed introduce a premature stop codon, we curated a list of all annotated isoforms 
of these 178 MIGs, and extracted all the isoforms that would require minor intron splicing for their 
production, resulting in a list of 330 isoforms. Bioinformatics analysis showed that minor intron 
retention in 99.1% of these isoforms would introduce a stop codon prior to the annotated stop 
codon (Figure 4.7B). Since stop codons found >50 nt upstream of an exon-exon junction are 
predicted to trigger the NMD pathway [343], we also interrogated the location of the premature 
stop codons in these 330 MIG transcripts in relation to their exon-exon junctions. Again, we found 
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that the majority (83.8%) of the premature stop codons would be predicted to activate NMD, 
resulting in transcript degradation (Figure 4.7B). For the remaining 53 MIG transcripts, minor 
intron retention would introduce a stop codon in the 3’ end of the transcript, potentially allowing 
these transcripts to escape NMD and be translated, resulting in the production of truncated proteins 
(Figure 4.7B inset). 
 
4.3.10 MIGs involved in mitosis and DNA synthesis have significant minor intron retention 
in the E12 U11-null pallium 
Regardless of whether a MIG transcript would be degraded via NMD or would produce an 
aberrant protein, the functions executed by these MIGs would likely be compromised. To identify 
which biological processes would be affected in the mutant, we submitted the 178 MIGs with 
elevated minor intron retention to DAVID [243, 244]. Functions significantly enriched for by these 
MIGs included both broad GO-terms, such as nucleotide binding (36 genes) and protein transport 
(19 genes), and more specific GO-terms, such as cell cycle (18 genes) and centrosome (13 genes). 
The enrichment of these more specific functions suggested that aberrant minor intron splicing 
might result in cell cycle defects (Figure 4.8B, Table S5). Moreover, the only downregulated MIG 
in the mutant pallium, Spc24, is involved in kinetochore assembly (Figure 4.6A&C, Table S3) 
[344]. Among the 21 cell cycle-regulating MIGs we identified with significantly elevated minor 
intron retention, there were two noteworthy enrichments: nine MIGs that regulate mitosis and 
cytokinesis, and six MIGs that regulate S-phase and DNA replication (Table S5). In all, disruption 
of minor intron splicing likely affected cell cycle in the E12 mutant pallium, particularly in 
mitosis/cytokinesis and S-phase. 
 
99 
 
4.3.11 U11-null radial glial cells display mitotic and cytokinetic defects 
To study mitosis in the U11-null pallium, we performed IF for Ki67 and PH3, a marker of 
mitosis [345], and quantified PH3+ mitotic cells as a percentage of the entire Ki67+ cycling cell 
population, to identify the mitotic fraction of the NPC population (Figure 4.7C). This 
quantification revealed a significantly larger mitotic fraction in the E12 mutant pallium relative to 
the control (Figure 4.7C). To investigate whether a specific stage within mitosis was affected in 
the U11-null E12 pallium, we employed the mitotic marker Aurora B. The staining pattern of 
Aurora B corresponds to specific phases within mitosis [346] (Figure 4.9A); by quantifying cells 
within these specific phases of mitosis, we were able to identify the fraction of mitotic cells in 
prophase, prometaphase+metaphase, anaphase, and telophase. Aurora B staining was combined 
with IF for either Pax6 or Tbr2, to assess cell type-specific defects. This staining paradigm revealed 
a significantly higher percentage of mitotic Aurora B+/Pax6+ RGCs in prometaphase+metaphase 
in the E12 mutant pallium than the control, while prophase, anaphase, and telophase were not 
significantly different (Figure 4.8D-E). In mitotic Tbr2+ IPCs, we did not observe any significant 
differences in the fractions in prophase, prometaphase+metaphase, anaphase, or telophase (Figure 
4.9B-C). To investigate cytokinesis in the E12 mutant pallium, we performed IF for citron kinase 
(Citk), which marks the cytokinetic midbody [347]. At E12, there was a significant reduction in 
Citk+ cytokinetic midbodies lining the ventricular edge in the U11-null pallium (Figure 4.8F). This 
reduction was not observed at E11, when the number of Citk+ cytokinetic midbodies across the 
U11-null pallium was similar to the control (Figures 4.8F and 4.9D). These data suggest that U11 
loss causes both prolonged prometaphase/metaphase, specifically in RGCs, and cytokinesis 
defects.  
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4.3.12 U11 loss affects the fraction of radial glial cells in S phase 
 Next, we explored how minor intron retention in the S phase-regulating MIGs impacted S-
phase kinetics in the mutant pallium. For this, we pulsed pregnant females with the thymidine 
analog EdU [348], followed by harvest one hour later. EdU detection revealed a significantly lower 
percentage of EdU+/Pax6+ RGCs in the mutant compared to the control at E12 (Figure 4.8G), while 
there was no significant difference in the percentage of EdU+/Tbr2+ IPCs between the E12 control 
and mutant pallium (Figure 4.8H). In addition, we observed no change in the percentage of 
EdU+/Pax6+ RGCs in the E11 mutant pallium compared to the control (Figure 4.9E). Thus, U11 
loss in RGCs causes S-phase defects at E12, while U11-null IPCs are spared. 
  Together, these findings indicate that U11 loss disrupts the splicing of MIGs that are 
involved in mitosis, cytokinesis, and S-phase, resulting in defects in these cell cycle phases. To 
determine whether other cell cycle phases were affected in the U11-null pallium, we employed the 
markers cyclin B1, which is cytoplasmic in G2 phase, and Aurora B, which is localized to 
condensing chromosomes in cells in G2 [349, 350] (Figure 4.9A). Neither quantification of cyclin 
B1+ G2 cells, nor quantification of the percentage of G2 Aurora B+ RGCs or IPCs, revealed a 
significant difference between the E12 mutant and control pallium (Figure 4.9B&F-G), further 
underscoring that U11 loss causes three significant and specific cell cycle defects, affecting (1) 
prometaphase/metaphase, (2) cytokinesis, and (3) S-phase. 
 
4.3.13 Most cells with DNA damage in the U11-null pallium were not in S-phase or mitosis 
Since the MIGs with significantly elevated minor intron retention enriched for cell cycle 
functions, we expected that the observed cell cycle defects were the primary cause of RGC death, 
while the observed DNA damage and p53 upregulation were secondary effects. To determine 
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whether DNA damage and p53 upregulation were occurring in NPCs in S-phase and 
mitosis/cytokinesis, we combined IF for either ɣH2AX or p53 with different cell cycle markers. 
To determine whether cells accruing DNA damage were in S-phase, we employed the 
aforementioned EdU pulse strategy. IF for ɣH2AX combined with EdU detection revealed that 
38.5±9.3% of ɣH2AX+ cells were also EdU+, similar to the total percentage of EdU+ cells in the 
mutant pallium (37.8±1.0%, Figure 4.10A). We did not observe any ɣH2AX+/PH3+ cells in the 
E12 mutant pallium, indicating that cells with DNA damage were not in mitosis (Figure 4.11).  
 
4.3.14 P53 upregulation in the U11-null pallium occurs predominantly in radial glial cells in 
G1 phase 
To investigate convergence between p53 upregulation and cell cycle phase, we employed 
the aforementioned EdU pulse paradigm along with IF for Aurora B. In the E12 mutant pallium, 
approximately one third (32.5±4.4%) of p53-upregulating cells were also EdU+ (Figure 4.10B). 
However, this enrichment was not statistically significant, when compared to the total percentage 
of EdU+ cells in the E12 mutant pallium (42.3±1.2%, Figure 4.10B). We then leveraged Aurora B 
to interrogate p53 upregulation in G2 and mitosis. Quantification of cells with G2-specific Aurora 
B staining in the E12 mutant pallium revealed that 14.4±2.1% of p53-upregulating cells were in 
G2 phase, a significantly lower percentage than would be expected based on the total percentage 
of G2 cells in the mutant pallium (26.5±1.4%, Figure 4.10C). Similar quantification of mitotic 
Aurora B+ cells showed that 2.4±0.3% of p53-upregulating cells were mitotic, which was 
significantly lower than expected from the total percentage of mitotic cells in the mutant pallium 
(8.5±0.5%, Figure 4.10C). Thus, approximately half of p53-upregulating cells were not labeled by 
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these S-, G2-, and M-phase markers, suggesting that these p53-upregulating cells were in G1 
phase.  
 
4.3.15 Most dying cells in the U11-null pallium are not in S, G2, or M phase 
Given that we observed a relationship between p53 upregulation and cell cycle phase, we 
sought to determine whether apoptosis in U11-null cells was also linked to cell cycle phase. Since 
pyknotic cells in later stages of apoptosis would not express cell cycle markers, we employed both 
IF for CC3, to mark cells in early-to-late apoptosis, with TUNEL, to mark cells in late stages of 
apoptosis. For our analysis, we excluded pyknotic TUNEL+ cells, so that we only considered cells 
in early stages of apoptosis. First, to investigate S-phase cells, we employed the aforementioned 
EdU pulse paradigm. Of the CC3+ cells of the E12 mutant pallium, 38.0±19.1% were also EdU+, 
which was expected based on the total percentage of EdU+ cells in the mutant pallium (42.2±1.2%, 
Figure 4.10D). To assess G2 and mitotic cells, we employed IF for Aurora B. In the E12 mutant 
pallium, we observed virtually no CC3+/Aurora B+ cells (2.1±2.1%, Figure 4.10E), indicative of 
minimal death of cells in G2 and M phases. Together, these findings indicate a relationship 
between apoptosis and cell cycle that mirrors that of p53 upregulation and cell cycle: few dying 
cells are in G2 or M phase, and less than half are in S phase. Therefore, the majority of dying cells 
in the E12 mutant pallium are most likely in G1 phase or are neurons.  
 
4.3.16 tdTomato+ cells are present in the neonatal mutant cortex 
 To determine whether U11-null cells survive postnatally, we utilized the Ai9 tdTomato Cre 
reporter line [351], which showed tdTomato+ cells in both the P0 and P21 control and mutant 
cortex (Figures 4.12 and 4.13). In rostral cortical sections at both time-points, landmarks such as 
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the anterior commissure (Figure 4.12I, bottom white arrow), the choroid plexus (Figure 4.13I-K, 
white arrow), and the lateral septum (Figures 4.12D&E, 4.12J&K, 4.13B&H; LS) were identifiable 
in the mutant. Additionally, scattered tdTomato+ cells were visible in the control and mutant 
striatum (Figures 4.12C’, 4.12I’, 4.13A’, 4.13G’), consistent with reports of Emx1-Cre-lineage 
cells in that brain structure [235, 329]. However, fewer landmarks were identifiable in more caudal 
sections of the mutant brain (Figures 4.12F-H, 4.12L-N, 4.13F&L). 
 
4.3.17 U11-null neurons are present in the neonatal mutant cortex 
Given that tdTomato expression in the Ai9 tdTomato mouse line is induced by Cre-
mediated recombination, the presence of tdTomato+ cells in the postnatal mutant cortex 
suggested that recombined, U11-null neurons were present in the postnatal mutant cortex. To test 
this, we performed ISH for U11 on coronal sections of the P0 control and mutant heads. In the 
P0 mutant cortex, we observed scattered U11-null cells in the mediorostral cortex; in contrast, 
U11 expression was observed throughout the cells of the P0 control cortex (Figure 4.14A-B). To 
determine whether these U11-null cells in the P0 mutant cortex were neurons, we employed U11 
FISH combined with IF for NeuN. This approach revealed the presence of scattered, U11-null 
neurons in the P0 mutant cortex; again, we did not observe U11-null cells in the P0 control 
cortex (Figure 4.14C-D’). 
 
4.3.18 U11-null neurons born after Rnu11 ablation are present in the neonatal and juvenile 
mutant cortex 
To determine whether the recombined, U11-null neurons in the postnatal mutant cortex 
were produced during embryonic development, we employed a pulse-chase strategy using EdU 
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[348]. We injected pregnant females with EdU once daily from E11, when U11 is first lost 
throughout the pallium (Figure 4.2F), until E13, to ensure we would label U11-null neurons born 
after Rnu11 ablation (Figures 4.4B-C and 4.5F). The EdU pulsed at each time-point would be 
incorporated into the replicating genome of S-phase NPCs, and this EdU signal would then be 
inherited by neurons born from these EdU-labeled progenitor cells. Since EdU signal is diluted by 
each round of cell division, only post-mitotic neurons born shortly after the initial EdU pulse would 
retain strong EdU signal postnatally. We harvested control and mutant brains at P0 and P21 and 
performed FISH for U11, followed by IF for NeuN and detection of EdU (Figure 4.15A). This 
approach revealed consistent expression of U11 across the P0 control cortex (Figures 4.15B and 
S1B). In the P0 mutant cortex, U11-null neurons were interspersed among U11+ neurons, 
consistent with the presence of tdTomato- cells in the P0 mutant cortex (Figures 4.12I’’, 4.15C, 
S1F-G, and S1I-J). By P21, control neurons displayed varying levels of U11 expression (Figures 
4.15D, S1K&L, and S1K’-O’). In the P21 mutant cortex, we observed U11-null neurons scattered 
among U11+ neurons (Figures 4.15E and S1P-T), consistent with the presence of tdTomato+ and 
tdTomato- cells in the P21 mutant cortex (Figure 4.13G’’). To interrogate the presence of U11-
null neurons born between E11 and E13, we quantified the number of U11-/NeuN+/EdU+ cells in 
the control and mutant cortex, as a percentage of the total number of NeuN+/EdU+ cells. This 
revealed significantly higher percentages of U11-/NeuN+/EdU+ cells in the mutant P0 cortex 
compared to the control (Figures 4.15B-C’’’’, 4.15F, and S1A-J) and in the P21 mutant cortex 
compared to the control (Figures 4.15D-E’’’’, 4.15G, and S1K-T). At both P0 and P21, we 
observed virtually no U11-/EdU+ neurons in the control sections (Figures 4.15B-G, S1A-E, and 
S1K-O). In conclusion, we found that U11-null neurons can survive postnatally.  
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4.3.19 Lack of corticospinal projections and the corpus callosum in the neonatal Rnu11 
mutant mouse 
To interrogate the effects of U11 loss on neurite outgrowth in the excitatory neurons of the 
cortex, we examined the whole brains of the Ai9 tdTomato+ control and mutant mice at P0. We 
found that the tdTomato+ subcerebral tracts, which originate from layer V neurons of the cortex 
[193], were not visible in the Rnu11 mutant brain (Figure 4.16B). Moreover, we observed agenesis 
of the corpus callosum in coronal sections of the P0 mutant brain (Figures 4.12I-N and 4.13G-L). 
Together, these findings suggested that although U11-null neurons could survive postnatally, their 
neurite outgrowth was profoundly affected by U11 loss.   
 
4.4 Discussion 
Patients with MOPD1, Roifman syndrome, or Lowry Wood syndrome are thought to 
escape embryonic lethality due to impairment, but not complete inactivation, of minor spliceosome 
activity. Despite the systemic impairment of minor splicing, the specific phenotypes observed in 
the brain and limbs of patients indicate tissue/cell-type specific sensitivity to minor spliceosome 
activity [106-108, 122, 124, 140, 143]. Even within the brain, progenitor cells of the cortex are the 
most sensitive to inhibited minor splicing, as evidenced by the consistent set of cortical 
abnormalities observed in MOPD1 [106]. However, investigation into the requirement of minor 
splicing for cortical development, and whether this requirement is cell type-specific within the 
cortex has, until now, been unexplored. 
Here, we present the first mammalian model of microcephaly caused by minor spliceosome 
inactivation (Figure 4.2D), allowing us to study the pathogenesis of microcephaly in disorders 
caused by minor spliceosome disruption. Unexpectedly, we found that even within the developing 
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cortex, different cells showed different sensitivities to U11 loss. Specifically, self-amplifying 
RGCs were highly sensitive to minor spliceosome inactivation, while RGCs undergoing 
differentiative divisions, IPCs, and neurons were less affected (Figures 4.4, 4.5C-F, and 4.17A). 
We did not observe a significant difference between the percentage of non-pyknotic BrdU+ cells 
that were NeuN+ neurons in the E13 control and mutant pallium, suggesting similar rates of 
neurogenesis from the control and U11-null NPCs labeled at E12 (Figure 4.5F). These findings 
are discordant with the similar numbers of neurons observed in the control and mutant at E13 
(Figure 4.4D), which may be explained by compensatory neuron production prior to the BrdU 
pulse. The U11-null neurons born from these U11-null NPCs can survive postnatally (Figure 4.15), 
although the observed agenesis of the cerebrospinal tracts and corpus callosum in the postnatal 
mutant brain indicated that their differentiation was profoundly affected (Figures 4.12, 4.13, and 
4.16). Together, our findings show that minor spliceosome inactivation in the developing mouse 
cortex predominantly affects the survival of self-amplifying RGCs and may shift RGCs to 
neurogenic divisions. Ultimately, this would deplete the RGC pool (Figures 4.4H & 4.17A), 
resulting in the observed microcephaly (Figure 4.2D). 
In the developing mouse cortex, the U11-null RGCs experience multiple cell cycle defects. 
For example, fewer U11-null RGCs were in S-phase (Figure 4.7G), suggesting faster S-phase 
progression or death in late G1/early S-phase. U11-null RGCs also displayed prolonged 
prometaphase/metaphase (Figure 4.7C-E), indicative of spindle assembly defects. Since 
prolongation of mitosis—and particularly of prometaphase/metaphase—has also been linked to 
increased neurogenic drive in cortical NPCs [294], this mitotic defect may drive U11-null RGCs 
to produce neurons. In addition, we observed fewer Citk+ cytokinetic midbodies along the 
ventricular edge where RGCs divide, without a change in the fraction of mitotic RGCs in telophase 
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(Figure 4.7E-F). This could be caused by RGC death prior to cytokinesis or improper Citk 
localization to the midbody. Since proper Citk localization is required for cytokinesis, 
mislocalization would cause aberrant cytokinesis, resulting in RGC death post-division [301]. In 
addition to these cell cycle defects, we observed accumulation of DNA damage at E11, followed 
by further DNA damage accumulation and p53 upregulation in RGCs at E12 (Figure 4.6E-G). The 
majority of RGCs with DNA damage also upregulated p53 (Figure 4.6E). Thus, activation of the 
DNA damage response pathway in these cells likely results in the stabilization of p53 protein, as 
has been reported [352]. However, the vast majority of p53-upregulating RGCs did not have DNA 
damage, suggesting that DNA damage accumulation is not the sole cause of p53 upregulation and 
cell death in the mutant pallium (Figure 4.6E). For these RGCs, we expect that p53 upregulation 
is triggered by prometaphase/metaphase prolongation and cytokinesis defects, as has been 
proposed (Figure 4.7C-E) [353, 354]. This is consistent with the observation that most p53-
upregulating cells were not in S-, G2-, or M-phases, suggesting that the majority of p53-
upregulating cells were either NPCs in G1 phase or neurons (Figure 4.10B-C). Since the vast 
majority of p53-upregulating cells were Pax6+ (Figure 4.6G), most of these p53-upregulating cells 
were likely RGCs in G1 phase (Figure 4.10B-C). RNAseq of the pallium revealed that upregulated 
genes enriched for “intrinsic apoptotic signaling pathway in response to DNA damage by p53 class 
mediator,” which is consistent with the observed DNA damage and p53 upregulation in RGCs 
(Figure 4.6F-G & Table S4). Two of the genes enriching for this functional category were the well-
known p53-mediated apoptosis effectors Puma and Noxa (Table S4). Upregulation of these p53-
mediated apoptosis effectors is likely specific to RGCs, particularly those in G1 phase, since (1) 
p53 upregulation was observed in RGCs (Figures 4.6G and 4.10B-D), and (2) the majority of cells 
in the E12 pallium are RGCs (Figure 4.4E).  
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In essence, all of these RGC-specific cellular defects are caused by minor spliceosome 
inactivation—i.e., missplicing of MIGs. In the U11-null pallium, 62% of minor introns were 
significantly retained compared to the control, 21 of which are involved in cell cycle regulation 
(Figure 4.8 & Table S5). Notably, four of these cell cycle-regulating MIGs—Cdc45, Dna2, Prim1, 
and Rfc5—regulate DNA replication and S-phase progression (Table S5); therefore, disruption of 
their function likely results in DNA damage and cell death in S-phase, which is consistent with the 
observed cellular defects (Figures 4.6D-E, 4.7G, & 4.17B). Ineffective DNA damage repair, due 
to minor intron retention in the 13 MIGs regulating this process (Table S6), would further 
contribute to DNA damage accumulation and the subsequent p53 upregulation. This pathway may 
underlie the DNA damage observed in the E11 mutant pallium, prior to p53 upregulation (Figure 
4.6E & 4.17B). Disrupted function of many of the remaining cell cycle-regulating MIGs, such as 
Ahctf1, Dctn3, Dync1li1, Gak, Mau2, and Zfp207, is reported to cause spindle assembly defects, 
chromosome mis-segregation, and aberrant cytokinesis (Table S5). Thus, minor intron retention 
in these genes likely contributes to the prolonged prometaphase/metaphase and cytokinesis defects 
observed in U11-null RGCs at E12, which may in turn trigger the observed p53 upregulation in 
the absence of DNA damage (Figures 4.6E, 4.7E-F, and 4.17B). The identification of these subsets 
of MIGs, which show significantly elevated minor intron retention and whose functions track with 
the observed cellular defects in the U11-null pallium, opens new avenues of research for scientists 
investigating the pathogenesis of the developmental disorders linked to minor spliceosome 
inactivation.  
Out of the 186 minor introns that showed significantly elevated retention in the U11-null 
pallium, we predicted that the majority would result in nonsense-mediated decay (Figure 4.6B). 
However, none of the 147 MIGs containing these retained minor introns were downregulated in 
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the E12 U11-null pallium. This is in agreement with the finding that mutation in an essential minor 
spliceosome protein (rnpc3) in zebrafish did not affect expression levels of 90% of MIGs, while 
still resulting in elevated minor intron retention [113]. These findings suggest that inactivation of 
the minor spliceosome, while disrupting minor intron splicing, does not necessarily result in 
downstream changes in overall gene expression. This could be a result of a transcriptional feedback 
loop that drives compensatory upregulation of MIG transcription in response to impaired function 
of these MIGs [106]. Translation of these transcripts could result in aberrant protein production, 
with loss- or gain-of-function effects, contributing to the RGC-specific cellular defects and death.  
In both the U11-null pallium and in MOPD1 patients, the observed differential sensitivity 
to minor spliceosome inactivation may be informed by differences in MIG expression across cell 
types, where higher MIG expression is correlated with increased sensitivity to minor spliceosome 
inactivation. Furthermore, if minor introns themselves display differential sensitivity to minor 
spliceosome inactivation, as our data suggest, then the identity of MIGs expressed in specific cell 
types could inform that cell type’s susceptibility to minor spliceosome inactivation. In all, our 
findings establish how minor spliceosome inactivation in the developing mammalian cortex leads 
to microcephaly. Moreover, we are the first to identify cell type-specific requirements for minor 
spliceosome activity within the developing cortex, raising new questions about the mechanisms 
underlying cell type-specific sensitivity to minor spliceosome activity in mammalian development 
and disease.  
 
4.5 Materials and methods 
 
Animal Procedures and Generation of the Rnu11 cKO Mouse 
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All mouse procedures were performed according to the protocols approved by the 
University of Connecticut Institutional Animal Care and Use Committee. The Rnu11 conditional 
knockout (cKO) mouse was generated by the University of Connecticut Health Center. A single 
targeting construct was utilized to introduce both loxP sites into the Rnu11 locus in mouse 
embryonic stem (ES) cells (Figure 4.1A). This construct contained a 5’ loxP site 1090 bp from the 
Rnu11 gene. Immediately upstream of the 3’ loxP site was a phosphoglycerine kinase (PGK)-
Neomycin (Neo) cassette flanked by Frt sites. Additionally, this construct contained a PGK-dTA 
(diphtheria toxin A) negative selection cassette downstream of the 3’ arm of homology. This 
construct was electroporated into 129X1/SvJ mouse embryonic stem (ES) cells. Successful 
targeting was verified by G418-mediated positive selection. Subsequently, nested long-range PCR 
was employed to confirm successful homologous recombination at both the 5’ and 3’ loxP sites 
(Figure 4.1C). Two ES-cell clones, F4 and H8, were then used for morula aggregation using 
C57BL/6 embryos to generate a chimera. Germline transmission and ablation of the Neo cassette 
was verified by introducing germline Flp recombinase. Proper loxP site placement in the resulting 
mouse line was confirmed by PCR (Figure 4.1A; Table S7) to identify loss of the wild-type allele 
in the homozygous floxed line and by breeding in the germline EIIa-Cre [355] (Figure 4.2A). 
Emx1-Cre was bred into the Rnu11 conditional knockout line to target Rnu11 for removal in the 
developing forebrain [235]. The primers used for Rnu11, Cre, Emx1-Cre zygosity, and Ai9 
tdTomato Cre reporter genotyping PCRs are listed in Table S7. All experiments were performed 
using male and female Rnu11WT/Flx and Rnu11Flx/Flx mice that were Emx1-Cre+/-. For matings 
intended for embryonic harvests, the plug date was considered E0; on the harvest date, the 
embryonic time-point was further verified by Theiler staging of the embryos. 
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Quantitative PCR 
Quantitative PCR (qPCR) using Genomic DNA To determine Rnu11 heterozygosity 
and loss of the WT allele, 25 ng of gDNA from Rnu11WT/KO and Rnu11WT/WT mice was used for 
qPCR with Rnu11 cKO, 5’ loxP primers (Table S7). Equal gDNA input was controlled with 
amplification for Hist1h1a, an intronless gene, which was then used to normalize amplification for 
Rnu11.  
Quantitative Reverse-Transcriptase PCR (qRT-PCR) Loss of U11 expression was confirmed 
by qRT-PCR with U11 primers (Table S7) on cDNA prepared from total RNA extracted from the 
pallium of control (N=3) and mutant (N=4) E12 embryos. In this case, Neat1, a non-coding RNA 
that did not show change in expression between the control and mutant samples by RNAseq, was 
used to normalize expression of U11 by qRT-PCR [356] (Table S3). The same cDNA was used to 
determine expression of Spc24, using primers designed in the 3’ UTR of the gene (Table S7). The 
Cq values obtained for Sfrs10 (Table S7) were used to normalize expression of Spc24 [251]. For 
minor intron retention in Coa3, Parp1, and Pten, expression values of exon-intron (unspliced) 
product were normalized using Cq values generated using intergenic primers (Table S7) to offset 
any gDNA contamination [251]. Expression values of exon-exon (spliced) product were 
normalized using Sfrs10 Cq values [251]. Minor intron retention for each of these MIGs was 
calculated by dividing the normalized fold expression values of the unspliced product by the 
normalized fold expression values of the spliced product. Statistical significance was determined 
by two-tailed student’s t-tests. 
 
Transcardial Perfusion 
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P21 and P70 control and mutant mice were anesthetized using isoflurane, followed by transcardial 
perfusion performed as previously described [357]. After the brains were removed, they were fixed 
overnight in 4% PFA at 4°C, followed by PBS washes and cryoprotection in 30% sucrose in PBS 
at 4°C for two days. Following an overnight incubation in half 30% sucrose/half OCT compound 
(Fisher Scientific, #23-730-571), the brains were embedded in OCT compound and sectioned 
using a cryostat (Leica CM 3050 S). 
 
Hematoxylin and Eosin Staining 
Frozen 16 µm coronal sections of P0 mouse brains were cured at room temperature for 15 
minutes, followed by incubation in PBS for 15 minutes. The tissue was then dehydrated using an 
ethanol gradient (25%, 50%, and 75%). Slides were washed twice in 100% ethanol for 30 seconds 
each, with agitation, then washed twice in 95% ethanol for 30 seconds each, with agitation. 
Following a rinse in running tap water, the sections were incubated in Harris hematoxylin (Fisher 
Scientific, #6765001) for 7 minutes. Excess hematoxylin was removed by washing in running 
water for 30 seconds. The slides were briefly agitated in 1% acid alcohol (1% HCl in ethanol), 
then briefly rinsed in running water. Sections were then incubated for 2-3 minutes in saturated 
lithium carbonate (1.54% in dH2O), followed by a 5-minute incubation in tap water. After a 30 
second wash in 80% ethanol with agitation, slides were incubated in an eosin Y-phloxine B 
solution (0.1% eosin Y, 0.01% phloxine B, 0.45% glacial acetic acid, 82.9% ethanol) for 1 minute. 
The sections were then washed in 95% ethanol for 30 seconds with agitation, followed by two 30-
second washes in 100% ethanol with agitation and incubation in 100% ethanol for 1 minute. After 
washing in xylene for 30 seconds with agitation, the slides were washed in xylene for 1 minute, 
then mounted using PermountTM mounting medium (Fisher Scientific, #SP15-100).  
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In Situ Hybridization 
16 µm cryosections of mouse heads (for E10–E12 and P0), telencephalons (E13–E14), and 
whole brains (for P21), N=3 for each time-point and genotype, were used for section in situ 
hybridization (SISH). SISH was performed using antisense, digoxigenin-labeled U11 RNA probe, 
which was detected using either alkaline phosphatase (AP) or fluorescent labeling (FISH), as 
described in [116]. The U11 probe was generated using the U11 expression primers in Table S7.  
 
TUNEL Assay 
Sixteen µm cryosections of either embryonic mouse heads (for E10 – E12) or 
telencephalons (E13 – E14) were used for terminal deoxynucleotidyl transferase dUTP nick ending 
labeling (TUNEL) analysis. The in situ cell death detection kit, TMR red (Roche, #12156792910), 
was used, according to the manufacturer’s instructions. 
 
Immunofluorescence 
Immunofluorescence was performed using one of three protocols. Staining for Tbr2 was 
performed as described in [233]. For staining with anti-NeuN antibody, heat-mediated antigen 
retrieval was performed using citrate buffer, per the manufacturer’s instructions (Vector 
Laboratories, #H-3300), followed by 10 minute PBS washes (3 times). After three 10 minute 
washes in 0.5% Triton® X-100 in PBS (PBT), sections were incubated in 10% FBS in PBS for 
one hour at room temperature. Sections were then incubated in a PBS solution containing 1% FBS, 
0.1% Triton® X-100, and the primary antibody overnight at 4°C. Following five-minute washes 
in PBT (10 times), incubation with the secondary antibody (1:500) was performed similarly to the 
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primary antibody incubation, except for two hours at room temperature. The slides were then 
washed five times with PBT, followed by three PBS washes and mounting with ProLong® Gold 
Antifade Mountant (ThermoFisher Scientific, #P36930). For all other antibodies, staining was 
performed as described in [358]. Primary antibodies were diluted to 1:50 (mouse anti-CRIK/CITK, 
BD Biosciences, #611376; rabbit anti-cyclin B1, Cell Signaling, #4138; MoBu-1 clone mouse 
anti-BrdU, Santa Cruz, #sc-51514), 1:100 (mouse anti-Aurora-B/AIM1, BD Biosciences, 
#611082; mouse anti-Pax6, Developmental Studies Hybridoma Bank, #PAX6-b), 1:200 (mouse 
anti-γH2AX, MilliporeSigma, #05-636; rabbit anti-NeuN, abcam, #ab17787), 1:300 (rabbit anti-
cleaved caspase 3, Cell Signaling, #9665S; mouse anti-KI67, BD Biosciences, #556003; rabbit 
anti-p53, Leica Microsystems, #p53-CM5p; rabbit anti-Pax6, MilliporeSigma, #AB2237), or 
1:500 (rabbit anti-PH3, Bethyl Laboratories, Inc., #IHC-00061; rabbit anti-TBR2, abcam, 
#ab23345). 
 
5-bromo-2’-deoxyuridine (BrdU) and 5-ethynyl-2’deoxyuridine (EdU) Pulse Experiments 
Timed-pregnant Rnu11WT/Flx::Emx1-Cre+/+ females were first weighed and peritoneally 
injected with 0.2 µL 25 mM BrdU or EdU in PBS per 100 mg body weight, one hour prior to 
embryonic harvest. BrdU incorporation was detected using the BrdU-specific MoBu-1 clone anti-
BrdU antibody (Santa Cruz, #sc-51514) [359]. EdU detection was then performed on sections of 
the pallium using the Click-iTTM EdU Alexa FluorTM 647 imaging kit (ThermoFisher Scientific, 
#C10340) in accordance with the manufacturer’s instructions. 
 
Image Acquisition and Quantification 
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Processed slides were imaged with a Leica SP2 confocal microscope, where settings for 
laser intensity, excitation-emission windows, gain, and offset conditions were identical between 
control and mutant sections on a given slide. For every slide that was processed for ISH, FISH, or 
IF, the slide contained at least one control and one mutant section. Sections serial to those that 
revealed loss of U11 by ISH analysis were used for IF staining, and images were collected in 
regions of the pallium that showed U11 loss in the mutant by ISH (Figure 4.2E). For each channel 
for every experimental condition, confocal imaging settings were optimized for fluorescence in 
the control section on a given slide, and maintained for all other sections on that slide. For TUNEL, 
CC3, γH2AX, and p53 imaging, collection settings were adjusted using the control section. These 
settings were maintained when imaging the mutant section(s) on the same slide. Further processing 
was performed on IMARIS v8.3.1 (Bitplane Inc.) and Adobe Photoshop CS4 (Adobe Systems 
Inc.). All image processing in IMARIS and Photoshop was identical between images of control 
and mutant sections from the same slide. Manual quantification was performed using the spot tool 
in the IMARIS software, on 240 µm-wide columns of the pallium; statistical significance was 
calculated using two-tailed student’s t-tests. For quantification of mitotic phases, as identified by 
Aurora B staining (Figure 4.9A), prometaphase and metaphase cells were summed together into a 
single category (prometaphase/metaphase). For the quantification of U11-/NeuN+/EdU+ cells, only 
DAPI+ nuclei were considered during the quantification process, due to the presence of non-
nuclear NeuN signal. We subsequently employed both the 3D view and slice functions in IMARIS 
to ensure these DAPI+ nuclei were truly U11-null, NeuN+, and EdU+ (Figures S3 and S4). In the 
P0 and P21 control and mutant cortices, we observed non-nuclear FISH signal in the raw MIP 
images, with some FISH signal observed ~10 µm from the nearest nucleus in the section (Figures 
S4 and S5). Given that U11 expression is predominantly nuclear, this non-nuclear FISH signal was 
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considered background staining. For quantification of U11-null cells, U11 signal for each slide 
was adjusted in IMARIS based on two criteria: (1) non-nuclear FISH signal in the control and/or 
mutant images, and (2) FISH signal in NeuN+ cells in the control. Specifically, FISH levels were 
adjusted to minimize the background FISH signal, while maintaining FISH signal in all NeuN+ 
cells in the control, to prevent false negative calls (Figures S2 and S3). Since we were only 
interrogating NeuN+ cells in the analysis, and due to the presence of U11-null glia/endothelial cells 
in the control P21 cortex (Figure S1), we did not consider NeuN-negative cells in the FISH 
thresholding process. In the case of P21 sections, we observed a high level of FISH background 
staining, which was not completely ablating using this thresholding process (Figures S4 and S5). 
Therefore, given the presence of FISH background in these images, U11+ cell calls were made 
based on the presence of multiple (>1) grains of FISH signal in the nucleus of a NeuN+/EdU+ cell. 
To further prevent false negatives from confounding our analysis, we divided the absolute number 
of U11-/NeuN+/EdU+ cells for each cortical column by the total number of NeuN+/EdU+ cells in 
that column, to determine the percentage of NeuN+/EdU+ cells that were U11-null. For analysis of 
Pax6+ and Tbr2+ cell quantification across mutant cortical development, statistical significance 
was determined by one-way ANOVA, followed by the post hoc Tukey test. For comparisons 
between the ɣH2AX+, p53+, or CC3+ subpopulation and all DAPI+ cells in the E12 mutant pallium, 
statistical significance was determined by Fisher exact test. Specifically, for each N, a separate 
Fisher exact test was performed on quantification data from a 240 µm-wide column of the mutant 
pallium. The P values from these Fisher exact tests were then combined using Fisher’s method. 
 
Bioinformatics Analysis 
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RNAseq The pallium was dissected from E12 (N=5 Rnu11WT/Flx Emx1-Cre+/-, N=5 
Rnu11Flx/Flx::Emx1-Cre+/-) embryos, followed by RNA extraction using TRIzol (Thermo Fisher 
Scientific, #15596018), per the manufacturer’s instructions. Sample preparation and sequencing 
were performed by the University of Connecticut Center for Genome Innovation. Total RNA 
library was prepared by Illumina TruSeq Stranded Total RNA Library Sample Prep Kit (RS-122-
2201) with Ribozero to remove ribosomal RNA, and were then sequenced using Illumina NextSeq 
500. Each sample was barcoded so that the sequencing could be multiplexed. In total, we obtained 
189,989,434 paired-end 151 bp reads for the control (N=5) and 219,849,711 paired-end 151 bp 
reads for the mutant samples (N=5).  
Gene expression First, reads of individual replicates were merges and mapped to the 
mm10 genome (UCSC genome browser) using Hisat2 (options –no-discordant and –no-mixed), 
with an overall alignment rate of 85% [248, 360]. Reads that mapped to multiple locations in the 
genome were removed. Since the samples were obtained from C57BL/6-129X1/SvJ mice, SNVQ 
was run to call single nucleotide variations (SNVs) [361], which were used to create a new 
reference genome. Reads from all replicates were then mapped separately to the newly generated 
reference genome using Hisat2. Isoform expression was determined by IsoEM2, an expectation-
maximization algorithm that bootstraps samples in order to determine an expression value in 
fragments per kilobase per million mapped reads (FPKM) unit [362]. Gene expression was then 
calculated by taking the sum of the FPKM values of a given gene’s constituent isoforms. Finally, 
differential gene expression (≥2 fold change, P≤0.01) was determined by IsoDE2 [362]. Briefly, 
this tool utilizes the 200 bootstrapping iterations to compute a confident log2FC, which is the 
maximum log2FC that can be computed within the specified P-value. A log2FC of 100 is reported 
when the FPKM value for one of the conditions was 0 in one of the bootstrapping iterations.  
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 Splicing efficiency To assess minor intron splicing, sequences of the 555 minor introns 
were curated from the U12DB [58] and blasted using Ensembl83 to obtain the minor intron 
coordinates in the canonical transcript. Sequences of eight minor introns (found in Arpc5l, 
Cacna1c, Exosc2, Golga7, Ift80, Mlst8, Tmem161b, and Morc4) that did not have 100% identity 
with any annotated intron in the Ensembl database were removed from our analysis. All gene and 
exon coordinates from the mm10 genome were obtained from a Biomart file (Ensembl v84) [363]. 
Major intron coordinates were downloaded from the UCSC genome browser (Ensembl v84) and 
randomized after removal of introns smaller than 4 nt. 
Reads from each of the biological replicates were separately mapped with Hisat2 to the 
previously described post-SNVQ generated reference genome. Reads that mapped to multiple 
locations were then filtered out. To determine splicing efficiency of minor introns, we employed 
the strategy described in [103]. Briefly, all reads mapping to an exon-intron boundary were 
extracted and quantified using BEDTools [364]. The mis-splicing index (MSI) was then calculated 
for each intron by dividing the number of exon-intron junction reads by the number of reads 
mapping to the canonical exon-exon splice-junctions. Only introns with >4 exon-intron boundary 
reads, ≥1 read aligning to either the 5’ or 3’ splice site, and >95% intron coverage in at least one 
sample were used for this analysis [103]. As a control for the 545 minor introns subjected to these 
criteria, we also generated 100 lists of 545 randomized major introns (54,500 randomized major 
introns in total), to which we applied the same criteria. For each intron that passed the filtering 
criteria, we calculated the difference between the mutant and the control (mutant MSI – control 
MSI; ∆MSI). To determine which minor introns were retained significantly more in the mutant, 
we compared the average MSI of each minor intron between the control and mutant samples using 
two-tailed student’s t-tests.  
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ORF analysis To analyze the effect of minor intron retention on the ORF, we curated all 
annotated isoforms of the 178 MIGs containing minor introns with significantly elevated retention 
in the mutant from Ensembl (v84) [363]. From this list of isoforms, we extracted only isoforms 
that would require minor intron splicing for their production, i.e. the blasted minor intron 
coordinates match one of the annotated intron coordinates 100%, resulting in 330 isoforms. 
Comparison of the annotated open reading frame (ORF) sequence, with the sequence of the 
isoform containing a retained minor intron, was performed to determine whether minor intron 
retention would result in introduction of a premature stop codon in these isoforms. Isoforms were 
then binned into one of four categories: (1) truncation of the ORF, due to a premature stop codon; 
(2) elongation of the ORF, with usage of a premature stop codon; (3) elongation of the ORF, with 
usage of the isoform’s annotated stop codon; and (4) no change in ORF size, with usage of a 
premature stop codon. For the 273 isoforms binned in category (1), we identified the location of 
the stop codon relative to the downstream exon-exon junction. Based on this information, we 
further subdivided isoforms from category 1 into (a) isoforms with premature stop codons >50 nt 
upstream of an exon-exon junction, which would be predicted to activate nonsense mediated decay 
(NMD) of the transcript [343]; and (b) isoforms with premature stop codons >50 nt upstream of 
an exon-exon junction, which might escape NMD and be used for protein production.  
 
RNA Extraction and cDNA Preparation  
Palliums were dissected from E12 Rnu11 control (N=3) and mutant (N=4) mice, and the 
tissue collected from each embryo was individually used for total RNA isolation. Tissue from each 
embryo was separately triturated in 100 µL of TRIzol (Invitrogen, #15596026). RNA was 
extracted using the DirectZOLTM RNA MiniPrep kit (Zymo Research, #R2050), per the 
120 
 
manufacturer’s instructions. For total RNA samples, 500 ng of RNA was used for cDNA synthesis, 
which was performed as previously described [116].  
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Chapter 4: Figures 
 
Figure 4.1. Generation and confirmation of the Rnu11 cKO mice.  
(A) Schematic of the Rnu11 locus. The gray box represents the predicted gene Gm28874. Below 
the Rnu11 locus schematic is the targeting construct used to introduce the loxP sites by 
homologous recombination (dashed lines). (B) Schematic representing the targeted allele, showing 
the primers used to interrogate the 5’ loxP site (black and green arrows, left) and the 3’ loxP site 
(black and purple arrows, right). For the 5’ loxP site primer set, the outermost forward primer 
(black arrow, left) was designed outside the 5’ arm of homology, with the outermost reverse primer 
(black arrow, left) positioned downstream of the 5’ loxP site. The inner set of nested primers (green 
arrows) were designed in the 5’ arm of homology and within the 5’ loxP site, respectively. For the 
3’ loxP site primer set, the outermost forward primer (black arrow, right) was designed in the Frt 
site located upstream of the 3’ loxP site, with the outermost reverse primer (black arrow, right) 
positioned downstream of the 3’ arm of homology. The inner set of nested primers (purple arrows) 
were designed in the 3’ loxP site and the 3’ arm of homology, respectively. (C) Agarose gel images 
of long-range nested PCRs, performed on genomic DNA (gDNA) from targeted ES cells, using 
the 5’ loxP site primer set (black and green arrows, left) and the 3’ loxP site primer set (black and 
purple arrows, right). The number at the right of each gel image represents the expected product 
size produced from this strategy.  
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Figure 4.2. U11 loss in the developing mouse neocortex causes severe microcephaly.  
(A) Schematic of the Rnu11 floxed (Flx) allele with positions of the loxP sites (blue triangles), 
with agarose gel image showing PCR results detecting the upstream (left) and downstream (right) 
loxP sites. Below is a schematic of the Rnu11 knockout (KO) allele, confirmed by PCR. See also 
Fig. S1 and Table S7. (B) Results of quantitative PCR (qPCR) detecting the WT allele. (C) Table 
showing genotype frequency of pups produced from crosses of Rnu11WT/KO mice. (D) Images of 
P0 Rnu11WT/Flx::Emx1-Cre+/- (control, ctrl) and Rnu11Flx/Flx::Emx1-Cre+/- (mutant, ctrl) pups, with 
lateral view of P0 ctrl and mut brains. Scale bar=5 mm. At right are coronal sections of P0 ctrl and 
mut brains stained with hematoxylin and eosin. Arrowheads indicate the choroid plexis. Scale 
bar=500 µm. (E-I) In situ hybridization (ISH) for U11 expression (purple signal) in sagittal 
sections of the telencephalon from ctrl (top row) and mut (bottom row) (E) E10, (F) E11, (G) E12, 
(H) E13, and (I) E14 embryos. Scale bars=500 µm. Insets show higher magnification of the boxed 
regions; scale bars=200 µm. (J) Bar graphs showing the average thickness of the E12, E13, and 
E14 ctrl and mut pallium. Quantification data are represented as mean±SEM. n.s.=not significant; 
*=P<0.05; ***=P<0.001. 
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Figure 4.3. Cell death contributes to microcephaly in the U11 cKO mouse.  
(A-E) Fluorescent ISH (FISH) signal for U11 (white) combined with TUNEL (red) on control 
(ctrl, left) and mutant (mut, middle) pallium sections from (A) E11, (B) E12, (C) E13, and (D) 
E14 embryos, with quantification of TUNEL+ cells (right). Ap=apical; ba=basal. (E-F) 
Immunofluorescence (IF) for cleaved caspase 3 (CC3) in ctrl (left) and mut (middle) pallium 
sections from (E) E11 and (F) E12 embryos, with quantification of CC3+ cells (right). Scale 
bars=30 µm. Data are represented as mean±SEM.. n.s.=not significant; *=P<0.05; **=P<0.01; 
***=P<0.001. 
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Figure 4.4. U11 loss results in depletion of radial glial cells. 
(A-C) IF for Ki67 (green) and NeuN (magenta) on sagittal sections of the control (left) and mutant (right) pallium across (A) E12, (B) 
E13, and (C) E14, with (D) quantification. (E-G) IF for Pax6 (green) on sagittal sections of the control (left) and mutant (right) pallium 
across (E) E12, (F) E13, and (G) E14, with (H) quantification. (I-K) IF for Tbr2 (green) on sagittal sections of the control (left) and 
mutant (right) pallium across (I) E12, (J) E13, and (K) E14, with (L) quantification. Scale bars=30 µm. Data are represented as 
mean±SEM. Subp.=subpallium; n.s.=not significant; *=P<0.05; **=P<0.01; ***=P<0.001. 
125 
 
 
Figure 4.5. U11 loss and death of self-amplifying radial glial cells in the mutant pallium.  
(A) Separated channels for sagittal section U11 FISH (middle row) and immunofluorescence (IF) for Ki67 (green) and NeuN (magenta) 
(top row), with overlay (bottom row), from the E12 and E13 control (ctrl) and mutant (mut) pallium. Scale bars=30 µm. (B) IF for Pax6 
(green) and cleaved caspase 3 (CC3, magenta) on sagittal section of E13 mutant pallium. White line marks the boundary between the 
subpallium and the pallium. Scale bar=30 µm. (B’-B’’’) Magnified images of the dashed box in (B), with overlay of all channels (B’), 
Pax6 and DAPI (B’’), and CC3 and DAPI (B’’’). Scale bars=7 µm. (C) IF for CC3 (magenta) and Tuj1 (green) in sagittal section of the 
E12 ctrl and mut pallium, with bar graphs showing the percentage of CC3+ cells that were pyknotic (left) and the percentage of non-
pyknotic CC3+ cells that were Tuj1+ (right). Scale bars=30 µm. (D-E) Bar graphs showing quantification of cells with nuclear Pax6 
staining (D) or cells with nuclear Tbr2 staining (E) across development in the mutant pallium, from E12 and E14. Statistical significance 
across the three tested time-points was determined by one-way ANOVA, followed by Tukey’s multiple comparison test to determine 
specific P values. (F) IF for BrdU (magenta) and NeuN (green) in the E13 ctrl and mut pallium, which had been pulsed with BrdU at 
E12. Scale bars=30 µm. At right are bar graphs showing the percentage of NeuN+ cells that were BrdU+ in the E13 pallium, or the 
percentage of non-pyknotic BrdU+ cells that were NeuN+ in the E13 pallium. Statistical significance was determined by two-tailed 
student’s t-tests. Quantification data are represented as mean±SEM from N=3 for each condition per time-point. Non-pyk.=non-
pyknotic. n.s.=not significant; *=P<0.05; **=P<0.01. 
126 
 
 
Figure 4.6. U11 loss triggers DNA damage and p53 upregulation in radial glial cells.  
(A) Scatterplot depicting the expression of protein-coding genes ≥1 FPKM in the control (ctrl, x-
axis) and mutant (mut, y-axis) E12 pallium. Inset shows U11 expression in the E12 mut pallium 
by SISH, with dashed lines marking the dissected region. (B-C) Normalized expression, 
determined by qRT-PCR on E12 ctrl and mut pallium, for (B) Rnu11 and (C) Spc24. (D) IF for 
CC3 (green) and ɣH2AX (magenta) in the E12 ctrl and mut pallium, with quantification. (E) IF 
for ɣH2AX (magenta) and p53 (green) in E11 and E12 ctrl and mut sagittal pallial sections, with 
quantification. Inset pie charts show the percentage of ɣH2AX+ cells that upregulated p53 (p53+) 
(left) and the percentage of p53+ cells that were ɣH2AX+ (right). (F) IF for ɣH2AX (magenta) and 
Pax6 (green), Tbr2 (green), or NeuN (green), on sagittal sections of the E12 mut pallium, with 
quantification. (G) IF for p53 (magenta) and Pax6 (green) in the E12 mut pallium, with pie charts 
showing the percentage of Pax6+ cells of the p53+ population (left) and of all DAPI+ cells (right). 
Scale bars=30 µm. Quantification data are represented as mean±SEM. n.s.=not significant; 
*=P<0.05; **=P<0.01; ***=P<0.001.  
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Figure 4.7. U11-null radial glial cells exhibit S-phase, metaphase, and cytokinesis defects.  
(A) Frequency plot of the change in mis-splicing index (∆MSI, x-axis) of major (blue) and minor 
(red) introns. (B) Pie chart showing the effect of minor intron retention on the open reading frame 
(ORF), for the 186 minor introns with significantly elevated retention, across all annotated MIG 
transcripts requiring minor intron splicing. The truncation category is further broken down into the 
percentage of transcripts predicted to be degraded by nonsense-mediated decay (NMD) or to 
produce protein (prot.). (C) IF for Ki67 (green) and PH3 (magenta) in sagittal sections of the E12 
control and mutant pallium, with quantification. (D) IF for Aurora B (green, AurB) and Pax6 
(magenta) in sagittal sections from E12 ctrl and mut pallium, with quantification of mitosis-
specific Aurora B staining (M). (E) Quantification of the percentage of Aurora B+ cells in different 
mitotic phases for E12 ctrl and mut pallium. (F) IF for Citk (green) in sagittal sections of ctrl and 
mut E12 pallium, quantification of Citk+ cytokinetic midbodies along the ventricular edge in the 
E11 and E12 control and mutant pallium. (G) IF for Pax6 (green) and EdU (magenta) on E12 ctrl 
and mut sagittal pallial sections, with quantification. (H) IF for Tbr2 (green) and EdU (magenta) 
on sagittal sections of E12 ctrl and mut pallium, with quantification. Scale bars=30 µm. Data are 
represented as mean±SEM. n.s.=not significant, *=P<0.05, **=P<0.01, ***=P<0.001.   
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Figure 4.8. Validation of expression and minor intron retention changes in the E12 mutant 
pallium.  
(A) Minor intron retention of Coa3 (left), Parp1 (middle), and Pten (right) in the E12 ctrl and mut 
pallium, as determined by qRT-PCR. The value plotted is the average ratio of normalized 
unspliced expression/normalized spliced expression ± SEM from N=3 for each condition. 
Individual data points are superimposed on the bar graphs. Statistical significance was determined 
by two-tailed student’s t-tests. *=P<0.05, **=P<0.01, ***=P<0.001. (B) GO Terms enriched for 
by DAVID analysis of MIGs with statistically significant elevated minor intron retention in the 
E12 mutant pallium, with cell cycle-related terms highlighted in yellow. 
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Figure 4.9. Cell cycle defects are not observed in the E11 mutant pallium, in IPCs of the E12 mutant pallium, or in G2 phase.  
(A) IF for Aurora B (green, AurB) showing phase-specific Aurora B staining patterns in cells in G2, prophase (pro.), prometaphase 
(prometa.), metaphase (meta.), anaphase (ana.), and telophase (telo.) in the E12 pallium. Scale bars=4 µm. (B) IF for Aurora B (green) 
and Tbr2 (magenta) in sagittal sections of control (ctrl) and mutant (mut) E12 pallium, with bar graph showing the percentage of Tbr2+ 
cells with mitosis- and G2-specific (N=4) Aurora B staining patterns. (C) Bar graph showing the percentage of Aurora B+/Tbr2+ mitotic 
cells in pro., prometa./meta., ana., and telo. (N=4). (D) IF for Citk (green) in sagittal sections of E11 control and mutant pallium. (E) IF 
for Pax6 (green) and EdU detection (magenta) in sagittal sections from E11 control (ctrl, left) and mutant (mut, right) pallium, with bar 
graph showing the percentage of Pax6+ cells that were EdU+ in the E11 ctrl and mut pallium. (F) IF for cyclin B1 (green) in sagittal 
sections of the E12 ctrl and mut pallium, with bar graph showing the number of cell with cytoplasmic (cytopl.) cyclin B1. (G) Bar graph 
showing the percentage of Pax6+ cells with G2-specific Aurora B+ staining in the E12 ctrl and mut pallium. Scale bars=30 µm, unless 
otherwise specified. Quantification data are represented as mean±SEM from N=3 for each condition per time-point, unless otherwise 
specified. Statistical significance was determined by two-tailed student’s t-test. n.s.=not significant. 
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Figure 4.10. P53 upregulation and apoptosis predominantly occur in either cells in G1 or post-mitotic cells.  
(A) IF for ɣH2AX (green) and EdU (magenta) in sagittal sections of E12 mutant (mut) pallium, with pie charts showing the percentage 
of EdU+ cells of the non-pyknotic (non-pyk.) ɣH2AX+ and DAPI+ populations. (B) IF for p53 (green) and EdU (magenta) in sagittal 
sections of E12 mut pallium, with pie charts showing the percentage of EdU+ cells of the p53+ and DAPI+ populations. (C) IF for Aurora 
B (green, AurB) and p53 (magenta) in sagittal section of the E12 mut pallium, with pie charts showing the percentage of G2 Aurora B+ 
cells of the p53+ and DAPI+ populations (left), and the percentage of mitotic (M) Aurora B+ cells of the p53+ and DAPI+ populations 
(right). (D) IF for CC3 (green), EdU (magenta), and TUNEL (yellow) in sagittal section of E12 mut pallium, with pie charts showing 
the percentage of EdU+ cells of the non-pyknotic CC3+ cell population. (E) IF for CC3 (green), Aurora B (magenta), and TUNEL 
(yellow) in sagittal sections of the E12 mut pallium, with quantification. Scale bars=30 µm. Quantification data are represented as 
mean±SEM. n.s.=not significant, ***=P<0.001. 
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Figure 4.11. U11-null cells with DNA damage are not in mitosis.  
IF for PH3 (green) and ɣH2AX (magenta) in a sagittal section of the E12 mutant pallium. Scale 
bar=30 µm. 
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Figure 4.12. Cells positive for the tdTomato Cre reporter are observed in the P0 mutant brain.  
(A-B) Dorsal view of the whole P0 control (A) and mutant (B) brain, showing tdTomato signal (red). Exposure time for red fluorescence 
was determined separately for these conditions. Scale bar=1 mm. (C-N) Rostral to caudal coronal sections of tdTomato+ P0 control (C-
H) and mutant (I-N) brain. Solid arrowheads indicate structures that are identifiable in both the control and the mutant brain. Open 
arrowheads denote structures unique to the mutant sections, relative to the control. Scale bars=500 µm. LS=lateral septum. (C’) and (I’) 
are magnified images of the boxed regions in (C) and (I), respectively. In these images, nuclei are marked by DAPI (blue). Ctx=cortex, 
str=striatum. Scale bars=250 µm. (I’’) Magnified image of the box in (I’). Scale bar=60 µm. 
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Figure 4.13. Cells positive for the tdTomato Cre reporter are observed in the P21 mutant brain.  
(A-L) Rostral to caudal coronal sections of tdTomato+ (red) control (A-F) and mutant (G-L) brain. Solid arrowheads indicate structures 
that are identifiable in both the control and mutant brain. Open arrowheads denote structures unique to the mutant sections, relative to 
the control. Scale bars=1 mm. LS=lateral septum. (A’) and (G’) are magnified images of the boxed regions in (A) and (G), respectively. 
In these images, nuclei are marked by DAPI (blue). Ctx=cortex, str=striatum. Scale bars=500 µm. (G’’) Magnified image of the box in 
(G’). Scale bar=60 µm
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Figure 4.14. U11-null neurons are present in the P0 mutant cortex.  
(A-B) AP SISH for U11 performed on coronal sections of P0 ctrl (A) and mut (B) heads. Scale 
bars=200 µm. (C-D) Combined FISH for U11 (green) and IF for NeuN (magenta) on coronal 
sections of P0 ctrl (C) and mut (D) heads. Scale bars=200 µm. (C’-D’) are magnified images of 
the boxes in (C) and (D), respectively. Scale bars=60 µm. Nuclei are marked by DAPI.   
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Figure 4.15. Embryonically-produced, U11-null neurons are present postnatally.  
(A) Schematic of the EdU pulse-chase strategy (top) and the order of signal detection (bottom). (B-C) Maximum intensity projection 
(MIP, z-stack=12 µm) images of U11 FISH (green), NeuN IF (blue), and EdU detection (magenta) on coronal sections of the P0 control 
(B) and mutant (C) cortex. (D-E) Maximum intensity projection (MIP, z-stack=18 µm) images of U11 FISH (green), NeuN IF (blue), 
and EdU detection (magenta) on the P21 control (D) and mutant (D) cortex. Scale bars=60 µm. Dashed lines indicate the division 
between the cortex and the striatum (str). Insets show high magnification images of optical slices of the boxed regions in (C) and (E), 
respectively, with arrowheads pointing to U11-null, NeuN+, EdU+ cells in the P0 (C’-C’’’’) and P21 (E’-E’’’’) mutant cortex. Inset 
scale bars=5 µm. (F-G) Bar graphs showing quantification of the percentage of U11-/NeuN+/EdU+ cells out of the total number of 
NeuN+/EdU+ cells in the control and mutant cortex at P0 (F) and P21 (G), based on cells observed within a 240 µm-wide column of 
the cortex. Statistical significance was determined by two-tailed student’s t-tests. *=P<0.05, **=P<0.01.  
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Figure 4.16. Subcerebral projection defects in the Rnu11 mutant brain.  
Ventral view of tdTomato+, Emx1-Cre+ brains from (A) ctrl and (B) mut P0 mice. Arrowheads 
point to the region of the brainstem where the corticospinal projections are normally observed. 
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Figure 4.17. Model of cortical development in U11 cKO mice.  
(A) Schematic representing cortical development in wild-type and mutant embryos, from E12 to 
E14. Black arrows show type of cell division. Question marks and dashed lines indicate events 
that remain to be explored. (B) Schematic of proliferating RGCs progressing through the cell cycle 
in the late E11/early E12 pallium. Arrow color denotes presence (blue) or absence (black) of U11. 
MIGs with significantly elevated minor intron retention, and with known functions at specific cell 
cycle phases, are listed in boxes. Pro.=prophase; met.=metaphase; ana.=anaphase; tel.=telophase; 
cyt.=cytokinesis.  
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Chapter 5: Identifying MIGs essential for the survival of cycling cells 
This chapter investigates the link between minor intron splicing and the survival of cycling 
cells, which I identified in Chapter 4. Specifically, this chapter first describes the published 
datasets I mined for this analysis. These datasets contain the identities of genes that, when 
disrupted, result in cycling cell death. Since these genes are essential for the survival of cycling 
cells, this set of genes is called the cycling cell “essential genome,” a.k.a. the “essentialome.” The 
chapter next describes the enrichment of MIGs in these cycling cell “essentialomes” and the 
functions these essential MIGs perform. 
 
5.1 Identification of the “essentialome” 
 In 2015, three separate reports were published in Science and Nature Cell Biology that 
sought to identify all genes of the human genome that are essential for the survival of cycling cells 
[365-367]. For this, all three groups employed methods to disrupt the expression of most protein-
coding genes in the human genome, via either gene trapping or CRISPR/Cas9-mediated 
mutagenesis. Between these three publications, the essentialomes of 10 different human cancer 
cell lines were identified [365-367]. Specifics about these cell lines, the methods, and findings of 
each of these reports are detailed below.  
 Unlike the other two groups, Blomen et al. only employed gene trapping to target protein-
coding genes for inactivation. In their approach, they designed a unidirectional, retroviral gene-
trapping vector, which contained a strong, adenoviral 3’ splice site at the 5’ end of the gene trap 
cassette, followed by blue fluorescent protein (BFP) and the SV40 polyadenylation signal, the 
latter of which functions as a transcriptional termination sequence [365, 368]. Sense insertion of 
this gene trap cassette into an intron would result in improper splicing of this intron, expression of 
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the BFP reporter, and production of a truncated mRNA, ultimately resulting in loss of gene 
function. In contrast, antisense insertion into an intron would have no effect on pre-mRNA splicing 
or gene expression [365]. Since retroviral infection inserts a single copy of the gene trap vector 
into the genome, this approach can only target one allele of one gene in each infected cell [369]. 
Therefore, Blomen et al. used two haploid cancer cell lines for their study: the near-haploid chronic 
myeloid leukemia line KBM7, and its derivative cell line, a nonhematopoietic haploid line called 
HAP1 [365]. Moreover, post-infection, Blomen et al. sorted cells by DNA content, to remove any 
diploid cells from the pool [365]. Insertion sites were amplified and identified by linear 
amplification-polymerase chain reaction (LAM-PCR) and deep sequencing of the resulting PCR 
product [365, 370]. By plotting the number of sense versus antisense insertions observed in each 
gene, Blomen et al. identified the genes with significantly fewer disruptive, sense insertions than 
antisense insertions to be the genes essential for cell survival. This revealed 2054 genes that were 
essential for the survival of KBM7 cells and 2181 that were essential for HAP1 cell survival. 
Through comparison of the 2054 genes of the KBM7 essentialome to the 2181-gene HAP1 
essentialome, Blomen et al. identified 1734 shared essential genes, which they referred to as the 
“core essentialome,” that are required for the survival of both KBM1 and HAP1 cells. Using the 
eggNOG protein orthology database [371], they found that the majority (77%) of the identified 
core essentialome genes are evolutionarily ancient, tracking back to Opisthokonta or earlier [365]. 
The functional properties of the core essentialome genes were also extracted from the eggNOG 
database, which revealed enrichment for functions relating to transcription, translation, and cell 
cycle [365]. 
The second Science paper, published by Wang et al., employed the CRIPSR/Cas9 system 
to introduce mutations in each gene targeted [367]. Specifically, they designed a library of guide 
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RNAs (gRNAs) such that the library would span the protein-coding exons of virtually all protein-
coding genes (18,166 protein-coding genes), allowing them to target these genes for Cas9-
mediated cleavage; non-targeting gRNAs were designed as controls. Cas9 and this genome-wide 
gRNA library were then sequentially transduced into cells via retroviral infection [367, 372]. Cells 
expressing gRNAs targeting essential genes would be depleted from the total cell population, 
allowing for the identification of essential genes via genomic DNA isolation, gRNA amplification 
by PCR, and deep sequencing of the amplified product [367, 372]. Wang et al. first tested this 
approach in the near-haploid KBM7 cell line. They assigned each gene they interrogated a CRISPR 
gene score (CS), calculated as the average log2 fold-change in gRNA abundance (final gRNA 
abundance / initial gRNA abundance). Using a CS score threshold of -0.1 and P<0.05, they 
identified 1878 essential genes in the KBM7 cell line. Application of a similar gene trapping 
strategy as Blomen et al. (2015) validated their findings in the KBM7 cell line, except for the 
diploid chromosome 8 [367]. While the gene trap approach was unable to reveal any essential 
genes from chromosome 8, the CRISPR/Cas9 method revealed a similar proportion of essential 
genes on chromosome 8 as those identified on the haploid autosomes. With this evidence of 
efficient biallelic inactivation via the CRISPR/Cas9 system, Wang et al. expanded their approach 
to three other, diploid cell lines: the chronic myeloid leukemia line K562 and the Burkitt’s 
lymphoma cell lines Raji and Jiyoye. This strategy revealed 1660 essential genes in the K562 line; 
1464 in the Raji line; and 1630 in the Jiyoye line. Unlike Blomen et al., Wang et al. did not 
investigate the genes shared between all four essentialomes they identified. Instead, they 
highlighted the presence of cell line- and tumor type-specific essential genes in their data [367]. 
The third report, from Hart et al., employed the same CRISPR/Cas9 approach as Wang et 
al., except they did not use gene trapping to validate their findings. This was likely due to their 
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decision to only investigate diploid cancer cell lines [366]. In all, Hart et al. designed gRNAs that 
would target the protein-coding exons of 17,232 protein-coding genes, and they used this gRNA 
library to interrogate the essentialomes of five cancer cell lines: the colorectal carcinoma cell lines 
HCT116 and DLD1; the cervical carcinoma HeLa cell line; a glioblastoma cell line (GBM); and 
the immortalized retinal epithelial cell line RPE1 [366]. Gene essentiality scores were calculated 
using a Bayesian algorithm, which had been trained using a previously published “gold standard” 
reference dataset of essential and non-essential genes [366, 373]. Using a 5% false discovery rate 
cut-off, Hart et al. identified 2073 genes essential for HCT116 cells; 1893 genes essential for 
DLD1 cells; 1696 genes essential for HeLa cells; 2197 genes essential for GBM cells; and 2038 
genes essential for RPE1 cells [366]. Comparison of these five cell line essentialomes revealed 
829 “core essentialome” genes that were essential for the survival of all five cell lines. However, 
Hart et al. instead used a weaker criterion in their analysis of “core fitness genes”: each gene had 
to be present in at least 3 of the 5 cell line essentialomes, resulting in a list of 1580 genes. The 
biological processes enriched in this 1580-gene set were identified using the Panther database, 
which revealed significant enrichment for RNA processing, DNA repair/replication, and mitosis 
[366]. Comparisons between the 1580-gene set and lists of essential genes extracted from yeast, 
C. elegans, D. melanogaster, and Mus musculus phenotype databases showed a high degree of 
overlap, suggesting that the essential functions of these genes have been conserved [366]. In 
addition to these “core fitness genes,” Hart et al. investigated the large number of cell line-specific 
essential genes in their dataset, employing functional enrichment analysis and drug-based assays 
to study differences in cell viability between these cell lines [366]. 
Together, these three reports identified the essentialomes of 10 human cancer cell lines; each of 
these essentialomes contains between ~1500 to ~2600 genes. Notably, the cancer cell lines studied 
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represent a broad swath of cancer type/origin, including two chronic myeloid leukemia lines, two 
lymphoma cell lines, two colon cancer lines, a glioblastoma line; one cervical carcinoma line, an 
immortalized RPE line, and a haploid, non-hematopoietic line derived from a chronic myeloid 
leukemia cell line. Since these papers were published back-to-back, none of them included 
comparisons among all of the 10 cycling cell essentialomes identified in 2015 [365-367]. However, 
comparisons between the cell line essentialomes identified within each paper suggest that genes 
of the core essentialome are evolutionarily ancient and function in transcription, translation, 
genome integrity, and cell cycle.  
 
5.2 Rationale 
 As detailed in Chapter 4, progenitor cells and neurons displayed vastly different responses 
to complete minor spliceosome inactivation. Constitutive inactivation of the minor spliceosome 
resulted in embryonic lethality (Figure 4.2C), and the distribution of genotypes identified in 
embryonic harvests suggested that this occurs early in embryonic development (data not shown). 
Loss of U11 in the developing cortex caused rapid death of self-amplifying RGCs, while U11-null 
neurons survived postnatally (Figures 4.5D and 4.15). Together, our findings indicate that minor 
spliceosome activity is essential for the survival of cycling cells, but it is not immediately necessary 
for neuron survival. Since inactivation of the minor spliceosome results in missplicing of MIGs, 
and the resulting disruption of MIG function is what ultimately leads to the observed phenotypes, 
I sought to identify MIGs known to be essential for cycling cell survival. To address this question, 
I extracted the 10 published cycling cell essentialomes to study MIG enrichment in these essential 
gene sets. 
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5.3 Results 
5.3.1 MIGs are significantly enriched in the “total” essentialome and in each of the 10 distinct 
essentialomes derived from 10 different cell lines 
 If MIGs are essential for the survival of cycling cells, then one would expect MIGs to be 
enriched in the essentialome gene sets. To test this, we first extracted lists of all genes interrogated 
by at least one of the three essentialome-defining papers and of the genes comprising the ten cell 
line essentialomes [365-367]. Since Blomen et al. did not report the full list of genes they 
investigated by their approach, the list of interrogated genes was derived from the Hart et al. and 
Wang et al. publications, resulting in a list of 18,835 genes. The ten cell-line essentialomes were 
also combined into a single, “total” essentialome of 5206 genes, consisting of all genes shown to 
be essential for the survival of at least one cell line. In parallel, a list of all human MIGs was 
extracted from the U12DB [58]; any MIGs that were not interrogated in at least one of the three 
essentialome publications were excluded from the downstream analysis, resulting in a list of 577 
human MIGs. 
Next, we examined the percentage of MIGs found in these gene sets. We observed 
significant enrichment of MIGs in the total essentialome (5.05%; P=1.33E-20) compared to their 
proportion in the list of all genes interrogated by these studies (3.06%; Figure 5.1A). Moreover, 
analysis of the individual cell line essentialomes revealed even higher enrichment of MIGs in all 
ten essentialomes, with MIG enrichments ranging from 6.74% to 7.82% (Figure 5.1B; P≤4.14E-
19). 
 
5.3.2 MIGs are significantly enriched in the core essentialome 
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 We observed little variation in MIG enrichment among the individual cell-line 
essentialomes. This could indicate minimal cell type-specificity for MIG enrichment, such that a 
core set of essential MIGs might be shared among all ten essentialomes. To investigate this, we 
identified the genes of the total essentialome that were common to all ten cell-line essentialomes, 
which produced a core essentialome of 460 genes (Figure 5.1C). In this process, we noticed that 
some genes in the 18835 genes of the total essentialome were not interrogated in both the Wang 
et al. and Hart et al. papers [366, 367]. Therefore, even if these genes were essential for the survival 
of all cycling cells, our approach would not identify them as part of the core essentialome. To 
circumvent this problem of false negatives, we only counted genes jointly interrogated by both 
Hart et al. and Wang et al. for the core essentialome analysis. This produced a 16994-gene list of 
all “jointly interrogated” genes and a list of 548 jointly interrogated MIGs.  
 Strikingly, we observed a significant, 3.1-fold increase in MIG enrichment in the core 
essentialome (10%; P=9.39E-12) compared to the proportion of MIGs in the jointly interrogated 
gene list (3.22%, Figure 5.1D). To further verify this enrichment, we sought to calculate the 
enrichment of a series of control gene lists, each linked by either a common function or a common 
feature, in the core essentialome. Since MIGs were chosen based on the presence of a specific 
intronic feature, we first sought to test whether genes sharing a different intronic feature would 
also be significantly enriched in the core essentialome. For this, we turned to micro RNA (miRNA) 
genes. While some miRNA genes are found in intergenic regions of the genome, many miRNA 
genes are found embedded in the introns of protein-coding genes [374]. Using the miRBase 
database [375], we extracted 705 protein-coding genes with intronic miRNA genes in the human 
genome. We did not observe significant enrichment for these genes in the core essentialome 
(3.91%; P=0.91) compared to their proportion in the jointly interrogated gene list (4.15%, Figure 
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5.1E), suggesting that a shared intronic feature alone does not explain the significant MIG 
enrichment we observe. We next sought to investigate the role of shared gene function on gene list 
enrichment in the core essentialome. In the three essentialome publications, genes involved in cell 
signaling were generally depleted in the core essentialome, while genes regulating RNA 
processing, transcription, translation, and cell cycle were enriched. Therefore, to generate two 
negative control lists, we extracted 492 human kinase genes (the kinome) and 1697 human 
transcription factor genes from the Gene Ontology knowledgebase [376]. For a positive control 
list, we also extracted 1712 human cell cycle genes [376]. As expected, analysis of the human 
kinome did not reveal significant enrichment in the core essentialome, relative to the jointly 
interrogated gene list (1.95% vs 2.90%, P=0.26; Figure 5.1F). Moreover, transcription factors were 
significantly depleted in the core essentialome, relative to the jointly interrogated gene list (3.91% 
vs 9.99%, P=1.23E-06; Figure 5.1F). In contrast, the cell cycle genes were significantly enriched 
in the core essentialome, with a 3.2-fold increase in cell cycle gene enrichment (31.74% vs 10.07%, 
P=1.22E-38; Figure 5.1F). Together, these results suggest that the enrichment of MIGs in the core 
essentialome is likely driven by shared essential function, not by a shared intronic feature. 
 
5.3.3 MIGs of the core essentialome are predominantly involved in RNA processing and cell 
cycle 
 To investigate the biological processes performed by the 46 MIGs found in the core 
essentialome, we manually curated the literature on each MIG of the core essentialome and 
extracted their functions (Table 5.1). Of the 46 MIGs, nearly half (21 genes) function in cell cycle 
regulation; moreover, 9 of these 21 MIGs are specifically involved in mitosis (Table 5.1). The next 
largest functional category is RNA processing, comprised of 11 MIGs. These 11 MIGs can be 
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further subdivided into two categories: those functioning in pre-mRNA splicing (7 MIGs), and 
those that regulate RNA metabolism (4 MIGs). The next largest functional categories are 
transcription, in which 9 MIGs function, and non-coding RNA biogenesis, which is regulated by 
8 MIGs. The remaining functional classifications are listed in Table 5.1. 
 
5.3.4 Genes of the core essentialome are evolutionarily ancient, including MIGs of the core 
essentialome 
When Hart et al. extracted the core essentialome of the five cell lines they identified, they 
observed enrichment of genes that overlapped with essential genes in yeast, C. elegans, D. 
melanogaster, and mouse [366]. Likewise, Blomen et al. extracted the core essentialome of the 
two cell lines they investigated and identified a subset of ancestral genes [365]. Therefore, we 
sought to interrogate whether the core essentialome genes we identified were similarly ancient. 
For this, we employed a similar ortholog identification approach as that used by Blomen et al., 
which utilized the evolutionary genealogy of genes: Non-supervised Orthologous Groups 
(eggNOG) database to identify "ancient" essential genes [371]. We found that 93% of the genes 
in the core essentialome we identified track back to the last eukaryotic common ancestor (LECA) 
or further, compared to the 78% of the non-core essentialome genes (P=3.12E-18; Figure 5.2A). 
To avoid any sampling biases, we generated 100 randomized lists of 460 genes from the 4745 
genes found in the total essentialome but not in the core essentialome, which we termed “non-core 
essential genes.” Fisher exact tests performed to determine ancient gene enrichment revealed that 
the proportion of ancient genes in the core essentialome was statistically significant, with a median 
P-value of 3.11E-11 (Figure 5.2A). Thus, even within the essentialome, there is an “old” or ancient 
essentialome that was present in or before LECA, and a “new” or younger essentialome that 
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emerged later. Moreover, we observed a statistically significant enrichment of MIGs in this ancient 
core essentialome relative to their prevalence in all jointly interrogated genes (9.58%; P=4.92E-
10; Figure 5.2B). Of the 46 MIGs of the core essentialome, 41 are found in the ancient core 
essentialome; the 5 MIGs missing from the ancient core essentialome are C1orf109, a cell cycle 
regulator; DDB1, which functions in DNA damage response; KANSL2, which encodes a subunit 
of the histone acetyltransferase complex; SPC24, a gene encoding a component of the kinetochore; 
and TAF1C, which regulates rRNA transcription (Table 5.1). 
 
5.4 Discussion 
Since the identification of MIGs in the 1990s, investigators have sought to understand why 
these specific genes have minor introns, and why these genes have such a high degree of minor 
intron conservation. One possibility is that MIGs share specific functions, and the presence of 
minor introns in these genes allow the cell to regulate specific processes en masse by adjusting 
minor spliceosome component expression, thereby modulating minor intron splicing efficiency 
and MIG expression/function [77, 86]. However, comparisons of MIG functions do not reveal a 
small, select set of functional categories; often, researchers who have attempted to identify 
common functions of MIGs have to generate new, broader categories, such as “information 
processing,” to adhere to this concept [77]. Our investigation of the U11-null pallium provided a 
new lens in which to view this question. Specifically, our results indicated that minor spliceosome 
activity, and therefore proper MIG expression, was essential for the survival of proliferating 
progenitor cells [117]. This is supported by numerous findings that minor spliceosome activity is 
necessary for early embryonic development, when the embryo is rapidly growing [89, 111-114, 
117]. Therefore, it was possible that MIGs might be linked by their requirement for cycling cell 
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survival, instead of by a specific function (e.g., cell cycle, transcription). Strikingly, we found that 
MIGs are highly enriched in the 460 human genes that are essential for survival of ten different 
cancer cell lines—i.e., cells that undergo rapid division. Genetic ablation of 13 of these core 
essentialome MIGs—Actl6a, Ddb1, Ddx54, Donson, Gars, Nepro, Nup155, Orc3, Pola2, Sacm1l, 
Upf1, Vps25, and Znf259—has been reported to cause early embryonic lethality in mice [319, 377-
386]. The functions performed by the 46 core essentialome MIGs—primarily cell cycle, RNA 
processing, and transcription—closely mirrored the functional enrichments identified both in the 
core essentialome Blomen et al. derived from two cell lines, which enriched for transcription, 
translation, and cell cycle, and in the core essentialome Hart et al. reported from five cell lines, 
which enriched for RNA processing, DNA repair/replication, and mitosis [265, 266]. Nearly half 
of the core essentialome MIGs function in cell cycle regulation, and a fifth of the core essentialome 
MIGs specifically regulate mitosis (Table 5.1). This is highly consistent with the cell cycle defects 
observed in the U11-null RGCs of the developing cortex, where most defects affected mitosis 
(Figure 4.7C-E).  
Notably, some of the core essentialome MIGs have been linked to microcephaly and/or 
dwarfism. For example, deleterious mutations in Donson are associated with two microcephalic 
primordial dwarfism syndromes, both of which present with limb and craniofacial abnormalities 
[319, 320]. Mutations in Ints8 are linked to intellectual disability with “borderline microcephaly,” 
limb dysmorphia, and craniofacial abnormalities [387]. While the MIG Orc3 has not been 
implicated in disease, it encodes a subunit of the origin recognition complex (ORC), which 
functions in the initiation of DNA replication during S-phase; mutations in the ORC subunits 
ORC1, ORC4, and ORC6 are associated with primary microcephaly [286-289]. Moreover, genetic 
ablation of Orc3 in the developing mouse cortex results in death of RGCs and microcephaly [388]. 
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Similarly, genetic ablation of Ddb1 in the developing mouse brain causes NPC apoptosis and 
subsequently microcephaly [379]. Primordial dwarfism without microcephaly has been linked to 
mutations of the MIGs Exosc2 and Znf259, presenting alongside either hearing loss and retinitis 
pigmentosa or renal syndrome, respectively [389, 390]. The identification of these MIGs, which 
both are necessary for the survival of rapidly dividing cells and are linked to microcephaly and/or 
dwarfism, represent exciting new targets for scientists investigating the pathogenesis of the 
developmental disorders linked to minor spliceosome inactivation. 
To better understand the molecular underpinnings of microcephaly caused by U11 ablation 
in the developing mouse cortex, we identified the 43 core essentialome MIGs found in the mouse 
genome and extracted their expression and minor splicing retention data from the RNAseq 
experiment described in Chapter 4 (Table 5.1). Of the 16 MIGs with significantly elevated minor 
intron retention in the U11-null pallium, six function in transcription, six are cell cycle regulators, 
and three are involved in non-coding RNA biogenesis (Table 5.1). Of the cell cycle-regulating 
MIGs, three function in mitosis (Nat10, Nup107, and Ssu72) and two regulate S-phase (Pole2 and 
Rfc5), which correspond to the cell cycle defects observed in the U11-null RGCs of the developing 
cortex (Figure 4.7; Table 5.1). These 16 MIGs also included Ddb1, a DNA damage regulator that 
is necessary for NPC survival [379], and the dwarfism-associated gene Exosc2 [390]. Many of the 
microcephaly-associated MIGs of the core essentialome either did not pass our minor intron 
retention criteria (see section 4.5) or were not significantly retained in the mutant pallium (Table 
5.1). This could be due to low levels of expression of these MIGs, resulting in fewer reads 
corresponding to these transcripts and therefore failure to pass our criteria for minor intron 
retention (see section 4.5); alternative splicing that circumvents minor intron splicing in the U11-
null pallium; slow turnover rates of correctly spliced mRNA transcripts produced prior to U11 loss 
150 
 
in the mutant pallium; or the correct splicing of the minor introns of these MIGs (Table 5.1). 
Ultimately, the 16 core essentialome MIGs with significantly elevated minor intron retention in 
the U11-null pallium represent high-priority targets for further investigation into the molecular 
underpinnings of microcephaly caused by minor spliceosome inactivation.  
In the U11 cKO mouse, we observed survival of neurons in the postnatal cortex, suggesting 
that the missplicing of MIGs does not significantly impact neuron survival (Figure 4.15). Nearly 
half of the core essentialome MIGs regulate cell cycle; these MIGs might not be expressed in post-
mitotic neurons, and if they were, their disruption would not likely have as detrimental an effect 
as their disruption in actively cycling cells. However, the other MIGs of the core essentialome 
perform functions that are not intuitively cell type-specific, such as RNA processing, non-coding 
RNA biogenesis, and transcription. One possibility is that neurons express a different complement 
of genes that perform these functions, allowing these functions to continue unaffected despite 
minor spliceosome inactivation. In this case, the MIGs performing these functions would likely be 
expressed at low levels, reducing the detrimental effects of minor spliceosome inactivation in 
neurons. As suggested in the Discussion in Chapter 4 (section 4.4), the MIGs that are expressed in 
neurons may contain minor introns with low sensitivity to minor spliceosome inactivation; this 
possibility is bolstered by our observations of such minor introns in RNAseq data from the E12 
mutant pallium (Figure 4.7A). Notably, numerous groups have shown that neuron-specific 
expression of splicing factors drive neuron-specific alternative splicing events in the mouse brain; 
it is possible that this unique complement of splicing factors may drive preferential expression of 
MIG isoforms that skip minor intron splicing specifically in neurons (reviewed in [391]).    
Our analysis of the core essential revealed that it is comprised of ancient genes, the majority 
of which can be traced back to the last eukaryotic common ancestor (LECA, Figure 5.2A). This 
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finding, together with our observation of significant MIG enrichment within this ancient core 
essentialome (Figure 5.2B), leads us to propose a modification to one of the models explaining the 
emergence of minor introns, called the parasitic invasion model [77]. In our revised model, minor 
introns emerged from a second invasion of group II self-splicing introns into the early eukaryotic 
genome, which already possessed major introns and the major spliceosome [392]. During genome 
evolution, the fragmentation of these group II self-splicing introns into catalytic subunits and inert 
sequences then gave rise to the minor-class snRNAs and minor introns, respectively. As a result 
of this invasion and subsequent fragmentation, minor introns were randomly distributed across the 
genome, in genes consisting primarily of major introns that executed both non-essential and 
essential functions. This gene organization resulted in inefficient splicing and reduction in the 
amount of mRNA encoding full-length proteins. Given this bottleneck, one can imagine a strong 
selective pressure to remove these minor introns from the genome. Indeed, this is supported by the 
progressive loss of minor introns across evolution, which can occur either by complete loss of the 
minor intron and fusion of the neighboring exons, or by conversion of the minor intron into a major 
intron [77, 82]. The latter of these mechanisms, minor-to-major intron conversion, would require 
specific mutations in the minor-class splice site sequences, which would allow the intron to be 
recognized and removed by the major spliceosome [393]. Both of these mechanisms of minor 
intron loss can cause perturbation in MIG expression levels or the production of aberrant proteins, 
ultimately impacting the functions executed by MIG-encoded proteins. While the risks associated 
with minor intron loss might not be an issue for genes executing non-essential functions, the same 
would not be true for genes essential for survival. Given the risks associated with perturbing the 
gene organization of essential MIGs, one would expect limited loss of the minor introns in these 
essential genes. Indeed, our data support this idea, as we observed significant enrichment of MIGs 
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in the essentialomes, especially in the core, ancestral essentialome (Figure 5.2). This revised model 
of minor intron emergence and evolution emphasizes the importance of studying minor intron 
conservation and MIG function in concert, particularly in organisms with few MIGs—i.e., species 
in lineages that have undergone significant minor intron loss/conversion. Ultimately, this revision 
of a model proposed 20 years ago will hopefully spark new investigations into the evolution of 
minor intron splicing, a subfield of minor splicing research that has been relatively dormant in 
recent years. 
 
5.5 Materials and methods  
Identification and extraction of human MIGs for the essentialome analysis 
 The list of 695 minor introns in the human genome was first extracted from the U12 
Database [58]. For each minor intron, the raw intron sequence was aligned to the current hg38 
assembly of the human genome using BLAST, in order to update the minor intron coordinates. 
Any minor intron that did not have 100% identity with an annotated intron in the hg38 assembly 
was removed from the analysis. This process also allowed us to extract updated gene IDs for each 
minor intron-containing gene. This approach produced a list of 640 minor introns, distributed 
across 583 MIGs.  
 Prior to the comparison of this MIG list to the essentialome, the MIG gene IDs were 
compared to the 18835 genes interrogated across the three essentialome studies [365-367]. Five 
MIGs (TSPY3, TSPY4, TSPY9P, TSPY10, and VPS11) were not interrogated in any of the three 
essentialome publications, and they were excluded from downstream analyses. For two MIGs, 
PTEN and SLC24A6, different synonyms were used in the separate essentialome papers (TEP1 
and SLC8B1, respectively) [365-367]. For each synonym pair, the essentialome data corresponding 
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to these synonyms were combined into a single entry. Together, these adjustments revised the MIG 
list to 577 genes. This 577-MIG list was used for assessing MIG enrichment in the total 
essentialome. For each cell line, the essentialome was identified using the thresholds detailed in 
the methods of its respective publication [365-367]. The KBM7 cell line was interrogated by two 
separate groups, utilizing different gene-targeting and thresholding methods. As a result, the two 
published KBM7 essentialomes were not identical in size (2054 genes vs 1878 genes) nor gene 
identity [365, 367]. This discrepancy was addressed by combining the two KBM7 essentialomes. 
Specifically, any gene that was present in at least one of the two KBM7 essentialomes was retained, 
resulting in a combined KBM7 essentialome of 2595 genes. Statistical significance for MIG 
enrichment was calculated by Fisher’s exact test. 
 
Analysis of gene enrichment in the core essentialome 
 Identification of the core essentialome was performed by extracting genes present in all 10 
cell-line essentialomes. To minimize the confounding effect of false negatives, we discarded any 
genes that were not interrogated in both the Wang et al. and Hart et al. publications [366, 367]. 
This rule did not extend to the Blomen et al. manuscript because that paper only reported the 
essential genes they identified, not all genes interrogated in their approach [365]. Application of 
this rule produced a “jointly interrogated” list of 16994 genes and a “jointly interrogated” MIG list 
of 548 genes. The same approach was used to revise the gene lists used for positive (cell cycle 
genes) and negative (genes with intronic miRNAs, the kinome, and transcription factor genes) 
controls. Statistical significance for MIG enrichment was calculated by Fisher’s exact test. 
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Chapter 5: Figures and Tables 
 
Figure 5.1. MIGs are enriched in the core essentialome.  
(A) Pie charts showing the percentage of MIGs (orange) in all genes interrogated in the 
essentialome reports (left) and in all essential genes (right). (B) Daisy model representing the ten 
published essentialomes (petals) and the 577 MIGs (orange center). The overlap of the center with 
the petals indicates the enrichment of MIGs in the cell-line essentialomes. (C) Daisy model 
showing the number of essential genes common to all ten cell-line essentialomes (“core 
essentialome”; circle). (D) Pie charts showing the percentage of MIGs in all genes jointly 
interrogated in the Hart et al. and Wang et al. essentialome reports (left) and in the core 
essentialome (right). (E) Pie charts showing the percentage of genes with intronic microRNA 
genes (GInt-miRs) in all jointly interrogated genes (left) and in the core essentialome (right). (F) 
Pie charts showing the percentage of genes with kinase activity (leftmost), transcription factor 
activity (middle), or a role in cell cycle regulation (rightmost) in all jointly interrogated genes and 
in the core essentialome. Statistical significance was determined by Fisher’s exact test. n.s.=not 
significant; *=P<2.0E-06. 
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Figure 5.2. Most genes of the core essentialome, including the MIGs, are ancient.  
(A) Evolutionary age of the core essentialome genes (green) and the non-core essentialome genes 
(purple). Clades are listed on the y-axis. The x-axis shows the percentage of genes that can be 
traced to the listed clade, but not to an older clade. The non-core essentialome gene data represent 
the median values of 100 lists of 460 genes from the non-core essentialome. (B) Pie chart showing 
the enrichment of MIGs (orange) in the ancient core essentialome (turquoise). Statistical 
significance, relative to the percentage of MIGs present in all jointly interrogated genes, was 
determined by Fisher’s exact test; *=P=4.92E-10. 
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Table 5.1. Mammalian functions of the MIGs identified in the core essentialome.  
MIGs are subdivided by species (Spp.) information, based on whether the MIG is found only in the Homo sapiens (Hs) genome (“Hs only”), only in 
the Mus musculus (Mm) genome (“Mm only”), or in both Hs and Mm genomes (“Hs + Mm”). For MIGs found in the mouse genome, average MIG 
expression and minor intron retention values from the E12 ctrl and mut RNAseq data analysis (Chapter 4) are reported. Syn=synonym; Ave=average; 
MSI=mis-splicing index. P values were calculated by two-tailed student’s t test. “-”=no mouse MIG data or value not calculatable; “N/A”=minor 
intron did not pass our thresholding criteria (see section 4.5). 
MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Actl6a  
Hs + 
Mm 
28.823 28.9842 1.1056 2.5092 0.09536 1.4036 
part of chromatin remodeling 
complex [394, 395]; necessary 
and sufficient for neural 
progenitor proliferation [394]; 
constitutive knockout is early 
embryonic lethal [383] 
transcription; cell 
cycle 
(proliferation) 
ARL2 ARFL2 
Hs 
only 
- - - - - - 
centrosomal protein that 
regulates microtubule nuclea-
tion and organization [396]; a 
fraction of ARL2 protein 
localizes to the mitochondria, 
where it regulates ATP levels 
and mitochondrial integrity 
[397]; based on work in non-
mammalian model systems, 
mutations in ARF2 may cause 
shortening of microtubules, 
aberrant microtubule and 
spindle organization, cell 
division and cytokinesis 
defects [398, 399] 
metabolism; cell 
cycle (mitosis/ 
cytokinesis) 
Atp6v1a  
Hs + 
Mm 
30.064 30.8883 1.7557 4.6257 0.05069 2.87 
acidifying vacuolar ATPase 
(vATPase) subunit A [400] 
ion transport 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
BC027231 
Nepro,  
C3orf17 
Hs + 
Mm 
4.4732 5.78214 N/A N/A N/A N/A 
involved in maintenance of 
neocortex neural progenitor 
cells downstream of Notch and 
plays a role in repression of 
proneural gene expression; 
misexpression causes inhibi-
tion of neuronal differentiation 
in the early neocortex, while 
knockdown drives neuron diff-
erentiation [401]; localized to 
nucleolus, and knockout in 
mice causes impaired blasto-
cyst formation and apoptosis 
[385] 
cell cycle 
(proliferation/ 
progenitor cell 
identity); CNS 
development 
C1orf109  
Hs 
only 
- - - - - - 
functions in cancer cell pro-
liferation, based on mis-
expression and knockdown 
studies [402] 
cell cycle 
(proliferation) 
Ddb1  
Hs + 
Mm 
86.094 88.3333 0.4618 2.7062 0.00438 2.2444 
large subunit of DNA damage-
binding complex [403]; nu-
cleotide excision repair [404]; 
involved in ubiquitin complex 
via interaction with the MIG 
Cul4a [405]; constitutive 
ablation is embryonically 
lethal in mice, and brain-
specific ablation leads to 
accumulation of cell cycle 
regulators, genomic instability, 
and apoptosis of proliferating 
NPCs [379] 
genome integrity 
(DNA repair) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Ddx18 
Has1,  
MrDb 
Hs + 
Mm 
13.787 14.2109 37.491 81.752 0.00073 44.261 
nucleolar RNA helicase; 
reduced function in cancer 
cells reduces proliferation 
[406]; cell cycle progression in 
hematopoeitic zebrafish cells, 
given that disruption causes 
p53-dependent G1 cell cycle 
arrest [407] 
cell cycle 
Ddx54 DP97 
Hs + 
Mm 
6.4588 6.934 N/A N/A N/A N/A 
RNA helicase that localizes to 
the nucleolus; in the DNA da-
mage response, increases splic-
ing efficiency of pre-mRNA 
transcripts generated in res-
ponse to DNA damage [408]; 
interacts with constitutive 
androstane nuclear receptor 
(response to xeno-chemical 
stimuli) and acts as co-
activator to upregulate ex-
pression of downstream genes 
involved in drug metabolism 
[409]; estrogen-dependent in-
teraction with nuclear estrogen 
receptors results in inhibition 
of transcriptional activity 
[410]; constitutive ablation is 
early embryonically lethal 
[386]; binds to myelin basic 
protein (MBP) in oligodendro-
cytes, and knockdown causes 
depletion of MBP [411] 
transcription; RNA 
processing 
(splicing); CNS 
development; stress 
response 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Donson  
Hs + 
Mm 
12.196 9.60999 N/A N/A N/A N/A 
a replisome protein that 
functions in stabilization of the 
replication fork and the intra-S 
phase checkpoint [320]; muta-
tion causes microcephalic 
dwarfism [319, 320]; 
constitutive ablation is early 
embryonic lethal in mice [319] 
genome integrity 
(DNA repair); cell 
cycle (checkpoint 
control) 
Eif3i TRIP1 
Hs + 
Mm 
211.31 129.232 N/A N/A N/A N/A 
translation initiation factor, but 
not required for translation 
initiation [412]; in intestinal 
epithelial cells, ectopic over-
expression triggers onco-
genesis [413]; mTOR directly 
interacts with eIF3 (all Eif3s, 
not just the product of this 
gene) to increase association to 
eIF4G [414]; regulates osteo-
blast differentiation and pro-
liferation, and knockdown 
decreases the number of cells 
in S phase while increasing 
cells in G2/M phase [415]; in 
vitro overexpression triggers 
increased cell size, increased 
proliferation and cell cycle 
progression [416] 
translation; cell 
cycle; development 
Exosc2  
Hs + 
Mm 
9.7051 9.16142 6.7412 15.899 0.01154 9.1576 
exosome component; high 
affinity for binding to phos-
phorylated Upf1  (involved in 
nonsense mediated decay…  
RNA metabolism 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Exosc2  
Hs + 
Mm 
9.7051 9.16142 6.7412 15.899 0.01154 9.1576 
… pathway; considered signal 
to recruit mRNA degradation 
factors to transcript) [417, 
418]; in HEp-2 cells, required 
for exosome stability, with 
knockdown inhibiting cell 
growth [419]; in yeast, 
required for processing of 7S 
pre-rRNA to 5.8S rRNA [420] 
RNA metabolism 
Fam96b  
Hs + 
Mm 
25.531 14.9509 - 100 - - 
component of the MMXD 
complex; possibly required for 
Aurora B localization; local-
ized to mitotic spindle, and 
knockdown results in ab-
normal mitotic spindle form-
ation, chromosome missegre-
gation, and multi-nucleation 
[421]; interacts with and down-
regulates E2-2 (role in endo-
thelial cell quiescence), while 
also enhancing endothelial mi-
gration, proliferation, and tube 
formation [422]; knockdown 
experiments indicate target 
specificity of its Fe-S assembly 
activity (necessary for matura-
tion of nucleotide metabolism 
proteins DPYD and GPAT; 
interacts with DNA2); invol-
ved in the regulation of iron 
homeostasis by decreasing…  
cell cycle (mitosis); 
iron homeostasis 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Fam96b  
Hs + 
Mm 
25.531 14.9509 - 100 - - 
… IRE-binding activity and 
protein levels of IRP2 [423] 
cell cycle (mitosis); 
iron homeostasis 
Gars  
Hs + 
Mm 
31.641 34.0717 100 100 #DIV/0! 0 
glycyl-tRNA synthetase, 
which covalently links glycine 
with corresponding tRNAs 
[424]; mutations are linked to 
Charcot-Marie-Tooth (CMT) 
disease, which specifically 
affects neurons [424]; constitu-
tive genetic disruption in mice 
is embryonically lethal [380] 
translation 
Ints8  
Hs + 
Mm 
39.174 38.3163 1.8454 4.1572 0.10709 2.3117 
in integrator complex, which 
associates with RNA poly-
merase II and mediates 3' end 
processing of snRNAs (only 
U1 and U2 tested here) [425] 
non-coding RNA 
biogenesis 
(snRNA) 
Kansl2 Nsl2 
Hs + 
Mm 
44.5 39.369 4.7214 20.86 9.4E-05 16.139 
subunit of the NSL histone 
acetyltransferase complex 
[426, 427] 
transcription 
Nat10  
Hs + 
Mm 
12.006 12.2529 8.4811 29.421 0.00872 20.94 
N-acetyltransferase [428]; di-
rect role in decondensation of 
chromosomes at mitosis exit; 
knockdown results in prolong-
ed chromosome condensation 
[429]; DNA damage triggers 
increased amount of Nat10 in 
mitotic midbody, and results in 
enhanced acetylation of alpha-
tubulin of midbody [428]…  
non-coding RNA 
biogenesis; 
transcription 
(rRNA); cell cycle 
(mitosis/cyto-
kinesis) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Nat10  
Hs + 
Mm 
12.006 12.2529 8.4811 29.421 0.00872 20.94 
… knockdown results in ab-
normal nucleolus size, length-
ened G2/M transition, multi-
nucleated cells, and defects in 
cytokinesis, sometimes result-
ing in cell death [428]; asso-
ciates with U3 snoRNA and is 
required for 18S rRNA pro-
cessing; knockdown results in 
decreased levels of 47S pre-
rRNA, indicating that Nat10 is 
a transcriptional UTP (partici-
pates in pre-rRNA tran-
scription) by targeting UBF for 
acetylation to facilitate 
association with RNA pol I-
associated factor [430]; 18S 
rRNA processing [431] 
non-coding RNA 
biogenesis; 
transcription 
(rRNA); cell cycle 
(mitosis/cyto-
kinesis) 
Ncbp1 Cbp80 
Hs + 
Mm 
24.319 27.8961 2.5035 4.8214 0.25505 2.3178 
one of two proteins in the 
mRNA cap binding protein 
complex (other = CBP20), 
which regulates mRNA spli-
cing [432]; nonsense mutation-
containing transcripts are 
bound with Ncbp1 during non-
sense-mediated decay (NMD) 
[433]; through interaction with 
TREX component Aly, allows 
proper mRNA export [434]; re-
quired for poly(A) RNA export 
[435]; as CBC, mediates…  
RNA metabolism; 
RNA processing 
(mRNA splicing); 
RNA transport; 
translation (pioneer 
round) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Ncbp1 Cbp80 
Hs + 
Mm 
24.319 27.8961 2.5035 4.8214 0.25505 2.3178 
…translation initially for 
pioneer round, then replaced 
by eIF4E, which controls 
steady-state translation [436]; 
associates with Upf1 to 
promote nonsense-mediated 
decay [437, 438] 
RNA metabolism; 
RNA processing 
(mRNA splicing); 
RNA transport; 
translation (pioneer 
round) 
Ncbp2 Cbp20 
Hs + 
Mm 
18.075 17.511 N/A N/A N/A N/A 
one of two proteins in the 
mRNA cap binding protein 
complex (other = CBP80), 
which affects RNA stability, 
splicing, export (specifically U 
RNA export), and translation 
initiation by binding 5' end 
[439]; Ncbp2 specifically 
binds the cap [440]; also invol-
ved in processing of 3' end of 
mRNA transcripts [441]; 
nonsense mutation-containing 
transcripts bound with Ncbp2 
during NMD [433]; as CBC, 
mediates translation initially, 
then replaced by eIF4E, which 
controls steady-state trans-
lation [442] 
RNA metabolism; 
RNA processing 
(mRNA splicing); 
RNA transport 
(snRNA); 
translation (pioneer 
round) 
Nop2 P120 
Hs + 
Mm 
10.392 10.5398 4.2518 7.7775 0.06934 3.5257 
initially discovered as prolif-
eration-associated based on 
expression, with moderately 
strong ribosome RNA methyl 
transferase activity [443]… …  
cell cycle 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Nop2 P120 
Hs + 
Mm 
10.392 10.5398 4.2518 7.7775 0.06934 3.5257 
… introduction of antisense 
RNA limited proliferation in 
NIH 3T3 cells [444]; 
proliferation marker of neural 
stem cells, and is expressed in 
adult brain [445]; potential role 
in neutrophil maturation [446] 
cell cycle 
Nup107  
Hs + 
Mm 
28.66 26.2714 2.0407 13.983 0.00037 11.942 
nucleoporin; depletion causes 
apoptosis [447]; prevents 
assembly of subset of nucleo-
porins into nuclear pore com-
plex (leads to codepletion of 
these proteins), mRNA export 
(not fully dependent on Nup-
107, but affected) [448]; 
required for bipolar spindle 
assembly [449]; nuclear pore 
complex disassembles during 
mitosis with many constituents 
distributing onto spindles and 
kinetochores, and the Nup107-
160 complex is implicated in 
spindle assembly by regulating 
microtubule nucleation [450] 
RNA transport 
(mRNA); cell cycle 
(mitosis) 
NUP155 
N155,  
ATFB15 
Hs 
only 
- - - - - - 
nucleoporin gene; functions in 
mRNA export and import of 
proteins to the nucleus [382]; 
constitutive loss of function is 
embryonically lethal in mice 
[382] 
protein transport; 
RNA transport 
165 
 
MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Orc3 
Lat,  
Orc3l,  
Latheo 
Hs + 
Mm 
37.179 36.4778 16.161 29.367 0.0544 13.206 
member of the origin recog-
nition complex (ORC) [451]; 
in Drosophila, knockdown 
results in reduced proliferation 
of NPCs of the CNS and death 
in the early pupae stage [452]; 
in human cells, directly inter-
acts with ORC2 and is required 
to recruit ORC4 and ORC5 to 
the core complex [453]; in 
conditional mutant mouse line 
crossed to Emx1-Cre, signi-
ficant reduction in cortical 
NPC division at E13, severe 
block of NPC division by E14, 
and disrupted cortical organiz-
ation [388]; in the cKO mouse, 
germline deletion is embryo-
nically lethal [384]; in the 
mouse cKO crossed with 
Nestin-Cre, reduction in NPCs 
by E15, fewer TBR2+ cells at 
E16, postnatal cortical reduc-
tion, compromised upper layer 
neuron production/migration, 
little/no effect on neural fate 
specification, and neonate 
cerebral hemorrhage concen-
trated on midline [384] 
cell cycle (DNA 
replication/S 
phase) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Pcid2  
Hs + 
Mm 
10.884 9.17728 N/A N/A N/A N/A 
expressed in immature and 
early-stage B lymphocytes; 
regulates mRNA export of 
mitotic checkpoint gene 
MAD2 [454]; involved in 
nuclear protein export, based 
on results of knockdown [455] 
RNA transport; 
protein transport; 
cell cycle (mitosis) 
Pdcd11 
Alg4, 
Nfbp, 
Rrp5 
Hs + 
Mm 
6.0127 6.71921 2.5879 10.345 0.09684 7.7567 
interacts with the U3 snoRNA 
(involved in rRNA maturation/ 
biogenesis), and knockdown 
represses 18S rRNA ma-
turation [456]; part of SSU 
processome, where it likely 
recruits U3 to sites of rRNA 
maturation [457] 
non-coding RNA 
biogenesis (rRNA) 
Pola2  
Hs + 
Mm 
21.661 21.6355 2.3927 3.7602 0.36278 1.3675 
indirectly, regulates DNA 
replication by increasing pro-
tein synthesis and nuclear 
translocation of catalytic alpha 
subunit (p180) [458]; 
hyperphosphorylated by 
cyclin-dependent kinases in 
G2 phase, which enhances 
activation of pol-alpha enzyme 
(DNA replication) by 
phosphorylated Rb [459]; 
constitutive knockout is 
embryonically lethal in mice 
[386] 
cell cycle (DNA 
replication/S 
phase) 
Pole2  
Hs + 
Mm 
17.927 15.1327 0.3623 4.3916 0.01647 4.0292 
DNA polymerase accessory 
subunit (epsilon), 55 kDa… 
cell cycle (DNA 
replication/S-phase  
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Pole2  
Hs + 
Mm 
17.927 15.1327 0.3623 4.3916 0.01647 4.0292 
… subunit [460]; possible 
stabilizing role for DNA 
polymerase epsilon complex 
[460]; role in chromatin 
regulation, based on reporter 
plasmid assays [461] 
cell cycle (DNA 
replication/S-phase 
phase); 
transcription 
Polr2e RPB5 
Hs + 
Mm 
62.784 40.1102 0.7415 3.1917 0.00269 2.4502 
subunit shared by all RNA 
polymerases [462]; role in 
transcription activation, 
according to work in yeast 
[463]; in COS1 cells, directly 
binds RAP30, component of 
the general transcription factor 
IIF (TFIIF) complex; this 
complex is assembled within 
the ini-tiation complex and is 
known to associate with RNA 
pol II, inhibiting association of 
TFIIF and pol II [464, 465] 
transcription 
Polr3c 
RPC3, 
RPC62 
Hs + 
Mm 
14.743 10.1487 N/A N/A N/A N/A 
subunit of RNA polymerase III 
[466]; likely directs pol III 
binding to TFIIIB-DNA 
complex [466]; required for 
promotor-specific 
transcription initiation by pol 
III [467] 
transcription; non-
coding RNA 
biogenesis 
Polr3h  
Hs + 
Mm 
11.154 8.41693 5.2643 15.526 0.00187 10.261 
subunit of RNA polymerase 
III, acting paralogously to 
Rpb7 in pol II [468] 
transcription; non-
coding RNA 
biogenesis 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Prmt1 
ANM1, 
HCP1, 
IR1B4, 
Mrmt1 
Mm 
only 
43.663 46.2355 N/A N/A N/A N/A 
arginine N-methyltransferase; 
regulates oligodendrocyte ma-
turation and myelination [469]; 
methylates FUS and regulates 
nucleocytoplasmic distribu-
tion, and is linked to disrupt-
tions in histone modifications/ 
chromatin remodeling in cyto-
plasmic FUS-related ALS 
[470]; chromatin regulation by 
methylation of histones [471]; 
regulates DNA repair and sig-
nal transduction [472]; requi-
red for early post-implantation 
mouse development but not for 
cell survival, based on gene 
trap approach [473]; knock-
down causes DNA damage and 
chromosomal segregation de-
fects [474]; involved in neurite 
outgrowth, via interaction with 
Btg2 [475] 
protein 
modification; 
transcription; 
protein transport; 
genome integrity; 
CNS development 
Psma1  
Hs + 
Mm 
162.68 155.28 N/A N/A N/A N/A 
component of 20S proteasome 
[476] 
protein metabolism 
Rabggta  
Hs + 
Mm 
6.0551 4.81826 7.8456 18.3 0.0595 10.454 
geranylgeranyl transferase; 
mutation in splice acceptor site 
results in gunmetal mouse, 
which has platelet and mega-
karyocyte defects (prolonged 
bleeding), and…  
protein 
modification; 
hemostasis 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Rabggta  
Hs + 
Mm 
6.0551 4.81826 7.8456 18.3 0.0595 10.454 
… macrothrombocytopinea 
[477] 
protein 
modification; 
hemostasis 
Rcl1 
Rnac, 
RPCL1 
Hs + 
Mm 
6.3878 5.57027 N/A N/A N/A N/A 
member of the small ribosomal 
subunit (SSU) processome 
[478]; functions in rRNA 
maturation and therefore 
ribosome biogenesis [479] 
non-coding RNA 
biogenesis (rRNA) 
Rfc5 
Recc5, 
RFC36 
Hs + 
Mm 
22.473 14.612 4.9543 12.849 0.00166 7.8948 
36.5 kDa subunit of the 
replication factor C complex; 
interacts with the DNA clamp 
PCNA, thereby regulating 
DNA replication during S 
phase [480] 
cell cycle (DNA 
replication/S 
phase) 
Rnpc3  
Hs + 
Mm 
17.448 31.214 4.1637 6.1783 0.4499 2.0146 
the minor spliceosome-specific 
U11/U12 65k protein; when 
bound to the U11/U12 di-
snRNP, it bridges the U12 
snRNA and U11-59K protein, 
stabilizing the di-snRNP and 
thereby regulating minor 
splicing [72]; disruption linked 
to isolated familial growth 
hormone deficiency [119] 
RNA processing 
(splicing) 
Rpl4  
Hs + 
Mm 
391.13 435.342 0.8984 11.067 0.00017 10.168 
ribosomal protein component 
of the 60S subunit [481] 
translation 
Rpp30  
Hs + 
Mm 
14.166 15.4626 1.2119 2.8378 0.0006 1.6259 
30 kDa subunit of the ribo-
nuclease P/MRP complex, 
which processes tRNA [482] 
non-coding RNA 
biogenesis 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
SACM1L SAC1 
Hs 
only 
- - - - - - 
phosphoinositide phosphatase 
integral membrane protein lo-
calized to endoplasmic reticu-
lum and Golgi apparatus [483, 
484]; mouse KO is early em-
bryonic lethal [381]; knock-
down causes Golgi apparatus 
disorganization, delayed G2/M 
transition, and aberrant mitotic 
spindle formation [381] 
cell cycle (mitosis); 
Golgi-mediated 
transport 
SNRPE 
SME, 
Sm-E, 
HYPT11 
Hs 
only 
- - - - - - 
the "E" subunit of the Sm com-
plex, which functions in 
snRNP maturation; associates 
with U snRNPs, including 
those involved in RNA spli-
cing and histone mRNA pro-
cessing [485-488]; in cancer 
cells, misexpression prevents 
DNA synthesis and arrests 
cells in G2, while knockdown 
drives cells through these 
phases [489] 
RNA processing 
(splicing); 
transcription; cell 
cycle 
Spc24  
Hs + 
Mm 
33.589 13.2965 100 100 #DIV/0! 0 
NDC80 kinetochore complex 
component; required to esta-
blish and maintain kineto-
chore-microtubule attachment 
in mitosis [344] 
cell cycle (mitosis) 
Ssu72  
Hs + 
Mm 
21.074 14.7427 6.0058 11.568 0.0025 5.5625 
phosphatase associated with 
CTD of RNA pol II (TFIIB) 
[490]; regulates RNA pol II…  
transcription; cell 
cycle (mitosis) 
171 
 
MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Ssu72  
Hs + 
Mm 
21.074 14.7427 6.0058 11.568 0.0025 5.5625 
… activity via CTD phos-
phatase activity in yeast [491]; 
phosphorylated by Aurora B to 
regulate sister chromatid 
cohesion during mitosis [492] 
transcription; cell 
cycle (mitosis) 
Taf1c 
Sl1, 
Tafi110,
Tafi95 
Hs + 
Mm 
4.3941 4.43861 9.5208 12.856 0.81863 3.3351 
TATA box-binding protein 
associated factor (TAF) for 
RNA pol I; part of SL1 
complex, which directs pol I 
transcription and can 
independently interact with 
rDNA promoter [493] 
non-coding RNA 
biogenesis (rRNA) 
Tcp1 Cct 
Hs + 
Mm 
127.7 128.145 2.1049 4.9633 0.00048 2.8584 
cytosolic chaperonin respon-
sible for stabilizing folding of 
numerous proteins, including 
actin [494] and tubulin [495, 
496]; involved in ciliogenesis 
and biogenesis of rod outer 
segment [497]; via chaperone 
function for Tcab1, controls 
scaRNA localization and telo-
merase function [498] 
protein folding 
UBL5 HUB1 
Hs 
only 
- - - - - - 
ubiquitin-like protein; knock-
down experiments indicate a 
role in stabilization of the 
spliceosome and in mitotic 
progression to anaphase [499]; 
via this role, important for the 
proper splicing of the cohesin 
factor sororin, thereby… 
RNA processing 
(splicing); cell 
cycle (mitosis) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
UBL5 HUB1 
Hs 
only 
- - - - - - 
… indirectly promoting sister 
chromatid cohesion [499] 
RNA processing 
(splicing); cell 
cycle (mitosis) 
Upf1  
Hs + 
Mm 
18.959 14.8731 3.9997 16.801 0.02216 12.802 
nonsense-mediated mRNA 
decay [500]; genome integrity 
[501]; constitutive knockout is 
embryonically lethal [377] 
RNA metabolism; 
genome integrity 
Vps25 
DERP9, 
EAP20, 
FAP20 
Hs + 
Mm 
13.868 13.4069 1.1976 4.9033 0.00487 3.7057 
part of ESCRT (endosomal 
sorting complex required for 
transport)-II [502]; role in 
cargo sorting, especially 
sorting of ubiquitinated cargo 
[503]; by regulating receptor 
number, affects FGF signaling 
in limbs, indicative of a role in 
skeletal/limb development 
[504]; constitutive knockout is 
embryonically lethal [386] 
transport; 
limb/skeletal 
development 
Znf259 
Zpr1, 
Zfp259 
Hs + 
Mm 
6.4644 4.51749 N/A N/A N/A N/A 
depletion disrupts nucleolar 
function, including pre-ribo-
somal RNA expression [505]; 
interacts with the Smn protein 
and colocalizes in Geminins 
and Cajal bodies; depletion an-
alysis indicates Zfp259 regu-
lates localization of Smn in nu-
clear bodies [506]; in condi-
tional knockout mouse, loss of 
Zfp259 disrupts the subcellular 
localization of Smn and… 
RNA processing 
(splicing) 
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MIG Syn Spp. 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
P-value ∆ MSI Function Description 
Functional 
Categories 
Znf259 
Zpr1, 
Zfp259 
Hs + 
Mm 
6.4644 4.51749 N/A N/A N/A N/A 
… the spliceosomal snRNPs; 
early embryonic lethality is 
observed, showing reduced 
proliferation and increased 
apoptosis [378]; depletion 
blocks S-phase progression, 
triggers G1 and G2 arrest, and 
causes mislocalization of Smn 
and NPAT [506]; in Zfp259 
deficient mice, observe axonal 
pathology, neurodegeneration 
[507]; in spinal muscular 
atrophy, loss of Zpr1 increases 
motor neuron loss and severity 
and depletes SMN-containing 
subnuclear bodies [508] 
RNA processing 
(splicing) 
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Chapter 6: The behavioral outcomes of Emx1-Cre-mediated U11 ablation in 
the Rnu11 conditional knockout mouse 
In Chapter 4, I described microcephaly in the embryonic and juvenile Rnu11 mutant mouse; in 
Chapter 5, I expanded upon the potential genes underlying the primary cause of microcephaly in 
these mice: progenitor cell death. This chapter covers the postnatal effects of minor spliceosome 
inactivation in the developing mouse cortex. The chapter begins by describing the Emx1-Cre 
transgenic mouse used to ablate Rnu11 in the developing mouse cortex, which is followed by 
examination of the postnatal survival and behavior of the Emx1-Cre+, Rnu11 mutant mice. 
 
6.1 The Emx1-Cre transgenic mouse 
Emx1 is one of two homeobox transcription factor orthologs of the Drosophila gene empty 
spiracles (ems), which functions in anterior head patterning in Drosophila development [509, 510]. 
In the developing mouse brain, Emx1 expression begins at E9.5, with specific enrichment in the 
progenitor cells and differentiating neurons of the dorsal telencephalon, spanning the primordium 
of the cerebral cortex and hippocampus, and the olfactory bulb [511-513]. Expression of Emx1 
persists in the excitatory neurons of the postnatal cerebral cortex, hippocampus, and olfactory bulb 
[513, 514]. Therefore, when the Jones group sought to generate a transgenic mouse line in which 
Cre-mediated recombination would be driven in the developing cortex, they chose the Emx1 
promoter. Specifically, they inserted the Cre expression cassette, comprised of an internal 
ribosomal entry site followed by the Cre recombinase gene and a polyadenylation signal, into the 
final exon of the endogenous Emx1 gene, which encodes the 3’ untranslated region of the Emx1 
mRNA [235]. This Emx1-Cre mouse was then bred with the transgenic R26R Cre reporter mouse 
line. In this Cre reporter mouse, the lacZ expression cassette is flanked by loxP sites, such that 
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expression of β-galactosidase only occurs in Cre-expressing cells [235, 515]. As expected, staining 
of E10.5 Emx1-Cre+::R26R+ mouse embryos with the β-galactosidase substrate X-gal revealed 
robust Cre-mediated recombination in the dorsal telencephalon. However, they also observed 
recombination in the branchial arches, which give rise to cells of the jaw and facial bones, the 
muscles of the jaw and face, and a subset of cranial ganglia; scattered recombination was also 
observed in the limb and tail ectoderm [235, 516-519]. Subsequent characterization of Emx1-Cre 
activity in the Mouse Genome Informatics database also revealed scattered recombination in the 
kidneys of postnatal Emx1-Cre+ mice [516-518]. 
 In the adult brain, Gorski et al. observed robust recombination in the excitatory, but not 
inhibitory, neurons of the cerebral cortex. Recombination was also observed in oligodendrocytes 
and astrocytes of the cortex and cortical white matter; they did not investigate the presence of Cre-
mediated recombination in OPCs or microglia [235]. However, Gorski et al. also reported the 
presence of recombined cells outside of the cerebral cortex, hippocampus, and olfactory bulbs. 
Scattered recombined cells were observed in the dorsal striatum, which receives input from layer 
V projection neurons [235, 520]. Notably, while virtually none of the recombined cortical neurons 
were inhibitory, the recombined striatal cells were medium spiny neurons (MSNs), which are 
inhibitory cells [235, 520]. Recombined cells were also prevalent in the lateral, basolateral, and 
medial regions of the amygdala [235]. 
 The identities of these recombined, Emx1-lineage striatal and amygdalar neurons were 
investigated by the Corbin group in 2009. Analysis of the Cre reporter-expressing, Emx1-lineage 
cells of the adult basolateral and lateral amygdala indicated that virtually all of the recombined 
cells in this region were excitatory neurons [329]. In contrast, analysis of the recombined cells in 
the dorsal striatum revealed that approximately half of the Emx1-lineage cells were neurons, while 
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the other half were glia, primarily oligodendrocytes and OPCs [329]. Virtually all of the 
recombined striatal neurons were medium spiny neurons (MSNs); these recombined MSNs 
represented approximately 4% of the entire MSN population in the dorsal striatum [329]. In the 
dorsal striatum, MSNs can be grouped based on their location within one of two striatal 
compartments—the striosome or the matrix—or based on the targets of their projections—the 
direct or indirect pathway. Generally, the MSNs of the striosome predominantly receive inputs 
from limbic-associated cortical regions, while those of the matrix are primarily innervated by 
projection neurons from the sensorimotor cortices [521, 522]. Unlike matrix MSNs, which project 
to the output nuclei of the basal ganglia, striosomal MSNs also project to the substantia nigra pars 
compacta (SNc), where they synapse with dopaminergic neurons [521, 522]. When Cocas et al. 
investigated the distribution of recombined MSNs between these two structural regions, they found 
that the majority (91%) were striosomal MSNs; all of these striosomal MSNs received inputs from 
the dopaminergic neurons of the substantia nigra [329]. The second method to categorize MSNs 
relies on their direct targets. MSNs of the direct pathway project to the entopeduncular nucleus 
(EP) and the substantia nigra pars reticulata (SNr). The inhibitory neurons from these two regions 
of the basal ganglia project both to motor nuclei of the brainstem and to the motor thalamus, which 
innervates the motor areas of the cortex. MSNs in the indirect pathway instead project to the globus 
pallidus, and the inhibitory neurons of the global pallidus project to the subthalamic nucleus 
(STN). These glutamatergic STN neurons innervate the EP and SNr, at which point the direct and 
indirect pathways converge. Put simply, activation of direct pathway MSNs generally increases 
motor cortex activity, thereby facilitating movement, while activation of the MSNs of the indirect 
pathway generally reduces motor cortex activity, inhibiting movement [521, 522]. Cocas et al. 
found that the majority (75%) of Emx1-lineage MSNs were part of the indirect pathway [329]. 
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 Cocas et al. also interrogated the origin of these non-cortical, Emx1-lineage cells. Via 
pulse-chase experiments, they established that the Emx1-lineage neurons of the amygdala were 
born between E9 and E13, while Emx1-lineage MSNs were born later, from E11 to E15. Most of 
these cells were born from Emx1-expressing progenitor cells that migrated from the Emx1 domain 
of the dorsal telencephalon into the ventral regions of the brain [329]. These migrating Emx1-
lineage progenitor cells displayed shifting gene expression profiles as they moved into the 
subpallium. Specifically, the migrating Emx1-lineage cells downregulated Emx1 expression [329]. 
A subset of these migrating Emx1-lineage cells maintained Pax6 expression as they traveled 
outside of pallium; these cells produced excitatory neurons of the amygdala [329]. In contrast, 
other migrating Emx1-lineage cells downregulated Pax6 and instead upregulated the subpallial 
markers Gsx2 and Dlx2; these cells produced inhibitory MSNs of the striatum [329].  
 In summary, Emx1-Cre drives robust recombination in the NPCs of the dorsal 
telencephalon and in the olfactory bulb; in the adult brain, the vast majority of Emx1-Cre-mediated 
recombination is observed in the glia and excitatory neurons of the cerebral cortex, hippocampus, 
and olfactory bulb [235, 329]. However, due to subpallial migration of Emx1-expressing NPCs 
during brain development, a relatively small subset of Emx1-lineage cells produces excitatory 
neurons of the amygdala and inhibitory MSNs of the dorsal striatum [235, 329]. Most of these 
inhibitory MSNs receive dopaminergic and limbic system inputs, and the majority of afferents 
from the Emx1-lineage MSNs project to the globus pallidus, as part of the indirect pathway of the 
basal ganglia [329]. Emx1-Cre-mediated recombination is also observed outside of the brain, 
primarily in the jaw/face primordium (the branchial arches) and kidneys [235, 516-518].  
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6.2 Rationale 
 While primary microcephaly precipitates during embryonic development, the effects of 
these developmental defects profoundly affect postnatal development and quality of life [523]. In 
MOPD1, Roifman syndrome, and Lowry Wood syndrome, patients display speech and motor 
delays and intellectual disability; some MOPD1 patients also suffer seizures [106-108, 122, 124-
129, 140-143]. Therefore, we sought to investigate the behavioral outcomes of microcephaly 
caused by minor spliceosome inactivation, which we pursued in collaboration with the Murine 
Behavioral Neurogenetics Facility (MBNF) at the University of Connecticut. In order to plan the 
behavioral testing paradigms to be used, it was first necessary to determine the survival kinetics 
of the microcephalic, Emx1-Cre+ Rnu11 mutant mice. 
 
6.3 Results 
 
6.3.1 Emx1-Cre heterozygous, Rnu11 mutant mice survive to adulthood 
 Despite their severe microcephaly, many Emx1-Cre+ Rnu11 mutant mice survived to 
adulthood, with some mutant mice surviving up to 1.5 years (Figure 6.1A-E). The adult mutant 
mice could breed successfully, although the females did not take care of their pups. However, we 
observed a sharp decline in mutant mouse survival around P20, indicating that a subpopulation 
within the mutant mouse cohort was dying prematurely (Figure 6.1E). This window corresponds 
to the weaning age of mice, which provided a potential explanation for this pattern of death: failure 
to transition to solid food. Indeed, we found that the mutant mice showed slower weight gain as 
they approached the age of weaning (P21) (Figure 6.1F). Notably, previous reports have shown 
Emx1-Cre reporter expression in the branchial arches of E10.5 embryos; these structures give rise 
to the developing jaw [235, 516-519]. In agreement with these reports, we observed expression of 
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the Ai9 tdTomato Cre reporter in the jaw of P0 control and mutant mice (Figure 6.1G&H) [351]. 
This expression persisted in both the masseter and temporalis muscles of P21 control and mutant 
mice (Figure 6.1I-J’). To ease the transition to solid food, the food given to the mutant mice was 
wet daily, starting at P19. However, this did not prevent death in the weaning period (Figure 6.1K). 
Genotyping to determine Emx1-Cre zygosity revealed that mutant mice homozygous for Emx1-
Cre (Rnu11Flx/Flx::Emx1-Cre+/+) were the ones dying in the weaning period; in contrast, virtually 
all mutant mice that were heterozygous for Emx1-Cre survived to adulthood (Figure 6.1K). Our 
findings suggest that homozygosity of Emx1-Cre may result in increased recombination in the 
branchial arches, failure to transition to solid food, malnourishment, and early death, even when 
wet food is provided.   
 
6.3.2 Rnu11 mutant mice display heightened anxiety 
Given that the microcephalic Emx1-Cre heterozygous, Rnu11 mutant mice survived to 
adulthood, we sought to understand how minor spliceosome inactivation-mediated microcephaly 
affected brain function—i.e., mouse behavior. For this, we employed a battery of behavioral tests 
in collaboration with Dr. Holly Fitch of the MBNF at the University of Connecticut, to assess a 
variety of behaviors in adult male Rnu11 wild-type (WT), heterozygous (het), and mutant (mut) 
mice. Specifically, two separate studies were performed, using a group of 22 male mice (7 WT, 7 
het, 8 mut) and a group of 43 male mice (15 WT, 15 het, 13 mut).  
Assessment of anxiety was performed using the elevated plus maze and open field task. In 
the elevated plus maze, anxiety is measured by the amount of time spent in the open arms vs the 
closed arms, and by the number of entries into the open vs closed arms. More time in and entries 
into the open arms indicate increased exploratory behavior and reduced anxiety [524]. Univariate 
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ANOVA revealed a significant effect of genotype on the number of closed arm entries 
[F(2,19)=14.208, P<0.001) and total number of arm entries [F(2,19)=10.151, P=0.001], but no 
significant effect of genotype on the number of open arm entries [F(2,19)=1.000, P=0.386] (Figure 
6.2A). Subsequent two-way student’s t-tests showed that the Rnu11 mutant mice entered closed 
arms significantly less than the Rnu11 wild-type controls (P<0.05); significantly fewer total arm 
entries were observed for Rnu11 mutant mice relative to both Rnu11 wild-type and Rnu11 
heterozygous control genotypes (P<0.05; Figure 6.2A). Univariate ANOVA also identified a 
significant effect of genotype on the percentage of time spent in the open arms [F(2,19)=9.948, 
P=0.001], driven by the substantially longer percentage of time Rnu11 mutant mice spent in the 
open arms [62.7±11.5% vs 15.2±9.9% (WT) and 8.3±5.0% (het); P<0.05; Figure 6.2B]. In 
summary, Rnu11 mutant mice spent significantly more time in the open arms and made 
significantly fewer closed arm and overall arm entries, compared to the control genotype groups. 
Notably, during the testing period, Rnu11 mutant mice displayed freezing behavior in the open 
arms, which would indicate high levels of anxiety and also explain these results (data not shown). 
Due to the robustness of these results, the elevated plus maze task was only employed in the first 
study, using 22 male mice. 
In the open field task, the subject is placed in a wall-enclosed, square arena; exploratory 
behavior is measured by the amount of time spent in the center region of the field, compared to 
the outer region adjacent to the walls. Distance traveled and velocity in the outer vs center regions 
can also indicate increased stress/anxiety in mice [525]. While most studies separate the open field 
into two regions (outer and center), we divided the open field into four zones (out-outer, in-outer, 
out-center, and in-center; Figure 6.2C) to identify nuanced shifts in behavior [525]. For this 
analysis, mice from both cohorts were tested using the open field task; since there was no 
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significant effect of study on duration, distance traveled, or velocity in the open field zones (P-
value range: 0.07–0.90), the results of these studies were pooled. In total, 16 WT, 16 het, and 17 
mutant mice were tested in the open field. Univariate ANOVA revealed a significant effect of 
genotype on the distance traveled in total [F(2,43)=7.5, P=0.002] and in the in-center 
[F(2,43)=20.6, P<0.001], out-center [F(2,43)=14.761, P<0.001], in-outer [F(2,43)=3.526, 
P=0.04], and out-outer [F(2,43)=12.8, P<0.001] zones; there was no significant effect of genotype 
on the duration spent in these open field zones (P-value range: 0.127-0.416). For velocity, 
univariate ANOVA identified a significant effect of genotype on velocity in the in-center 
[F(2,43)=19.476, P<0.001], out-center [F(2,43)=5.585, P=0.007], and out-outer [F(2,43)=16.393, 
P<0.001] zones.  
Subsequent two-way student’s t-tests revealed that Rnu11 mutant mice travelled a 
significantly longer distance in the out-outer zone, relative to Rnu11 wild-type (P<0.001) and 
heterozygous (P=0.001) control groups (Figure 6.2D). However, Rnu11 mutant mice travelled 
significantly shorter distances in the out-center and in-center zones, compared to Rnu11 wild-type 
(P=0.21; P=0.003) and heterozygous (P<0.001; P<0.001) controls (Figure 6.2E-F). Overall, 
Rnu11 mutant mice travelled significantly farther than Rnu11 wild-type (P=0.002) and 
heterozygous (P=0.016) mice (data not shown). As expected from our open field distance findings, 
Rnu11 mutants travelled at a significantly higher velocity in the out-outer zone, and a significantly 
lower velocity in the in-center zone, relative to both the Rnu11 WT (P<0.001) and heterozygous 
(P<0.001) control mice (Figure 6.2G; data not shown). While there was not a significant difference 
in the velocity of Rnu11 mutant and wild-type mice in the out-center zone, Rnu11 mutant mice 
travelled at a significantly slower velocity than Rnu11 heterozygous mice (P=0.011; data not 
shown). In all, our findings indicate that Rnu11 mutant mice travelled significantly faster and 
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farther in the outermost zone of the open field (the out-outer zone), while they travelled 
significantly more slowly, and a shorter distance, in the innermost zone of the open field (the in-
center zone). 
 
6.3.3 Rnu11 mutant mice have significantly impaired motor coordination 
To investigate the effect of Rnu11 ablation on motor coordination, we employed the rotarod 
test, in which the mouse is placed on a rotating beam, and latency to fall from the beam is measured 
[526]. To also assess motor learning, testing was performed across five consecutive days. Rotarod 
testing was performed in both studies, on a total of 21 WT, 19 het, and 20 mut mice. ANOVA 
indicated that there was no significant effect of study on the rotarod results [F(1,54)=2.384, 
P=0.128], allowing us to pool the rotarod data. A 5 (day) x 3 (genotype) repeated measures 
ANOVA revealed a significant effect of genotype on latency to fall from the rotarod [F(2,54)=30.2, 
P<0.001] and a significant effect of day tested on latency to fall [F(4,216)=6.5, P<0.001], evidence 
of motor learning (Figure 6.2H). However, we did not identify a significant interaction between 
day and genotype [F(8,216)=1.183, P=0.311], indicating that all groups displayed learning over 
the five day period. Subsequent two-way student’s t-tests identified significantly shorter latencies 
to fall (i.e., worse motor performance) for Rnu11 mutant mice relative to wild-type (P<0.001) and 
heterozygous (P<0.001) control groups across all days of testing (Figure 6.2H). 
 
6.3.4 Rnu11 mutant and heterozygous mice vocalize significantly less than wild-type controls 
in socio-sexual encounters 
To assess social behavior, we employed an analysis of socio-sexual ultrasonic 
vocalizations (USVs). For this analysis, one male mouse was placed in a cage housing a female, 
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wild-type mouse for five minutes, and the amount of time the male test subject spent vocalizing 
was quantified. This analysis was performed in the second study, on the 43 mice in that cohort. 
Univariate ANOVA revealed a significant effect of genotype on the percentage of time spent 
vocalizing [F(2,40)=8.6; P=0.001]. Specifically, Rnu11 mutant mice vocalized for a significantly 
smaller percentage of time than Rnu11 wild-type mice, by two-way student’s t-test (P=0.001; 
Figure 6.1I). Unexpectedly, we also found that Rnu11 heterozygous mice vocalized significantly 
less than Rnu11 wild-type controls (P=0.01; Figure 6.2I). Moreover, comparison of the percentage 
of time spent vocalizing between Rnu11 heterozygous and mutant mice revealed no significant 
difference (P=0.622), suggesting that cortical U11 haploinsufficiency may impact sociability as 
severely as complete U11 ablation (Figure 6.2I). 
 
6.3.5 Rnu11 heterozygous mice display enhanced performance on complex, whole-body 
motor tasks 
Further investigation into the Rnu11 heterozygous mice revealed significantly affected 
performance in other behavioral tasks, particularly in motor tasks. While Rnu11 heterozygous mice 
behaved similarly to wild-type controls in the elevated plus maze (Figure 6.2A), Rnu11 
heterozygous mice traveled significantly farther in the out-center and in-center zones of the open 
field relative to wild-type controls (P=0.043, P=0.024; Figure 6.2E-F). In the pooled rotarod data, 
the average latency to fall for the Rnu11 heterozygous mice trended longer than wild-type controls 
on all days tested, although this difference was not statistically significant (P=0.157; Figure 6.2H). 
However, separating the rotarod data by study revealed two visibly different trends in Rnu11 
heterozygous performance on the rotarod task. In the first study, P80 Rnu11 heterozygous mice 
had significantly shorter latencies to fall on days 1 and 2 of testing, relative to P80 Rnu11 wild-
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type controls (Figure 6.3A). In the second study, the average performance of P105 Rnu11 
heterozygous mice was virtually identical to P105 wild-type controls on days 1 and 2 of testing, 
with slight, insignificant gains relative to wild-type performance on the following days (Figure 
6.3B).  
To further investigate motor behavior in the Rnu11 heterozygous mice, we added several 
motor tasks to the testing paradigm used for the second study: a modified, faster rotarod task; a 
balance beam test, to assess coordination/balance; a grid-walking task, to test coordination; and a 
wire hang task, to assay strength [526]. In all, 14 WT, 12 het, and 12 mut mice were tested in this 
paradigm. A 2 (day) x 3 (genotype) repeated measures ANOVA revealed a significant effect of 
genotype, but not day, on latency to fall on the faster rotarod task [F(2,35)=8.5, P=0.001; 
F(1,35)=1.1, P=0.294]. As expected, Rnu11 mutant mice performed significantly worse than 
Rnu11 wild-type (P=0.008) and heterozygous (P=0.001) mice, by two-way student’s t-test (Figure 
6.3C). While the average latency to fall trended higher in the Rnu11 heterozygous mice relative to 
wild-type controls, there was no significant difference in rotarod performance between these 
groups (P=0.716; Figure 6.3C). In the balance beam test, univariate ANOVA revealed no 
significant effect of genotype on the time taken to cross the balance beam [F(2,35)=2.7, P=0.084] 
(Figure 6.3D). Coordination was further investigated using the grid walking task, in which the 
mouse must cross an elevated metal grid and the number of correct foot placements on the wire 
grid is counted. Univariate ANOVA revealed a significant effect of genotype on the number of 
correct foot placements (P=0.003), due to the significantly fewer correct foot placements by Rnu11 
mutant mice relative to Rnu11 wild-type (P=0.005) and heterozygous (P=0.011) mice, by two-
way student’s t-tests (Figure 6.3E). There was no significant difference in performance between 
Rnu11 heterozygous and wild-type mice (P=0.986). Finally, for the wire hang task, in which a 
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mouse is coaxed to grasp a wire grid and the latency to fall from this grid is quantified, univariate 
ANOVA identified a significant effect of genotype on latency to fall [F(2,35)=78.7, P<0.001]. 
Consistent with previous results, Rnu11 mutant mice performed significantly worse than Rnu11 
wild-type (P<0.001) and heterozygous (P<0.001) mice, based on two-way student’s t-tests (Figure 
6.3F). However, virtually none of the Rnu11 wild-type or heterozygous mice fell from the wire 
grid during the 60-second task; as a result, their performance in this task was not significantly 
different (P=1.000) (Figure 6.3F).  
In parallel with these tests, we had begun investigating spatial learning and memory in the 
Rnu11 wild-type and heterozygous mice using the Morris water maze. In this test, the mouse is 
placed in a circular pool and must find and swim to a submerged platform to escape the water, 
using spatial cues located outside of the maze itself. This test is then repeated across five 
consecutive days. There are two general measures of memory/spatial learning in this task: latency 
to reach the platform (“escape latency”), where shorter latency corresponds to better 
memory/spatial learning; and path length from the starting position to the platform, which is a 
more accurate measurement of memory/spatial learning in this task [527]. A 5 (day) x 2 (genotype) 
repeated measures ANOVA revealed a significant effect of genotype (P=0.011) and day 
[F(4,27)=15.9, P<0.001], and a significant interaction between day and genotype [F(4,27)=2.6, 
P=0.038], on average escape latency (data not shown). Overall, performance of the Rnu11 
heterozygous mice was better than the wild-type controls (data not shown). However, the average 
path length from the starting position to the platform was not significantly affected by genotype 
(P=0.559); repeated measures ANOVA only identified a significant effect of day on average path 
length [F(4,27)=8.2, P<0.001] (Figure 6.3G). Instead, a repeated measures ANOVA revealed that 
the average swimming velocity was significantly impacted by genotype [F(1,27)=9.5, P=0.005] 
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and day [F(4,27)=25.3, P<0.001]. On all days of testing, the Rnu11 heterozygous mice had higher 
average swimming velocities relative to wild-type controls (Figure 6.3H). In summary, we did not 
observe a significant difference in Rnu11 heterozygous performance, relative to wild-type controls, 
on simple motor tasks designed to test specific domains of motor performance. Instead, significant 
enhancement of motor performance in the Rnu11 heterozygous mice, compared to wild-type 
controls, was primarily observed in complex, whole-body tests of motor performance (e.g., 
rotarod, swim test). 
 
6.4 Discussion 
 In the multiple developmental disorders linked to minor spliceosome disruption, patients 
have numerous behavioral abnormalities. In MOPD1, patients display psychomotor 
developmental delays in infancy and early childhood. In the patients with mild MOPD1 who reach 
late childhood, intellectual disability is common [107, 108, 124-129]. In the more mild Roifman 
syndrome, cognitive delays and hypotonia are often observed [106, 140]. Patients with Lowry 
Wood syndrome have a variable degree of intellectual disability, ranging from significant to mild 
or no intellectual disability [122, 141-143, 528-530]. Our effort to characterize the behavioral 
outcomes of minor spliceosome inactivation-induced microcephaly revealed a wide range of 
behavioral abnormalities in the microcephalic, Emx1-Cre+ Rnu11 mutant mice, including 
increased anxiety, global impairment of motor behavior, and reduced vocalization in socio-sexual 
encounters. The mutant mice particularly struggled in tasks requiring coordination and fine motor 
skills, such as the rotarod and grid-walking tasks (Figures 6.2H, 6.3C&E); in contrast, general 
locomotion appeared relatively unaffected, based on their performance in the open field test 
(Figure 6.2D&G). In the P0 mutant brain, we observed loss of the corticospinal tracts, which are 
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comprised of primary motor neuron axons (Figure 4.16B). Notably, lesion studies in both primates 
and rodents indicate that disruptions of the corticospinal tracts severely impact fine motor skills, 
such as skilled walking, coordination, and manual dexterity, while voluntary locomotion and gait 
are not significantly affected [531, 532]. Therefore, the observed motor impairments in the Rnu11 
mutant mice may be due to loss of the descending cortical axons in the spinal cord.  
There are many potential causes of the observed anxiety and vocalization deficits in the 
mutant mice. For example, Emx1-lineage excitatory neurons are observed in the basolateral 
amygdala, an important region for fear conditioning [329, 533]; it is possible that either loss or 
dysfunction of these Emx1-lineage excitatory neurons could underlie this phenotype. 
Alternatively, changes in Emx1-lineage cortical neurons that project to the amygdala could explain 
the heightened anxiety. Specifically, activation of the medial prefrontal cortex (mPFC), which 
projects to the basolateral and central amygdala, has been shown to inhibit amygdalar activity, 
linking mPFC activity to reduction in conditioned fear [235, 534]. Loss of these mPFC-amygdala 
projections, or their reduced activity, could result in increased activity in the amygdala and 
increased anxiety. The prefrontal cortex (PFC) is also implicated in social behavior, including 
social motivation. Lesion of the anterior cingulate cortex (ACC), a region within the PFC, reduces 
interest in social interaction [535, 536]. Moreover, the PFC also regulates social dominance, which 
informs socio-sexual vocalization emission such that more dominant males vocalize more than 
subordinates [535, 537]. Therefore, disruption of either of these PFC functions could cause the 
observed reduction in socio-sexual vocalizations in Rnu11 mutant mice. Yet another possibility is 
that inefficient motor control could underlie this change in vocalization. Specifically, orofacial 
motor deficits have been linked to impaired vocalization production [538, 539]. Notably, in 
addition to their poor motor performance, Rnu11 mutant mice struggled to transition to solid food, 
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likely due to the prevalence of Emx1-lineage cells in the jaw musculature (Figure 6.1E-K). This is 
consistent with the micrognathia commonly observed in MOPD1 patients [126, 127]. It is feasible 
that motor deficits, caused by disruption of motor cortex function and/or impaired 
development/function of the jaw musculature, could contribute to the reduction in socio-sexual 
vocalization in the Rnu11 mutant mice.  
During the span of both behavioral studies, multiple Rnu11 mutant mice died unexpectedly, 
despite being provided wetted food daily. These mice were visibly smaller than littermate controls 
and displayed signs of dehydration, including hunched posture and mussed facial fur caused by 
piloerection [540, 541]. Similar symptoms were observed in the Emx1-Cre heterozygous, Rnu11 
mutant mice that died unexpectedly during adulthood (data not shown; Figure 6.1E&K). Given 
that thirst originates in the hypothalamus [542], which is located outside of the Emx1-Cre domain, 
these unexpected deaths most likely relate to Emx1-Cre activity in non-brain structures, 
specifically the jaw musculature and/or the kidneys (Figure 6.1G-J’) [235,  516-518]. Abnormal 
function of the jaw musculature could prevent these mice from efficiently drinking from the 
available water bottle. However, outcomes of occasional cage flooding events, wherein piled cage 
bedding came in contact with the water bottle nozzle and leached most of the water from the bottle, 
in cages housing control and Rnu11 mutant female mice suggested that Rnu11 mutant mice were 
more sensitive to dehydration than their control cage-mates (data not shown). Thus, it is most 
likely that Emx1-Cre-mediated U11 ablation in the renal cortex and, to a lesser extent, the renal 
medulla negatively impacts kidney function, resulting in water loss and dehydration.  
Unexpectedly, we observed significantly altered social and motor behavior in the Rnu11 
heterozygous mice relative to wild-type controls, even though Rnu11 wild-type and heterozygous 
mice appeared morphologically similar. Like the Rnu11 mutant mice, Rnu11 heterozygous mice 
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vocalized significantly less in socio-sexual interactions than wild-type controls; in fact, Rnu11 
heterozygosity had a similar impact on USV production as complete Rnu11 ablation (Figure 6.2I), 
suggesting that the development/function of the cortical circuits underlying social behavior is 
highly sensitive to U11 levels. Since (i) the Rnu11 heterozygous brain is grossly similar to the 
wild-type control brain, and (ii) Rnu11 heterozygous mice did not display motor deficits by any of 
the tasks we employed, the underlying cause of reduced USV production in these mice likely 
differs from that of the microcephalic Rnu11 mutant mice. In the literature, vocalization defects 
have been observed in transgenic mice without microcephaly [543-547]. For instance, Epac2-
deficient mice display severe sociosexual vocalization deficits alongside reduced cell density and 
dendritic spine number specifically in layer II/III neurons of the ACC [545]. Thus, one possibility 
in the Rnu11 heterozygous mice is that a subset of MIGs is required specifically for prefrontal 
cortex development, rendering the prefrontal cortex particularly sensitive to U11 levels. As a 
result, U11 haploinsufficiency would cause abnormal splicing and function of these MIGs, leading 
to prefrontal cortex-specific changes in cell density, neuron differentiation, and prefrontal cortex 
function. While many MIGs, such as Atxn10 [548], Braf [549], Dock4 [550, 551], and Myo10 
[552], have been linked to abnormal neuron differentiation, we did not find any reports linking 
these MIGs to prefrontal cortex-specific defects. A potential mechanism that could reduce cell 
density in the upper layers of the prefrontal cortex is abnormal cell cycle in the prefrontal cortex 
NPCs. In the U11-null pallium, we observed a significantly higher fraction of mitotic NPCs, with 
a significant fraction of mitotic RGCs in prometaphase/metaphase, relative to the control pallium 
(Figure 4.7C-E). Prolongation of these mitotic phases is associated with increased neuron 
production [294]. If NPCs of the rostral pallium express MIGs at higher levels than NPCs 
elsewhere in the pallium, or if cell cycle in these rostral NPCs is primarily controlled by MIGs, 
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then slight changes in minor splicing efficiency could prolong mitosis length. This would shift 
NPCs toward differentiative divisions, which would increase the production of early-born, lower 
layer neurons and gradually deplete the NPC population as development continued. In turn, fewer 
later-born, upper-layer neurons would be produced in the rostral cortex, resulting in a similar 
phenotype as that seen in the Epac2-deficient mice [545].  
Alternatively, the social deficits in the Rnu11 heterozygous mice might be linked to 
abnormal olfaction. Emx1-Cre expression is mosaic in the olfactory bulb, with substantial 
recombinase activity observed in the mitral/tufted cells, the output neurons of the region [235, 516-
518, 553]. Moreover, mitral cell function has been linked to urine detection, with a subset of mitral 
cells specifically responding to the volatile compounds found in mouse urine [554]. Impaired 
detection of such scents has been associated with impaired social behavior [555-557]. Therefore, 
it is possible that U11 haploinsufficiency disrupts the function of MIGs important for olfactory 
bulb development/function, resulting in defective olfaction and social deficits. Further 
investigation is needed to determine whether U11 haploinsufficiency specifically impacts 
development/function of the prefrontal cortex, the olfactory bulb, or both. Regardless, these results 
are the first to implicate the minor spliceosome in either social behavior or cortical region-specific 
development/function in the mammalian brain, raising the possibility that MOPD1, Roifman 
syndrome, and Lowry Wood syndrome patients may display subtle social or olfaction deficits that 
have not yet been tested/identified.   
In contrast with the social behavior phenotype of Rnu11 heterozygous mice, which 
correlated with Rnu11 mutant social deficits, we observed subtle but significant improvement of 
complex, whole-body motor task performance in the Rnu11 heterozygous mice relative to that of 
wild-type controls. The subtlety of this phenotype was highlighted by the differing rotarod 
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performance across our two studies. In our first study, in which the rotarod task was performed 
around P80, Rnu11 heterozygous mice performed significantly better than wild-type controls on 
days 1 and 2 of testing. The enhanced performance on the first two days of testing suggested that 
these mice displayed better baseline motor control than wild-type controls, rather than enhanced 
motor learning. However, in our second study, wherein the rotarod task was performed around 
P105, we did not observe a significant difference between Rnu11 heterozygous and wild-type 
control performance. This appeared to be due to better performance of the wild-type control mice 
in study two, rather than worse performance by the Rnu11 heterozygous mice (Figure 6.3A-B). 
While increased age has been associated with worse rotarod performance, most studies 
investigating the relationship between age and rotarod performance group mice by age intervals 
of two months or longer, while the difference in age between the mice in studies one and two is 
less than one month (2.67 months vs. 3.5 months) [558, 559]. Therefore, it is unclear if this 
observed shift in wild-type performance represents normal mouse motor development or if this 
shift is unique to the Rnu11 transgenic mouse line. In addition to age, multiple groups have 
reported that weight has a confounding effect on rotarod performance, with increased weight 
linked to shorter latencies to fall from the rod [560-562]. If the Rnu11 heterozygous mice of study 
two, but not study one, weighed more than the wild-type controls, this could explain why we did 
not observe improved heterozygous rotarod performance in study two. Assessment of complex 
motor performance by swimming speed, which has not been correlated with weight [563], would 
allow us to circumvent the confounding effect of weight on rotarod performance in the study two 
mice. In fact, when motor performance was tested via the Morris water maze task, the Rnu11 
heterozygous mice used in study two swam significantly faster than wild-type controls on all days 
of testing (Fig. 6.3H). Similar to the rotarod performance enhancement observed in the first study, 
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the average Rnu11 heterozygous mouse swimming speed was significantly higher than that of 
wild-type controls on the first days of testing, indicating a higher baseline level of complex motor 
task performance as opposed to enhanced motor learning (Fig. 6.3H). We did not observe 
significantly enhanced performance on tasks that test specific domains of motor behavior, such as 
strength, coordination, or balance, indicating the presence of subtle motor performance 
enhancements that were only detectable in complex, whole-body motor tasks.  
In the mouse brain, voluntary motor control originates from the motor cortex, which sends 
projections to the brainstem, spinal cord, and the dorsal striatum. The dorsal striatum integrates 
signals from the motor, sensory, and limbic cortices and signals to other nuclei in the basal ganglia, 
ultimately modulating motor signals via brainstem motor nuclei and thalamic neurons, which 
project back to the motor cortex (see section 6.1). Dopaminergic signaling from the ventral 
striatum, specifically the substantia nigra pars compacta (SNc), to the dorsal striatum regulates 
MSN firing, thereby informing motor coordination and motivation [564, 565]. Generally, signaling 
from the motor cortex is associated with movement initiation and direction, while dorsal striatum 
function is linked to the regulation of movement speed, response time, and movement size [566-
570]. In the Emx1-Cre transgemic mouse, Cre-mediated recombination has been reported 
throughout the cortex, in both excitatory neurons and in pallium-derived glia, and in scattered cells 
of the dorsal striatum [235, 329]. Specifically, Emx1-lineage cells in the dorsal striatum include a 
subset of oligodendrocytes and their precursors (OPCs) and approximately 4% of the MSNs [329]. 
Therefore, in the Emx1-Cre+, Rnu11 heterozygous mice, U11 haploinsufficiency could affect 
enhanced motor performance by impacting the development and/or function of the motor cortex 
or the basal ganglia.  
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Enhanced rotarod performance in transgenic mouse lines is often linked to changes in 
striatal function (MGI refs)[516-518, 571-574]. In contrast, neither literature curation nor a 
phenotype-based search, using the MGI database, revealed any transgenic mouse lines in which 
enhanced motor performance has been associated with altered motor cortex function [516-518]. 
Thus, we suspect that changes in the dorsal striatum of the Emx1-Cre+, Rnu11 heterozygous mice 
most likely underlie the enhanced motor performance we observed. While Emx1-lineage MSNs 
comprise only ~4% of MSNs of the dorsal striatum, Cocas et al. found that most of the Emx1-
lineage MSNs are found in striosomes (91% of all Emx1-lineage MSNs) and most are D2-receptor 
expressing MSNs of the indirect pathway (75% of all Emx1-lineage MSNs) [329]. In the wild-type 
rodent dorsal striatum, approximately 15% of all MSNs are found in the striosome; of these 
striosomal MSNs, 20-40% are D2 receptor-expressing MSNs of the indirect pathway. Based on 
the reported prevalences of these cell types in the rodent dorsal striatum, one can calculate that ~3-
6% of all dorsal striatum MSNs are D2 receptor-expressing striosomal MSNs. Thus, even though 
Emx1-lineage MSNs comprise only a small fraction of the total MSN population in the dorsal 
striatum, they likely represent a substantial fraction of the D2 receptor-expressing striosomal MSNs 
of the region. It is possible that Emx1-Cre-mediated Rnu11 haploinsufficiency in these striosomal, 
indirect pathway MSNs would impair the development/function of these cells, resulting in the 
enhanced motor performance observed in the Rnu11 heterozygous mice. Since most of the cortical 
inputs to striosomal MSNs originate from the limbic system-associated cortices [521, 522], Rnu11 
haploinsufficiency may alter limbic system-mediated control of motor coordination in these mice. 
However, since most research on striosome function targets either all striosomal cells or the D1 
receptor-expressing MSNs of the direct pathway, it is unclear how the striosomal, indirect pathway 
MSNs specifically regulate motor behavior. It is possible that altered function/development of 
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these cells leads to secondary effects in the ventral striatum, which houses the dopaminergic 
neurons that project to the dorsal striatum [564, 565]. Increased levels of dopamine in the dorsal 
striatum have been linked to enhanced attention, motivation, and/or motor learning, in turn leading 
to better performance on the rotarod task in transgenic mice [516-518, 571, 572, 574-577]. 
Specifically, motor learning is particularly sensitive to dopamine levels [572, 574, 578-580]. While 
the Rnu11 heterozygous mice display enhanced baseline motor performance on the rotarod and 
Morris tasks, our data do not support enhanced motor learning in these mice, relative to wild-type 
controls (Figures 6.2H, 6.3A-B, and 6.3H). Therefore, if high dopamine levels contribute to the 
observed phenotype, they likely increase motivation and/or attention in the Rnu11 heterozygous 
mice [565]. Yet another possibility is that striatal function in the Emx1-Cre+, Rnu11 heterozygous 
mice is modulated by Emx1-lineage OPCs and oligodendrocytes, which comprise ~50% of all 
Emx1-lineage cells of the dorsal striatum [329]. Changes in myelination could impact striatal 
performance, thereby causing the observed motor phenotype. Since little is known about the 
specific roles of OPCs and oligodendrocytes, or the myelination patterns, in the dorsal striatum, it 
is unclear if increased myelination or regionally increased myelination could enhance motor 
performance/coordination.  
Generally, it is difficult to predict the effects of U11 haploinsufficiency on the expression, splicing, 
and function of specific MIGs. For example, the majority of voltage-gated sodium channel alpha 
subunit genes and voltage-gated calcium channel alpha subunit genes contain at least one minor 
intron [58]. If one predicts that U11 haploinsufficiency results in inefficient minor intron splicing, 
in turn causing abnormal splicing around all minor introns and impaired MIG function, then one 
would expect impaired neuron firing across the cortex and significantly worse performance on all 
tasks relative to the wild-type controls. However, we did not observe signs of global cortical 
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function impairment in the Rnu11 heterozygous mice. Instead, we observed region-specific 
changes in brain function, likely affecting the prefrontal cortex and the basal ganglia.  Moreover, 
the behavioral phenotypes of the Rnu11 heterozygous mice caused impairment of one of these 
domains (sociability), while enhancing the other (whole-body motor performance). Together, our 
findings indicate that specific regions of the brain are differentially sensitive to U11 
haploinsufficiency, with regions underlying sociability being the most sensitive. These findings 
raise numerous questions regarding the carriers of mutant minor spliceosome-specific snRNAs—
e.g., the parents of MOPD1, Lowry Wood syndrome, and Roifman syndrome patients. While these 
heterozygous carriers have previously been considered asymptomatic, these findings suggest that 
heterozygous carriers of these mutations may display subtle behavioral phenotypes that have not 
yet been described.   
 
6.5 Materials and methods 
Animal Procedures 
 All mouse procedures were performed according to the protocols approved by the 
University of Connecticut Institutional Animal Care and Use Committee. The Rnu11 conditional 
knockout (cKO) mouse and its generation is described in Chapter 4 (section 4.5). The primers used 
for Rnu11, Cre, Emx1-Cre zygosity, and Ai9 tdTomato Cre reporter genotyping PCRs are listed in 
Table S7. For survival and weight gain kinetics, both male and female control (Rnu11 wild-type 
and heterozygous) and mutant mice were used. To minimize suffering, animals with profound 
weight loss, indicative of starvation; severe dehydration, identified by hunched posture, moderate 
to severe skin tenting, and sunken eyes; or self-inflicted wounds were euthanized [541]. These 
mice were included in the survival kinetics data, using the age at which they were examined and 
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euthanized. Mice transferred to the MBNF for behavioral testing that were euthanized or died 
unexpectedly were not included in the survival kinetics data. For behavioral testing, adult male 
mice were used for pioneer studies, since behavioral analysis of female mice necessitates 
synchronization of estrus cycle, which has been shown to impact behavior in mice [581]. 
 To generate the mice used for behavioral testing, timed matings were set such that each 
cohort would be comprised of age-matched male mice born within a 20-day (study 1) or a 13-day 
(study 2) window. For study 1, 7 wild-type (WT; Emx1-Cre-negative Rnu11WT/Flx and Rnu11Flx/Flx), 
7 heterozygous (het; Rnu11WT/Flx::Emx1-Cre+), and 8 mutant (mut; Rnu11Flx/Flx::Emx1-Cre+/-) mice 
born between 7/22/2015 and 8/11/2015 were transferred to the MBNF vivarium in late-September 
of 2015. For study 2, 15 wild-type (WT; Rnu11WT/WT::Emx1-Cre+), 15 heterozygous (het; 
Rnu11WT/Flx::Emx1-Cre+/-), and 15 mutant (mut: Rnu11Flx/Flx::Emx1-Cre+/-) mice born between 
7/2/2016 and 7/15/2016 were transferred to the MBNF vivarium in early October of 2016. Upon 
arrival, subjects were singly housed, with water and food available ad libitum, and maintained on 
a 12-hour light/12-hour dark cycle. Behavioral testing did not begin until all subjects in a study 
reached adulthood (>P60). All behavioral testing was performed during subjects’ light period and 
blind to subject genotype. The number of mice used for each behavioral test was determined both 
by the number of healthy mice available, as unexpected deaths particularly depleted the mutant 
mouse groups, and feasibility of testing within a given time window. 
 
Transcardial Perfusion 
P70 control and mutant mice were anesthetized using isoflurane, followed by transcardial 
perfusion performed as previously described [117]. After the brains were removed, they were 
fixed overnight in 4% PFA at 4°C, followed by PBS washes and cryoprotection in 30% sucrose 
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in PBS at 4°C for two days. Following an overnight incubation in half 30% sucrose/half OCT 
compound (Fisher Scientific, #23-730-571), the brains were embedded in OCT compound and 
sectioned using a cryostat (Leica CM 3050 S). 
 
Hematoxylin and Eosin Staining 
Frozen 16 µm coronal sections of P0 mouse brains were cured at room temperature for 15 
minutes, followed by incubation in PBS for 15 minutes. The tissue was then dehydrated using an 
ethanol gradient (25%, 50%, and 75%). Slides were washed twice in 100% ethanol for 30 seconds 
each, with agitation, then washed twice in 95% ethanol for 30 seconds each, with agitation. 
Following a rinse in running tap water, the sections were incubated in Harris hematoxylin (Fisher 
Scientific, #6765001) for 7 minutes. Excess hematoxylin was removed by washing in running 
water for 30 seconds. The slides were briefly agitated in 1% acid alcohol (1% HCl in ethanol), 
then briefly rinsed in running water. Sections were then incubated for 2-3 minutes in saturated 
lithium carbonate (1.54% in dH2O), followed by a 5-minute incubation in tap water. After a 30 
second wash in 80% ethanol with agitation, slides were incubated in an eosin Y-phloxine B 
solution (0.1% eosin Y, 0.01% phloxine B, 0.45% glacial acetic acid, 82.9% ethanol) for 1 minute. 
The sections were then washed in 95% ethanol for 30 seconds with agitation, followed by two 30-
second washes in 100% ethanol with agitation and incubation in 100% ethanol for 1 minute. After 
washing in xylene for 30 seconds with agitation, the slides were washed in xylene for 1 minute, 
then mounted using PermountTM mounting medium (Fisher Scientific, #SP15-100).  
 
Elevated Plus Maze 
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 The elevated plus maze apparatus consisted of four arms arranged in a “plus” (+) 
configuration and an open square in the middle of the apparatus. Two arms, located opposite of 
one another, had high walls blocking their sides and ends; the other two arms were open, i.e., 
without walls. The arm maze apparatus was elevated approximately 1 meter from the ground and 
oriented perpendicular to the ground. Trials were performed in a room with consistent illumination 
and a downward-facing, ceiling-mounted digital video camera that captured the full apparatus 
within its field of view. For each trial, the subject was placed in the center of the apparatus, facing 
an open arm; mouse activity was then recorded for five minutes. Videos were analyzed using the 
TopScan (CleverSys, Reston, VA) tracking software, with manual verification.  
 
Open Field Task 
 The open field consisted of a square, plastic chamber with smooth, high walls. Trials were 
performed in a room with consistent illumination and a downward-facing, ceiling-mounted digital 
video camera that captured the full open field chamber within its field of view. For each trial, the 
subject was placed in the center of the open field, and mouse activity was recorded for 30 minutes. 
Videos were analyzed using the TopScan tracking software. For analysis, the open field was 
divided into four zones of equal width: an out-outer zone, located along the walls of the chamber; 
an in-outer zone, located just within the out-outer zone; an out-center zone, located internal to the 
in-outer zone; and the in-center zone, comprised of the centermost region of the open field. 
Analysis of time spent in, distance travelled, and velocity within these zones was performed using 
the TopScan software. 
 
Rotarod 
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 For the rotarod test, each mouse was placed on a rotating cylindrical rod; the rotation speed 
gradually increased from 4 to 40 rotations per minute across each two-minute trial. For every test 
day, four trials were administered, and mouse performance was recorded on a digital camera set 
on a tripod. Latency to fall from the rotating rod was then quantified based on these video 
recordings. For each mouse, the latency to fall was averaged across the four trials for every test 
day. For the accelerated rotarod paradigm employed in section 6.3.5, rotation speed of the rod 
increased from 4 to 40 rotations in a one-minute period. 
 
Socio-sexual vocalization assessment 
 Adult male mice were introduced to a recording chamber containing an unfamiliar, wild-
type female, along with seven-day dirty bedding from the female’s cage to ensure exposure to 
pheromones from the full estrus period, for a five-minute interacting period. Socio-sexual 
vocalizations were recorded using a ¼ inch condenser microphone [Bruel & Kjaer (B&K) type 
4136, Naerum, Denmark] hung 10 cm above the recording chamber. Since female vocalizations 
in socio-sexual encounters are both rare and much quieter than that of males, this set-up would 
efficiently detect socio-sexual vocalizations from the male test subjects. For preamplification and 
subsequent amplification of the microphone signal, we employed a B&K type 2619 preamplifier 
and a B&K type 2636 amplifier, respectively. Digitization of the amplified signal was performed 
using a Tucker Davis Technologies (Alachua, FL) multifunction processor (RX6), at a 200 kHz 
sampling rate; a custom MatLab program run on a Dell Pentium IV PC was used to save the 
resulting data as a .wav file. Vocalization recordings were then analyzed using the Adobe Audition 
software. From these recordings, the total time spent vocalizing was extracted using vocalization 
intervals (defined as continuous epochs of vocalization <200 ms apart), which were distinguished 
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from periods of silence. The resulting calculation of total time spent vocalizing was then used to 
calculate the percentage of time spent vocalizing during the five-minute interacting period. All 
recordings were performed in a sound-proofing room to both block external auditory stimuli during 
the encounter and minimize acoustic noise during the recording. 
 
Domain-specific motor tasks 
 Balance beam test The balance beam apparatus employed consisted of a 1 meter-long, 
flat, 6 mm-wide beam raised above a table-top. One end of the beam was illuminated by light, 
while the opposite end was enclosed in a box with one side removed, to allow entry from the beam 
into the box. Bedding from the test subject’s home cage was added to this “safe box” to encourage 
mice to travel across the beam. For each test, the test mouse was placed at the illuminated end of 
the beam; mouse movement was recorded using a ceiling-mounted, downward-facing digital 
camera. The resulting recording was then used to calculate the latency to cross the balance beam 
to the enclosed platform. For each mouse, the results of four trials were averaged to calculate the 
latency to cross used for downstream comparisons. 
 Grid walking test The grid walking test, also known as the foot fault task, was performed 
using a metal wire grid with a 3.5 cm x 13.5cm grid. For the task, the wire grid was elevated and 
the test mouse was coaxed to cross the grid. The number of correct foot placements, in which the 
mouse successfully grasps the wire grid with its paw, was quantified from recordings made on a 
tripod-mounted digital camera.   
 Wire hang test The same metal wire grid used for the grid walking test was employed for 
the wire hang test. In this task, the test mouse was coaxed to grip the elevated wire grid and 
suspended from the grid for a 60-second interval. A tripod-mounted digital camera recorded each 
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trial, and the resulting recordings were used to calculate the latency to fall from the grid for each 
mouse.  
 
Morris water maze 
 The Morris water maze apparatus was comprised of a 48-inch diameter, oval tub of room-
temperature (~22˚C) water and a 8-inch diameter platform submerged in 2 cm of water; this hidden 
platform was located at the same location in the pool across all trials across all testing days. Testing 
was performed in a testing room with large black shapes painted on the walls and doorframe, to 
provide extra-maze cues for the test animals. For each trial, the mouse was placed in one of four 
quadrants of the pool (north, east, south, or west) and required to swim until it located the 
submerged platform. Prior to testing on the Morris water maze, test animals were acclimated using 
a water escape task, which employed the same apparatus design except that the platform was 
located above the water’s surface. Due to overall poor motor performance, declining health, and 
increased anxiety of the Rnu11 mutant mice, they were not tested on either the water escape task 
or the Morris water maze to prevent severe stress/drowning. For both the water escape task and 
the Morris water maze trials, mouse performance was recorded using a ceiling-mounted, 
downward-facing Sony Handcam DCR-TRV280 digital camera. The SMART Version 2.5 
tracking software, installed on a Dell Dimensions E21 computer, was employed to trace mouse 
swimming paths and record time to reach the platform (i.e., time to escape the maze). 
Measurements of path length and escape time were then used to calculate swimming velocity for 
each trial. If a test subject took longer than 45 seconds to escape the maze, the experimenter guided 
the mouse to the platform and allowed it to rest there for 10 seconds. Four trials were performed 
each day, with a rest period of 2 minutes under a warming lamp between trials. For each trial, the 
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start position was varied between the north, east, south, and west starting locations, without 
repetition on that testing day; the order of start position location was randomized for each separate 
day of testing. Results from these four trials were averaged to calculate performance for that day; 
this testing was performed across five consecutive days. 
 
Statistical analysis 
 All statistical testing was performed using the SPSS 15.0 software. Two-tailed statistical 
tests were employed, with an alpha cut-off of 0.05. For all behavioral tests performed on both 
studies, ANOVA was used to determine the effect of study on test performance; if no significant 
effect of study was observed, the results from the two studies were pooled. Univariate analyses of 
variation (ANOVAs) were employed to compare performance on each task as a function of 
genotype (3 levels: WT, het, mut). For behavioral tests performed over multiple days, such as the 
rotarod and Morris water maze testing paradigms, repeated measures ANOVAs were employed. 
In both cases, variables included genotype (3 levels: WT, het, mut) and day (5 levels: day 1, day 
2, day 3, day 4, day 5). If a significant effect of genotype was revealed by ANOVA, pairwise 
comparisons of genotype-specific performance (e.g., WT vs mut, het vs mut, WT vs het) was 
completed using two-way student’s t-tests.  
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Chapter 6: Figures 
 
Figure 6.1. Survival and weight gain kinetics in the microcephalic Rnu11 mutant mice.  
(A) Lateral view of skulls from P70 ctrl and mut mice. Scale bar=5 mm. (B) Dorsal view of the 
brains removed from the skulls in (A). Scale bar=5 mm. (C-D) Coronal sections of the P70 brains 
in (B), stained with hematoxylin and eosin. Scale bar=1 mm. (E) Survival kinetics of control (solid 
line, N=5) and mutant (dashed line, N=22) mice from P10 to P700. (F)Weight kinetics of Emx1-
Cre+/- Rnu11 ctrl (solid line, N=3) and Rnu11 mut (dashed line, N=3) mice from birth until P30. 
Statistical significance at each time point was determined by two-tailed student’s t-test. *=P<0.05. 
(G-H) tdTomato Cre reporter signal (red) in lateral views of the P0 ctrl (G) and mut (H) head. (I-
J) Lateral views of the jaw musculature of P21 ctrl (I) and mut (J) mice; Mas=masseter, 
tm=temporalis. (I’-J’) tdTomato Cre reporter signal in the jaw musculature of the ctrl and mut 
mice in (I) and (J), respectively. (K) Survival kinetics of ctrl (solid line, N=69), Rnu11 mutants 
heterozygous for Emx1-Cre (dashed line, N=25), and Rnu11 mutants homozygous for Emx1-Cre 
(dotted line, N=11) from birth to adulthood (P60).  
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Figure 6.2. Anxiety, motor performance, and socio-sexual behavior analysis of Rnu11 wild-
type (WT), heterozygous (het), and mutant (mut) mice.  
(A-B) Elevated plus maze performance by (A) arm entry number and (B) time spent in open arms. 
(C) Schematic of the zones in the open field test. (D-G) Open field performance by distance in the 
(D) out-outer, (E) out-center, and (F) in-center zones, and by (G) velocity in the out-outer zone. 
(H) Latency to fall on the rotarod across 5 days of testing for mice pooled from both studies. (I) 
Percent time spent vocalizing in male-female, 5-minute interactions. Green=WT, orange=het, 
blue=mut. Statistical significance was determined by either univariate or repeated measures 
ANOVA, followed by two-tailed student’s t-tests. N.s.=not significant, *=P<0.05, **=P<0.01, 
***=P<0.001. 
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Figure 6.3. Analysis of motor ability in the Rnu11 heterozygous (het) mouse.  
(A-B) Latency to fall off the rotarod across 5 days of testing for mice from (A) study 1, tested at 
P80, and (B) study 2, tested at P105. (C) Latency to fall off the rotarod using a rapid acceleration 
protocol across 5 days of testing for mice from study 2. (D) Balance beam performance by time to 
cross the beam, using mice from study 2. (E) Grid walking performance, measured by number of 
correct foot placements, for mice from study 2. (F) Wire hang test performance, measured by 
latency to fall, for mice from study 2. (G-H) Morris water maze performance by (G) path length 
to platform and (H) average swimming velocity, for mice from study 2. Orange=WT, green=het, 
blue=mut. Statistical significance was determined by either univariate or repeated measures 
ANOVA, followed by two-tailed student’s t-tests. *=P<0.05, **=P<0.01, ***=P<0.001. 
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Chapter 7: Conclusions and future directions 
In Chapter 3, it was shown that the minor spliceosome-specific snRNAs are enriched in 
the developing CNS and limb buds, which corresponds strongly to the tissues affected in MOPD1 
[107, 108, 124, 125] (Figure 3.4). In the early embryonic retina, expression of these snRNAs was 
relatively high in the retinal progenitor cells, but as development continued, the highest enrichment 
was later observed in the differentiating retinal neurons (Figures 3.6&3.7). Moreover, P0 
electroporation of U12 morpholino revealed death of differentiating retinal neurons, with complete 
loss of electroporated cells observed by P14 (Figure 3.11). In contrast, genetic Rnu11 ablation in 
the E12 pallium caused widespread death of self-amplifying RGCs, while both IPCs and neurons 
were produced (Figures 4.4, 4.5C-F, and 4.15). In fact, our data suggest that U11-null neurons 
produced in the pallium can survive postnatally (Figure 4.15). It is unclear if this discrepancy is 
due to a difference in the knockdown/knockout strategy used—for example, morpholino-based 
knockdown can lead to artifacts due to non-specific binding [582]—or the timing of the 
knockdown/knockout, since Rnu11 ablation occurred prior to the start of cortical neurogenesis 
while the U12 morpholino was introduced at P0, in the middle of retinal neurogenesis [235, 329] 
(Chapter 3). Alternatively, cell type-specific differences in MIG expression and splicing may 
underlie this discrepancy. Notably, retinal phenotypes are not commonly reported in MOPD1, 
while microcephaly is observed in MOPD1, Roifman Syndrome, and Lowry Wood syndrome, 
which supports this possibility [106-108, 122, 124-129, 139-143]. To test this, breeding the retinal 
progenitor cell-specific Chx10-Cre transgenic mouse into the Rnu11 cKO moue line would allow 
for the genetic ablation of U11 in the retinal progenitor cells starting at E11 [583], and would 
circumvent the problems associated with the U12 morpholino experiment. 
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 In Chapter 4, prolongation of mitosis, and particularly of prometaphase/metaphase, was 
observed in the U11-null RGCs (Figure 4.7C-E); in 2016, Pilaz et al. reported that prolongation of 
prometaphase/metaphase in RGCs results in increased differentiative drive [294]. To investigate 
IPC and neuron production in the developing cortex, a two-pronged approach employing in vitro 
and in vivo techniques would be the most effective. To study IPC and neuron production from 
RGCs in vitro, NPC derivation from E11 or E12 Emx1-Cre+ and Emx1-Cre- Rnu11Flx/Flx::Mapt-
EGFP and Rnu11Flx/Flx::Tbr2-EGFP pallia followed by live-imaging would allow us to track and 
quantify the number of proliferative, IPC-producing, and neurogenic divisions in the wild-type 
and mutant pallium [220, 294, 584]. Subsequent fixation and immunofluorescence for the RGC 
marker Pax6 would further allow us to identify the unlabeled, dividing cells. This approach would 
also allow us to calculate the length of cell division in the wild-type RGCs, wild-type IPCs, mutant 
RGCs, and mutant IPCs. To study divisions in vivo, in utero electroporation (IUE) of either a 
pCAG-Cre or pTbr2-Cre plasmid into Rnu11WT/WT::loxp-STOP-loxp-CAG-tdTomato+ and 
Rnu11Flx/Flx::loxp-STOP-loxp-CAG-tdTomato+ E13 embryos would allow us to specifically ablate 
Rnu11 in a subset of either RGCs (pCAG-Cre) or IPCs (pTbr2-Cre) [585, 586]. Harvest of the 
electroporated embryos after 48 hours, followed by quantification of tdTomato+ RGCs, IPCs, and 
neurons in the wild-type or mutant embryos, would allow us to determine whether IPC or neuron 
production is altered by U11 loss. Moreover, this strategy would allow us to distinguish between 
the effects of U11 loss on RGCs versus IPCs, by employing the IPC-specific pTbr2-Cre plasmid, 
gifted to the Kanadia lab by Dr. Tarik Haydar [585]. Additionally, by performing this experiment 
and harvesting at postnatal time-points, we can also use this strategy to verify and study U11-null 
neuron survival and differentiation. 
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 To further study the cell type-specificity observed in Chapter 4, fluorescence-assisted cell 
sorting (FACS) is a powerful method that would allow us to study MIG expression and splicing 
across distinct cell types of the cortex and, potentially, the striatum [587]. This approach would 
allow us to determine whether the U11-null neurons in the Rnu11 mutant pallium have shifted 
their transcriptional programs to circumvent those requiring MIG function, or if all neurons rely 
on transcriptional programs with few MIGs. Moreover, we could determine whether neurons 
express any of the core essentialome MIGs identified in Chapter 5. To this end, we have bred the 
Mapt-EGFP mouse in the Emx1-Cre+, tdTomato+ Rnu11 cKO line. By dissociating the pallium, 
pooling embryos of the same genotype, and employing FACS to separate the EGFP+/tdTomato+ 
Emx1-Cre+ neurons from the EGFP-/tdTomato+ Emx1-Cre+ NPCs, we can perform RNAseq on 
these distinct populations. The same approach can be used to study the Emx1-lineage cells of the 
striatum at later embryonic time-points, once these cells have fully migrated from the pallium to 
their final positions in the striatum [329]. This approach would also identify any cell type-specific 
alternative splicing occurring in either MIGs or non-MIGs; Anouk Olthof of the Kanadia lab is 
currently pursuing this line of research.  
 In Chapter 4, the self-amplifying RGC death we observed occurred alongside DNA damage 
and p53 accumulation (Figure 4.6E). In numerous microcephalic transgenic mouse lines, p53-
mediated apoptosis drives microcephaly, and genetic ablation of p53 can rescue the cell death and 
microcephaly (see section 4.2.3). It is unclear if this is the case in the Rnu11 mutant mouse, because 
(1) a subset of MIGs are essential for cycling cell survival, as discussed in Chapter 5; and (2) 
inactivation of the minor spliceosome is projected to affect the expression and function of hundreds 
of genes, each of which has its own distinct interactors. To determine if p53-mediated apoptosis is 
the single driver of cell death in the Rnu11 mutant pallium, we have begun crossing the Trp53 
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conditional knockout mouse into the Emx1-Cre+ Rnu11 cKO line, which will be analyzed using 
the same postnatal and embryonic approaches detailed in Chapter 4 [588]. Alisa White of the 
Kanadia lab is currently pursuing this line of investigation.  
 In the behavioral testing described in Chapter 6, we observed significant behavioral 
changes as a result of Rnu11 heterozygosity, raising the question of whether U11 
haploinsufficiency impacts progenitor cell behavior, neuron production, neuron differentiation, 
and/or neuron function. To understand how Rnu11 heterozygosity impacts cortical development, 
we must first extend the embryonic analyses described in Chapter 4 to the Rnu11 heterozygous 
pallium, to determine if cell survival, proliferation/differentiation, and migration is affected by 
U11 haploinsufficiency. The histological analysis would have to be extended to postnatal time-
points spanning from P0 to P21, to assess changes in glial cell production from the developing 
postnatal cortex [202, 230-232]. Given the laminar structure of the cortex, wherein the neurons of 
each layer have different morphologies, projections, and overall functions, we would also need to 
employ layer-specific neuronal markers, such as an antisense FISH probe for Cux2, to mark layers 
II-IV [589]; Rorb antisense probe to mark neurons in layer IV [590]; Ctip2 antibody or Er81 
antisense probe to mark layer V [591]; Foxp2 antibody to mark layer VI [592]; and Ctgf antisense 
probe to mark the subplate [593]. Both the absolute and relative numbers of the neurons of each 
layer would need to be quantified, using NeuN antibody to mark all excitatory neurons. In addition 
to histological characterizations, qRT-PCR and RNAseq of the Rnu11 heterozygous vs the wild-
type pallium would be essential, to characterize the relative levels of U11 in the Rnu11 
heterozygous pallium and identify any minor intron retention and/or MIG alternative splicing in 
the heterozygous pallium. To understand the effects of Rnu11 heterozygosity on neuronal 
differentiation, we have begun breeding the Thy1-YFP allele in the Emx1-Cre+ Rnu11 cKO mouse 
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line. In this transgenic mouse, high YFP expression is observed in scattered pyramidal cells of 
layer V; this strong fluorescent staining would allow us to trace the dendritic branches of the 
labeled neurons, and therefore assess neuronal differentiation [594, 595]. In parallel, Golgi-Cox 
staining could be used to assess dendritic branching and spine morphology of pyramidal cells of 
the cortex [596]. To understand the effects of U11 haploinsufficiency on the Emx1-lineage 
oligodendrocytes, OPCs, and MSNs of the dorsal striatum, we would employ the Ai9 tdTomato 
cre reporter, combined with staining for the oligodendrocyte marker CC1, the OPC marker Ng2, 
and the MSN marker DARPP-32 [329], to quantify the number of these Emx1-lineage cells. To 
cover the possibility of changes in neuron firing, we have discussed collaborating with Dr. 
Anastasios Tzingounis to investigate changes in the electrophysiology of the cortical Rnu11 
mutant and heterozygous neurons, and to potentially perform calcium imaging. For this purpose, 
we have begun crossing the GCaMP5 calcium reporter into the Emx1-Cre+ Rnu11 cKO line, to 
visualize calcium flux in live brain slices [597]. This is particularly relevant, given the number of 
voltage-gated calcium channel alpha subunit genes that contain minor introns [58]. 
 Finally, as discussed in section 6.4, there are many potential causes underlying the 
unexpected behavioral changes in the Rnu11 heterozygous mice. For example, changes in 
olfaction could impair sociability, and changes in motivation/attention could cause the increased 
motor performance observed. Therefore, additional behavioral experiments could help narrow 
down the specific domains affected by U11 haploinsufficiency. The olfactory 
habituation/dishabituation test, using both non-social and social odors, could eliminate impaired 
olfaction as a potential cause of the sociability deficit [598]. The use of home cage running 
wheels, which can record the amount of voluntary motor activity, would provide insight into the 
inherent motivation of these mice to perform motor behaviors. Finally, the 5-choice serial 
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reaction time task (5-CSRTT) could be employed to study changes in attention—an essential 
test, given that increased attention has been linked to better rotarod performance [599, 600].    
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Chapter 9: Supplementary figures 
 
Figure S1. Related to Figure 4.15. Dynamic expression of U11 in the control P21 cortex. Individual channels showing NeuN IF staining (blue), 
U11 FISH staining (green), EdU (magenta), merged channels, and merged channels+DAPI signal (white) in the P0 control (A-E), P0 mutant (F-J), 
P21 control (K-O), and P21 mutant (P-T) cortex. Scale bars=60 µm. (K’-O’) Magnified images of the three cells boxed in (K-O) with low U11 
expression. The nuclei of these three cells, as defined by DAPI staining, were outlined in (K’-O’). Scale bars=5 µm. Str=striatum.  
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Figure S2. Related to Figure 4.15. Raw maximum intensity projection (MIP) and optical slice images used in Figure 4.15C-C’’’’. (A) One of 
the raw MIP images used in Figure 6C, which contains the cells magnified in Figure 4.15C’-C’’’’. This is one of three images used in the collage in 
Figure 4.15C, which shows a column of a coronal section of the P0 mutant cortex, with NeuN IF staining (blue), U11 FISH staining (green), and EdU 
detection (magenta). Scale bar=30 µm. (A’-A’’’’’) Magnified images of the boxed region in (A, MIP image), representing the raw MIP images of the 
cells shown in Figure 4.15C’-C’’’’, with NeuN IF staining (blue, A’), U11 FISH staining (green, A’’), EdU detection (magenta, A’’’), merged channels 
(A’’’’), and merged channels with DAPI (white) (A’’’’’). Open arrowheads mark where the arrowheads in Figure 4.15C’-C’’’’ are located. The nuclei 
of the three cells indicated by these arrowheads are outlined in dashed lines, as determined by DAPI staining. The color of the dashed lines indicates 
proximity of the outlined region to neighboring nuclei. Dashed white lines indicate that, in this MIP image, no other nuclei lie directly above or below 
this region, while dashed red lines indicate that at least one other nucleus is located directly above or below this region. Scale bars=5 µm. (B) Schematic 
of the optical slices (24 in total) comprising the MIP image in A’’’, corresponding to the raw MIP version of Figure 4.15C’. Raw optical slices numbered 
16 to 20 are shown below this schematic; optical slice 18 (red box) was used to generate Figure 4.15C’-C’’’’. (C) The raw optical slice 18 image that 
corresponds to the MIP image shown in (A). (C’-C’’’’’) Magnified images of the boxed region in (C, optical slice), representing the raw optical slice 
images of the cells shown in Figure 4.15C’-C’’’’, showing NeuN IF staining (blue, C’), U11 FISH staining (green, C’’), EdU detection (magenta, 
C’’’), merged channels (C’’’’), and merged channels with DAPI (white) (C’’’’’). Open arrowheads mark where the arrowheads in Figure 4.15C’-C’’’’ 
are located. The nuclei of the three cells indicated by these arrowheads are outlined in dashed lines, as determined by DAPI staining. Scale bars=5 µm.
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Figure S3. Related to Figure 4.15. Adjusted maximum intensity projection (MIP) and optical slice images 
used in Figure 4.15E-E’’’’. (A) One of the channel-adjusted MIP images used in Figure 4.15E, which contains 
the cells magnified in Figure 4.15E’-E’’’’. This is one of the three images used in the collage in Figure 4.15E, 
which showed a column of a coronal section of the P21 mutant cortex. with NeuN IF staining (blue), U11 FISH 
staining (green), and EdU detection (magenta). Scale bar=30 µm. (A1’-A1’’’’) Magnified images of the boxed 
regions in (A, MIP image), showing U11-negative, NeuN+, EdU+ cells, with EdU detection (magenta, A1-A3), 
Neun IF staining (blue, A1’-A3’), U11 FISH staining (green, A1’’-A3’’), merged channels (A1’’’-A3’’’), and 
merged channels with DAPI (white) (A1’’’’-A3’’’’). The nuclei of the U11-/NeuN+/EdU+ cells in these images 
were outlined in dashed lines, as determined by DAPI staining. The color of the dashed lines indicates proximity 
of the outlined region to neighboring nuclei. Dashed white lines indicate that, in this MIP image, no other nuclei 
lie directly above or below this region. Dashed red lines indicate that, in this MIP image, at least one other nucleus 
is located directly above or below this region. (A1-A’’’) represent the channel-adjusted MIP images of the cells 
shown in Figure 4.15E’-E’’’’. Scale bars=5 µm. (B) Schematic of the optical slices (36 in total) comprising the 
channel-adjusted MIP image in A. The optical slices numbered 3 to 7 are shown below this schematic; optical 
slice 5 (red box) was used to generate Figure 4.15E’-E’’’’. (C) The channel-adjusted optical slice 5 image that 
corresponds to the MIP image shown in (A). (C’-C’’’’’) Magnified images of the boxed region in (C, optical 
slice), representing the channel-adjusted optical slice images of the cells shown in Figure 4.15E’-E’’’’, showing 
EdU detection (magenta, C’), NeuN IF staining (blue, C’’), U11 FISH staining (green, C’’’), merged channels 
(C’’’’), and merged channels with DAPI (white) (C’’’’’). The nuclei of the two U11-/NeuN+/EdU+ cells were 
outlined in dashed lines, as determined by DAPI staining. The optical slice images in (C’-C’’’’) represent the 
images used to generate Figure 4.15E’-E’’’’. Scale bars=5 µm. 
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Figure S4. Related to Figure 4.15. High non-nuclear U11 FISH staining in P21 control and mutant cortical 
sections. (A-B) One of the raw MIP images used in Figure 4.15D (A, P21 control) and Figure 4.15E (B, P21 
mutant). These images were used in the collages in Figure 4.15D&E, which show a column of coronal sections 
of the P21 control and mutant cortices, with U11 FISH staining (green), NeuN IF staining (blue), EdU detection 
(magenta), and nuclear staining by DAPI (white). The raw MIP image from the P21 mutant cortex (B) contains 
the cells magnified in Figure 4.15E’-E’’’’; the raw MIP image from the P21 control cortex (A) corresponds to the 
same location within the cortex as (B). Scale bars=30 µm. Magnified images of the boxed regions in (A) and (B) 
are shown in (A’-A’’’) and (B’-B’’’), respectively, showing U11 FISH staining (green, A’&B’), DAPI staining 
(white, A’’&B’’), and merged channels (A’’’&B’’’). Open arrowheads indicate non-nuclear U11 FISH staining. 
Scale bars=5 µm. (C-D) The channel-adjusted MIP images of the P21 control (C) and mutant (D) cortices, 
corresponding to panels (A) and (B), respectively, with the U11 channel adjusted to minimize the non-nuclear 
U11 FISH staining observed in both the P21 control and mutant cortices (A-B’’’), while retaining U11 FISH 
signal in NeuN+ cells in the P21 control cortex (Figure S1K’-O’). Scale bars=30 µm. Magnified images of the 
boxed regions in (C) and (D) are shown in (C’-C’’’) and (D’-D’’’), respectively, showing U11 FISH staining 
(green, C’&D’), DAPI staining (white, C’’&D’’), and merged channels (C’’’&D’’’). Open arrowheads indicate 
non-nuclear U11 FISH staining. Scale bars=5 µm.
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Figure S5. Related to Figure S4. Higher resolution images of the non-nuclear U11 FISH staining in P21 control and mutant cortical sections. 
(A-F) Non-nuclear U11 FISH staining in raw MIP images from the P21 control (A-C) and P21 mutant (D-F) cortical images from Figure S4A’-B’’, 
showing U11 FISH staining (green, A&D), DAPI staining (white, B&E), and merged channels (C&F). (A’-F’) Non-nuclear U11 FISH staining in 
channel-adjusted MIP images from the P21 control (A’-C’) and P21 mutant (D’-F’) cortical images in Figure R6C’-D’’, showing U11 FISH staining 
(green, A’&D’), DAPI staining (white, B’&E’), and merged channels (C’&F’). Open arrowheads indicate non-nuclear U11 FISH staining. Scale bars=5 
µm. 
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Chapter 10: Supplementary tables 
Table S1. Select results from DAVID analysis of the 461 MIGs interrogated by custom 
microarray. Only terms from the GOTERM category with a Bonferroni correction ≤0.005 were 
included. Domain-specific DAVID results were discarded. Synonymous terms were also 
discarded in favor of a representative term with the highest number of genes. 
Term # Genes Bonferroni 
Intracellular transport 42 2.82E-10 
Protein transport 48 8.96E-08 
Nucleocytoplasmic transport 17 3.05E-06 
Protein import into nucleus, docking 7 1.57E-03 
Nuclear lumen 49 3.23E-04 
Nuclear pore 12 1.04E-04 
Transmembrane transport 33 3.07E-04 
Voltage-gated ion channel activity 21 7.47E-06 
Voltage-gated calcium channel activity 9 8.52E-06 
Voltage-gated sodium channel activity 7 3.96E-05 
MAP kinase activity 10 2.39E-09 
SAP kinase activity 6 2.31E-05 
Nucleotide binding 96 2.41E-06 
ATP binding 66 3.91E-04 
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Table S2. Primers used for in situ hybridization probe preparation. 
RNA 
Target 
Primer 
Direction 
Primer Sequence 
7SK 
Forward 5'-CTCCAAACAAGCTCTCAAGGTCCA-3' 
Reverse 5'-ATGCAGCGCCTCATTTGGATGTGT-3' 
U11 
Forward 5'-AAAGGGCTTCTGTCGTGAGTGGC-3' 
Reverse 5'-CCGGGACCAACGATCACCAG-3' 
U12 
Forward 5'-ACGCCCGAGTCCTCACTGCTTAT-3' 
Reverse 5'-ACCCAGGCATCCCGCAAAGTA-3' 
U4atac 
Forward 5'-TTTCTTGGGGTTGCGCTACTGTC-3' 
Reverse 5'-AAATTGCACCAAGGTAAAGCAGAGCT-3' 
U6atac 
Forward 5'-GTGTTGTATGAAAGGAGAGAAGGTTAGCAC-3' 
Reverse 5'-AACAGTGGTTAGATGCCACGAAGTAGGT-3' 
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Table S3. Expression data for key genes in RNAseq data in Chapter 4. FC=expression fold-
change between control and mutant; Ave=average. 
Gene Log2FC 
Fold-Change 
(FC) 
Ave FPKM Control Ave FPKM Mutant 
Dbx1 0 1 0.608509842 0.530471762 
Emx1 0.062359 1.04417 19.0897891 20.28353723 
Hist1h1a -0.19403 1.14395 1229.474093 998.5326327 
Lhx6 0.111118 1.08007 0.681803986 0.487783471 
Neat1 0.254737 1.19312 1.388437498 1.185303486 
Rnu11 -1.56145 2.95151 1877.723894 766.3865674 
Spc24 -1.32088 2.49818 33.58894779 13.29649526 
Tp53 0.188527 1.1396 9.33811728 10.35488266 
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Table S4. Mammalian functions of the 4 genes upregulated in the mutant pallium that enriched for “intrinsic apoptotic signaling pathway in 
response to DNA damage by p53 mediator” by DAVID. Related to Figure 4.6. FC=expression fold-change between control and mutant. 
Ave=average. 
Gene Synonyms 
Ave 
FPKM 
Ctrl 
Ave FPKM 
Mut 
FC Function Description 
Bbc3 
Puma, Jfy1,  
Jfy-1 
0.7199858 1.8057943 2.43627 
p53 upregulated modulator of apoptosis, a BH3 domain-containing gene 
(PMID: 11572983); alongside Pmaip1 (below), important activator of 
genotoxic stress-induced apoptosis in NPCs (PMID: 16822983); required for 
apoptosis driven by increased p53 expression (PMID: 12574499) 
Eda2r Xedar 1.6703153 10.5807371 6.85729 
both EDA2R and its ligand, EDA, are transcriptionally activated by p53 
(PMID: 19543321, 20501644); regulator of p53-mediated apoptosis via 
interaction with the death receptor FAS, and increased expression of EDA2R 
results in upregulation/stabilization of FAS protein levels (PMID: 19543321)  
Perp 
Kcp1, Krtcap1, 
Pigpc1, Thw 
0.4671268 1.0282991 2.23922 
p53 apoptosis factor related to PMP-22; transcriptionally activated by p53 
during p53-mediated apoptosis, but not during p53-mediated G1 arrest 
(PMID: 10733530, 14707288); induces p53 upregulation, post-translational 
p53 modifications that disrupt MDM2-p53 binding, and p53 nuclear 
translocation (PMID: 21451571); important positive regulator of p53-
mediated apoptosis in the embryonic mouse brain (PMID: 14614825); DNA 
damage upregulates Perp expression (PMID: 14614825) 
Pmaip1 Noxa, Apr 0.7210288 2.3228602 2.56006 
pro-apoptotic, BH3 domain-containing gene whose transcription is activated 
by p53 (PMID: 10807576, 14500851); alongside Bbc3 (above), important 
activator of genotoxic stress-induced apoptosis in NPCs (PMID: 16822983) 
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Table S5. Mammalian functions of the 21 MIGs regulating cell cycle with significantly elevated minor intron retention the mutant pallium. 
Related to Figure 4.7&9. P-values were determined by two-tailed student’s t-test. Syns=synonyms, ave=average. MSI=mis-splicing index. 
MIG Syns 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
MSI  
P-
value 
∆MSI Cell Cycle Function Description 
Ahctf1 
Elys, 
Mst108, 
Tmbs62 
25.9714 27.71142 7.64499 27.5516 0.0018 19.9066 
in HeLa cells, localizes to nuclear pore and kinetochores, and 
RNAi-mediated knockdown causes cytokinesis defects 
(PMID: 17098863); required for nuclear pore assembly 
(PMID: 17098863); siRNA-mediated knockdown in HeLa 
cells results in mislocalization of LBR, which is important 
for reforming nuclear envelope post-mitosis (PMID: 
22555603) 
Ccnk 
Cpr4, 
CycK 
5.34881 5.326958 5.05311 27.0929 0.0046 22.0398 
cyclin K; highly expressed in pluripotent mouse embryonic 
stem cells, and knockdown results in increased cell 
differentiation (PMID: 22547058); knockdown of two Cdk 
partners identified in study (Cdk12 & Cdk13), enhanced 
differentiation, suggesting role in self-renewal (PMID: 
22547058) 
Ccnt1 
Ccnt, 
Cyct1, 
Hive1 
16.7709 19.37268 8.40885 16.5704 0.0456 8.16158 
normally associates with chromosomes during mitosis, and 
mislocalization caused arrest at G1 and apoptosis, indicating 
necessary role in transcribing genes during cell division 
(PMID: 18292778) 
Cdc45  24.4613 27.80446 2.46166 19.2321 0.0017 16.7704 
initiation of DNA replication (PMID: 25933514); recruits 
DNA polymerase α-primase (see Prim1 below) to the DNA 
replication complex (PMID: 10518787) 
Cep164 Nphp15 5.06087 5.324126 5.90409 30.0608 0.0004 24.1567 
siRNA-mediated knockdown in HeLa cells shows important 
role in G2/M checkpoint of cell cycle (PMID: 18283122); in 
human RPE-FUCCI cells, knockdown causes shorter G1, 
G2, and M phases, but reduced proliferation, slowed S phase, 
and increased apoptosis (PMID: 25340510) 
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MIG Syns 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
MSI  
P-
value 
∆MSI Cell Cycle Function Description 
Cgrrf1 
Cgr19, 
Rnf197 
3.37512 3.102399 7.18815 35.1293 0.0015 27.9411 
cell growth regulator; transcriptionally upregulated by p53, 
and its overexpression suppresses cell proliferation (PMID: 
8968090) 
Dna2 Dna2l 3.92161 3.757846 4.80785 17.4288 0.015 12.6209 
helicase/nuclease; functions in DNA replication & S/G2 
phase DNA stability (PMID: 22570476); chromosome 
segregation role, based on effect of knockdown (PMID: 
23604072) 
Dctn3 
Dctn22, 
p22, p24 
49.6795 41.57011 1.6562 12.2327 0.002 10.5765 
dynactin necessary for mitosis progression and chromosome 
segregation (PMID: 25645239, 21163948) 
Dync1li1 
Lic1, 
Dncli1, 
Dnclic1 
11.1754 11.34764 2.30119 8.52481 0.021 6.22362 
dynein, light intermediate chain 1; knockdown alongside 
LIC2 results in  misregulation of centriole cohesion during 
mitosis (PMID: 25422374); depletion in human cells causes 
metaphase delay and increased interkinetichore distance, 
suggesting a role in the spindle assembly checkpoint (PMID: 
19229290) 
E2f1 
Rbp3, 
Rbap1, 
Rbbp3 
6.06778 6.486815 12.9125 53.2398 0.001 40.3273 
transcription factor induced by cellular stress, including 
DNA damage, resulting in apoptosis (PMID: 12717439); 
target of pRB and complexes with it—depending on 
circumstance and cell cycle stage, can drive either activation 
or repression (PMID: 20016602, 20224733); however, based 
on KO mouse studies (which interrogated E2f1, E2f2, & 
E2f3), not required for cell division in embryonic tissues and 
specific adult tissues tested, but it is required for DNA 
integrity and cell survival (PMID: 20016602); misexpression 
in embryonic lens fiber cells causes cell cycle entry and 
subsequent apoptosis (PMID: 11095619); AKT is a target of 
E2f1 (PMID: 22298593) 
E2f6 
E2f6b, 
Ema 
9.95253 8.848759 6.96865 31.4943 0.0006 24.5257 
Rb-independent transcription repressor that may repress 
E2F-responsive genes during S phase; also interacts with 
chromatin remodeling complex member Brg1 on G1/S gene.. 
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MIG Syns 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
MSI  
P-
value 
∆MSI Cell Cycle Function Description 
E2f6 
E2f6b, 
Ema 
9.95253 8.848759 6.96865 31.4943 0.0006 24.5257 
… promoters during S phase, suggesting role in G1/S phase 
transition (PMID: 23082233); in response to DNA 
replication stress, E2f6 replaces activating E2fs at promoters 
to repress transcription before G1/S transition, and 
dissociation is driven by Chk phosphorylation of E2f6 
(PMID: 23954429) 
Gak 
Dnaj26, 
Dnajc26 
17.3443 19.80183 4.88252 15.8289 0.0012 10.9464 
cyclin G-associated kinase; in Nestin-cre conditional 
knockout, observed morphological changes in ventricular 
zones (cells less dense) and hypothalamus, indicating 
proliferation defects (PMID: 18434600); siRNA revealed 
importance of GAK for spindle assembly and chromosome 
alignment during mitosis (arrest during mitosis) (PMID: 
20237935) 
Maea 
Emp, 
Emlp, 
Gid9, 
Pig5, 
Hlc-10 
16.3218 17.36623 1.20219 4.79234 0.0407 3.59015 
macrophage erythroblast attacher protein; localizes to mitotic 
spindle and contractile ring during mitosis/cytokinesis 
(PMID: 16510120) 
Mau2 Scc4 20.3413 22.14701 1.78068 9.64785 0.0129 7.86717 
sister chromatid cohesion factor required for loading cohesin 
onto chromosomes (PMID: 16802858, 16682347); siRNA-
mediated knockdown in HeLa cells disrupted sister 
chromatid cohesion, resulting in chromosome mis-
segregation and prolonged prometaphase, at the expense of 
metaphase and anaphase (PMID: 16682347) 
Nedd1 
Gcp-wd, 
Tubgcp7 
23.2697 21.244 7.73854 14.7733 0.0263 7.0348 
centrosomal protein that is required for γ-tubulin ring 
complex localization to the centrosome, with knockdown 
causing defects in centrosomal microtubule nucleation, 
aberrant mitotic spindles, and inhibition of centriole 
duplication (PMID: 16461362) 
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MIG Syns 
Ave 
FPKM 
Ctrl 
Ave 
FPKM 
Mut 
Ave 
MSI 
Ctrl 
Ave 
MSI 
Mut 
MSI  
P-
value 
∆MSI Cell Cycle Function Description 
Ppp2r2d 
Pr55δ, 
PP2A-
B55δ 
13.9211 11.13086 5.06246 17.2976 0.005 12.2351 
phosphatase regulatory subunit; in cancer cell line, 
knockdown enhanced T-cell proliferation and cytokine 
production, and inhibited T-cell apoptosis (PMID: 
24476824); work in Xenopus suggests PP2a-B55δ inhibits 
CDK1 activation, thereby regulating mitosis entry/exit 
(PMID: 19696736) 
Prim1 p48, p49 22.8139 25.48825 4.46452 23.1345 5E-06 18.67 
catalytic primase subunit of DNA polymerase α-primase 
(PMID: 20030400); generates an RNA primer, followed by 
primer extension to produce RNA-DNA primer, to initiate 
DNA replication (reviewed in PMID: 9759502) 
Rfc5 
Recc5, 
36kDa, 
36.5kDa, 
p36 
22.4726 14.61202 4.95427 12.8491 0.0017 7.89481 
component of the replication factor C complex, which loads 
PCNA onto DNA at primer-template junctions or onto 
nicked duplex DNA, in turn allowing for DNA synthesis via 
DNA polymerase δ (PMID: 9759502) 
Uba3 
Nae2, 
Ube1c 
44.7306 35.89686 2.52561 8.4869 0.0199 5.96128 
in KO mouse, observe embryonic lethality ~E7, with 
impaired growth of inner cell mass, inability of trophoblast 
cells to enter S phase, with ICM cells undergoing 
endoreduplication, with dysregulation of cyclin expression 
and reduced degradation of B-catenin (PMID: 11696557) 
Vash1  6.94233 6.493455 2.45056 6.43191 0.0212 3.98134 
overexpression in ovarian cancer cells causes inhibition of 
vascularization of tumor and of tumor growth (PMID: 
26460696); knockdown in cancer cells, followed by 
transplantation into mice led to significantly increased tumor 
growth and metastasis (PMID: 25797264) 
Zfp207 Bugz 74.5366 99.31389 2.50424 11.093 0.0003 8.58876 
microtubule-associated factor required for chromosome 
alignment in mitosis (PMID: 24462186, 24462187) 
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Table S6. The DNA damage response functions of 14 MIGs with significantly elevated minor intron retention in the mutant pallium. Related 
to Figure 4.6. MSI=mis-splicing index. P-values were determined by two-tailed student’s t-test. Syns=synonyms, ave=average. 
MIG Syns 
Ave 
FPKM 
Ctrl 
Ave  
FPKM  
Mut 
Ave MSI 
Ctrl 
Ave MSI 
Mut 
MSI 
P-value 
∆MSI DNA Damage Response Function Description 
Baz1b 
Wstf, 
Wbscr9, 
Wbscr10 
21.907384 25.945518 5.447441 12.41971 0.019728 13.97227 
forms nucleosome remodeling complex with ISWI 
(complex: WICH), which phosphorylates and 
maintains this phosphorylation of H2AX 
(ɣH2AX), thereby regulating important steps in 
the DNA damage response process (PMID: 
19092802) 
Ccnk 
Cpr4,  
CycK 
55.348807 5.326979 5.053107 27.09289 0.004641 22.03978 
cyclin K; when complexed with Cdk9, 
accumulates on chromatin in response to 
replication stress, and ssDNA in stressed cells 
(PMID: 20930849) 
Cep164 Nphp15 5.060874 5.324126 5.904086 30.06079 0.000429 
24.15670
1 
centrosomal protein that is phosphorylated by the 
DNA damage response proteins ATR and ATM;  
siRNA-mediated knockdown in HeLa cells results 
in reduced phosphorylation of multiple DNA 
damage response proteins and chromosome 
missegregation (PMID: 18283122) 
Cul1  41.697261 47.309440 2.804814 16.18051 0.001812 13.3757 
as part of the SCF E3 ubiquitin ligase complex, 
ubiquitinates Ku80, a component of the initiating 
complex of the NHEJ double-strand break DNA 
repair pathway, thereby regulating this complex's 
removal from DNA (PMID: 23324393) 
Cul4a  11.101313 12.071160 3.608965 15.74483 0.044297 12.13587 
cullin; ubiquitin ligase that targets Ddb1 (another 
MIG, below) and Ddb2, both of which act to 
initiate the DNA damage response, for 
ubiquitination and degradation, thereby regulating 
the DNA damage response (PMID: 19481525)  
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MIG Syns 
Ave 
FPKM 
Ctrl 
Ave  
FPKM  
Mut 
Ave MSI 
Ctrl 
Ave MSI 
Mut 
MSI 
P-value 
∆MSI DNA Damage Response Function Description 
Dna2 Dna2l 3.9216094 3.7578457 4.807850 17.42876 0.015044 12.62091 
due to 5’ to 3’ endonuclease activity, involved in 
resection extension in homologous recombination- 
mediated DNA double stranded break repair 
(PMID: 28718810) 
Ddb1 
XPE, 
DDBA, 
XAP1, 
XPCE 
86.093717 88.333331 0.461818 2.706198 0.004385 2.244381 
large subunit of DNA damage-binding complex, 
which functions in nucleotide excision repair 
(PMID: 16951172); loss of Ddb1 in mouse brain 
results in accumulation of cell cycle regulators and 
increased genomic instability, ultimately causing 
apoptosis of proliferating neuronal progenitors 
(PMID: 17129780) 
E2f1 
Rbp3, 
Rbap1, 
Rbbp3 
6.067779 6.486815 12.91249 53.23981 0.000964 40.32732 
upregulated in response to DNA damage, and 
promotes DNA damage-induced apoptosis 
(PMID: 11459832); indirectly regulates the 
transcription of the DNA damage response gene 
GADD45A (PMID: 20713352)  
Ercc5 Xpg 5.363914 6.275879 1.333767 7.642992 0.048076 6.309225 
single strand-specific DNA endonuclease 
involved in the 3' incision step of nucleotide 
excision repair (PMID: 7657672) 
Exo1 
Msa, 
Hex1 
4.4268470 4.1420745 3.731127 9.386061 0.008405 5.654934 
5’ to 3’ endonuclease involved in DNA mismatch 
repair and resection extension in homologous 
recombination-mediated DNA double stranded 
break repair (PMID: 24705021) 
Ints7  8.821004 8.814813 3.590800 13.52046 0.012655 9.929663 
recruited to sites of DNA damage and interacts 
with SSB1, a DNA damage sensor recognized by 
ATM (PMID: 21659603)  
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MIG Syns 
Ave 
FPKM 
Ctrl 
Ave  
FPKM  
Mut 
Ave MSI 
Ctrl 
Ave MSI 
Mut 
MSI 
P-value 
∆MSI DNA Damage Response Function Description 
Parp1 
Parp, 
Ppol, 
Adprt, 
Artd1, 
Adprt1 
47.879274 47.679811 0.771961 14.72329 0.002560 13.95133 
nuclear protein that promotes formation of 
poly(ADP-ribose) chains (PARylation), which 
transfers ADP-ribose group from NAD+ to target 
protein and forms a scaffold around DNA breaks, 
allowing for recruitment of essential DNA damage 
response factors (PMID: 21989215, 22431722) 
Usp10 
UBPO, 
Uchrp 
10.625277 8.050707 4.474797 17.26511 0.012563 12.79031 
after DNA damage, phosphorylated by ATM, 
resulting in Usp10 stabilization and transport to 
the nucleus, where it deubiquitylates p53, thereby 
stabilizing p53 (PMID: 20096447) 
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Table S7. Primer sequences employed in Chapter 4. 
Primer Name Primer Direction Sequence (5' to 3') 
Rnu11 cKO, 5' loxP 
Forward (primer 1) ACCCTCCCCTACTGTTTTAC 
Reverse (primer 2) AGGCTGCTACAGGATGACTC 
Rnu11 cKO, 3' loxP 
Forward (primer 3) CATGTGTTTGCTGGGAATTG 
Reverse (primer 4) CTCATGAGGCAGATCTCTGAA 
Hist1h1a expression 
Forward AGAAGAACAACAGCCGCATCAAACTGG 
Reverse CTTGGACTCAGCCTTCTTGTTCAGCTT 
Cre genotyping 
Forward TATCCAGCAACATTTGGGCCAGCT 
Reverse AACATTCTCCCACCGTCAGTACGTGA 
Emx1-Cre zygosity, 
wild-type 
Forward AAGGTGTGGTTCCAGAATCG 
Reverse CTCTCCACCAGAAGGCTGAG 
Emx1-Cre zygosity, 
mutant 
Forward GATCTCCGGTATTGAAACTCCAGC 
Reverse GCTAAACATGCTTCATCGTCGG 
Ai9 tdTomato Cre 
reporter, wild-type 
Forward AAGGGAGCTGCAGTGGAGTA 
Reverse CCGAAAATCTGTGGGAAGTC 
Ai9 tdTomato Cre 
reporter, mutant 
Forward GGCATTAAAGCAGCGTATCC 
Reverse CTGTTCCTGTACGGCATGG 
U11 expression 
Forward AAAGGGCTTCTGTCGTGAGTGGC 
Reverse CCGGGACCAACGATCACCAG 
Neat1 expression 
Forward AATTGGCCAGAAGACAACAGGGTTTGC 
Reverse GTATTCAGTGGCAAAGCACTCATGAGG 
Coa3 minor intron 
splicing 
Forward CAGTTGCAGTTTATGCGGCAGGTG 
Reverse (intronic) CTAGCCACCCTTGCTGTTTTCCCAAA 
Reverse (exonic) CAGCTTTGGCTTCATCTTCCAGCTC 
Pten minor intron 
splicing 
Forward CTCCCAGACATGACAGCCATCATCAA 
Reverse (intronic) CTACTCCCACGTTATCAGAGTGACAGAA 
Reverse (exonic) CAAGTCTTTCTGCAGGAAATCCCATAGC 
Parp1 minor intron 
splicing 
Forward AAAACCACCCCTGACCCTTCG 
Reverse (intronic) GCACACAGCATAGCCAAGAAAGG 
Reverse (exonic) AATGTACCTGGGGAGGGCAGTT 
Sfrs10 expression 
Forward AGCAGGTCTTACAGCCGAGATTATCG 
Reverse CCAAACACGCCAAGACAACAGTTG 
Spc24 expression  
Forward CTCATACCTTGCACAGAACTGGGGTT 
Reverse AATAAAAAAGAAGCTGCAGGCCAGCC 
Intergenic primers 
Forward GGATAGTTCATCTCCTGCAGGTCACAAG 
Reverse GTCCCACCCATCTAGTTTAGCATCAGC 
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Chapter 11: Appendix I 
Before I began my graduate work studying the role of minor intron splicing on CNS 
development, I pursued an independent research project in the Kanadia laboratory as an 
undergraduate, in which I sought to identify transcriptional networks underpinning mouse retinal 
development. In the process, I found that replication-dependent histone genes were differentially 
expressed in the E16 and P0 mouse retina, contradicting long-standing models about the regulation 
of these genes. In my final semester of my undergraduate education at Mount Holyoke College, I 
continued to investigate the expression of these replication-dependent histone genes across mouse 
retinal development. My findings culminated in my first publication, entitled “Replication-
dependent histone genes are actively transcribed in differentiating and aging retinal neurons,” 
which comprises the entirety of this appendix [251]. 
 
Background 
Paralogous genes are functionally related with a high degree of amino acid (AA) 
conservation, and are derived via gene duplication. The value of paralogous genes was 
conceptualized by Ohno, who proposed the idea of evolution through gene duplication [601]. The 
central idea was that when a gene duplicated, the new paralog was relieved from the pre-existing 
functional constraints and was now free to evolve novel functions [601]. Recently, a more nuanced 
interpretation of this original idea has emerged, and it suggests that the most likely outcome of 
gene duplication is an accelerated evolution of both paralogs, which in turn leads to 
subcompartmentalization of the function of the ancestral genes. This subcompartmentalization can 
be achieved by transcription regulation of these paralogs in a tissue specific manner and across 
development. A good example of paralogs is that of the histone and the snRNA genes of the major 
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spliceosome. Here the genes have duplicated as clusters of many gene copies, or isotypes, within 
a locus. The large number of paralogs in this case is thought to have evolved to meet the heavy 
demands of the cell for these proteins and snRNAs. However, a recent publication from the 
Ackerman laboratory showed that the loss of function of one of the U2 snRNA genes, called Rnu2-
8, results in ataxia and neurodegeneration [602]. This observation showed that, like protein-coding 
gene paralogs, a snRNA gene whose expression was thought to be ubiquitous was in fact 
spatiotemporally regulated. Thus, the question we sought to study was whether histone genes 
followed similar spatiotemporal transcription regulation. 
 There are five classes of histone proteins in the eukaryotic chromatin, including H2a, H2b, 
H3, H4, and H1. The core nucleosome octamer consists of two molecules of histone H2a, H2b, 
H3, and H4, around which 146 bp of left-handed superhelical DNA is wrapped in ~1.6 turns. 
Higher order structure is achieved by linking these DNA-wrapped octamers via linker histone 
called H1. In mammals each histone protein is encoded by multiple genes that are categorized into 
two major groups: replication-dependent (canonical) and replication-independent (replacement) 
histone genes [603, 604]. Here we focus on transcription regulation of replication-dependent 
histone genes that are found in three clusters: Hist1 (Chr-13), Hist2 (Chr-3) and Hist3 (Chr-11) in 
the mouse genome. An exception to this is the single replication-dependent histone Hist4h4, which 
is located on chromosome 6. In mice there are 6 paralogs for histone H1, 20 for H2a, 18 for H2b, 
12 for H3, and 13 for H4 (Table A1.1) [603].   
 Replication dependent histone genes have been shown to be actively transcribed during the 
S-phase of the cell cycle. They also generally lack introns and are not poly-adenylated [605-607]. 
Instead, their 3’ untranslated region (3’UTR) has a stem loop to which two trans-acting factors, 
stem-loop binding protein (SLBP) and U7 snRNP, bind to facilitate rapid export [606, 607]. This 
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in turn allows for rapid histone protein production necessary for a cell undergoing cell division. 
This suggests that in a developing tissue that is composed of mitotic and post-mitotic cells, 
replication-dependent histone genes are not transcribed in the post-mitotic cells. However, a recent 
publication showed that histone proteins are translated in adult neurons, which suggests that in the 
central nervous system, transcription of replication-dependent histones might not be coupled to 
cell cycle [608]. To further understand the transcriptional regulation of histones in senescent 
neurons, we employed the mouse retina as our model system. The retina is derived from the 
developing central nervous system and is composed of six neurons, including rod photoreceptors, 
cone photoreceptors, amacrine cells, bipolar cells, horizontal cells, and retinal ganglion cells. The 
retina also contains one glial cell type, called Müller glia. The retina has a stereotypic architecture 
where different cells are tiled together to form three layers, including the ganglion cell layer 
(GCL), which contains retinal ganglion cells and displaced amacrine cells; the inner nuclear layer 
(INL), which contains amacrine cells, bipolar cells, horizontal cells, Müller glia, and displaced 
ganglion cells; and the outer nuclear layer (ONL), which contains rod photoreceptors and cone 
photoreceptors. The retinal cell types are produced from the multipotent retinal progenitors in a 
stereotypic temporal sequence [609, 610]. In mice, the production of retinal neurons spans from 
embryonic day (E) 12.5 to approximately postnatal day (P) 10 followed by terminal differentiation, 
synaptogenesis, and pruning until P21 [184, 609].  
 Here, we discovered that replication-dependent histone genes were not only transcribed 
during development, but also in adult and aging retinal neurons. Similarly, the replication-
dependent histone genes of a gene family, irrespective of coding for identical or different protein 
variants, were differentially expressed during embryonic and postnatal development. Similar 
variation was observed in the single cell microarray analysis on individual retinal neurons. This 
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suggests that there is differential contribution of the various histone isotypes to the total histone 
pool that will ultimately constitute the nucleosome. This suggests the existence of a variant 
nucleosome across retinal development and among the various retinal neurons. Thus, mutations 
that lead to loss of function of one isotype might not be compensated by other histone genes. 
Indeed, this possibility was recently confirmed by a report that showed that mutations in specific 
histone genes can lead to pediatric glioblastoma [611, 612]. 
 
Results 
Deep sequencing shows differential transcription of replication-dependent histone genes 
Transcription of replication-dependent histone genes in yeast and HeLa cells has been 
shown to be synchronized to the S-phase of the cell cycle [613]. We wanted to interrogate whether 
this holds true in a developing tissue such as the retina. To this end, we mined our deep sequencing 
data from cytoplasmic extract (CE) of E16 and P0 retinae [241]. First, we interrogated the 
expression patterns of housekeeping genes, such as Actb and Gapdh, along with Pax6, which 
showed equivalent expression in both E16 CE and P0 CE (Figure A1.1A) [614-616]. Next, we 
interrogated genes that are known to shift in their expression patterns, such as Fgf15, Fgf13, Nr2e3, 
Nrl, and Rho [617-621].  We also used Xist to determine cross-contamination from the nuclear 
extract to the cytoplasmic extract. As expected, Fgf15 and Fgf13 showed higher expression at E16 
than P0, while Nr2e3 and Nrl showed expression only at P0 (Figure A1.1A), which is in agreement 
with previous reports [618-620]. Finally, Rho did not show expression at either of these time 
points, and the nuclear-specific Xist transcripts were not observed in the cytoplasmic extracts at 
either time point (Figure A1.1A). Here we found that all histone genes were not transcribed at the 
same level within and between the two time points (Figure A1.1B-F). Specifically, for H1 genes 
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Hist1h (1a and 1b) were highly expressed followed by Hist1h (1e and 1c) (Figure A1.1B). 
Hist1h1d was the lowest expressed H1 histone. As predicted, Hist1h1t was not detected (Figure 
A1.1B) in the retina as it is exclusively expressed in spermatozoa [622]. Overall, the trend for H1 
genes was higher expression in P0 CE than in E16 CE. For the H2a genes, Hist1h (2aa2, 2al, 2an, 
2ao, and 2ag) were highly expressed (Figure A1.1C). This was followed by Hist2h2ac, Hist3h2a, 
Hist1h (2ab and 2ak), Hist2h (2aa1 and 2ab), Hist1h (2ap, 2ah, 2af, 2ai, 2ae, 2ad, and 2ac) (Figure 
A1.1C). In contrast, Hist1h (2aj and 2aa) were not expressed (Figure A1.1C). Again, like H1 
genes, higher transcript levels were observed for the H2a genes in P0 CE compared to E16 CE 
(Figure A1.1B&C). For H2b genes, the highly expressed genes were Hist2h2bb, Hist1h (2bk, 2bb, 
and 2bf) followed by Hist1h (2bp and 2bc), Hist3h2ba, and Hist1h (2bj, 2bg, 2bh and 2br) (Figure 
A1.1D). The three genes Hist1h2bn, Hist2h2be, and Hist1h2bm were expressed at lower levels, 
and all three had higher expression levels in P0 CE compared to E16 CE. Finally, the H2b genes 
that were not expressed were Hist1h (2be, 2ba, 2bl, and 2bq) (Figure A1.1D). Overall, the 
expression pattern for H2b was similar to that of H2a (Figure A1.1C&D). For H3 genes, the highly 
expressed genes were Hist1h3b, Hist2h3b, and Hist1h (3i and 3h), followed by Hist1h (3g), 
Hist2h3c2, and Hist1h (h3e, h3d, 3c, 3a, and 3f), while Hist2h3c1 was not expressed (Figure 
A1.1E). Overall, most of the H3 genes had relatively higher expression levels at P0 than at E16, 
except for Hist1h3g and Hist2h3c2, which had the same expression levels at both time points 
(Figure A1.1E).  For H4 genes, Hist1h (4f, 4k, and 4m) were relatively highly expressed compared 
to Hist1h (4h, 4c, 4d, 4a, 4j, and 4b), Hist2h4, Hist4h4, and Hist1h (4n and 4i) (Figure A1.1F). 
Again, the overall expression for H4 was higher at P0 than E16. 
 
Replication-dependent histone gene isotypes encode variant proteins 
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Given that most of the histone genes were differentially expressed at E16 and P0, we 
wanted to investigate whether there are functional consequences to these dynamic expression 
patterns. To study this, we interrogated whether all of the histone paralogs encode identical 
proteins. First, we sought to arrange the amino acid (AA) sequences of each histone protein. 
Previously, primary sequence variants have been reported [603], but there have been continuous 
updates in the databases, so we revisited this analysis. Based on NCBI, Ensembl, UCSC genome 
browser, MGI, and published literature, we organized the histone genes by name and cluster (Table 
A1.1). Second, we performed multiple sequence alignments based on neighbor-joining by percent 
identity of polypeptides (Figure A1.2). All H1 polypeptide sequences diverged significantly at the 
N-terminus (1-60 AA) and C-terminus (119-223 AA), but were highly conserved from AA 60-118 
(Figure A1.2A). These sequence variations have previously been described for human H1 proteins 
[623]. The most divergent protein was Hist1h1t followed by Hist1h1a, and the most similar were 
Hist1h1d and Hist1h1e (Figure A1.2A). In the case of H2a, 9 proteins had 100% identical 
(canonical protein) AA sequence, while 10 had AA variations compared to the canonical protein 
(Figure A1.2B). Among the latter nine histone variants, Hist1h2ak and Hist1h2af differed from 
the canonical protein at S123T and A127P, respectively (Figure A1.2B). Two proteins, Hist1h2am 
and Hist1h2ah, lacked two AA residues at the end of the C-terminus compared to the canonical 
form. Four proteins, Hist1h2al, Hist2h2aa1, Hist3h2a, and Hist2h2ac, showed AA changes at 
T17S, S41A, L52M, and R100K (Figure A1.2B). Hist2h2ac also showed amino acid changes at 
H125K and G129S, and it lacked an amino acid at position K126 (Figure A1.2B). The most 
divergent polypeptides were Hist2h2ab and Hist1h2aa (Figure A1.2B). Hist2h2ab differed at 
T17S, S41A, L52M, I88V, R100G, H125K, K126P, A127G, and G129N (Figure A1.2B). 
Hist1h2aa differed from the canonical polypeptide at R4P, G5T, Q7R, A15V, T17S, K37Q, S41A, 
280 
 
E42Q, V44I, I63V, I80T, H125K, K126S, A127Q, K128T, G129K, and it also lacked a ‘K’ at 
position K130 (Figure A1.2B). For H2b, 6 proteins had 100% identical (canonical protein) AA 
sequence, while 12 proteins had variations (Figure A1.2C). For example, Hist1h2bk differed from 
the canonical polypeptide at position S126A (Figure A1.2C). Three H2b proteins, Hist1h2b (c, e, 
and g), were the same, but differed from the canonical polypeptide at position S77G (Figure 
A1.2C). Similar proteins were encoded by Hist1h2bm and Hist1h2bh, but they also differed from 
the canonical peptide at positions A5T and V20L, respectively. The rest of the H2b proteins varied 
from the canonical polypeptide at several positions, such as Hist1h2bb (A5S, V20I, and T21S), 
Hist2h2bb (E3D, A23V, and S77G), Hist3h2ba (A5S, K7R, A9T, V20I, S34G, V41I, and I96V) 
and Hist2h2be (P4L, V41I, S77N, A99S, and S126A) (Figure A1.2C). The two most distant 
polypeptides were Hist1h2bp and Hist1h2ba (Figure A1.2C), which differed from the canonical 
polypeptide at many positions. The former differed at A5V and A9V, and the latter at P4V, S8G, 
P10T, A11I, P12S, S16F, A23T, D27E, K29R, S34C, V41I, V43I, G62S, and N69T (Figure 
A1.2C). Additionally, the Hist1h2bp protein had 12 extra AA residues (ILWNKFYYLPSF) at its 
C-terminal, and Hist1h2ba had an extra AA ‘V’ at position six (Figure A1.2C). For H3, there were 
12 proteins, of which 8 were 100% identical and 4 were the same, except for a single AA change 
at S97C (Figure A1.2D). For H4, all 13 proteins were 100% identical (Figure A1.2E).     
 
Histone genes are dynamically expressed across embryonic and postnatal retinal 
development 
The various histone genes were differentially expressed at E16 and P0. Moreover, the 
proteins encoded by these genes have variations in their AA sequences. Taken together it suggested 
that expression of the different paralogs might be regulated during retinal development. To address 
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this issue, we employed qRT-PCR analysis to interrogate the transcription of specific histone 
isotypes across retinal development starting with E14, E16, E18, P0, P2, P4, P10, and P25. For 
this, we fractionated the retinae from each time point into cytoplasmic and nuclear RNA followed 
by cDNA synthesis. However, first we wanted to check the level of cross-contamination between 
the two retinal fractions. For this, we determined the expression profiles of two genes, Xist and 
Malat1, both of which are known to reside predominantly in the nucleus [356, 624, 625]. Here the 
qRT-PCR results showed that across all time points, Xist and Malat1 RNA was predominantly 
observed in the nuclear fraction (Figure A1.3A). The expression levels shown in Figure 2A were 
normalized to that of Gapdh and the values were plotted on a log scale where values below 0.001 
were considered not expressed. For Xist, expression was observed only in the nuclear fraction 
while the values for the cytoplasmic fraction were below the threshold (Figure A1.3A). Moreover, 
the primers employed for Xist were designed such that they would only detect successfully spliced 
RNAs, thereby eliminating any genomic DNA contribution. For Malat1, expression was enriched 
in the nuclear fraction, but it was also observed in the cytoplasmic fraction (Figure A1.3A). This 
is consistent with previous reports that show that Malat1 does shuttle between the two fractions, 
but is predominantly localized in the nucleus [356]. In the case of P25, levels of Xist were below 
the threshold in the nuclear fraction, which was not surprising, since the retinae used in this case 
were obtained from male mice and Xist is exclusively expressed in females. Regardless, the 
enriched levels of Malat1 in the nuclear fraction confirmed minimal contamination between the 
two fractions from P25 (Figure A1.3A). The validation of the integrity of fractions across time 
also revealed the expression kinetics of these two genes. In this case, the expression kinetics for 
Xist and Malat1 were such that mRNA levels remained relatively steady across retinal 
development. While the differences in the levels of expression of Xist can vary based on the 
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number of female retinae in the pool, the expression of Malat1 is not sex-linked. Thus, the trends 
observed for Malat1 reflected its transcription. For example, there was a ~2.5-fold higher 
expression of Malat1 in the nuclear fraction than in the cytoplasmic fraction from E14 to P0 
(Figure A1.3A). However, this difference in expression between the nuclear and cytoplasmic 
fraction was reduced at P4 and P10 followed by an increase at P25 in the NE fraction (Figure 
A1.3A).  
The expression profile of Malat1 raised another issue regarding the quality of the cDNA 
as it relates to development, i.e., whether these changes are developmental or due to variation in 
cDNA quality. To address this issue, we interrogated the expression of fibroblast growth factor 15 
(Fgf15) and rhodopsin (Rho) in all the fractions across development. Fgf15 expression is known 
to be high in embryonic development and fall during postnatal development [617], while Rho 
expression begins around P0 and increases postnatally [621]. Again, the qRT-PCR results for 
Fgf15 and Rho were as predicted. Expression of Fgf15 and Rho intersected at P2 where Fgf15 
levels were declining while levels of Rho were increasing (Figure A1.3B). For both genes, 
relatively higher levels were observed in the nuclear fraction compared to the cytoplasmic fraction, 
which was also the case for Gapdh (data not shown). Interestingly, for Rho, the expression in the 
nuclear fraction approached the threshold around E18, and Rho levels in the cytoplasmic fraction 
mirrored this at P0 (Figure A1.3B). In all, the retinal cDNA prepared had minimal cross-
fractionation contamination, and it reflected expression profiles of known retinal genes. Therefore, 
these cDNA libraries were suitable for assessing the expression of histone genes.  
Having confirmed the integrity our retinal cDNA libraries, we next sought to interrogate 
the expression kinetics of the histone genes. In order to profile histone gene expression, we selected 
several candidate genes for qRT-PCR analysis from each histone gene family that met the 
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following criteria. First, the availability of sequences to which qRT-PCR-quality primers with the 
right Tm, GC contribution, no palindromic sequences, no self-annealing, and no hairpins could be 
designed. Second, the interrogated paralogs of a specific histone family should encode a specific 
protein variant. Third, the primers for qRT-PCR should amplify only that paralog and not cross-
hybridize to other members. Based on these criteria we found a limited number of genes from each 
of the five histone families to interrogate across retinal development. For histone H1, we 
interrogated Hist1h1a, Hist1h1b, Hist1h1c, and Hist1h1e across retinal development (Figure 
A1.4A). Overall, expression of Hist1h1a, Hist1h1b, and Hist1h1e was higher during embryonic 
development compared to Hist1h1c expression, which was ~3-fold lower at E14 (Figure A1.4A). 
In contrast, the expression of Hist1h1a, Hist1h1b, and Hist1h1e declined postnatally, while that of 
Hist1h1c was higher, with peak expression observed at P4 followed by a steady decline at P10 and 
P25 (Figure A1.4A). Specifically, expression of Hist1h1a was highest at E14 followed by a steady 
decline, and its transcript levels were consistently higher in the cytoplasmic extract compared to 
the nuclear extract (Figure A1.4A). In the case of Hist1h1b, expression remained steady from E14 
to P2, followed by a precipitous fall at P4, where transcript levels in the nuclear fraction exceeded 
levels in the cytoplasmic fraction. This was followed by a steady decline at P10 and P25 (Figure 
A1.4A). Similarly, Hist1h1e expression pattern followed the trends observed for Hist1h1b during 
embryonic development, except that it was expressed at a lower level than levels of cytoplasmic 
Hist1h1b (Figure 3A). However, during postnatal development the expression of Hist1h1e peaked 
at P4, to coincide with the peak of Hist1h1c, followed by a steady decline at P10 and P25 (Figure 
A1.4A). Again, the difference in transcript levels of Hist1h1e between the nuclear and cytoplasmic 
fractions was the largest at P4 (Figure A1.4A).  
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For histone H2a, we interrogated Hist3h2a, Hist1h2ac, and Hist1h2ab across retinal 
development. Overall, the expression of Hist3h2a and Hist1h2ab was 4-fold higher than 
Hist1h2ac, except at P0, when Hist3h2a and Hist1h2ab levels were 2-fold higher (Figure A1.4B). 
Expression of both Hist3h2a and Hist1h2ab was similar in that the expression levels remained 
steady across postnatal development. Specifically, Hist3h2a expression dipped at E18, followed 
by a spike at P0, and then it remained steady during postnatal development. In contrast, expression 
of Hist1h2ab showed a steady increase in expression with a peak at P0, followed by a steady 
decline, but one that was not as drastic as the decline observed for the histone H1 genes examined 
(Figure A1.4B). Finally, transcript levels of Hist1h2ac were not observed over the threshold at any 
time (Figure A1.4B).  
For histone H2b, we interrogated Hist2h2bb, Hist2h2be, and Hist3h2ba during retinal 
development. Overall, the expression of Hist3h2ba was 1-fold higher than the expression of 
Hist2h2bb or Hist2h2be (Figure A1.4C). Specifically, Hist3h2ba expression dipped at E18 
followed by a spike at P0 and then steady decline through P4. This was followed by an increase 
from P10 to P25 (Figure A1.4C). Also, the transcript levels of Hist3h2ba were consistently higher 
in the cytoplasmic extract compared to the nuclear extract, which was not observed for Hist2h2bb 
or Hist2h2be at E16, P4, P10, and P25 (Figure A1.4C).  
For histone H3 genes, we were able to design only a single primer pair that could meet the 
aforementioned criteria, and it was for Hist2h3c2. Regardless, we designed two additional primer 
pairs, of which the first could hybridize to Hist1h3e and Hist1h3f and the second set could bind to 
all of the H3 genes. Overall, the expression of all H3s was such that it was high embryonically and 
peaked at P0, with a steady decline postnatally. Specifically, expression of Hist2h3c2 was high 
embryonically with a dip at E18, followed by a spike at P0 and a steady increase postnatally (Figure 
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A1.4D). A similar expression pattern was observed for Hist1h3e&f, albeit at a lower level (Figure 
A1.4D). Interestingly, RNA for Hist1h3e&f and Hist2h3c2 were highly enriched in the nuclear 
fraction compared to the cytoplasmic fraction, except for Hist1h3e&f at E18 (Figure A1.4D). 
Finally, for Hist2h3c2, expression was only above threshold in both nuclear and cytoplasmic 
fractions after P10 followed by increased expression at P25 (Figure A1.4D). 
For histone H4 genes, we interrogated Hist1h4a, Hist1h4d, and Hist4h4 across retinal 
development (Figure A1.4E). Overall, the expression Hist1h4a, Hist1h4d, and Hist4h4 genes 
showed the same pattern across retinal development (Figure A1.4E). Moreover, their transcript 
levels were consistently higher in the cytoplasmic extract compared to the nuclear extract, except 
for Hist4h4 at P25 when it was reversed (Figure A1.4E). Specifically, expression of all three H4 
genes, like that of Hist3h2a and Hist3h2ba, dipped at E18 followed by a spike at P0 and then a 
steady decline during postnatal development. 
For most histone genes tested by qRT-PCR, we observed that their transcript levels were 
comparatively very low at E18 and very high at P0. In order to ensure that it was not an artifact of 
RNA preparation, we further tested our fractionated RNA samples (n=3) by examining expression 
of known genes. We analyzed three genes, Nr2e3 and Nrl, which are known to be expressed at late 
embryonic and postnatal time points [618-620], and Pax6, which is known to be expressed across 
retinal development [614-616] (Figure A1.4F). As predicted, we found that Nr2e3 and Nrl 
transcript levels were very low at E14 and E16 but were considerably high from E18 onward, with 
a steady increase through all postnatal time points examined. Nuclear transcript levels were higher 
than cytoplasmic levels at E14 and E16. The Pax6 expression levels were high at E18 and low at 
P0, which further confirmed that histone expression levels were not due to artifacts of RNA 
preparation (Figure A1.4F).  
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Our qRT-PCR analysis reported the levels of histone transcripts in nuclear and cytoplasmic 
extracts across retinal development. To understand the export kinetics of histone mRNA during 
development, we further analyzed the qRT-PCR data for representative genes from each family, 
except for H3, where our primer pairs hybridized with all H3 transcripts. Here, we found that 
Hist1h1b transcripts were predominantly in the cytoplasmic extract relative to the nuclear extract, 
and the pattern continued until postnatal day 2, which is in agreement with previous reports of 
efficient histone transport (Figure A1.5A) [626]. Hist1h1b levels were also higher in the cytoplasm 
than the nucleus at P10. However, at P4 and P25, there were higher levels of transcript observed 
in the NE compared to the CE (Figure A1.5A). A similar pattern was observed for Hist3h2a, where 
the CE had higher transcript levels compared with the NE from E14 until P2 (Figure A1.5B). Like 
Hist1h1b, at P4 the ratio of Hist3h2a transcripts in the cytoplasmic and nuclear extracts began to 
shift, although not enough for the majority of transcripts to be nuclear. At P10 and P25, higher 
levels of Hist3h2a were detected in the NE compared to the CE (Figure A1.5B). This, however, 
was not the case for Hist2h2bb, where higher transcript levels in the NE were observed as early as 
E16, followed by a shift toward higher levels in the CE from E18 to P2 (Figure A1.5C. 
Interestingly, the levels in the NE were consistent with the previously mentioned histone genes in 
the postnatal retina, except that the NE levels were significantly higher than the CE levels (Figure 
A1.5C). The transcript levels for Hist1h4d were consistently higher in the CE compared to the NE 
from E14 to P25, which differed from the pattern observed for the three aforementioned histone 
genes (Figure A1.5D). Finally, we also mined our deep sequencing data for the P0 CE and P0 NE 
data [241] for these four histone genes and found that the transcript levels in the P0 CE vs. P0 NE 
were in agreement with our qRT-PCR data at P0 (Figure A1.5A-D). 
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Replication-dependent histone mRNAs are expressed in progenitor cells and retinal neurons 
during development 
The qRT-PCR analysis revealed a dynamic transcription pattern of the different histone 
genes during retinal development. However, it only revealed the presence/absence of a transcript, 
not the specific cell types of the retina that express these genes. Additionally, expression of specific 
histone genes was gradually increasing after P10 (Figure A1.4), when there are no cycling cells 
[627]. Together, it suggested that replication-dependent histone genes might not be restricted to 
dividing cells and that they might be transcribed in differentiating retinal neurons. To address this 
issue, we employed section in situ hybridization (ISH) across retinal development starting with 
E14, E16, E18, P0, P3, P7, and P14 using probes specifically designed for Hist1h1c, Hist1h2ab, 
Hist3h2ba, Hist1h3a, and Hist4h4. However, given the similarity of the nucleotide sequences 
among the paralogs of a given histone family, three of the probes tested here, Hist1h2ab, 
Hist3h2ba, and Hist1h3a, would cross-hybridize to the transcripts of other members of that family 
(Table A1.4).  
 
H3 ISH:  At E14, ISH analysis showed expression of H3 in progenitor cells toward the 
peripheral retina and asymmetric enrichment toward the vitreal side of the developing retina 
(Figure A1.6A’&A’’). At E16, expression of H3 in progenitor cells continued in the outer 
neuroblastic layer (ONBL). Again, expression of H3 in the peripheral retina was enriched 
asymmetrically toward the vitreal side of the retina (Figure A1.6B&B’). In addition, H3 expression 
was observed elsewhere in the brain (Figure A1.6B’’). At E18, expression of H3 in progenitor 
cells continued in the ONBL across the whole retina (Figure A1.6C). Moreover, the ISH signal for 
H3 was enriched in cells asymmetrically toward the apical end of the retina (Figure A1.6C’&C’’), 
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where the retinal progenitor cells undergo the M-phase of their cell cycle [165, 184]. A similar 
expression pattern was observed elsewhere in the brain, where the signal was enriched 
asymmetrically in a sub-population of cells (Figure A1.6D&D’), possibly either in M-phase or 
exiting the cell cycle. During postnatal development, H3 mRNA was again observed in 
proliferating progenitor cells, and the ISH signal was enriched toward the lower part of the ONBL 
at P0 and P3 (Figure A1.6E&F). Specifically, at P0, H3 mRNA was highly enriched in the central 
retina compared to the peripheral retina (Figure A1.6E’&E’’). At P3, the signal was highly 
enriched in the periphery compared to the central retina. The latter was in agreement with the 
decrease in progenitor population in the center compared to the periphery (Figure A1.6F’&F’’). 
At P7, H3 ISH signal was enriched in progenitor cells in the peripheral retina; however, in the 
central retina, its expression was asymmetrically enriched in the GCL and amacrine cells of the 
INL (Figure A1.6G-G’’). Finally, at P14, H3 expression was enriched in the INL across the whole 
retinal section with very little signal observed in the photoreceptor layer (Figure A1.6H).  
 
Hist1h1c ISH: At E14, Hist1h1c mRNA was enriched in progenitor cells toward the peripheral 
retina and there the mRNA was enriched asymmetrically toward the vitreal side of the developing 
retina (Figure A1.7A-A’’).  A similar expression pattern was observed elsewhere in the brain, 
where it was asymmetrically enriched in a small population of cells (Figure A1.7A’’’). At E16, 
expression of Hist1h1c in progenitor cells continued as it was observed in the ONBL where 
progenitor cells reside, but not in the newly formed GCL (Figure A1.7B). Again, expression of 
Hist1h1c in the peripheral retina was enriched asymmetrically toward the vitreal side of the retina 
(Figure A1.7B’&B’’). Moreover, Hist1h1c was also observed toward the apical end in cells evenly 
distributed across the whole retinal section. Like E14, expression of Hist1h1c at E16 was also 
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observed elsewhere in the brain and was highly expressed in a subpopulation of cells (Figure 
A1.7B’’’). At E18, Hist1h1c expression was observed in progenitor cells and was also enriched in 
the peripheral retina, but it was toward the apical end of the retina (Figure A1.7C-C’’). During 
postnatal development, Hist1h1c expression was enriched in proliferating progenitor cells, and the 
ISH signal was enriched toward the lower part of the ONBL at P0 (Figure A1.7D). Specifically, 
expression level was higher in the periphery compared to the central retina, which was in 
agreement with the decrease in progenitor population in the center compared to the periphery 
(Figure A1.7D’&D’’). This trend continued at P3 and P7 (Figure A1.7E&F), except that at P7, 
expression was also observed in cells that were most likely bipolar cells, based on their localization 
(Figure A1.7F’&F’’). Finally, at P14, expression of Hist1h1c was observed in the outer plexiform 
layer and in photoreceptor cells, which were most likely rods and cone photoreceptors (Figure 
A1.7G).     
 
Hist4h4 ISH: At E14, ISH analysis showed expression of Hist4h4 in progenitor cells with 
enrichment of signal in puncta toward the apical end in the peripheral retina (Figure A1.8A-A’). 
Similar expression was observed at E16, except the puncta observed at E14 in the periphery were 
now observed across the entire retina (Figure A1.8B&B’). Again, like H3, expression of Hist4h4 
was observed in specific brain regions, where cells appeared to be migrating away from the 
dividing progenitor pool (Figure A1.8B’’&B’’’). At E18, expression was again observed in 
progenitor cells in the ONBL, except the puncta observed at E16 were not observed (Figure 
A1.8C&C’). Elsewhere in the brain, cells expressing Hist4h4 all appeared to be migrating (Figure 
A1.8C’’&C’’’). At P0, expression was highly enriched in progenitor cells (Figure A1.8D), and the 
pattern continued at P3 with a central to peripheral gradient (Figure A1.8E-E’’). At P7, Hist4h4 
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ISH signal was enriched in few cells of the INL, which, by their location, were most likely 
amacrine cells and also toward the apical part of the ONL (Figure A1.8F). The cells in the apical 
end of the ONL, by their position, were most likely differentiating photoreceptors (Figure A1.8F). 
Finally, at P14, robust Hist4h4 expression was observed in all of the retinal neurons (Figure 
A1.8G-G’’). 
 
H2a ISH: Section ISH showed that H2a mRNA was not restricted to progenitor cells during 
embryonic development at E14, E16, and E18 (Figure A1.9A-C). Expression at E18 appeared to 
be highly enriched in differentiating neurons and in cells at the apical end, which might be RPE 
cells and/or cells at the M-phase of the cell cycle (Figure A1.9C’&C’’). Expression in ganglion 
cells continued at P0 (Figure A1.9D&D’), but was not observed at P3, where only the progenitor 
cells showed H2a expression (Figure A1.9E). Specifically, at P3, H2a mRNA was highly enriched 
in the peripheral retina compared to the central retina (Figure A1.9E’&E’’). This is in agreement 
with the decrease in progenitor population in the center compared to the periphery. At P7 and P14, 
H2a ISH signal was observed in all three layers of retina but was enriched in the GCL and some 
cells in the INL, which were possibly horizontal cells based on their location (Figure A1.9F&G).  
H2b ISH: Section ISH of H2b gene showed a similar trend to that of H2a (Figure A1.9&10). At 
E14, H2b gene expression was enriched in progenitor cells, but the mRNA was again 
asymmetrically enriched toward the vitreal side and the apical side of the developing retina (Figure 
A1.10A-A’’). The apical enrichment is likely in the RPE cells. A similar pattern was observed at 
E16, where expression of H2b in progenitor cells was observed in the ONBL and was enriched in 
the newly formed GCL (Figure A1.10B-B’’). At E18, ISH signal for H2b was enriched in the 
ONBL compared to the GCL (Figure A1.10C-C’). During postnatal development, H2b mRNA was 
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again observed in proliferating progenitor cells that reside in the ONBL at P0 and P3 (Figure 
A1.10D&E). Specifically, at P0, H2b mRNA was highly enriched in the periphery compared to 
the central retina (Figure A1.10D’&D’’), while at P3, few cells showed expression in a central to 
peripheral gradient (Figure A1.10E-E’’). At P7, H2b ISH signal was enriched in few cells of the 
INL, which, by their location, are most likely horizontal cells (Figure A1.10F). Like H2a, H2b 
ISH signal was observed in all three layers of retina but was enriched in the GCL and some cells 
in the INL at P14 (Figure A1.10G). 
 
Replication-dependent histone genes are differentially expressed among the different cell 
types of the retina 
ISH analysis revealed expression of the different histone genes in subtypes of 
differentiating retinal neurons. Therefore, we sought to investigate whether the histone isotypes 
are differentially expressed among the different neurons at the same developmental time point. For 
this, we mined the published single-cell microarray data from the Cepko laboratory [242, 628-
630]. This analysis showed differential expression of the histone isotypes in single neurons 
profiled at different developmental stages starting at E12 through adult (Figure A1.11). First, 
ganglion cells from E12, E13, E14, E15, E16, and P0 showed large variation in the subtype of 
histone genes that were expressed. For example, Hist2h2ab was expressed in most of the 
embryonic ganglion cells and P0, but not in the ganglion cell from E16. In contrast, expression of 
Hist1h2be was observed in the E16 ganglion cell, but not in the E14 or E15 ganglion cells. Similar 
variation was observed in amacrine and bipolar cells (Figure A1.11). The most dramatic expression 
pattern was observed in the adult cone photoreceptor, in which expression of isotypes for all 
histone families except H4 was observed. In this cone photoreceptor, expression of specific histone 
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isotypes, such as Hist2h2bb, was observed, but this was not the case for Hist1h2bp (Figure A1.11). 
Expression of histone genes was significantly different in the adult rod photoreceptor compared to 
the adult cone photoreceptor in that very few histone isotypes were expressed in both, including 
Hist1h1c and Hist1h3a. Interestingly, the same histone isotypes were not observed in a developing 
rod photoreceptor cell from P5, which showed expression of Hist2h2ab, Hist1h2bp, and 
Hist1h2be, which were absent in the adult rod photoreceptor cell (Figure A1.11). Finally, 
expression of H1, H2a, and H2b was observed in the P13 Müller glial cell, while expression of H3 
and H4 isotypes was not observed. The microarray utilized for single-cell profiling does not have 
probe sets for every histone isotype. The data obtained for the subset of histone genes showed 
dynamic patterns of expression of histone genes among retinal neurons across time.  
 
Replication-dependent histone genes are transcribed in the aging retina 
Our qRT-PCR analysis showed that replication-dependent histone genes are differentially 
transcribed in the retina long after cell proliferation has stopped (Figure A1.4). Specifically, genes 
such as Hist2h3c2, Hist1h2ab, and Hist1h1c showed upward trends in expression at P25 (Figure 
A1.4B-D). This observation was further confirmed by our in situ analysis, which showed 
expression of histone genes in differentiating neurons (Figures A1.6-A1.10). Together, this 
suggested that the transcription of replication-dependent histone genes might continue throughout 
aging. To study this, we mined our microarray data obtained from retinae starting with P12, 5 
weeks (w), 8w, 9w, 25w, 40w, and 75w. First, we organized the microarray values for the histone 
genes within the context of the values obtained for genes with known expression patterns, such as 
Rho, Nrl, Nr2e3, Pax6, Gapdh, and Fgf15 (Figure A1.12). The values for these genes were used 
as boundaries to define categories of histone genes that were expressed at high, intermediate, and 
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low levels. The histone genes that were highly expressed included Hist1h2bc, Hist3h2a, and 
Hist1h1c, in that order, and were flanked by the expression values for Rho and Pax6 (Figure 
A1.12). The histone genes that were expressed at intermediate levels included Hist3h2ba, 
Hist2h2aa1, Hist2h3c1, and Hist2h2be, in that order, and were flanked by the expression values 
for Pax6 and Gapdh. Hist1h4h, Hist1h2be, Hist1h3d, Hist2h2bb, Hist1h2bp, Hist1h1t, Hist1h4i, 
and Hist1h3i were expressed at low levels and were flanked by the expression values for Gapdh 
and Fgf15, which has been reported to be turned off in the adult retina [617]. Thus, the genes with 
values below that of Fgf15, such as Hist1h4i, Hist1h1e, and Hist1h4f, were considered not 
expressed (Figure A1.12). Most histone genes showed steady expression across time, except for 
Hist1h3d and Hist2h2bb, which showed an increase in expression at 75w. Surprisingly, Hist1h1t, 
which has been reported to be a spermatozoa-specific histone, was expressed at 75w [622] (Figure 
A1.12).  
 
mTOR-mediated regulation of cyclins D1 and E is decoupled in retinal neurons 
Our data thus far suggest that the transcription of replication-dependent histones is decoupled from 
cell cycle, which implies that neurons might lose histones due to chromatin remodeling and, as a 
result, there is active histone transcription in aging neurons. However, there is a second possibility: 
that replication-dependent histone transcription is being driven by the accumulation of cyclins in 
these aging neurons. Elevated expression of cyclins E, D, A, and B has been observed in 
differentiated neocortex neurons, and recent cell culture experiments have also shown that cyclins 
D1 and E accumulate in senescent cells [631, 632]. Previous studies have described a relationship 
between cyclin E and replication-dependent histone transcription, mediated by Cdk2 and Npat. In 
this pathway, cyclin E, when bound to Cdk2, activates the protein Npat, which then initiates the 
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transcription of replication-dependent histones [633]. Thus, senescence-driven cyclin E 
accumulation could drive replication-dependent histone expression in post-mitotic cells. Before 
testing this possibility, it is necessary to define “senescence.” In a senescent cell, its cell cycle is 
arrested and growth-promoting pathways, such as mTOR, remain active. As a result, the cell loses 
its ability to proliferate entirely. In a quiescent cell, the cell cycle is arrested, but growth-promoting 
pathways are inactive [634]. Based on these definitions, neurons are senescent, as they have not 
been shown to have the potential to enter cell cycle and also possess an active mTOR pathway 
[635, 636]. In cell culture, Leontieva et al. were able to show that treatment with rapamycin, an 
inhibitor of the mTOR pathway, resulted in a reduction in cyclins D1 and E [632]. Given that 
cyclin E interacts with Cdk2 to activate Npat, a transcription factor that regulates histone 
transcription, we reasoned that mTOR inhibition in neurons might decrease transcription of 
replication-dependent histones. To test this idea, we treated adult mice with rapamycin or carrier 
for 5 days by IP injections. The retinae were harvested, and both protein and RNA were generated 
from these samples. To confirm the effectiveness of rapamycin in the inhibition of mTOR, we 
interrogated the phosphorylation of S6K, a key target of mTOR activity. We saw loss of S6K 
phosphorylation in rapamycin-treated to untreated samples, suggesting the effective 
downregulation of mTOR activity (Figure A1.13A). This was followed by qRT-PCR analysis on 
cDNA prepared from rapamycin-treated and untreated samples for cyclin D1 (Ccnd1), cyclin E1 
(Ccne1), cyclin E2 (Ccne2), and Npat (Table A1.3). Here, we found no significant change in 
transcript levels for all four tested genes in the treated and untreated samples (Figure A1.13B). 
This suggested that in the adult retina, inhibition of mTOR by rapamycin did not significantly alter 
transcription of targets observed in cell culture experiments. This result, in turn, predicted that we 
would not observe changes in replication-dependent histone transcription between the treated and 
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untreated samples. To test this idea, we only selected histones that showed active transcription in 
the postnatal retina and performed qRT-PCR on cDNA from treated and untreated samples. We 
tested two histone genes from each histone type. Hist1h1a and Hist1h1c were selected from the 
H1 histones, Hist1h2ab and Hist3h2a were selected from the H2a histones, Hist2h2be and 
Hist3h2ba were selected from the H2b histones, and Hist1h4a and Hist4h4 were selected from the 
H4 histones. For the H3 histones, we used the all H3s primer pair and the primer pair for 
Hist2h3c2. For all 10 histones tested, none showed a significant difference in normalized fold 
expression between the treated and untreated samples (Figure A1.13C-G). To determine whether 
there is a change in cyclins during aging, we also interrogated our microarray data and found that 
Ccnd1, Ccne1, and Ccne2 remain relatively steady in expression, except for a slight inversion in 
Ccnd1 and Ccne1 where, at 75 weeks, Ccnd1 is upregulated while Ccne1 is further downregulated 
(Figure A1.13H). 
 
Discussion 
The clustered organization of the different replication-dependent histone genes for the five 
different histone families has been thought to play a vital role in synchronized transcription of 
these genes to the S-phase of the cell cycle [603, 613].  However, our deep sequencing data showed 
that not all histone genes are transcribed simultaneously at the same levels in either E16 or P0 
retinae. This is in agreement with a recent report by Singh et al., which showed that H2A genes 
are differentially transcribed in cancer cells [637]. This suggests that histone genes within clusters 
are also differentially transcribed and regulated during retinal development. For example, we did 
not observe expression of specific histone genes, such as Hist1h2aa (H2a), Hist1h2bq (H2b), and 
Hist2h3c1 (H3) (Figure A1.1C-E). We also did not observe the expression of the spermatozoa-
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specific histone Hist1h1t (Figure A1.1B) [622, 638].  Thus, it is possible that these histone genes 
are expressed in other tissues and/or in the retina at a different time point. The utilization of a 
subset of histone genes within a family that encode a specific histone can have developmental 
consequences, since these subsets of genes encode different protein variants (Figure A1.2). For 
example, Hist2h2bb was expressed at a much higher level than Hist1h2bn (Figure A1.1D), which 
suggests that, of the two, Hist2h2bb is the predominant H2b protein in the nucleosome octamer. 
Amino acid sequence alignment of these two proteins shows that Hist2h2bb differs from 
Hist1h2bn at E3D, A23V, and S77G (Figure A1.2C). Thus, the constituent H2b proteins of the 
nucleosome at these developmental time points are a mix of different H2b variants. Similarly, 
differential expression of H2a and H3 family members was also observed, along with amino acid 
sequence variations for the different protein variants (Figure A1.1C&E). For H4 histone genes, the 
expression kinetics of the different isotypes were not different, which was expected, since all of 
the H4 family members encode for proteins that are 100% identical (Figures A1.1F and A1.2E). 
Interestingly, all of the H1 histone genes that are expressed in the retina show a great degree of 
variation in their amino acid sequences (Figure A1.2A). Thus, the H1 variant that is used as the 
linker for the nucleosome octamers could impact higher-order chromatin organization, which in 
turn could influence gene expression. In all, our data suggest that the nucleosome at a specific 
developmental time can be composed of an assortment of histone variants for H1, H2a, H2b, and 
H3.  
The differential contribution of the different histone isotypes to the production of the 
nucleosome during development was further confirmed by our qRT-PCR analysis across retinal 
development. This observation was underscored by the expression kinetics of Hist1h1c compared 
to that of Hist1h1b (Figure A1.4A). Specifically, Hist1h1b was expressed ~3-fold higher than 
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Hist1h1c from E14 to P2, at which point Hist1h1b expression began to decline while Hist1h1c 
expression spiked (Figure A1.4A). This suggests that two genes within the same cluster must be 
controlled by a higher-order regulatory mechanism. Since these two genes encode for different H1 
histone variants, our qRT-PCR data suggest a dynamic switch in the expression of the gene 
contributing to the linker protein between P2 and P4. This observation is coincident with the 
initiation of terminal differentiation and the decline of the progenitor cell population, which was 
further reflected in our ISH results (Figure A1.7) [627]. Here we observed expression of Hist1h1c 
at P14 in differentiating photoreceptor cells (Figure A1.7G). The expression of Hist1h1c in 
photoreceptor cells is in accord with a recent publication that showed that Hist1h1c regulates the 
condensation of chromatin in rod photoreceptor cells [639].  
Similarly, for H2a, we observed dynamic expression of Hist3h2a and Hist1h2ab, which 
encode different H2a variants. For example, at E18, the expression of Hist1h2ab was elevated, 
while that of Hist3h2a expression was significantly lower (Figure A1.4B). This difference in 
expression suggests differential contribution of these two genes toward the production of the H2a 
proteins incorporated into the nucleosome. This phenomenon is also observed at later time points, 
suggesting the existence of variant nucleosomes throughout retinal development. For H2b, H3, 
and H4, the expression of all genes examined showed similar patterns in that they all showed a dip 
in expression at E18, followed by a spike at P0 (Figure A1.4C-E). This suggests the possibility of 
the existence of a regulatory mechanism that represses transcription of histone at a very critical 
time in development, i.e., birth. The drop in transcription prior to birth was specific to these histone 
genes, as genes with known expression profiles, including Nr2e3, Nrl, and Pax6 [614-616, 618-
620], and other histone genes, such as Hist1h1b and Hist1h2ab, did not show a drop in expression 
at E18 (Figure A1.4A,B&F). Moreover, for all five histone protein families, specific genes showed 
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an upward trend in expression levels between P10 and P25 (Figure A1.4). For example, all 
examined H2a genes and Hist2h3c2 showed an increase in expression between P10 and P25 
(Figure A1.4B). Given that there are no progenitor cells dividing at this stage, expression of these 
replication-dependent histone genes must occur in differentiating neurons. Indeed, like Hist1h1c 
(Figure A1.7), our ISH results showed expression of H3 and H2b in bipolar, amacrine, and 
ganglion cells in the P14 retina (Figure A1.6&A1.10). Similarly, expression of Hist4h4 was 
observed in newly differentiating photoreceptors at P7, and then it was panretinal, i.e., in all retinal 
layers, at P14 (Figure A1.8). The expression of all the histone genes tested by qRT-PCR and ISH 
strongly suggests the continued expression of replication-dependent histone genes in 
differentiating neurons.  
Another important feature of replication-dependent histone genes is that their mRNA is 
efficiently transported to the cytoplasm. Histone transcripts do not have a poly-A tail; instead, their 
3’ UTR has a hairpin loop structure to which trans-acting factors, such as SLBP and U7 snRNA, 
bind and mediate export [613]. This efficient export mechanism affords dividing cells the ability 
to produce large amounts of histone proteins [613]. Indeed, our observation of higher transcript 
levels in the CE compared to the NE during early retinal development for the histone genes 
examined is in agreement with this idea. However, during postnatal development starting with P4, 
there were higher transcript levels in the NE compared to the CE for most of the histone genes 
examined (Figure A1.5). This is coincident with a decrease in progenitor cell population and the 
initiation of retinal differentiation [627]. Thus, it is possible that the histone transcript export might 
be regulated like that of other protein-coding transcripts in differentiating neurons, as the demand 
for histones might be lower than for a progenitor cell. Another possibility is that the turnover of 
the histone transcripts in the CE increases in differentiating neurons compared to turnover in 
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progenitor cells. In either case, our results show a dynamic shift in histone mRNA transport and 
turnover between progenitor cells and neurons. 
In all, we observed differential spatiotemporal expression of histone isotypes encoding 
different histone variants in the developing retina. Based on this, here we propose a model of a 
variant nucleosome that consists of histone variants of H1, H2a, and H2b. This model does not 
include H3, even though H3 has two different replication-dependent protein variants, because our 
primer pairs do not distinguish transcripts from genes that encode these two variants. In this model, 
for the four tested genes in the H1 family, we propose that the mRNA contribution shifts from 
predominantly Hist1h1b and Hist1h1a during embryonic development to Hist1h1c and Hist1h1e 
after P4 (Figures A1.4A&A1.14A). Interestingly, for H2a, of the three genes we examined, the 
predominant contribution across development was observed for Hist1h2ab (Figures 
A1.4B&A1.14B). However, the overall percentage of Hist1h2ab and Hist3h2a changed over time. 
Similarly, for H2b, the predominant contribution across development was observed for Hist3h2ba, 
and the overall percentage of Hist3h2ba, Hist2h2bb, and Hist2h2be changed over time (Figures 
A1.4C&A1.14C). It must be noted that the model we propose is only based on the genes we were 
able to interrogate via qRT-PCR. However, one could imagine that the complexity of this model 
would increase significantly if the expression of all the isotypes were considered across 
development.  
Our model predicts variant nucleosomes across time, but our ISH results also suggested 
that variant nucleosomes might exist among the different retinal cell types at a given time point. 
Indeed, interrogation of the single-cell microarray data supports this possibility, as cell type-
specific expression of histone isotypes is observed. For example, Hist1h1c, which was expressed 
in photoreceptor cells according to ISH (Figure A1.7), showed high expression in the two adult 
300 
 
rod and cone photoreceptor cells, while expression was not observed in ganglion and amacrine 
cells from E12, E13, E14, E15, E16, and P0 (Figure A1.11). In contrast, Hist3h2a was observed 
in all of the single cells tested, except for the ganglion cell at P0 and the adult rod photoreceptor 
(Figure A1.11). This dataset further confirms the possibility of variant nucleosomes within the 
different neurons of the retina, which in turn could inform the specific transcriptome profiles 
necessary for the differentiation/function of these neurons.  
The persistent expression of the replication-dependent histone isotypes post-development 
was an intriguing observation, which was further confirmed by our microarray analysis of the 
aging retina. Here, we found a subset of histone genes that were expressed at levels above Gapdh 
and Pax6, suggesting high demand for these histone protein variants (Figure A1.12). The 
decoupling of the transcription of a subset of replication-dependent histones and cell cycle 
warrants a change in the nomenclature for these specific histone isotypes. While these isotypes are 
linked to cell cycle early in development, their transcriptional regulation in neurons suggests 
independent mechanisms of regulation, one in progenitor cells and the other in neurons. Another 
possibility is that the transcription of this subset of genes is regulated similarly to the other histones 
in progenitor cells, except that they are not turned off in neurons. The specific pathway that ensures 
the transcription of this subset of histones in neurons is also not directly linked to the mTOR 
pathway that, in neurons, is shown to operate other biological processes, such as neuromodulation 
[636, 640]. One possibility is that the age-related changes in the chromatin require exchange of 
these histones, as has been described for replacement histones [641, 642], except that here we show 
a similar phenomenon for replication-dependent histones. Indeed, recent reports show that while 
some histone proteins are long-lived, such as H3.3, others, including H2a and H2b, are actively 
translated [608]. 
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The significance of our findings is that replication-dependent histone genes are actively 
transcribed in non-dividing cells, i.e., neurons. Moreover, we show that there is dynamic 
expression of the different isotypes, which might contribute to the production of a variant 
nucleosome within cell types across time. This suggests that the histone function is 
subcompartmentalized by the differential transcription regulation of the various paralogs. This in 
turn might inform chromatin organization and transcriptional profiles of the different retinal cell 
types. Indeed, recent publications show that single point mutations at the amino acids that are 
specific to histone variants cause cancers, such as carcinoma of the endometrium, large intestine, 
lung, and breast tissue and lymphoid neoplasm of hematopoietic and lymphoid tissue (Table A1.6) 
[642, 643]. Recent publications further underscore the importance of investigating specific 
replication-dependent histone genes [611, 612]. Here, they found that a point mutation in either 
H3F3A, a replacement histone gene, or HIST1H3B, a replication-dependent histone gene, was 
observed in nearly 80% of pediatric diffuse intrinsic pontine gliomas (DIPGs) and 22% of non–
brain stem gliomas. In addition, a recent study showed that siRNA knockdown of replication-dependent 
HIST1H2AC gene leads to the increased rates of cell proliferation and tumorigenicity [637]. These 
findings, along with our observation of the continued expression of replication-dependent histone 
genes in retinal neurons across development and aging, show the need to further investigate the 
regulation of the different replication-dependent histone isotypes.  
 
Materials and Methods  
Animal Procedures  
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All experiments used CD1 mice from Charles River Laboratory, MA. All mice procedures were 
compliant with the protocols approved by the University of Connecticut’s Institutional Animal 
Care and Use Committee (IACUC). 
Fractionation and cDNA Preparation  
CD1 mice retinae were collected at different developmental time points. Retinal RNA 
isolation was performed using the Thermo Scientific NE-PER Nuclear and Cytoplasmic Extraction 
Kit (Thermo Fisher Scientific, 78833*) with the following modifications. Approximately 20 
retinae at E14, E16, E18, and P0; 8-15 retinae at P2 and P4; 6-8 retinae at P10 and P14; and 2-4 
retinae at P25 were used for fractionation. The retinae were harvested in PBS pH 7.4 and washed 
once in a microfuge tube followed by centrifugation at 4° C for 30 seconds. After aspirating the 
PBS out of the tube, the retinae were resuspended in 500 µL of CER-I reagent from the NE-PER 
kit followed by the addition of 5 uL 1M DTT and 10 µL of RNase Inhibitor (Roche, 03335402001). 
The retinae were then vortexed for 15 seconds at room temperature followed by incubation on ice 
for 10 minutes. Subsequently, 27.5 uL of Cer-II (NE-PER Kit) was added followed by vortexing 
for 5 seconds and incubation on ice for 1 minute. The lysed retinae with intact nuclei were then 
centrifuged at 14,000 rpm for 10 minutes at 4° C. The supernatant, which was the cytoplasmic 
extract, was then mixed with 500 uL of TRIzol followed by RNA preparation as per the 
manufacturer’s instructions. The nuclei were obtained as a pellet, which was resuspended in 500 
uL of TRIzol followed by sonication to lyse the nuclei. This step was followed by RNA preparation 
as per the manufacturer’s instructions. 1 μg of retinal RNA was used for cDNA synthesis [644]. 
Deep Sequencing 
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Fractionated cytoplasmic RNA of E16 and P0 retinal time points was used for RNAseq on 
the Illumina HighSeq 2000 platform, as described in [241]. 
qRT-PCR  
qRT-PCR was performed in 20 μL reactions containing 30 pmol of each primer, 1 μL of 
diluted (1:100) cDNA template, and 10 μL of SsoFastTM EvaGreen® Supermix (Bio-Rad, 172-
5203) using the CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad, 185-5195). All 
reactions were formed in triplicate by using qRT-PCR protocol as seen in Table A1.2. Xist and 
Malat1 primers were used to validate cDNA fractionation. Primers for Fgf15, Rho, Nr2e3, Nrl, 
and Pax6 were used to verify cDNA quality. Primers for 16 histone genes across all five histone 
groups were designed to examine histone expression trends throughout development (Table A1.3). 
Gapdh was used for normalization, as suggested by a recent publication for retina [645]\. The 
analysis was performed by the 2(-delta delta Cq) method [646].  
In situ Hybridization  
Sixteen μm cryosections of CD1 mouse heads (for embryonic time points) and retinae (for 
postnatal time points) were used for in situ hybridization as previously described [242]. Five DIG-
labeled antisense probes against Hist1h1c, Hist1h2ab, Hist3h2ba, Hist1h3a, and Hist4h4 mRNA 
were created from PCR amplified product. Each probe was created by adding T7 and SP6 sites 
onto their respective qRT-PCR primer sequences (Table A1.4). To determine probe specificity, 
we performed BLAST analysis. We found that except for the H1 and H4 probes, H3, H2a, and 
H2b probes can hybridize with various histone isotypes within their families (Table A1.5).  
Microarray 
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Three to four retinae from each time point were used for RNA extraction with TRIzol, as 
per the manufacturer’s instructions (Invitrogen, 15596-026). A minimum of three arrays were 
analyzed per time point, including P12, 5 weeks (w), 8w, 9w, 25w, 40w, and 75w. The microarray 
platform utilized and the bioinformatics analysis performed were the same as described previously 
[647]. The microarray platform did not include probes for all histone isotypes.  
Rapamycin Treatment 
Rapamycin (LC Laboratories) stock was diluted at 10 mg/mL in 50% ethanol. For intra-
peritoneal injections, the stock was further diluted to 2.5 mg/mL in 50% ethanol. Adult (9 week) 
CD1 mice (n=4) were injected daily with rapamycin at a concentration of 3 µg/g body weight for 
5 days. Control mice (n=3) were injected with equivalent volumes of 50% ethanol. Retinae were 
harvested 5 hours after the fifth injection.  
Protein and RNA Extraction 
Retinae were dissected in ice-cold 1x PBS. From each mouse, one retina was placed in 250 
µL of TRIzol (Life Technologies), and the other was sonicated in 100 µL RIPA buffer containing 
protein and phosphatase inhibitors (Roche; cOmplete: protease inhibitor cocktail; and PhosStop: 
phosphatase inhibitor cocktail). RNA extraction was performed according to the manufacturer’s 
instructions. The sonicated sample was centrifuged at 10,000 RPM for 10 minutes at 4°C, and the 
supernatant was collected into a fresh tube. 
Western Blot Analysis 
Protein extracts (10 µg) were resolved on a 4-20% Tris-Glycin gradient gel (BioRad), 
followed by immunoblot analysis, as described previously [253]. The following primary antibodies 
were used: rabbit α-pS6240/244 (1:1000; Cell Signaling) and rabbit α-S6 (1:1000; Cell Signaling). 
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Appendix I: Figures and Tables 
 
Figure A1.1. Expression of replication-dependent histone genes by deep sequencing analysis. 
Shown here are the heat maps representing the FPKM values converted to log2. (A) Expression of 
genes with known expression kinetics in E16 and P0 CE. Expression of H1 isotypes (B), H2a 
isotypes (C), H2b isotypes (D), H3 isotypes (E), and H4 isotypes (F) in E16 and P0 CE. Shown in 
the box in the top right corner is the key representing the expression levels ranging from 12 (blue) 
to 0 (yellow). 
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Figure A1.2. Multiple amino acid sequence alignment of all histone families. ClustalW was 
employed to generate the images. Shown on left are the gene names with sequences that are 
identical shown in blue background, while the changes are indicated by white boxes. Amino acid 
sequences of all H1 (A), H2a (B), H2b (C), H3 (D), and H4 (E) proteins in mouse. The 5 AA 
residues at the N-terminal of Hist1h2al were not annotated in the MGI database.   
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Figure A1.3. Validation of fractionation/quality of cDNA. Shown here are graphs representing 
expression values determined by qRT-PCR analysis, with the x-axis showing different time points 
at which the retinae were harvested. The y-axis is in log scale showing gene expression levels 
normalized to Gapdh values. Here the error bars represent the standard error of the mean. Dashed 
lines indicate expression levels of the genes tested in the nuclear fraction, while the solid lines 
represent expression in the cytoplasmic fraction. (A) Normalized expression of Xist (gray) and 
Malat1 (black) across all time points and fractions. (B) Normalized expression of Rho (gray) and 
Fgf15 (black) across all time points and fractions.  
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Figure A1.4. Histone mRNA expression across retinal development and fractions as 
determined by qRT-PCR analysis. Shown here are graphs representing expression values 
determined by qRT-PCR analysis, with the x-axis showing different time points at which the 
retinae were harvested. The y-axis is in log scale showing gene expression levels normalized to 
Gapdh values. Here the error bars represent the standard error of the mean. Dashed lines indicate 
expression levels of the genes tested in the nuclear fraction, while the solid lines represent 
expression in the cytoplasmic fraction. (A) Normalized expression of four H1 histone genes, 
including Hist1h1a (blue), Hist1h1b (black), Hist1h1e (green), and Hist1h1c (red). (B) Normalized 
expression of three H2a histone genes, including Hist3h2a (red), Hist1h2ac (blue), and Hist1h2ab 
(black). (C) Normalized expression of three H2b histone genes, including Hist2h2bb (red), 
Hist3h2ba (blue), and Hist2h2be (black). (D) Normalized expression of H3 histone genes, 
including all H3 histone genes (red), Hist1h3e and Hist1h3f (black), and Hist2h3c2 (blue). (E) 
Normalized expression of H4 histone genes, including Hist1h4d (red), Hist4h4 (black), and 
Hist1h4a (blue). (F) Additional validation of cDNA preparation across retinal development 
interrogated by the expression of Nr2e3 (red), Nrl (black), and Pax6 (green).
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Figure A1.5. Transcript levels of replication-dependent histone genes in CE vs. NE fractions. The values observed in qPCR analysis 
shown in Figure 4 were employed to generate pie charts to reflect histone transcript levels in CE and NE fractions. One histone from 
each family was selected for this analysis across retinal development: (A) Hist1h1b, (B) Hist3h2a, (C) Hist2h2bb, and (D) Hist1h4d. 
Shown in the far right column are the pie charts generated from deep sequence from P0 CE and NE for these genes.
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Figure A1.6. Spatiotemporal expression analysis by in situ hybridization for all H3 histone mRNA across retinal development. 
In situ hybridization with DIG-labeled anti-sense RNA probe detecting all H3 histone mRNA across retinal development from E14 to 
P14. (A) All H3 histone mRNA in situ signal in E14 section including the brain and retina. (A’) and (A’’) are magnified images of the 
boxes around the retina in (A) and (A’), respectively, and (A’’’) is a magnified image of the box around the brain in (A). (B) All H3 
histone mRNA in situ signal in E16 section including the brain and retina. (B’) and (B’’) are magnified images of the boxes around the 
retina and brain (B), respectively. (C) All H3 histone mRNA in situ signal in E18 retinal section. (C’), (C’’), and (C’’’) are magnified 
images of the boxes in the central retina in (C), the peripheral retina in (C), and the peripheral retina in (C’’), respectively. (D) All H3 
histone mRNA in situ signal for E18 brain section. (D’) is a magnified image of the box in (D). (E) All H3 histone mRNA in situ signal 
in P0 retinal section. (E’) and (E’’) are magnified images of the boxes in the peripheral and central retina in (E), respectively. (F) All 
H3 histone mRNA in situ signal in P3 retinal section. (F’) and (F’’) are magnified images of the boxes around the peripheral and central 
retina in (F), respectively. (G) All H3 histone mRNA in situ signal in P7 retinal section. (G’) and (G’’) are magnified images of the 
boxes around the peripheral and central retina in (G), respectively. (H) All H3 histone mRNA in situ signal in P14 retinal section.
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Figure A1.7. Spatiotemporal expression analysis by in situ hybridization for Hist1h1c across retinal development. In 
situ hybridization with DIG-labeled anti-sense RNA probe detecting Hist1h1c across retinal development from E14 to P14. (A) Hist1h1c 
in situ signal in E14 section including the brain and retina. (A’), (A’’), and (A’’’) are magnified images of the boxes around the retina 
in (A), the retina in (A’), and the brain in (A), respectively. (B) Hist1h1c in situ signal in E16 section including brain and retina. (B’), 
(B’’), and (B’’’) are magnified images of the boxes around the retina in (B), the peripheral retina in (B’), and the brain in (B), 
respectively. (C) Hist1h1c in situ signal in E18 section including brain and retina. (C’) and (C’’) are magnified images of the boxes 
around the retina in (C) and the peripheral retina in (C’), respectively. (C’’’) Hist1h1c in situ signal in the brain at E18. (D) Hist1h1c in 
situ signal in P0 retinal section. (D’) and (D’’) are magnified images of the central and peripheral retina from (D), respectively. (E) 
Hist1h1c in situ signal in P3 retinal section. (E’) and (E’’) are magnified images of the central and peripheral retina from (E), 
respectively. (F) Hist1h1c in situ signal in P7 retinal section. (F’) and (F’’) are magnified images of the central and peripheral retina 
from (F), respectively. (G) Hist1h1c in situ signal in P14 retinal section. 
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Figure A1.8. Spatiotemporal expression analysis by in situ hybridization for Hist4h4 mRNA 
across retinal development. In situ hybridization with DIG-labeled anti-sense RNA probe 
detecting Hist4h4 mRNA across retinal development from E14 to P14. Hist4h4 mRNA in situ 
signal in the peripheral (A) and central (A’) retina in E14 retinal section. (B) Hist4h4 mRNA in 
situ signal in E16 retinal section. (B’) is a magnified image of the box around the retina in (B). 
(B’’) Hist4h4 mRNA in situ signal in E16 brain section. (B’’’) is a magnified image of the box in 
(B’’). (C) Hist4h4 mRNA in situ signal in E18 retinal section. (C’) is a magnified image of the box 
in (C). (C’’) Hist4h4 mRNA in situ signal in E18 brain section. (C’’’) is a magnified image of the 
box in (C’’). (D) Hist4h4 mRNA in situ signal in P0 peripheral retinal section. (E) Hist4h4 mRNA 
in situ signal in P3 retinal section. (E’) and (E’’) are magnified images of the boxes around the 
peripheral and central retina in (E), respectively. (F) Hist4h4 mRNA in situ signal in P7 retinal 
section. Hist4h4 mRNA in situ signal in P14 peripheral (G) and central (G’) retinal section. (G’’) 
is a magnified image of the box in (G’). 
 
  
313 
 
 
Figure A1.9. Spatiotemporal expression analysis by in situ hybridization for H2a histone 
mRNA across retinal development. In situ hybridization with DIG-labeled anti-sense RNA 
probe detecting H2a histone across retinal development from E14 to P14. (A) H2a histone in situ 
signal in E14 retinal section. (A’) is a magnified image of the box around the retina in (A). (B) 
H2a histone in situ signal in E16 retinal section. (B’) is a magnified image of the box around the 
retina in (B’). (C) H2a histone in situ signal in E18 retinal section. (C’) and (C’’) are magnified 
images of the boxes around the central and peripheral retina in (C), respectively. (D) H2a histone 
in situ signal in P0 retinal section. (D’) is a magnified image of the box around the retina in (D). 
(E) H2a histone in situ signal in P3 retinal section. (E’) and (E’’) are magnified images of the 
boxes around the peripheral and central retina in (E), respectively. (F) H2a histone in situ signal 
in P7 retinal section. (G) H2a histone in situ signal in P14 retinal section.
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Figure A1.10. Spatiotemporal expression analysis by in situ hybridization for H2b histone 
mRNA across retinal development. In situ hybridization with DIG-labeled anti-sense RNA 
probe detecting H2b histone across retinal development from E14 to P14. (A) H2b histone in situ 
signal in E14 retinal section. (A’) and (A’’) are magnified images of the boxes around the 
peripheral and central retina in (A), respectively. (B) H2b histone in situ signal in E16 retinal 
section. (B’) and (B’’) are magnified images of the boxes around the peripheral and central retina 
in (B), respectively. (C) H2b histone in situ signal in E18 retinal section. (C’) is a magnified image 
of the box around the retina in (C). (D) H2b histone in situ signal in P0 retinal section. (D’) and 
(D’’) are magnified images of the boxes around the central and peripheral retina in (D), 
respectively. (E) H2b histone in situ signal in P3 retinal section. (E’) and (E’’) are magnified 
images of the boxes around the central and peripheral retina in (E), respectively. (F) H2b histone 
in situ signal in P7 peripheral retinal section. (G) H2b histone in situ signal in P14 retinal section.
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Figure A1.11. Cell type-specific expression of histone genes by single-cell microarray 
analysis. Shown here is a heat map (blue = high, yellow = low) reflecting expression of different 
histone genes within specific cells at different time points (embryonic and postnatal). GC = 
ganglion cell, AC = amacrine cell, BP = bipolar cell, MG = Müller glia.  
316 
 
 
Figure A1.12. Expression of replication-dependent histone genes in the aging retina. Shown 
here is the heat map reflecting expression values (blue = high, yellow = low) of histone transcripts 
as observed by microarray analysis. Genes with known expression kinetics in the retina were used 
to contextualize the expression of the histone genes and are shown in red.  
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Figure A1.13. Cyclin and histone transcription in rapamycin-treated retinae. (A) Validation 
of rapamycin treatment shown by immunoblot analysis, using rabbit α-pS6240/244 (1:1000; Cell 
Signaling) antibody. Total S6 detected by rabbit α-S6 (1:1000; Cell Signaling) antibody used as 
the loading control. (B) Shown are normalized fold expression changes as detected by qPCR 
analysis in untreated (ctrl) and rapamycin-treated (rap) for Ccnd1, Ccne1, Ccne2, and Npat. 
Normalized fold expression of the various histone genes in ctrl and rap detected by qRT-PCR for 
Hist1h1a, Hist1h1c (C); Hist1h2ab, Hist3h2a (D); Hist2h2be, Hist3h2ba (E); Hist2h3c2, all H3s 
(F); and Hist1h4a and Hist4h4 (G). All qRT-PCR values for ctrl (n=3) and rap (n=4) were first 
normalized to the geometric mean of Gapdh values, followed by averaging and two-tailed t-test, 
which showed no statistical significance for all values shown. (H) Gapdh, Ccnd1, Ccne1, and 
Ccne2 expression levels detected in the microarray analysis of the aging retina.  
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Figure A1.14. Variant nucleosome model. Shown here is the schematic of DNA wrapped around 
the core octamer and connected to the linker histone. Shown here are pie charts reflecting the total 
mRNA contributions (qRT-PCR data) of the different histone isotypes to the total RNA of that 
histone family across retinal development. (A) Relative contributions of Hist1h1a (blue), Hist1h1b 
(red), Hist1h1e (green), and Hist1h1c (purple) to the production of the linker histone H1 across 
retinal development. (B) Relative contributions of Hist1h2ab (green), Hist3h2a (blue), and 
Hist1h2ac (red) to the production of the core histone H2a across retinal development. (C) Relative 
contributions of Hist3h2ba (red), Hist2h2bb (blue), and Hist2h2be (green) to the production of the 
core histone H2b across retinal development.  
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Table A1.1, Mouse replication-dependent histone genes organized by type and cluster. 
Histone 
Type 
Gene Cluster Locus 
(Cluster Name) 
Histone Genes 
H1 Chromosome 13 (Hist1) 
Hist1h1a 
Hist1h1b 
Hist1h1c 
Hist1h1d 
Hist1h1e 
Hist1h1t 
 
H2A 
Chromosome 13 (Hist1) 
Hist1h2aa 
Hist1h2ab 
Hist1h2ac 
Hist1h2ad 
Hist1h2ae 
Hist1h2af 
Hist1h2ag 
Hist1h2ah 
Hist1h2ai 
Hist1h2aj 
Hist1h2ak 
Hist1h2al 
Hist1h2an 
Hist1h2ao 
Hist1h2ap 
Chromosome 3 (Hist2) Hist2h2aa1 Hist2h2aa2 Hist2h2ab Hist2h2ac 
Chromosome 1 (Hist3) Hist3h2a    
H2B 
Chromosome 13 (Hist1) 
Hist1h2ba 
Hist1h2bb 
Hist1h2bc 
Hist1h2be 
Hist1h2bf 
Hist1h2bg 
Hist1h2bh 
Hist1h2bj 
Hist1h2bk 
Hist1h2bl 
Hist1h2bm 
Hist1h2bn 
Hist1h2bp 
Hist1h2bq 
Hist1h2br 
Chromosome 3 (Hist2) Hist2h2bb  Hist2h2be  
Chromosome 1 (Hist3) Hist3h2ba    
H3 
Chromosome 13 (Hist1) 
Hist1h3a 
Hist1h3b 
Hist1h3c 
Hist1h3d 
Hist1h3e 
Hist1h3f 
Hist1h3g 
Hist1h3h 
Hist1h3i 
 
Chromosome 3 (Hist2) Hist2h3b Hist2h3c1 Hist2h3c2  
H4 
Chromosome 13 (Hist1) 
Hist1h4a 
Hist1h4b 
Hist1h4c 
Hist1h4d 
Hist1h4f 
Hist1h4h 
Hist1h4i 
Hist1h4j 
Hist1h4k 
Hist1h4m 
Hist1h4n 
Chromosome 3 (Hist2) Hist2h4 
Chromosome 6 (Hist4) Hist4h4 
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Table A1.2. qRT-PCR protocol used. 
Step Number Temperature Time Number of Cycles 
Step 1 95°C 3 minutes 1 
Step 2 95°C 10 seconds  
40 Step 3 60°C 30 seconds 
Step 4 65°C 30 seconds 1 
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Table A1.3. Full qRT-PCR Primer List. 
Gene Primer Direction Primer Sequence 
Ccnd1 
Forward 5’-CTGCCGAGAAGTTGTGCATCTACACT-3’ 
Reverse 5’-CAGGTTCCACTTGAGCTTGTTCACCA-3’ 
Ccne1 
Forward 5’-GGGCAATAGAGAAGAGGTTTGGAGGA-3’ 
Reverse 5’-GCCAATCCAGAAGAACTGCTCTCATC-3’ 
Ccne2 
Forward 5’-AAGTGTGAGTCCAGTGAAGCTGAAGAC-3’ 
Reverse 5’-CCTCCATTACACACTGGTGACAGCT-3’ 
Fgf15 
Forward 5'-AGATATACGGGCTGATTCGCTACTCG-3' 
Reverse 5'-GCTTGGCCTGGATGAAGATGATATGG-3' 
Hist1h1a 
Forward 5’-AGAAGAACAACAGCCGCATCAAACTGG-3’ 
Reverse 5’-CTTGGACTCAGCCTTCTTGTTCAGCTT-3’ 
Hist1h1b 
Forward 5’-TCTCCCGCCAAGAAGAAGACAACGAA-3’ 
Reverse 5’-CTCCTTAGAGGCAGAAACAGCCTTAG-3’ 
Hist1h1c 
Forward 5'-GCGTCTAAAGCCGTAAAGCCAAAGG-3' 
Reverse 5'-TCGAGTCCCTTGCAACCTTGCTTCATT-3' 
Hist1h1e 
Forward 5’-CCAAGAAGAGCACCAAGAAGACTCCA-3’ 
Reverse 5’-TTAGTTGCCTTTGCCTTCTTCGGGCT-3’ 
Hist1h2ab 
Forward 5’-AACGACGAGGAGCTCAACAAGCTG-3’ 
Reverse 5’-CTTGTGGTGGCTCTCGGTCTTCTT-3’ 
Hist1h2ac 
Forward 5’-GCAGCTGAGAATGACTGTGGACTACTGA-3’ 
Reverse 5’-GCACAGTGATATCAGACTTCGTAAGCCC-3’ 
Hist3h2a 
Forward 5’-TGACTGCTGAGATCCTGGAATTGGCTG-3’ 
Reverse 5’-TTGTTGAGCTCCTCGTCGTTGCGGAT-3’ 
Hist2h2bb 
Forward 5’-GGTCTACCTTACGTTGCATCTTTAGACGC-3’ 
Reverse 5’-TTTCGTGACAGCTTTCTTAGAGCCCTTCT-3’ 
Hist2h2be 
Forward 5’-TGTGTACAAAGTGCTGAAGCAGGTGC-3’ 
Reverse 5’-AGAAGCCTCGTTTGCTATGCGCTCAA-3’ 
Hist3h2ba 
Forward 5’-TACTCCATCTACGTGTACAAGGTGCTG-3’ 
Reverse 5’-CGATGCGCTCGAAGATGTCATTGACG-3’ 
all H3s 
Forward 5’-ACTTCAAGACCGACCTGCGCTT-3’ 
Reverse 5’-ATGATGGTGACACGCTTGGCGT-3’ 
Hist1h3e&f 
Forward 5’-TGTCACCATCATGCCCAAGGACAT-3’ 
Reverse 5’-TTTGGTGGATAATGGAGGTGGCTC-3’ 
Hist2h3c2 
Forward 5’-CACATTATCCCGCTCCATAGCTCTAG-3’ 
Reverse 5’-CAAGCTAGGAGTCTGAATAAGACCGC-3’ 
Hist1h4a 
Forward 5’-GATAACATCCAGGGCATCACCAAG-3’ 
Reverse 5’-TCACGTTCTCCAGGAACACCTTCA-3’ 
Hist1h4d 
Forward 5’-AAGGGTCTTGGTAAGGGTGGTGCTAA-3’ 
Reverse 5’-AACACCTTCAGCACACCACGGGTCT-3’ 
Hist4h4 Forward 5’-TTTCCTTGAGAATGTGATCCGCGACG-3’ 
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Reverse 5’-TTGAGCGCGTACACCACGTCCATA-3’ 
Malat1 
Forward 5'-TTTGCATTGGACTTGAGCTGAGGTGC-3' 
Reverse 5'-TTCCTAGCTTCACCAAACTGGCTTCG-3' 
Npat 
Forward 5’-TGCCAAGATAACTCTCCACTGCAGAG-3’ 
Reverse 5’-CAACAGACGCTGCATCATTAGAGAGCTG-3’ 
Nr2e3  
Forward 5'-CCTGGTCCTCTTCAAACCTGAAACAC-3' 
Reverse 5'-TGAGCCTTGCTATGCTGGCTTAGCAT-3' 
Nrl 
Forward 5'-GGCAGTAGTCTCAACTGTGTCACACA-3' 
Reverse 5'-TCTTGAGGAGACCATTAGACCTGCCA-3' 
Pax6 
Forward 5'-GGAGTGAATCAGCTTGGTGGTGTCTT-3' 
Reverse 5'-TGGAGTCGCCACTCTTGGCTTACT-3' 
Rho 
Forward 5'-GAGAATCACGCTATCATGGGTGTGGT-3' 
Reverse 5'-GCTTGAGTGTGTAGTAGTCAATCCCG-3' 
Xist 
Forward 5'-TTTGTGCTCCTGCCTCAAGAAGAAG-3' 
Reverse 5'-AATAGGTCGCCAGCACTGCAAA-3' 
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Table A1.4. In situ probe primer table. 
 
  
Primer 
Name 
Gene Primer Sequence (5’-3’) 
All H3s All H3s F: TAAATCCACTGTGATATCGACTTCAAGACCGACCTGCGCTT 
R: ATTATGCTGAGTGATATCTCGTGTGTGGCTCTGAAAAGAGCCT 
H1C Hist1h1c F: 
TAAATCCACTGTGATATCGCGTCTAAAGCCGTAAAGCCAAAGG 
R: 
ATTATGCTGAGTGATATCCACAAGCAGGGCGGAACTTTCAAATC 
Hist4h4 Hist4h4 F: 
TAAATCCACTGTGATATCAAGCATCAGAAAGGAGCTGTGGACAT 
R: ATTATGCTGAGTGATATCTGCCCTCATTCAGGTCCACTGTCT 
Hist1h2ab Hist1h2ab F: TAAATCCACTGTGATATCAACGACGAGGAGCTCAACAAGCTG 
R: 
ATTATGCTGAGTGATATCGGGTGGCTCTGAAAAGAGCCTTTGTT 
Hist3h2ba Hist3h2ba F: 
TAAATCCACTGTGATATCTACTCCATCTACGTGTACAAGGTGCTG 
R: 
ATTATGCTGAGTGATATCGAGCTGGTGTATTTGGTGACTGCCTT 
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Table A1.5. BLAST alignment percent identity (%age of match) from alignment of the 
individual in situ probe sequences to the relevant histone genes. 
Probe Gene %age of match 
All H3s 
Hist1h3a 100 
Hist1h3h 98 
Hist1h3g 97 
Hist1h3i 97 
Hist1h3f 95 
Hist1h3c 95 
Hist1h3b 95 
Hist1h3e 94 
Hist1h3d 94 
Hist2h3c1 92 
Hist2h3c2 92 
Hist2h3b 92 
Hist4h4 Hist4h4 100 
H2a 
Hist1h2ab 100 
Hist1h2ai 100 
Hist1h2ac 99 
Hist1h2ae 99 
Hist1h2ag 99 
Hist1h2ad 99 
Hist1h2ak 99 
Hist1h2ao 98 
Hist1h2ap 98 
Hist3h2a 98 
Hist1h2ah 100 
Hist1h2af 97 
Hist1h2an 97 
Hist2h2aa2 94 
Hist2h2aa1 94 
Hist1h2aa  97 
H2afx  96 
H2afj 97 
Hist2h2ac 97 
H2b 
Hist1h2bl 96 
Hist1h2br 94 
Hist1h2bq 94 
Hist1h2bp 94 
Hist1h2bb 94 
Hist1h2bn 94 
Hist1h2bf 94 
Hist1h2bg 94 
Hist1h2bc 93 
Hist1h2bh 93 
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Hist1h2bk 93 
Hist1h2be 96 
Hist1h2bm 93 
Hist1h2bj 93 
Hist1h2ba 90 
Hist2h2be 89 
Hist2h2bb 86 
H1C Hist1h1c 100 
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Table A1.6. Carcinoma-linked mutations in replication-dependent histone genes. 
 
  
Gene  Mutation: 
CDS 
Mutation: 
AA 
Disease  Tissue  Protein 
Domain  
Zygosity  Ref  
HIST1H2AA  10C>T  R4  Carcinoma  Endometrium 
Large Intestine  
N-
Terminal  
Heterozygous   NA  
HIST2H2BE  c.11C>T 
   
P4L  Carcinoma  Lung  
Breast  
N-
Terminal  
Unknown 
Heterozygous  
(642) 
HIST1H1D  c.75G>A 
   
p.K25K 
   
Lymphoid 
neoplasm  
Haematopoietic 
and Lymphoid 
Tissue  
N-
Terminal  
Unknown 
   
NA  
 HIST1H1E  c.74G>C 
   
p.R25P  
   
Carcinoma  Lung  N-
Terminal  
Unknown NA  
HIST1H1B  c.80A>G 
   
p.K27R 
   
Carcinoma  Large Intestine  N-
Terminal  
Heterozygous  NA  
HIST1H1A c.38C>T 
   
p.A13V 
   
Carcinoma  Endometrium  N-
Terminal  
Heterozygous  NA  
HIST1H1C  c.540G>A 
   
p.A180A 
   
Carcinoma  Lung 
Ns  
   Heterozygous  (643) 
HIST1H1B  
   
 c.410C>G 
   
p.A137G 
   
Lymphoid 
neoplasm  
Haematopoietic 
And Lymphoid 
Tissue 
   
   Unknown 
   
(642)  
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